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The PhD project has implemented flow crystallisation / self-assembly methods compatible with 
Diamond beamlines.  Specifically, monitoring of continuous crystallisation processes by a 
range of synchrotron radiation techniques have been developed in a series of in situ 
experiments, using bespoke crystallisers optimised for operation on the beamlines at the 
Diamond Light Source (DLS). 
The technique of in situ X-ray diffraction (XRD) is applied to the continuous segmented flow 
crystallisation of highly polymorphic and pharmaceutically relevant model systems: Urea 
barbituric acid (UBA), carbamazepine (CBZ) and paracetamol (PCM). The cooling 
crystallisation processes yield crystalline powder and single crystals grown in situ within 
solution slugs in the flow crystallisation platforms KRAIC-D and KRAIC-S respectively. As a 
result of the steady-state operation employed in these crystallisers, events that evolve with time, 
such as polymorphic transitions and crystal growth, can be monitored. The KRAIC-D and 
KRAIC-S platforms were installed and data captured at the high-resolution powder diffraction 
beamline I11 and the small molecule single crystal beamline I19 respectively.  
Chapter 1 contains a review of the literature of in situ XRD characterisation and flow 
crystallisation processes, which considers current limitations and opportunities for further 
investigation. The literature review provides context and builds towards the research project 
aims and objectives presented at the end of the first chapter. These objectives are targeted at 
the use of in situ XRD characterisation to provide additional insight to the pathway of 
crystallisation processes, which is unobtainable from offline analysis. In Chapter 2, the theory 
behind the analytical techniques used are described. In Chapter 3, the experimental methods 
implemented in this research project to achieve these research goals are reported.  
Chapter 4 applies the synchrotron powder XRD technique at I11 in the study of the cooling 
crystallisation processes of UBA and CBZ in the KRAIC-D. In addition to unseeded 
crystallisations, investigation into the introduction of a controlled solid interface in the form of 
seeds of polymorphic purity introduced at pre-nucleation and post-nucleation stages is 
investigated. The use of integrated intensity values at various set-points along the length of the 
KRAIC-D provides an approach to investigate crystal growth. Engineering advances have been 
made to the KRAIC-D platform, allowing for optimisation to the crystallisation processes 
under investigation, as well as data capture capabilities. Significant advances to the data 
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analysis of this in situ powder XRD data have been achieved. Chapter 5 applies the synchrotron 
single crystal XRD technique at I19 in the study of the cooling crystallisation of PCM in the 
KRAIC-S. Seeding of the metastable PCM form II is investigated. Data processing in 
CrysAlisPro investigated the degree of crystals rotation with respect to the instrument. 
Comparison of single crystals grown in situ with single crystals of known crystal size, 
facilitated crystal sizing predictions of single crystals within the KRAIC-S. An automated data 
processing strategy using DIALS has also been devised, which allows data processing to be 
triggered after data acquisition. Chapter 6 explores crystal engineering for materials discovery 
of the profen family; co-crystallisation is investigated as an approach to improve 
physicochemical properties of profen targets. In addition to the discovery of new profen co-
crystals, the study looks at accessing the multi-component materials via a wide range of 
crystallisation methods, as well as encompassing structural characterisation and property 
determination. Chapter 7 investigates in situ XRD monitoring of the slurrying crystallisation 
process of the IBU-ISO co-crystal discovered by crystallisation in Chapter 6. 
In Chapter 8, conclusions from the findings in Chapters 4 to 7 are pulled together and patterns 
explored. Drawing on these overall findings, some suggestions for future work are also made.  
In addition to the academic discovery achieved in this work, this PhD project contributes to the 
vision of the EPSRC National Centre in Continuous Manufacturing and Advanced 
Crystallisation (CMAC) and the Diamond Light Source. CMAC is an academic-industrial 
consortium, aimed at advancing the adoption of continuous manufacturing into the 
pharmaceutical industry. Diamond Light Source is the UK’s national synchrotron science 
facility, which allows scientific research advances to be made, which extend beyond the 
capabilities of standard laboratory facilities. The significant synchrotron component of this 
project, which has advanced previous data collection and processing capabilities, provides a 
demonstration and offers additional potential to the beamtime experiments that can be 
investigated by synchrotron users in the future. Furthermore, the KRAIC-D and KRAIC-S 
crystallisation platforms developed in this PhD project can be used by Diamond users in the 



















There are a number of people I would like to acknowledge for their contributions, both academic 
and personal, in helping me reach this milestone. 
First, I would like to thank Professor Chick Wilson for offering me this fantastic opportunity to 
study for a PhD in Chemistry joint between the University of Bath and the Diamond Light 
Source synchrotron in Didcot. Chick’s advice, expertise and guidance throughout my PhD and 
MChem studies has been invaluable and most memorable. Chick, I am forever grateful for all 
you have done for me. 
Second, a massive thank you to my co-supervisor Dr. Karen Robertson for all your help, 
tenacity, detailed guidance, knowledge sharing and feedback. I have learnt so much and in 
working together, I have really developed my scientific thinking. Thank you also for providing 
feedback on my thesis.  
Third, a huge thank you to my co-supervisor Dr. Mark Warren for all his help, guidance, 
knowledge sharing and feedback on the KRAIC-S work. I have thoroughly enjoyed developing 
data processing methods together and have learnt so much from working alongside you.   
Fourth, to my great external collaborator Dr. Mark Levenstein, thank you for sharing your data 
processing expertise. I really enjoyed working together at the University of Leeds and at 
Diamond beamtimes. 
The rest of the Wilson group have also been a constant support; in addition to their combined 
knowledge, their willingness to help and answer my never-ending questions has created a great 
learning environment for me. The support network for my Master’s project was made complete 
by Dr. Lauren Agnew, a great foundation for starting my PhD studies. I have had the opportunity 
to carry out experiments at a number of facilities during my PhD including at the Diamond Light 
Source, on Beamlines I11 and I19, and at the Advanced Light Source on Beamline 12.2.1. I 
would also like to thank everyone who was a part of one of our beamtime teams or provided 
beamline support. For the KRAIC-D beamtimes: Dr. Karen Robertson, Dr. Mark Levenstein, 
Dr. Pierre-Baptiste Flandrin, Dr. Daniel Scott, Dr. Ruth Lunt and Pollyanna Payne. For the 
KRAIC-S beamtimes: Dr. Mark Warren, Dr. Karen Robertson, Dr. Daniel Scott, Pollyanna 
Payne, Dr. Lauren Hatcher and Dr. Lucy Saunders. For the in situ slurrying beamtimes: 
Pollyanna Payne and Dr. Lauren Hatcher. 
v 
 
Thank you to my Diamond supervision team: Dr. Dave Allan, Prof. Chiu Tang, Dr. Sarah Day 
and Dr. Mark Warren, for all your expertise and guidance in such an amazing working 
environment at the Diamond Light Source synchrotron. Thank you to the Research Complex at 
Harwell for the laboratory space to carry offline KRAIC-D runs, which was particularly 
beneficial in the run up to beamtimes.  
Thank you to Dr. Thomas McGlone and Dr. Alan Martin for their support and help during my 
week at the University of Strathclyde and an additional thank you to Alan for continuing to take 
measurements on my behalf, once I had returned to Bath.  
As a joint CMAC-Bath-Diamond PhD student, thanks go to the EPSRC Future Manufacturing 
Hub in Continuous Manufacturing and Advanced Crystallisation (CMAC) and Diamond Light 
Source for funding. Thank you to CMAC also for the opportunity to complete the Doctoral 
Training Centre in Continuous Manufacturing and Advanced Crystallisation. The intensive 
pharmaceutical training programme at the University of Strathclyde, comprising chemical 
engineering, pharmaceutical sciences and operations management including supply chain, was 
a fantastic learning opportunity and really heightened my interest in the pharmaceutical 
industry. Thank you to Dr. Mei Lee at GSK for being my mentor, I have hugely benefited from 
our Skype conversations about my project. 
To the fantastic friends I have made including, Maria, Connie, Amelia, Ruth, Dan, Polly, Dan, 
Alex, Piba, Lauren, Aneesa, Lauren, Beth, Clare, Emma, Adam, Lucy, Stephen, Mark and Ben.  
Finally, Mum, Dad and Jodie, your continual support and encouragement is so important, thank 
you so much. Mum and Dad, the fantastic opportunities you have given me during my 








Table of Contents  
Abstract ....................................................................................................................................... i 
Acknowledgements ................................................................................................................... iv 
Table of Contents ...................................................................................................................... vi 
List of Figures ........................................................................................................................ xvii 
List of Tables ................................................................................................................... xxxviii 
List of Abbreviations .............................................................................................................. xlv 
Chapter 1 – Introduction ....................................................................................................... 1 
1.1 Context of Research .................................................................................................... 1 
1.2 Types of Crystalline Compounds ..................................................................................... 1 
1.2.1 Polymorphism ............................................................................................................ 2 
1.2.1.1 Thermodynamics of Polymorphism ................................................................... 3 
1.2.2 Solvates ...................................................................................................................... 5 
1.2.3 Salts ........................................................................................................................... 5 
1.2.4 Co-crystals ................................................................................................................. 6 
1.2.4.1 Crystal Engineering and Multi-Component Crystallisation .............................. 6 
1.2.5 Intermolecular Interactions in the Solid State ........................................................... 8 
1.2.5.1 Hydrogen Bonding ............................................................................................. 8 
1.2.5.2 Supramolecular Synthons and the Cambridge Structural Database (CSD) ....... 9 
1.3 Crystallisation................................................................................................................. 10 
1.3.1 Solubility and Supersaturation................................................................................. 11 
1.3.2 Nucleation ................................................................................................................ 13 
1.3.3 Crystal Growth ........................................................................................................ 16 
1.3.4 Crystal Morphology ................................................................................................. 19 
1.3.5 Crystallisation Methods ........................................................................................... 20 
1.3.5.1 Evaporative Crystallisation .............................................................................. 20 
vii 
 
1.3.5.2 Cooling Crystallisation .................................................................................... 21 
1.3.5.3 Seeded Crystallisation ...................................................................................... 22 
1.3.5.4 Anti-solvent Crystallisation ............................................................................. 22 
1.3.5.5 Reactive Crystallisation ................................................................................... 23 
1.3.5.6 Slurrying Crystallisation .................................................................................. 23 
1.3.5.7 Mechanochemical Crystallisation .................................................................... 25 
1.3.6 Continuous Manufacturing ...................................................................................... 26 
1.3.7 Flow Chemistry and Flow Crystallisation ............................................................... 28 
1.3.7.1 Residence Time (RT) ....................................................................................... 29 
1.3.7.2 Steady-State Operation .................................................................................... 30 
1.3.7.3 Mixing, Mass and Heat Transfer ..................................................................... 31 
1.4 Aims of Research ........................................................................................................... 34 
Chapter 2 – Theory of Diffraction Methods ....................................................................... 36 
2.1 X-ray Crystallography .................................................................................................... 36 
2.1.1 The Crystal .............................................................................................................. 36 
2.1.2 The Unit Cell ........................................................................................................... 36 
2.1.3 Crystal Symmetry .................................................................................................... 38 
2.1.4 Lattice Planes ........................................................................................................... 39 
2.2 Diffraction of X-rays by crystals .................................................................................... 39 
2.2.1 Generation of X-rays ............................................................................................... 39 
2.2.2 Scattering of X-rays by crystallographic planes ...................................................... 40 
2.2.3 The Reciprocal Lattice ............................................................................................. 41 
2.2.4 The Ewald construction ........................................................................................... 43 
2.2.5 Scattering of X-rays by atoms ................................................................................. 44 
2.2.6 A single crystal diffraction experiment ................................................................... 45 
2.3 Crystal structure determination using X-ray diffraction ................................................ 46 
2.3.1 Pattern geometry ...................................................................................................... 46 
viii 
 
2.3.1.1 Unit cell determination .................................................................................... 46 
2.3.1.2 Symmetry and Space Group determination ..................................................... 46 
2.3.2 Reflection intensities ............................................................................................... 47 
2.4 Crystal structure refinement ........................................................................................... 49 
2.4.1 Constraints and Restraints ....................................................................................... 50 
2.5 Powder X-ray Diffraction (PXRD) ................................................................................ 51 
2.6 Synchrotron Crystallography ......................................................................................... 52 
2.6.1 Synchrotron Radiation at Diamond Light Source (DLS) ........................................ 52 
Chapter 3 – Experimental Techniques and Instrumentation .............................................. 54 
3.1 Materials ......................................................................................................................... 55 
3.2 Solubility and Metastable Zone Width (MSZW) Measurements................................... 55 
3.2.1 Turbidity .................................................................................................................. 56 
3.2.2 Visual Observation .................................................................................................. 57 
3.3 Crystallisation Methods.................................................................................................. 58 
3.3.1 Evaporative Crystallisation ...................................................................................... 59 
3.3.2 Mechanochemical Crystallisation ............................................................................ 59 
3.3.3 Slurrying Crystallisation .......................................................................................... 60 
3.3.3.1 Multi-component Slurrying Experiments ........................................................ 60 
3.3.3.2 Competitive Slurrying ...................................................................................... 61 
3.3.4 Cooling Crystallisation ............................................................................................ 61 
3.3.4.1 Batch Cooling Crystallisation .......................................................................... 61 
3.3.4.2 Continuous Cooling Crystallisations in the KRAIC / KRAIC-D / KRAIC-S 
platforms ...................................................................................................................... 62 
3.3.5 Seeded Cooling Crystallisation ............................................................................... 68 
3.4 Analytical Methods ........................................................................................................ 69 
3.4.1 Powder X-Ray Diffraction (PXRD) ........................................................................ 69 
3.4.2 Single Crystal X-ray Diffraction (SCXRD) ............................................................ 72 
ix 
 
3.4.2.1 Optical Microscopy .......................................................................................... 73 
3.4.3 Differential Scanning Calorimetry (DSC) ............................................................... 78 
3.4.4 Thermogravimetric Analysis (TGA) coupled with Mass Spectrometry (MS) ........ 79 
3.4.5 Hot-Stage Microscopy (HSM) ................................................................................. 79 
3.4.6 Spectroscopy ............................................................................................................ 80 
3.4.6.1 Fourier Transform Infrared Spectroscopy (FTIR) ........................................... 80 
3.4.7 Process Analytical Technology (PAT) .................................................................... 81 
3.4.7.1 Inline Ultraviolet Visible Spectroscopy (UV-Vis) monitoring ........................ 81 
Chapter 4 – In situ X-ray Diffraction (XRD) Analysis of Continuous Segmented Flow 
Cooling Crystallisation in KRAIC-D at High Resolution Powder Diffraction Beamline I11 
Diamond Light Source – Urea-barbituric acid (UBA) and Carbamazepine (CBZ) ................ 82 
4.1 Introduction and Aims .................................................................................................... 82 
4.2 KRAIC-D Design and Overview ................................................................................... 87 
4.2.1 Union Detail ............................................................................................................ 89 
4.2.2 Experimental Set-up ................................................................................................ 90 
4.2.3 Seeding Inlets .......................................................................................................... 92 
4.2.3.1 Seed Inlet Geometry and Flow Rate ratio Optimisation .................................. 92 
4.2.3.2 Seed Addition Monitoring using inline UV-vis Spectroscopy ........................ 93 
4.2.4 Seed Generation and Slurry Stability Studies .......................................................... 98 
4.2.4.1 CBZ Seed Generation and Feed Slurry Stability ............................................. 98 
4.2.4.2 Pumping Stability Testing.............................................................................. 102 
4.3 Platform Development and Optimisation ..................................................................... 105 
4.3.1 Kapton® Window Treatment ................................................................................. 105 
4.3.2 Aquapel® Coating Deterioration ............................................................................ 105 
4.3.3 Blockage Mitigation .............................................................................................. 105 
4.3.4 Thin Wall Tubing Cutting Procedure .................................................................... 107 
4.4 Cooling Crystallisations ............................................................................................... 107 
x 
 
4.4.1 Seeded Cooling Crystallisations ............................................................................ 109 
4.4.1.1 Pre-nucleation Seeding .................................................................................. 109 
4.4.1.2 Post-nucleation Seeding ................................................................................. 109 
4.5 Data Capture and Analysis Procedure .......................................................................... 110 
4.5.1 Data Capture .......................................................................................................... 110 
4.5.2 Data Analysis Procedure ....................................................................................... 111 
4.6 Growth Studies ............................................................................................................. 113 
4.7 Polymorphic Monitoring of Carbamazepine (CBZ) .................................................... 113 
4.7.1 Offline KRAIC / KRAIC-D Experiments: CBZ in ethanol (EtOH) (CBZK/KD) 116 
4.7.2 Online KRAIC-D Runs at Beamline I11: CBZ in EtOH (CBZKDB) ................... 121 
4.7.3 Unseeded CBZ in EtOH KRAIC-D at I11 (CBZKDB1 and CBZKDB2) ............ 122 
4.7.4 Pre-nucleation Seeding of CBZ form III (CBZKDB3) ......................................... 125 
4.7.5 Post-nucleation Seeding of CBZ form III (CBZKDB4) ........................................ 126 
4.7.5.1 Single exposure polymorph identification ..................................................... 128 
4.7.5.2 Offline slurrying of CBZ form II and CBZ form III ...................................... 129 
4.7.6 Conclusions of CBZ in situ XRD Characterisation ............................................... 130 
4.8 Polymorphic Monitoring of Urea Barbituric acid (UBA) ............................................ 131 
4.8.1 Offline KRAIC Experiments: UBA in methanol (MeOH) (UBAK1) ................... 131 
4.8.2 Online KRAIC-D Runs at Beamline I11: UBA in MeOH (UBAKDB) ................ 133 
4.8.3 Unseeded UBA in MeOH KRAIC-D at I11 (UBAKDB1) ................................... 134 
4.8.4 Pre-nucleation Seeding of UBA form III (UBAKDB2) ........................................ 135 
4.8.5 Post-nucleation Seeding of UBA form III (UBAKDB3) ...................................... 137 
4.8.6 Pre-nucleation Seeding of UBA form I (UBAKDB4)........................................... 139 
4.8.7 Stability of UBA Seeds.......................................................................................... 140 
4.8.8 Conclusions of UBA in situ XRD Characterisation .............................................. 141 
4.9 Comparison and Conclusions of model systems: CBZ and UBA ................................ 142 
4.10 Overall Discussions and Conclusions ........................................................................ 146 
xi 
 
Chapter 5 – In situ X-ray Diffraction (XRD) Analysis of Continuous Segmented Flow 
Cooling Crystallisation in KRAIC-S at Small Molecule Single Crystal Beamline, I19 Diamond 
Light Source – Paracetamol (PCM) ....................................................................................... 149 
5.1 Introduction and Aims .................................................................................................. 149 
5.1.1 Data Requirements ................................................................................................ 150 
5.1.2 Model System: Paracetamol (PCM) ...................................................................... 152 
5.2 Data Processing Trials .................................................................................................. 154 
5.2.1 CrysAlisPro Data Processing Trials ...................................................................... 154 
5.2.2 Automated Data Processing Trials via DIALS...................................................... 156 
5.2.3 Automated Data Processing Trials via Xia2 .......................................................... 158 
5.2.4 Data Processing Trials Conclusions ...................................................................... 158 
5.3 KRAIC-S Design and Overview .................................................................................. 159 
5.3.1 Experimental Set-up .............................................................................................. 160 
5.3.2 Seeding Coil Optimisation ..................................................................................... 161 
5.3.3 Cooling Crystallisations ........................................................................................ 164 
5.4 Slug Triggering ............................................................................................................ 166 
5.4.1 In vitro Data Processing Optimisation................................................................... 168 
5.5 Data Capture and Analysis Procedure .......................................................................... 171 
5.5.1 Data Capture .......................................................................................................... 171 
5.5.2 Data Analysis Procedure ....................................................................................... 172 
5.5.2.1 CrysAlisPro .................................................................................................... 172 
5.5.2.2 DIALS ............................................................................................................ 173 
5.6 Growth Studies ............................................................................................................. 176 
5.7 Polymorphic Monitoring of Paracetamol (PCM) ......................................................... 177 
5.7.1 Offline KRAIC Experiments: PCM in 60:40 H2O:IPA (HI) (PCMK) .................. 177 
5.7.2 Online KRAIC-S Runs at Beamline I19: PCM in 60:40 HI (PCMKSC and 
PCMKSB) ....................................................................................................................... 187 
xii 
 
5.7.2.1 Commissioning Time at I19 EH2 (PCMKSC) .............................................. 187 
5.7.2.2 Slug Triggering Mechanism Optimisation..................................................... 192 
5.7.2.3 Beamtime at I19 EH2 (PCMKSB) ................................................................. 194 
5.7.3 Data Processing of Unseeded Cooling Crystallisations of Paracetamol (PCM) in 
60:40 H2O:IPA (HI) KRAIC-S at I19 ............................................................................ 200 
5.7.3.1 Monitoring later stage crystallisation using CrysAlisPro: 8.7 m along 
crystalliser length, crystallisation time of 10.7 minutes ............................................ 202 
5.7.3.2 Monitoring earlier stage crystallisation using CrysAlisPro: 6.7 m along 
crystalliser length, crystallisation time of 8.2 minutes .............................................. 202 
5.7.3.3 Comparison of Lattice Rotations at earlier and later stage crystallisation (6.7 m 
and 8.7 m crystalliser lengths) ................................................................................... 204 
5.7.3.4 DIALS Processing Results ............................................................................. 205 
5.7.4 Data Processing of Seeded PCM form II Cooling Crystallisation of Paracetamol 
(PCM) in 60:40 H2O:IPA (HI) KRAIC-S (PCMKSS) at I19 using CrysAlisPro .......... 211 
5.7.5 Crystal Sizing and Crystal Growth at various set-points ....................................... 211 
5.8 Overall Discussions and Conclusions .......................................................................... 214 
Chapter 6 – Crystal Engineering for Materials Discovery: Co-crystals in the Profen family
 217 
6.1 Introduction and Aims of Research .............................................................................. 217 
6.2 Materials and Methods ................................................................................................. 221 
6.2.1 Evaporative Crystallisation for Co-crystal Screening ........................................... 223 
6.2.2 Mechanochemical Crystallisation .......................................................................... 224 
6.2.3 Slurrying Crystallisation ........................................................................................ 224 
6.2.4 Cooling Crystallisation .......................................................................................... 225 
6.2.4.1 Solubility Measurements ............................................................................... 225 
6.2.5 Stability Testing ..................................................................................................... 226 
6.2.5.1 Thermal Stability ........................................................................................... 226 
6.2.5.2 Humidity Stability .......................................................................................... 226 
xiii 
 
6.3 Analysis ........................................................................................................................ 227 
6.3.1 Single Crystal X-ray Diffraction (SCXRD) .......................................................... 227 
6.3.2 Thermogravimetric Analysis (TGA) coupled with Mass Spectrometry (MS) ...... 228 
6.3.3 Hot-Stage Microscopy (HSM) ............................................................................... 229 
6.3.4 Infrared (IR) Spectroscopy .................................................................................... 229 
6.3.5 Particle Visualisation Measurements (PVM) Inline Images on Crystalline® ........ 229 
6.4 Ibuprofen Isonicotinamide (IBU-ISO) ......................................................................... 230 
6.4.1 Evaporative Crystallisations of IBU-ISO .............................................................. 230 
6.4.1.1 IR Spectroscopy of IBU-ISO ......................................................................... 234 
6.4.2 Mechanochemical Crystallisations of IBU-ISO .................................................... 236 
6.4.3 Slurrying Crystallisations of IBU-ISO .................................................................. 238 
6.4.4 IBU-ISO crystallisations in 60:40 water:isopropanol (HI).................................... 240 
6.4.4.1 Relative Thermal Stability Studies of IBU-ISO ............................................ 242 
6.4.4.2 Humidity Stability studies of IBU-ISO.......................................................... 242 
6.4.4.3 Solubility measurements of IBU ISO in 60:40 HI ......................................... 244 
6.4.4.4 Cooling Crystallisations of IBU-ISO ............................................................. 252 
6.4.4.5 Slurry stability testing of IBU-ISO co-crystal ............................................... 258 
6.4.4.6 Continuous Cooling Co-crystallisation in the KRAIC and KRAIC-D platforms: 
IBU-ISO in 60:40 HI (IBU-ISOK and IBU-ISOKD) ................................................ 261 
6.5 Oxaprozin Isonicotinamide (OXA-ISO) ...................................................................... 268 
6.5.1 Evaporative Crystallisations of OXA-ISO ............................................................ 268 
6.5.1.1 IR Spectroscopy of OXA-ISO ....................................................................... 272 
6.5.2 Mechanochemical Crystallisations of OXA-ISO .................................................. 274 
6.5.3 Slurrying Crystallisations of OXA-ISO ................................................................ 276 
6.5.4 OXA-ISO crystallisations in 60:40 water:isopropanol (HI) .................................. 278 
6.5.4.1 Relative Thermal Stability Studies and Humidity Studies of OXA-ISO ....... 279 
6.5.4.2 Solubility measurements of OXA ISO in 60:40 HI ....................................... 279 
xiv 
 
6.5.4.3 Cooling Crystallisations of OXA-ISO ........................................................... 280 
6.6 Oxaprozin Imidazole (OXA-IMID) ............................................................................. 284 
6.6.1 Evaporative Crystallisations of OXA-IMID .......................................................... 284 
6.6.1.1 Variable Temperature (VT) Single Crystal X-ray Diffraction (SCXRD) analysis 
of OXA-IMID ............................................................................................................ 290 
6.6.1.2 Thermogravimetric Analysis (TGA) of OXA-IMID solvate ......................... 293 
6.6.1.3 IR Spectroscopy of OXA-IMID..................................................................... 294 
6.6.2 Mechanochemical Crystallisations of OXA-IMID................................................ 295 
6.6.3 Slurrying Crystallisations of OXA-IMID .............................................................. 295 
6.6.4 OXA-IMID crystallisations in 60:40 H2O:IPA (HI) ............................................. 297 
6.6.4.1 Relative Thermal Stability Studies of OXA-IMID ........................................ 297 
6.6.4.2 Relative Humidity Stability studies of OXA-IMID ....................................... 299 
6.6.4.3 Cooling Crystallisations of OXA-IMID ........................................................ 299 
6.7 Discussion and Conclusions of Crystal Engineering for Materials Discovery in the Profen 
Family................................................................................................................................. 300 
Chapter 7 – In situ X-ray Diffraction (XRD) analysis for capturing Solution Mediated Phase 
Transformations (SMPTs) during slurrying crystallisations in capillaries at High Resolution 
Powder Diffraction Beamline, I11 – Ibuprofen-isonicotinamide (IBU-ISO) ........................ 306 
7.1 Introduction and Aims .................................................................................................. 306 
7.2 Slurry preparation and capillary loading ...................................................................... 307 
7.2.1 Preparation of Slurrying Crystallisations .............................................................. 307 
7.2.2 Capillary Loading .................................................................................................. 308 
7.3 Data Capture and Analysis Procedure .......................................................................... 309 
7.3.1 Data Capture .......................................................................................................... 309 
7.3.2 Data Analysis Procedure ....................................................................................... 309 
7.4 Solution Mediated Phase Transformation (SMPT) monitoring of IBU-ISO ............... 310 
7.4.1 Offline XRD analysis of slurrying crystallisation of IBU_ISO in 60:40 HI ......... 310 
xv 
 
7.4.2 In situ XRD monitoring of early stage crystallisation: IBU_ISO in 60:40 HI ...... 311 
7.4.3 In situ VT-XRD monitoring of early stage crystallisation: IBU_ISO in 60:40 HI 312 
7.4.4 In situ VT-XRD monitoring of IBU-ISO .............................................................. 314 
7.5 Conclusions of IBU-ISO in situ XRD characterisation ............................................... 316 
7.6 Overall discussion and conclusions.............................................................................. 316 
Chapter 8 – Conclusions and Future Work ...................................................................... 317 
8.1 Conclusions .................................................................................................................. 317 
8.2 Future Work ................................................................................................................. 320 
Chapter 9 – References ..................................................................................................... 323 
Chapter 10 – Appendix .......................................................................................................... 333 
Chapter 4 Appendix (A4) ................................................................................................... 333 
4.1 Seeding Inlet Development – UV-vis Data for PP T-piece Configuration .............. 333 
4.2 Seeding Inlet Development – UV-vis Data for Glass T-piece Configuration .......... 336 
4.3 Seeding Inlet Development – UV-vis Data for PP Y-piece Configuration .............. 340 
4.4 Absorbance data for each seed inlet geometry and flow rate ratio ........................... 344 
4.5 CBZ Seed Generation and Stability Testing ............................................................. 345 
4.6 Integrated intensity values for growth plots for all crystallisation runs ................... 350 
4.7 UBA form III pre-nucleation seeded experiment UBAKDB2 showing combined data 
from 10 scans .................................................................................................................. 353 
Chapter 5 Appendix (A5) ................................................................................................... 354 
5.1 Automated Data Processing Trials via Xia2 ............................................................. 354 
5.2 Slug Triggering Testing ............................................................................................ 355 
5.2.1 Identifying constituent media in segmented flow on oscilloscope read-out ..... 355 
5.2.2 In vitro Data Processing Optimisation .............................................................. 355 
5.3 DIALS Commands ................................................................................................... 356 
5.3.1 DIALS Data Processing Trials.......................................................................... 356 
5.3.2 Xia2 Data Processing Trials.............................................................................. 357 
xvi 
 
5.3.3 DIALS Data Analysis Procedure ...................................................................... 357 
5.4 Lattice Rotations from Commissioning Time .......................................................... 358 
5.5 Diode read-out for PCMKSB1 ................................................................................. 359 
5.6 Unseeded PCM in 60:40 HI at 8.7 m (Beamtime) ................................................... 360 
5.6.1 Unit cell parameters over time for each of the five datasets at 8.7 m ............... 360 
5.6.2 Lattice rotations over time for each of the five datasets at 8.7 m ..................... 362 
5.7 Unseeded PCM in 60:40 HI at 6.7 m (Beamtime) ................................................... 364 
5.7.1 Unit cell parameters over time for each of the five datasets at 6.7 m ............... 364 
5.7.2 Lattice rotations over time for each of the five datasets at 6.7 m ..................... 366 
5.8 Details of Electronic Supplementary Information (ESI) – Videos of single crystals 
tracked in solution slugs ................................................................................................. 368 
Chapter 6 Appendix (A6): .................................................................................................. 369 
6.1 Linear cooling profiles for cooling crystallisations .................................................. 369 
6.2 Thermal Behaviour of ISO Co-former ..................................................................... 370 
6.3 Microscope Images of IBU-ISO ............................................................................... 370 
6.4 Thermal stability studies of IBU-ISO monitored over one month ........................... 371 
6.5 Thermal stability studies of IBU monitored over one month ................................... 372 
6.6 IR Spectroscopy for the OXA-IMID multi-component material ............................. 373 
6.7 Mechanochemical Crystallisations of OXA-IMID ................................................... 374 
6.8 OXA-IMID crystallisations in 60:40 H2O:IPA (HI) ................................................ 375 
6.9 Relative Humidity Stability studies of OXA-IMID ................................................. 376 





List of Figures 
Figure 1.1 – Representation of crystalline forms including polymorphs and multi-component 
crystal systems compared to amorphous solids. ........................................................................ 2 
Figure 1.2 – The packing arrangements of the two main polymorphic forms of paracetamol 
(PCM) under standard conditions: PCM form I (left) and PCM form II (right), with CSD 
refcodes of HXACAN30 and HXACAN31 respectively.24 ....................................................... 3 
Figure 1.3 – The energy landscape of stable and metastable polymorphs. ............................... 4 
Figure 1.4 – Solubility curves in monotropic (left) and enantiotropic systems (right). ............ 5 
Figure 1.5 – Schematic representation of multi-component co-crystallisation involving API 
and co-former molecules............................................................................................................ 7 
Figure 1.6 – Co-crystal formation of the pharmaceutical co-crystal Betachlor, with hydrogen-
bonded chains of betaine and chloral hydrate molecules, forming a herringbone arrangement 
of molecules.24, 33 ....................................................................................................................... 7 
Figure 1.7 – Examples of a supramolecular homosynthon (left) and heterosynthon (right). . 10 
Figure 1.8 – Solubility curve (solid line), metastable boundary (dashed line) and MSZW 
highlighted as the region between the two curves. .................................................................. 12 
Figure 1.9 – The mechanisms of Nucleation.11 ....................................................................... 14 
Figure 1.10 – Free energy diagram for nucleation, indicating the presence of the ‘critical 
nucleus’ size, rc.
45 ..................................................................................................................... 15 
Figure 1.11 – Diagram comparing classical nucleation theory (CNT) and the two-step 
nucleation theory (TST).45 ....................................................................................................... 16 
Figure 1.12 – Crystal surface structure containing flat (F), step (S) and kink (K) faces.11 .... 17 
Figure 1.13 – Formation of surface nuclei / islands. ............................................................... 18 
Figure 1.14 – The mechanism of spiral growth. ..................................................................... 19 
xviii 
 
Figure 1.15 – Cuboid and plates/needle morphology comparison for filtration processing.2520 
Figure 1.16 – Schematic of an evaporative crystallisation profile. ......................................... 21 
Figure 1.17 – Schematic of a cooling crystallisation profile. ................................................. 22 
Figure 1.18 – Schematic of an anti-solvent crystallisation profile. ........................................ 23 
Figure 1.19 – Schematic of solubility curves of single components A and B, compared to the 
solubility curve of the multi-component co-crystal A-B. ........................................................ 25 
Figure 1.20 – Derivation of the operators for Residence Time calculation expressed in 
Equation 1.5 for a tubular reactor. ........................................................................................... 30 
Figure 1.21 – Schematic of a single spatial point of a continuous flow process operating at 
steady-state, between the stages of start-up and shutdown. ..................................................... 31 
Figure 1.22 – Fluid flow profiles for the different types of fluid flow: plug flow, laminar flow, 
transitional flow and turbulent flow. ........................................................................................ 33 
Figure 1.23 – Segmented flow comprising three immiscible media: media 1 (green), media 2 
(blue) and media 3 fills the inside of the tubing (off-white). ................................................... 33 
Figure 2.1 – Unit cell parameters labelled on unit cell axis. ................................................... 37 
Figure 2.2 – A repeating array of lattice points found in a crystal lattice, where the orange cross 
represents a molecule and the red points are the lattice points, shown in two dimensions. .... 37 
Figure 2.3 – Four lattice types: Primitive (P), Body-Centred (I), Base-Centred (C) and Face-
Centred (F). .............................................................................................................................. 38 
Figure 2.4 – The Bragg condition for the diffraction of X-rays from a set of parallel crystal 
planes. ...................................................................................................................................... 41 
Figure 2.5 – Two families of parallel crystallographic planes hkl labelled as planes 1 and 2 
separated by d-spacings of d1 and d2 respectively (left) and the normal to these families of 
planes from a common origin, O with lengths d*1 and d*2.
81 .................................................. 42 
xix 
 
Figure 2.6 – The Ewald construction (E) (left) and the limiting sphere (L) of observable 
reflections (right).81 .................................................................................................................. 43 
Figure 2.7 – Scattering factor functions fA and fB from atoms A and B, showing the relative 
fall-off of scattering with angle, θ for a heavier (A) and lighter (B) atom. ............................. 44 
Figure 2.8 – Schematic representation of a four-circle goniometer with Eulerian geometry. 45 
Figure 2.9 – Diffraction of a powder crystalline product, its detection and data conversion to a 
PXRD pattern. .......................................................................................................................... 51 
Figure 2.10 – Aerial view of Diamond Light Source.88 .......................................................... 52 
Figure 2.11 – The production of synchrotron X-ray radiation at Diamond Light Source, 
including the electron gun, linear accelerator, booster ring and electron beam around the 
synchrotron ring.88 ................................................................................................................... 53 
Figure 2.12 – Insertion devices: wiggler (left) and undulator (right) in principle differ only in 
the size of the excursions from a straight path that these insertion devices force the electrons to 
execute.86 .................................................................................................................................. 54 
Figure 3.1 – The Technobis Crystal16®. ................................................................................. 56 
Figure 3.2 – Temperature (℃) versus time (seconds) plot (blue) superimposed with 
transmission (%) versus time (seconds) plot (orange) for repeat heat-cool cycles in the 
Crystal16®  and Crystalline®  platforms. Clear and cloud points are highlighted by red and green 
circles respectively. .................................................................................................................. 57 
Figure 3.3 – The Cambridge Reactor Designs (CRD) Polar Bear Plus Crystalliser, featuring 
overhead stirring. ..................................................................................................................... 58 
Figure 3.4 – Bath-developed KRAIC platform. ...................................................................... 63 
Figure 3.5 – Installation of the KRAIC-D at I11 (left) and installation of the KRAIC-S at I19 
(right). ...................................................................................................................................... 63 
Figure 3.6 – Schematic of tri-segmented flow through the combination of three separate 
streams at the X-piece. ............................................................................................................. 64 
xx 
 
Figure 3.7 – End-piece set-up in the KRAIC, KRAIC-D and KRAIC-S platforms including 
the carrier fluid recovery holes and the NS inlet, adapted from Robertson et al.72 ................. 66 
Figure 3.8 – Schematic of KRAIC-D showing segmented flow and position of viewing 
windows. .................................................................................................................................. 67 
Figure 3.9 – A schematic of the beamline I1I layout at DLS, which shows the main components 
along with the approximate distances from the undulator X-ray source, adapted from 
Thompson et al.89 ..................................................................................................................... 71 
Figure 3.10 – A schematic of the beamline I1I layout at DLS.90 ............................................ 71 
Figure 3.11 – The experimental set-up for a laboratory SCXRD diffractometer, pictured is the 
Rigaku Oxford Diffraction SuperNova diffractometer.92 ........................................................ 74 
Figure 3.12 – A schematic of the beamline I19 layout at DLS.97 ........................................... 76 
Figure 3.13 – The experimental set-up of the KRAIC-S at EH2, I19 DLS, featuring 1) 
Newport98 four-circle diffractometer and 2) DECTRIS99 PILATUS 2M detector. ................. 77 
Figure 4.1 – Chemical structure of carbamazepine (CBZ). .................................................... 85 
Figure 4.2 – Chemical structure of the components urea (left) and barbituric acid (right), which 
comprise the co-crystal system urea-barbituric acid (UBA).................................................... 86 
Figure 4.3 – (a) Diagram of the KRAIC-D by Dr. Mark Levenstein, operating in transmission 
mode with X-ray penetration initiated behind the window section, (b) enlarged view of a single 
analysis window comprising a Kapton® tube and two PTFE unions (inset shows the triphasic 
(solution, air, and carrier fluid) plug flow), (c) accumulation of 2D diffraction pattern frames 
from 100 ms exposures which are combined to achieve (d) the 1D diffraction plot (shown here 
is a combined scan of CBZ form II). ....................................................................................... 89 
Figure 4.4 – Computer-aided drawing (CAD) of PTFE unions by Dr. Mark Levenstein, with 
all measurements set to mm, with the ID of the union equalling the ID of the KRAIC-D body, 
highlighted in red. .................................................................................................................... 90 
xxi 
 
Figure 4.5 – (a) KRAIC-D schematic highlighting X-ray transparent windows and seed inlet 
positions. (b-d) Photographs of the KRAIC-D in experimental hutch 2 (EH2) of beamline I11 
at Diamond Light Source showing (b) KRAIC-D analysis section with beam outlet behind, (c) 
detector and trolley positioning, (d) trolley with pumping, segmentation, and fluidic apparatus.
.................................................................................................................................................. 91 
Figure 4.6 – Schematic of KRAIC-D unseeded experiments. ................................................ 92 
Figure 4.7 – Images of segmentation X-piece connected to (clockwise) PP T-piece, glass T-
piece and PP Y-piece seed / dye inlet connectors for seeding optimisation studies. ............... 94 
Figure 4.8  – Full UV-Vis spectra of all three phases in dye studies of seeding inlet optimisation 
(ethanol trace measured to confirm background subtraction).................................................. 95 
Figure 4.9 – 870 nm peak absorbance versus time (5 ms increments) for 1 mL/min seed flow 
rate, with 1.0, 1.2 or 1.4 mL/min solution flow rate, with a PP T-piece (used for optimal seeding 
configuration). N.B. orange vertical bars show location of detected local minima (left) and the 
corresponding slug analysis chart for each flow rate combination featuring solution troughs 
(blue) and slug distances (orange) (right). ............................................................................... 96 
Figure 4.10 – PXRD patterns showing CBZ form III stability in EtOH at 300 rpm for a 
slurrying time of 1 hour at 20 ℃. ............................................................................................ 99 
Figure 4.11 – PXRD patterns for CBZ form II slurry testing at 400 rpm over various slurrying 
times at 20 ℃. ........................................................................................................................ 100 
Figure 4.12 – PXRD patterns of varying concentrations of CBZ in EtOH at 500 rpm for 10 
minutes slurrying time. .......................................................................................................... 101 
Figure 4.13  – PXRD patterns of varying concentrations of CBZ in EtOH at 500 rpm for 20 
minutes slurrying time. .......................................................................................................... 101 
Figure 4.14 – Schematic of experimental set-up for CBZ form III seed solution pumping 
stability studies....................................................................................................................... 103 
Figure 4.15 – PXRD result of CBZ form III seed solutions pumping stability studies. ....... 104 
xxii 
 
Figure 4.16 – Removal of PTFE unions as part of blockage mitigation strategy. ................ 106 
Figure 4.17 – Photograph of Kapton® tube cutting set-up. ................................................... 107 
Figure 4.18 – Schematic of KRAIC-D showing seeding position for pre-nucleation seeding 
experiments. ........................................................................................................................... 109 
Figure 4.19 – Schematic of KRAIC-D showing seeding position for post-nucleation seeding 
experiments. ........................................................................................................................... 110 
Figure 4.20 – PXRD patterns of the five anhydrous forms of CBZ and CBZ DH reference 
patterns simulated in Mercury33 (Refcodes: CBMZPN11 (CBZ form I), CBMZPN03 (CBZ 
form II), CBMZPN01 (CBZ form III), CBMZPN12 (CBZ form IV), CBMZPN16 (CBZ form 
V) and FEFNOT (CBZ DH, orthorhombic interpretation of space group)). The intense peaks 
between 5-13° 2θ for CBZ DH have been truncated to ensure clarity of less intense peaks for 
comparison. ............................................................................................................................ 114 
Figure 4.21 – CBZ in EtOH solubility curve adapted from N. Briggs thesis.137 Avantium: 
turbidity data collected on 8 mL parallel crystallisation system. Optimax: collected in a 1 L 
stirred tank crystalliser with ATR-FTIR as the method of detection. Literature curve: laser 
monitoring technique determined by the synthetic method.138 The data from each of the 
methods defined are overlaid. ................................................................................................ 116 
Figure 4.22  – Schematic of the experimental set-up for the unseeded CBZ crystallisation in 
EtOH run in the KRAIC (CBZK1). ....................................................................................... 117 
Figure 4.23  – Schematic of the experimental set-up for the offline unseeded CBZ 
crystallisation in EtOH runs in the KRAIC-D. ...................................................................... 118 
Figure 4.24 – PXRD patterns of CBZ in EtOH in KRAIC and KRAIC-D platforms identified 
as CBZK and CBZKD respectively compared to the reference patterns simulated in Mercury33 
(Refcodes: CBMZPN03 (CBZ form II), CBMZPN01 (CBZ form III) and FEFNOT (CBZ 
DH)). ...................................................................................................................................... 120 
Figure 4.25 – PXRD patterns of CBZKDB2 unseeded CBZ in EtOH at W1, W2 and W3 in the 
KRAIC-D at I11. The scale of the experimental diffraction patterns has been adjusted for clarity 
(W1 scaled by a factor of 8 relative to W2 and W3) and converted into Cu Kα wavelength for 
xxiii 
 
comparison to the reference CBZ form II simulated in Mercury33 (Refcode: CBMZPN03 (CBZ 
form II)). ................................................................................................................................ 123 
Figure 4.26 – Growth plots for CBZKDB2 unseeded CBZ in EtOH KRAIC-D run at I11. 125 
Figure 4.27  – PXRD patterns of  CBZKDB3 pre-nucleation seeded CBZ in EtOH at W1, W2 
and W3 in the KRAIC-D at I11, which have been converted into Cu Kα wavelength for 
comparison to the reference CBZ form III simulated in Mercury33 (Refcode: CBMZPN01 
(CBZ form III)). ..................................................................................................................... 125 
Figure 4.28 – Growth plots for CBZKDB3 pre-nucleation seeded CBZ form III in EtOH 
KRAIC-D run at I11. ............................................................................................................. 126 
Figure 4.29 – PXRD patterns of CBZKDB4 post-nucleation seeded CBZ in EtOH at W2 and 
W3 in the KRAIC-D at I1. W2 is scaled by a factor of 20 relative to W3 for clarity and the 
diffraction patterns are converted into Cu Kα wavelength for comparison to the references CBZ 
form II and CBZ form III simulated in Mercury33 (Refcodes: CBMZPN03 (CBZ form II) and 
CBMZPN01 (CBZ form III))................................................................................................. 127 
Figure 4.30 – Growth plots for CBZKDB4 post-nucleation seeded CBZ form III in EtOH 
KRAIC-D run at I11. ............................................................................................................. 127 
Figure 4.31 – (a) Photograph of CBZ form II needles and CBZ form III blocks separated by 
flow patterns in slugs, (b) CFD volume of fluid (VOF) image with flow streamlines overlaid, 
(c) CFD velocity contour image. N.B. CFD calculations were performed with Ansys Fluent by 
P.-B. Flandrin.139 .................................................................................................................... 128 
Figure 4.32 – PXRD patterns of CBZ obtained from post-nucleation seeded cooling 
crystallisation in the KRAIC-D at windows (a) W2 and (b) W3 comparing the data obtained 
from the combined scan method (5 scans), a single scan with a total of 51 exposures and a 
single 100 ms exposure (frame). The dotted lines are a guide to the eye for the identification of 
selected characteristic peaks of CBZ II and III in (a) and (b), respectively. The experimental 
diffraction patterns have been  converted into Cu K wavelength for comparison to reference 
data. (Refcodes: CBMZPN03 (CBZ form II) and CBMZPN01 (CBZ form III)).33 .............. 129 
xxiv 
 
Figure 4.33 – PXRD plots of offline slurrying experiments of CBZ form II and III mixture 
showing some transformation towards CBZ form III in the 4 minute slurrying experiment.130 
Figure 4.34 – PXRD of material collected from an unseeded offline KRAIC UBA in MeOH 
experiment (UBAK1) showing a mixture of UBA form I and III in the final product. ......... 133 
Figure 4.35 – PXRD patterns of UBAKDB1 unseeded cooling crystallisation of UBA in 
MeOH in the KRAIC-D showing a progression of UBA form III to form I in patterns obtained 
from W1 to W3. The scale of the experimental diffraction patterns has been adjusted for clarity 
(W1 scaled by a factor of 40, W2 by 3 relative to W3); the synchrotron data has been converted 
into Cu K wavelength for comparison to reference data. (Refcodes: EFOZAB (UBA form I) 
and EFOZAB02 (UBA form III)). ......................................................................................... 135 
Figure 4.36 – Growth plots for a UBAKDB1 unseeded UBA in MeOH KRAIC-D run at I11.
................................................................................................................................................ 135 
Figure 4.37 – PXRD patterns of UBAKDB2 pre-nucleation UBA form III seeded cooling 
crystallisation of UBA in MeOH in the KRAIC-D showing a progression of UBA form III to 
form I in patterns obtained from W1 to W3. The scale of the experimental diffraction patterns 
has been adjusted for clarity (W1 scaled by 5, W2 by 2.5 relative to W3); the synchrotron data 
has been converted into Cu K wavelength for comparison to reference data. (Refcodes: 
EFOZAB (UBA form I) and EFOZAB02 (UBA form III)). ................................................. 136 
Figure 4.38 – Growth plots for UBAKDB2 pre-nucleation seeded UBA form III in MeOH 
KRAIC-D run at I11. ............................................................................................................. 137 
Figure 4.39 – PXRD patterns of UBAKDB3 post-nucleation UBA form III seeded cooling 
crystallisation of UBA in MeOH in the KRAIC-D showing a partial transformation of UBA 
form III to form I in the pattern obtained at W3. The scale of the experimental diffraction 
patterns has been adjusted for clarity (W2 scaled by 50 relative to W3); the synchrotron data 
has been converted into Cu K wavelength for comparison to reference data. (Refcodes: 
EFOZAB (UBA form I) and EFOZAB02 (UBA form III)). ................................................. 138 
Figure 4.40 – Growth plots for UBAKDB3 post-nucleation seeded UBA form III in MeOH 
KRAIC-D run at I11. ............................................................................................................. 138 
xxv 
 
Figure 4.41 – PXRD patterns of UBAKDB4 pre-nucleation UBA form I seeded cooling 
crystallisation of UBA in MeOH in the KRAIC-D showing UBA form I at W1 and W2. The 
experimental diffraction patterns have been converted into Cu K wavelength for comparison 
to reference data. (Refcode: EFOZAB (UBA form I)). ......................................................... 139 
Figure 4.42 – Growth plots for UBAKDB4 pre-nucleation seeded UBA form I in MeOH 
KRAIC-D run at I11. ............................................................................................................. 140 
Figure 4.43 – PXRD plots of UBA form I and III seeds before and after dry storage for over 
12 months and XRD pattern obtained from slurrying a UBA form I and III 50:50 mixture in 
MeOH for 4 minutes. N.B. UBA form I and III stock t=0 data taken on a Bruker D8 Advance, 
t=14/15 months and slurrying experiment taken on a STOE STADI P diffractometer. ........ 141 
Figure 4.44 – Measure temperature profiles across KRAIC-D for CBZ and UBA experiments.
................................................................................................................................................ 145 
Figure 4.45 – Box plots of diffraction intensity for (a) unseeded (CBZKDB2), (b) pre-
nucleation form III seeded (CBZKDB3), and (c) post-nucleation form III (CBZKDB4) seeded 
CBZ KRAIC-D experiments. N.B. red lines indicate the median intensity found in all frames 
containing non-solvent diffraction, boxes encompass upper to lower quartiles, and the absolute 
maximum and minimum intensity values are represented as whiskers. ................................ 145 
Figure 4.46 – Box plots of diffraction intensity for (a) unseeded (UBAKDB1), (b) pre-
nucleation form III seeded (UBAKDB2), (c) pre-nucleation form I seeded (UBAKDB4), and 
(d) post-nucleation form III seeded (UBAKDB3) UBA KRAIC-D experiments. N.B. red lines 
indicate the median intensity found in all frames containing non-solvent diffraction, boxes 
encompass upper to lower quartiles, and the absolute maximum and minimum intensity values 
are represented as whiskers. ................................................................................................... 146 
Figure 5.1 – Principles of the KRAIC-S flow cell implemented at I19. ............................... 151 
Figure 5.2 – Chemical structure of paracetamol (PCM). ...................................................... 152 
Figure 5.3 – The crystal structures of PCM form I (left) and PCM form II (right), displaying 
their distinct differences in packing arrangements of the two forms, adapted from Agnew et 
al.151, 152 .................................................................................................................................. 153 
xxvi 
 
Figure 5.4 – Schematic of KRAIC-S unseeded experiments, featuring the original laser diode 
slug triggering set-up employed in the commissioning time experiments. ........................... 160 
Figure 5.5 – Schematic of PCM form II seed addition via a carrier fluid suspension, in which 
the net flow is controlled by a syringe pump, whilst a piston provides an oscillation to the 
system. ................................................................................................................................... 163 
Figure 5.6 – Piston attached to a motorised stage to provide oscillation, with a needle 
connected to the coil tubing. .................................................................................................. 164 
Figure 5.7 – Schematic of seeded KRAIC-S experiments (PCMKSS). ............................... 165 
Figure 5.8 – Photograph of KRAIC-S installed in experimental hutch 2 (EH2) of beamline I19 
at Diamond Light Source during the beamtime. .................................................................... 165 
Figure 5.9 – The use of a laser on the segmented flow to provide an optical trigger. .......... 166 
Figure 5.10 – Principles of the slug triggering testing. ......................................................... 167 
Figure 5.11 – Schematic of the initial translation / triggering set-up trialled for installation at 
EH2 I19. ................................................................................................................................. 168 
Figure 5.12 – FEP tube holder and motorised stage (left) and photodiode / laser box (right).
................................................................................................................................................ 169 
Figure 5.13 – Diode read-out produced from Python script, red data points correspond with 
the diode reading and the blue line corresponds with the leading edge detection. ................ 170 
Figure 5.14 – Dectris 2M PILATUS detector employed for beamtime experiments 
(PCMKSB). ............................................................................................................................ 172 
Figure 5.15 – 2D diffraction image from a PCM form II seeded crystallisation run. ........... 174 
Figure 5.16 – Distribution histograms with respect to the reciprocal lattice: a*-axis, b*-axis 
and c*-axis from a PCM form II seeded crystallisation run. ................................................. 175 
Figure 5.17 – Single diffraction frame after DIALS spot finding (background subtracted), with 
spots highlighted in pink. ....................................................................................................... 175 
xxvii 
 
Figure 5.18 – Complete rocking curve represented by a normal distribution function. ....... 177 
Figure 5.19 – Solubility curve of PCM form I in 60:40 (v/v) H2O:IPA (HI) using data from 
Agnew22, 152, fitted with an exponential trend curve. ............................................................. 178 
Figure 5.20 – Schematic of the experimental set-up for the unseeded PCM in 60:40 HI run, 
without a nucleation promoter in the KRAIC (PCMK1). ...................................................... 179 
Figure 5.21 – Schematic of the experimental set-up for the unseeded PCM in 60:40 HI runs, 
with a nucleation promoter in the KRAIC (PCMK2-4). ....................................................... 180 
Figure 5.22 – Measured cooing profiles of temperature versus crystalliser length in the KRAIC 
for experiments PCMK2, PCMK3 and PCMK4.................................................................... 182 
Figure 5.23 – Microscope images of FP1 (top) and FP2 (bottom) from PCMK4 vacuum 
filtration collections, with varying levels of magnification, lower (left) and higher (right) for 
each PCM collection sample. ................................................................................................. 186 
Figure 5.24 – 2D diffraction frame showing diffraction spots (left) with the corresponding 
solution slug held in the X-ray beam during data collection, captured by a camera positioned 
by the X-ray beam (right), the single crystal is positioned at the back of the solution slug 
highlighted by the red circle. ................................................................................................. 191 
Figure 5.25 – Side on view of the updated slug triggering mechanism set-up featuring the 
photodiode / laser box with mirrors. ...................................................................................... 193 
Figure 5.26 – CAD drawings of updated slug triggering mechanism design, above (top) and 
side (bottom) view. ................................................................................................................ 193 
Figure 5.27 – Schematic of KRAIC-S used for unseeded (where the sample loop is 
disconnected) and seeded (with the sample loop) experiments with T-pieces in series 
configuration, featuring optimised slug triggering mechanism, whereby the laser diode resides 
on the motorised stage. .......................................................................................................... 195 
Figure 5.28 – a-axis lattice parameter over time for each of the five datasets at 8.7 m compared 
to the magnitude of the a-axis for PCM form I obtained from the CSD. .............................. 203 
xxviii 
 
Figure 5.29 – a-axis lattice parameter over time for each of the five datasets at 6.7 m compared 
to the magnitude of the a-axis for PCM form I obtained from the CSD. .............................. 203 
Figure 5.30 – R1 rotation with respect to the instrument over time as the crystal grows between 
6.7 m and 8.7 m...................................................................................................................... 204 
Figure 5.31 – R2 rotation with respect to the instrument over time as the crystal grows between 
6.7 m and 8.7 m...................................................................................................................... 205 
Figure 5.32 – R3 rotation with respect to the instrument over time as the crystal grows between 
6.7 m and 8.7 m...................................................................................................................... 205 
Figure 5.33 – Varying movement of a single crystal in the X-ray beam: Crystal moving in and 
out of beam for dataset 1 at 8.7 m (top), crystal starts in beam and moves out of beam dataset 
4 at 8.7 m (middle) and crystal remains in beam dataset 5 at 6.7 m (bottom). ...................... 208 
Figure 5.34 – Scan-varying orientation parameters for dataset 5 at 6.7 m and dataset 1 at 8.7 
m, elucidating the relationship between the extent of crystal growth with lattice rotation using 
DIALS. ................................................................................................................................... 209 
Figure 5.35 – Sample tumbling angle versus frame number for dataset 5 at 6.7 m and dataset 
1 at 8.7 m, elucidating the relationship between the extent of crystal growth with overall lattice 
rotation using DIALS [combined rotration calculations courtesy of a Python script provided by 
Dr Ben Williams, DLS]. ........................................................................................................ 210 
Figure 6.1 – Chemical structures of the target materials from the profen family. ................ 219 
Figure 6.2 – Chemical structures of the co-former molecules involved in co-crystal formation 
with the four profen family targets. ....................................................................................... 220 
Figure 6.3 – Chemical structures of co-former molecules used in co-crystallisations with 
profen targets. ........................................................................................................................ 222 
Figure 6.4 – Welled DrySyn forms fitted on hot-plates for crystallisation via evaporation of 
the solvent at elevated temperatures of 30, 40 and 50 ᵒC. ..................................................... 224 
xxix 
 
Figure 6.5 – Cambridge Reactor Design (CRD) Polar Bear Plus crystalliser for temperature 
controlled batch cooling crystallisations. ............................................................................... 225 
Figure 6.6 – Inside of humidity ageing unit containing raised ledge for humidity sensor (left) 
and humidity sensor within sealed plastic container containing salt solution slurry (right). . 227 
Figure 6.7 – PXRD patterns of the IBU-ISO 1:1 molecular complex prepared via evaporative 
crystallisation in three different solvents each at 30 °C, compared to the PXRD patterns of the 
constituent starting materials including various polymorphic, racemic and S-enantiomeric 
forms (Refcodes: IBPRAC (IBU), JEKNOC (S-IBU),  EHOWIH01-05 (ISO I-V 
respectively)).......................................................................................................................... 230 
Figure 6.8 – DSC heat profile for the molecular complex IBU-ISO 1:1 prepared via 
evaporative crystallisation methods in ACE, EtOH and IPA solvent systems at 30 °C. ....... 231 
Figure 6.9 – The asymmetric unit of the novel co-crystal structure IBU-ISO...................... 233 
Figure 6.10 – The packing of the novel co-crystal structure IBU-ISO. ................................ 234 
Figure 6.11 – FTIR spectra of IBU-ISO compared to the constituent IBU and ISO starting 
materials. ................................................................................................................................ 235 
Figure 6.12 – PXRD patterns comparing IBU-ISO predicted pattern simulated in Mercury and 
IBU_ISO 1:1 evaporated from EtOH, with the PXRD patterns of the polymorphs of the pure 
starting materials as well as the KIPPAD170 co-crystal obtained from Mercury (Refcodes: 
IBPRAC (IBU), EHOWIH01-05 (ISO I-V) respectively). The intense IBU-ISO peak at 2° 2θ 
has been truncated for clarity. ................................................................................................ 236 
Figure 6.13 – PXRD patterns of the IBU-ISO 1:1 molecular complex prepared via 
mechanochemical crystallisation both NG and LAG in 3 different solvents, compared to the 
PXRD pattern of the IBU-ISO predicted pattern simulated in Mercury and IBU (Ref code: 
IBPRAC) and IBU_ISO 1:1 evaporated from EtOH powder patterns. ................................. 237 
Figure 6.14 – DSC heat profile for the molecular complex IBU-ISO 1:1 prepared via 
mechanochemical crystallisations using both NG and LAG in ACE, EtOH and IPA solvent 
systems compared to the DSC trace of the IBU-ISO 1:1 crystallised from evaporation of EtOH, 
and those of the starting materials IBU and ISO. .................................................................. 238 
xxx 
 
Figure 6.15 – PXRD patterns of the IBU-ISO 1:1 molecular complex prepared via slurrying 
crystallisations for 1 week in three different solvents systems (truncated in intensity), compared 
with the PXRD pattern of the IBU-ISO predicted pattern simulated in Mercury and IBU 
(Refcode: IBPRAC) powder pattern. ..................................................................................... 239 
Figure 6.16 – DSC heat profile for the molecular complex IBU-ISO 1:1 prepared via slurrying 
crystallisation for 1 week in ACE, EtOH, IPA solvent systems. ........................................... 240 
Figure 6.17 – PXRD patterns of the IBU-ISO 1:1 molecular complex prepared in 60:40 HI via 
various crystallisation methods: evaporative, LAG, slurrying at 20 ℃ at 10 mL scale for a 
slurry time of 24 hours, compared to the PXRD patterns of pure IBU and the IBU-ISO predicted 
pattern simulated in Mercury. ................................................................................................ 241 
Figure 6.18 – DSC heat profiles of the IBU-ISO 1:1 molecular complex prepared in 60:40 HI 
via various crystallisation methods: evaporative, LAG, slurrying at 20 ℃ at 10 mL scale for a 
slurry time of 24 hours, compared to the DSC traces of pure IBU and pure ISO starting 
materials. ................................................................................................................................ 241 
Figure 6.19 – IBU-ISO 1:1 prepared in 60:40 HI via LAG for 5 minutes – Humidity studies at 
46 % RH monitored over 40 days. The intensity of the 3° 2θ peak for both the t = 28 and t = 
40 days diffraction patterns has been truncated for ease of display and comparison. ........... 242 
Figure 6.20 – IBU-ISO 1:1 prepared in 60:40 HI via LAG for 5 minutes – Humidity studies at 
80 % RH monitored over 40 days. The intensity of the 3° 2θ peak for both the t = 28 and t = 
40 days diffraction patterns has been truncated for ease of display and comparison. ........... 243 
Figure 6.21 – IBU-ISO 1:1 prepared in 60:40 HI via for 5 minutes slurrying – Humidity studies 
at 46 % RH monitored over 40 days. The intensity of the 3° 2θ peak for both the t = 28 and t = 
40 days diffraction patterns has been truncated for ease of display and comparison. ........... 243 
Figure 6.22 – Solubility curve of IBU and ISO 1:1 physical mixture in 60:40 HI at 1 mL scale 
in Crystal16®. ......................................................................................................................... 244 
Figure 6.23 – Repeated heat-cool cycles to obtain clear (red circle) and cloud points (green 
circle) for IBU_ISO 1:1 physical mixture in 60:40 HI in Crystal16 and Crystalline® platforms. 
The heat-cool cycles presented coincide with a sample containing 0.4 g IBU and 0.474 g ISO 
xxxi 
 
in 5 mL 60:40 HI in the Crystalline®. The PVM images obtained alongside the Crystalline® 
turbidity measurements convey different stages of the crystallisation process at various time 
points. The unusual double spike in solubility is highlighted by the orange stars. ................ 246 
Figure 6.24 – Solubility curve of IBU and ISO 1:1 physical mixture in 60:40 HI at 5 mL scale 
in Crystalline®. ....................................................................................................................... 247 
Figure 6.25 – Solubility of IBU in 60:40 HI via visual observation, three repeats Obs 1, 2, 3 
with exponential trend curve to fit the median data. .............................................................. 248 
Figure 6.26 – Solubility of ISO in 60:40 HI via visual observation, three repeats Obs 1, 2, 3.
................................................................................................................................................ 249 
Figure 6.27 – Solubility of IBU_ISO 1:1 physical mixture in 60:40 HI via visual observation, 
three repeats Obs 1, 2, 3 with exponential trend curve to fit the median data. ...................... 249 
Figure 6.28 – Cloudy emulsion resulting from solubility of IBU_ISO 1:1 physical mixture in 
60:40 HI. ................................................................................................................................ 250 
Figure 6.29 – PXRD patterns of the resultant crystalline material produced from the solubility 
by visual observation of the physical mixture (phys mix) of IBU and ISO in 60:40 HI, compared 
to the PXRD patterns of pure IBU and the IBU-ISO predicted pattern simulated in Mercury.
................................................................................................................................................ 250 
Figure 6.30 – Solubility of IBU_ISO 1:2 physical mixture in 60:40 HI via visual observation, 
three repeats Obs 1, 2, 3 with exponential trend curves to fit the median data. .................... 251 
Figure 6.31 – PXRD of products from cooling crystallisations of IBU_ISO 1:1 in 60:40 HI at 
1 mL scale over a concentration range performed in the CRD Polar Bear Plus crystalliser. 253 
Figure 6.32 – DSC trace of cooling crystallisation of IBU_ISO 1:1 in 60:40 HI at 1 mL scale 
(vial 5) versus starting material DSC traces of IBU, ISO and the co-crystal IBU-ISO accessed 
via LAG in 60:40 HI for 30 minutes. ..................................................................................... 253 
Figure 6.33 – PXRD of products of cooling crystallisations of IBU_ISO 1:1 and 1:2 in 60:40 
HI at 1 mL scale cooled at 0.05 ℃ min-1 (slow) and 1 ℃ min-1 (fast) cooling rates performed 
xxxii 
 
in the CRD Polar Bear Plus crystalliser, with the intense peak at 17° 2θ truncated for clarity.
................................................................................................................................................ 254 
Figure 6.34  – DSC traces of cooling crystallisations of IBU_ISO 1:1 and 1:2 in 60:40 HI 
cooled at 0.05 ℃ min-1 (slow) and 1 ℃ min-1 (fast) cooling rates performed in the CRD Polar 
Bear Plus crystalliser at 1 mL scale versus starting material DSC traces of IBU and ISO. .. 255 
Figure 6.35 – PXRD of products from cooling crystallisations of IBU_ISO 1:2 in 60:40 HI 
scale-up with magnetic bottom stirring.................................................................................. 256 
Figure 6.36 – PXRD of products from cooling crystallisations of IBU_ISO 1:2 in 60:40 HI 
scale-up with overhead stirring. ............................................................................................. 256 
Figure 6.37 – DSC traces of cooling crystallisations of IBU_ISO 1:2 in 60:40 HI scale-up with 
overhead stirring. ................................................................................................................... 257 
Figure 6.38 – Comparison of Solubility of IBU-ISO co-crystal with IBU in 60:40 HI and 
IBU_ISO 1:2 physical mixture via visual observation, three repeats Obs 1, 2, 3. The data for 
the solubility behaviour of the co-crystal IBU-ISO does not follow an exponential trend and 
therefore exponential fitting was not carried out. .................................................................. 258 
Figure 6.39 – PXRD patterns of IBU-ISO pre-prepared co-crystal used in 60:40 HI mediated 
slurry at room temperature (RT), sampled at t = 2, 4, 6, 8, 24 and 48 hours after slurry 
preparation. The intensity of the 2.5° 2θ peak has been truncated for ease of display and 
comparison. ............................................................................................................................ 259 
Figure 6.40 – DSC traces of IBU-ISO pre-prepared co-crystal used in 60:40 HI mediated slurry 
at room temperature (RT), sampled at t = 2, 4, 6, 8, 24 and 48 hours after slurry preparation 
compared to IBU and ISO starting material DSC traces. ...................................................... 260 
Figure 6.41 – PXRD patterns of IBU-ISO pre-prepared co-crystal used in 60:40 HI mediated 
slurry at 37.5 ℃ (HT), sampled at t = 2, 4, 6, 8, 24 and 48 hours after slurry preparation. .. 260 
Figure 6.42 – DSC traces of IBU-ISO pre-prepared co-crystal used in 60:40 HI mediated slurry 
at 37.5 ℃ (HT), sampled at t = 2, 4, 6, 8, 24 and 48 hours after slurry preparation compared to 
IBU and ISO starting material DSC traces. ........................................................................... 261 
xxxiii 
 
Figure 6.43 – Schematic of KRAIC-D IBU-ISO cooling co-crystallisation experimental set-
up employed for IBU-ISOKD experiments1-3 at I11. ........................................................... 263 
Figure 6.44 – Schematic of KRAIC-D IBU-ISO cooling co-crystallisation experimental set-
up employed for IBU-ISOKD4 at I11. .................................................................................. 263 
Figure 6.45 – PXRD patterns from experiment IBU-ISOK2, sample 1 and 2 were collected at 
15 minutes and 35 minutes into the experiment respectively. The PXRD patterns for IBU-
ISOK2_sample 1 and IBU-ISOK2_sample 2 have been truncated for clarity. ..................... 266 
Figure 6.46 – DSC traces of IBU_ISO 1:2 in 60:40 HI in the KRAIC platform sampled at two 
different time points corresponding with experiment times of 15-30 minutes and 35-44 minutes 
compared to the DSC traces of the IBU and ISO starting materials. ..................................... 266 
Figure 6.47 – PXRD patterns of attempted co-crystallisations of OXA-ISO prepared via 
evaporative crystallisations in three different solvents each at 30 °C, compared to the PXRD 
patterns of the constituent starting materials including various polymorphic forms (Refcodes: 
OJURAO (OXA),  EHOWIH01-05 (ISO I-V respectively)). ................................................ 268 
Figure 6.48 – DSC heat profiles for the molecular complex OXA-ISO 1:1 prepared via 
evaporative crystallisations at 30 °C in ACE, EtOH and IPA solvent systems. .................... 269 
Figure 6.49 – Half of the asymmetric unit of the novel co-crystal structure of OXA-ISO. . 271 
Figure 6.50 – The packing diagram of the novel co-crystal structure OXA-ISO, viewed down 
the crystallographic b-axis. .................................................................................................... 272 
Figure 6.51 – FTIR spectra of OXA-ISO compared to the constituent OXA and ISO starting 
materials. ................................................................................................................................ 273 
Figure 6.52 – PXRD patterns comparing OXA-ISO predicted pattern simulated in Mercury 
and OXA_ISO 1:1 evaporated from ACE, with the PXRD patterns of the pure starting materials 
obtained from Mercury (Refcodes: OJURAO (OXA), EHOWIH01-05 (ISO I-V respectively)).
................................................................................................................................................ 274 
Figure 6.53 – PXRD patterns of the OXA-ISO 1:1 molecular complex prepared via 
mechanochemical crystallisation both NG and LAG in three different solvents, compared to 
xxxiv 
 
the PXRD pattern of OXA_ISO 1:1 crystallised from evaporation of ACE, as well as OXA 
(Refcode OJURAO) and OXA-ISO predicted patterns simulated in Mercury...................... 275 
Figure 6.54 – DSC heat profile for the molecular complex of OXA-ISO 1:1 prepared via 
mechanochemical crystallisation using both NG and LAG in ACE, EtOH and IPA solvent 
systems, compared to the DSC trace of OXA_ISO 1:1 crystallised from evaporation of ACE, 
as well as the DSC traces of OXA and ISO starting materials. ............................................. 275 
Figure 6.55 – PXRD patterns of the OXA-ISO 1:1 molecular complex prepared via slurrying 
crystallisations for 1 week in three different solvents systems compared to the PXRD pattern 
of the OXA-ISO predicted pattern simulated in Mercury and OXA (Ref code: OJURAO) 
powder pattern. ...................................................................................................................... 277 
Figure 6.56 – DSC heat profile for the molecular complex OXA-ISO 1:1 prepared via slurrying 
crystallisation for 1 week in three different solvent systems. ................................................ 277 
Figure 6.57 – PXRD patterns of the OXA-ISO 1:1 prepared in 60:40 HI via various 
crystallisation methods: evaporative, LAG, slurrying at 20 ℃ at 10 mL scale for a slurry time 
of 24 hours, compared to the PXRD pattern of the OXA-ISO predicted pattern simulated in 
Mercury and OXA (Refcode: OJURAO) starting material. .................................................. 278 
Figure 6.58 – DSC heat profiles of the OXA-ISO 1:1 molecular complex prepared in 60:40 HI 
via various crystallisation methods: evaporative at 30 ℃, LAG, slurrying at 20 ℃ at 10 mL 
scale for a slurry time of 24 hours, compared to the DSC traces of pure OXA and pure ISO 
starting materials. ................................................................................................................... 279 
Figure 6.59 – Solubility curve of OXA and ISO 1:1 physical mixture in 60:40 HI at 1 mL scale 
in Crystal16®. ......................................................................................................................... 280 
Figure 6.60 – Solubility of OXA in ACE via visual observation, three repeats Obs 1, 2, 3 with 
an exponential trend curve to fit the median data. ................................................................. 281 
Figure 6.61 – Cooling crystallisations of OXA_ISO 1:1 in ACE at 1 mL scale over a 




Figure 6.62 – DSC heat profiles of OXA_ISO 1:1 in ACE at 1 mL scale over a concentration 
range for samples 1, 2 and 3 performed in the CRD Polar Bear Plus crystalliser versus starting 
material DSC traces of OXA and ISO. .................................................................................. 282 
Figure 6.63 – Cooling crystallisation of OXA_ISO 1:1 in ACE scale-up with overhead stirring, 
with exception of 1 mL scale, which utilised magnetic bottom stirring. ............................... 283 
Figure 6.64 – DSC profiles of OXA_ISO 1:1 in ACE scale-up with overhead stirring, with 
exception of 1 mL scale, which utilised magnetic bottom stirring compared to the starting 
material DSC traces of OXA and ISO. .................................................................................. 284 
Figure 6.65 – PXRD patterns of the OXA-IMID 1:1 molecular complex prepared via 
evaporative crystallisation in three different solvents each at 30 °C, compared to the PXRD 
patterns of the constituent starting materials (Refcodes: OJURAO (OXA) and IMAZOL01 
(IMID)). ................................................................................................................................. 285 
Figure 6.66 – DSC heat profiles for the molecular complex OXA-IMID 1:1 prepared via 
evaporative crystallisations at 30 °C in ACE, EtOH and IPA solvent systems. .................... 286 
Figure 6.67 – Single crystals with varying crystal morphologies formed from repeat samples 
of OXA_IMID 1:1 in an ethanol:butanol 50:50 (v/v) solvent mixture: yellow blocks (left) clear 
plates (middle) and yellow lathes (right). .............................................................................. 287 
Figure 6.68 – The asymmetric unit of the OXA-IMID solvate molecular complex. ............ 288 
Figure 6.69 – The crystal packing of the OXA-IMID solvate molecular complex as viewed 
down the crystallographic b-axis. .......................................................................................... 289 
Figure 6.70 – Variation in N2-H bond distance with temperature for OXA-IMID molecular 
complex. ................................................................................................................................. 291 
Figure 6.71 – Variation in O1-H bond distance with temperature for OXA-IMID molecular 
complex. ................................................................................................................................. 291 
Figure 6.72 – Variation in O1-N2 intermolecular bond distance with temperature for OXA-
IMID molecular complex. ...................................................................................................... 292 
xxxvi 
 
Figure 6.73 – HSM images of OXA-IMID solvate at different temperatures, with solvent 
emerging at 86 ℃. ................................................................................................................. 293 
Figure 6.74 – TGA spectra of the novel OXA-IMID solvate (10 ℃ min-1, under air). ........ 293 
Figure 6.75 – Resonance structures arising from the hydrogen bond donation from the 
hydrogen on the OXA carboxylic acid group (donor) to the IMID (acceptor). ..................... 294 
Figure 6.76 – PXRD patterns comparing OXA-IMID predicted pattern simulated in Mercury, 
with OXA-IMID crystallised from evaporation of ACE, as well as the PXRD patterns of the 
pure starting materials obtained from Mercury (Refcodes: OJURAO (OXA) and IMAZOL01 
(IMID)). ................................................................................................................................. 295 
Figure 6.77 – PXRD patterns of the OXA-IMID molecular complex prepared via slurrying 
crystallisations for 1 week in three different solvents systems compared to the predicted PXRD 
pattern of the OXA-IMID solvate simulated in Mercury. ..................................................... 296 
Figure 6.78 – DSC heat profiles for the molecular complex OXA-IMID prepared via slurrying 
crystallisation for 1 week in ACE, EtOH, IPA solvents. ....................................................... 297 
Figure 6.79 – OXA-IMID prepared in 60:40 HI via LAG for 30 minutes – Thermal studies at 
45 ℃ monitored over 28 days. ............................................................................................... 298 
Figure 6.80 – DSC heat profiles for OXA-IMID prepared in 60:40 HI via LAG for 30 minutes 
– Thermal studies at 45 ℃ monitored over 28 days. All samples were heated to 200 ℃, with 
no thermal events evident above 160 ℃ for any of the samples. .......................................... 299 
Figure 7.1 – Capillary containing slurry sample set-up. ....................................................... 308 
Figure 7.2 – Offline PXRD patterns of a physical mixture of IBU_ISO 1:1 slurry mediated for 
24 hours in 60:40 HI at 20 ℃, 30 ℃ and 40 ℃ compared to IBU (Refcode: IBPRAC) and IBU-
ISO predicted PXRD pattern simulated in Mercury. ............................................................. 311 
Figure 7.3 – In situ PXRD characterisation of a physical mixture of IBU_ISO 1:1 in 60:40 HI 
loaded into a borosilicate slurry and monitored at room temperature over a 10 minute data 
collection time (t = 10:00) at I11, compared to the IBU in 60:40 HI experimental reference 
collected at I11 and the IBU-ISO predicted powder pattern simulated in Mercury. ............. 312 
xxxvii 
 
Figure 7.4 – In situ VT-PXRD measurements collected in capillary mode at I11 of a physical 
mixture of IBU_ISO 1:1 slurry mediated in 60:40 HI. The 313 K and 318 K patterns overlap 
in this plot as DAWN uses a set stacking for the diffraction patterns and the 318 K amorphous 
pattern with a higher background overlaps that at 313 K. ..................................................... 314 
Figure 7.5 – VT-PXRD measurements collected in capillary mode at I11 of the pre-made IBU-
ISO co-crystal prepared by grinding of the constituent IBU and ISO starting components for 
30 minutes. ............................................................................................................................. 315 















List of Tables 
Table 1.1 – Properties of hydrogen bonds.36 ............................................................................. 9 
Table 1.2 – Opportunities for and barriers to Continuous Manufacturing.62 .......................... 26 
Table 1.3 – Comparison  of the fundamental characteristics of batch and flow processing 
methods.63 ................................................................................................................................ 28 
Table 1.4 – Scale of reactor and corresponding flow regime.63 .............................................. 34 
Table 2.1 – The seven crystal systems, ordered from highest to lowest symmetry. ............... 38 
Table 4.1 – Flow rates for the dye and solution feeds used in seed optimisation study. ........ 95 
Table 4.2 – Images of segmentation corresponding with a range of flow rate combinations for 
the solution feed and seed addition. ......................................................................................... 97 
Table 4.3 – Experimental parameters for seed stability testing of CBZ form III in EtOH. .... 98 
Table 4.4 – Experimental parameters for CBZ form II slurry stability testing. .................... 100 
Table 4.5 – Summary of CBZ seeding stability testing. ....................................................... 102 
Table 4.6 – CBZ slurry delivery parameters. ........................................................................ 103 
Table 4.7 – Slurry wt % of CBZ form III seed solutions used for pumping stability studies via 
collection of 5 mL aliquots. ................................................................................................... 103 
Table 4.8 – Flow rates (in mL/min) used for all KRAIC (CBZ unseeded), as well as (offline 
and online) KRAIC-D runs: unseeded, † ‘pre-seed pos.’ and ‘post-seed pos.’ refer to the flow 
rates prior to and after the post-nucleation seeding inlet. ...................................................... 117 
Table 4.9 – Experimental parameters including feed concentration, seed loading and 
experimental set-up for CBZ offline experiments in the KRAIC and KRAIC-D are identified 
by CBZK and CBZKD respectively. ..................................................................................... 118 
Table 4.10 – Experimental residence times for various analytical set points along the length of 
the KRAIC-D for CBZ offline experiments (CBZKD). N.B No residence time measurements 
xxxix 
 
were taken for CBZKD2. The difference between CBZKD1 and CBZKD2 is attributed to the 
removal of the unions, which would reduce the length of the crystalliser slightly for CBZKD2.
................................................................................................................................................ 119 
Table 4.11 – Yield and polymorphic outcome of crystallisation for CBZ offline experiments 
(CBZK and CBZKD). ............................................................................................................ 121 
Table 4.12 – Experimental set-up, as well as concentrations of feed and seed solutions for the 
various CBZKDB beamtime experiments. ............................................................................ 122 
Table 4.13  – Crystallisation parameters for all CBZ runs, with temperature until segmentation 
and nucleation promoter defined in Figures 4.6, 4.18 and 4.19 ‡denotes RTs which are 
extrapolated from observed values. ....................................................................................... 122 
Table 4.14 – Integrated intensity values for growth plots for all crystallisation runs ........... 124 
Table 4.15  – Crystallisation parameters for all UBA in MeOH runs with temperature until 
segmentation and nucleation promoter defined in Figures 4.6, 4.18 and 4.19, ‡denotes RTs 
which are extrapolated from observed values. ....................................................................... 132 
Table 4.16 – Flow rates (in mL/min) used for all KRAIC and KRAIC-D runs, † ‘pre-seed pos. 
and ‘post-seed pos’ refer to the flow rates prior to and after the post-nucleation seeding inlet.
................................................................................................................................................ 132 
Table 4.17 – Experimental set-up, as well as concentrations of feed and seed solutions for the 
various UBAKDB beamtime experiments............................................................................. 134 
Table 4.18 – Qualitative summary of polymorphic expression observed in all KRAIC-D 
experiments. †A mixture of CBZ form III needles and CBZ form III blocks are visually 
separated in the flow paths within the solution slugs. ........................................................... 144 
Table 5.1 – Crystal data including unit cell parameters of PCM form I and form II obtained 
from the CSD.24 ..................................................................................................................... 153 
Table 5.2 – Cytidine: the full 124° dataset was collected on a PILATUS 300K diffractometer 
and processed across a range of wedge sizes using CrysAlisPro. ......................................... 155 
xl 
 
Table 5.3 – PCM: the full 180° dataset was collected on a PILATUS 2M diffractometer and 
processed across a range of wedge sizes using CrysAlisPro. ................................................ 155 
Table 5.4 – Cytidine: the full 124° dataset was collected on a PILATUS 300K diffractometer 
and processed across a range of wedge sizes using DIALS. Attempts to index a 1° wedge of 
data via manual input of unit cell parameters failed. ............................................................. 157 
Table 5.5 – PCM: the full 180° dataset was collected on a PILATUS 2M diffractometer and 
processed across a range of wedge sizes using DIALS. ........................................................ 158 
Table 5.6 – Flow parameters and segmentation separation for the three trial combinations 
employed in the in vitro data processing optimisations. ........................................................ 170 
Table 5.7 – Unit cell parameters (a, b, c, α, β, γ) and lattice rotations R1, R2, R3 after 
refinement from a PCM form II seeded crystallisation run. .................................................. 174 
Table 5.8 – Experimental parameters including feed concentration, seed loading and 
experimental set-up for PCM offline experiments in the KRAIC platform (PCMK). .......... 180 
Table 5.9 – Set temperatures in the KRAIC platform *For PCMK1, the temperature of the 
water bath was reduced to 30 ℃ at 40 minutes into the run and subsequently the heating of the 
water bath was switched off and ice added to the bath (final temp 12.1 ℃) in attempt to promote 
nucleation. †For PCMK2 the temperature of the nucleation promoter was reduced to 5 ℃ at 1 
hour 20 minutes into the crystallisation run. ‡For PCMK4, the nucleation promotor was turned 
on (from RT) to 10 ℃. #For PCMK4, 78 minutes into run the temperature of the tubing jackets 
was raised to 60 ℃................................................................................................................. 181 
Table 5.10 – Flow rates (mL/min) used for all KRAIC runs. *For PCMK1, the flow rate of the 
solution was reduced to 1.4 mL/min to allow more time for crystallisation to proceed. Later on 
in PCMK1 the flow rate of the carrier fluid was reduced to 2.1 mL/min.  #For PCMK2, the flow 
rate of the carrier fluid and feed were reduced to 2.1 mL/min and 1.5 mL/min respectively at 
42 minutes, the flow rate of the feed was further reduced to 1 mL/min at 1 hour 12 minutes. 
‡For PCMK4, 78 minutes into run the flow rate of the solution pump was increased to 3.6 
mL/min. .................................................................................................................................. 181 
xli 
 
Table 5.11 – Experimental residence times for various set points along the length of the 
KRAIC for PCM offline experiments (PCMK) *For PCMK1, total residence time before 
solution flow rate reduction is shown, all other residence times quoted in PCMK1 refer to the 
reduced 1.4 mL/min flow rate for the solution. For PCMK2-4, residence times are measured 
before any alterations to the flow rates are carried out. ......................................................... 182 
Table 5.12 – Experimental parameters including feed concentration and experimental set-up 
for the KRAIC-S platform used for the various experimental runs in the Commissioning time 
at EH2 I19 (PCMKSC). ......................................................................................................... 188 
Table 5.13 – Set temperatures in the KRAIC-S platform used for the various experimental runs 
in the Commissioning time at EH2 I19 (PCMKSC). *RT – room temperature. ................... 188 
Table 5.14 – Flow rates (mL/min) used for the various experimental runs in the Commissioning 
time at EH2 I19 (PCMKSC). *For PCMKSC3, the flow rates of the solution and air were 
altered to 2.1 mL/min and 2.5 mL/min respectively at 50 minutes into the crystallisation run.
................................................................................................................................................ 188 
Table 5.15 – Experimental residence times for various analytical set points along the length of 
the KRAIC-S in the various experimental runs in the Commissioning time at EH2 I19 
(PCMKSC) N.B There are no residence times recorded for PCMKSC5, but they would be 
expected to be similar to PCMKSC4, which utilises the same flow rates. *A blockage in the 
solution feed was observed at this crystallisation time; as a result, the residence time may not 
be accurate. **The flow rate of the carrier fluid was briefly increased to 8.3 mL/min; therefore, 
the residence time of the outlet may not be accurate. ............................................................ 189 
Table 5.16 – Experimental parameters including feed concentration, seed loading and 
experimental set-up for the KRAIC-S platform used for the various experimental runs in the 
Beamtime at EH2 I19 (PCMKSB). ........................................................................................ 196 
Table 5.17 – Set temperatures in the KRAIC-S platform used for the various experimental runs 
in the Beamtime on I19 (PCMKSB). *For PCMKSB4 the temperature of the water bath was 
reduced to 35 ℃ at 1 hour 13 minutes into the crystallisation experiment, the bath reached 38 
℃ and 35 ℃ at 1 hour 15 minutes and 1 hour 40 minutes respectively. For PCMKSB4 the 
temperature of the water bath was further reduced to 32 ℃ at 2 hours 32 into the crystallisation 
xlii 
 
run. #For PCMKSB5, the temperature of the water bath was reduced to 30 ℃ at 54 minutes.
................................................................................................................................................ 196 
Table 5.18 – Flow rates (mL/min) used for the various experimental runs in the KRAIC-S 
Beamtime on I19 (PCMKSB). ............................................................................................... 197 
Table 5.19 – Experimental residence times for various analytical set points along the length of 
the KRAIC-S in the various experimental runs in the Beamtime on I19 (PCMKSB). The 
various lengths along the KRAIC-S were calculated from the speed of the motorised stage 
employed in PCMKSB3 employed to directly oppose the net segmented flow at a rate of 6.47 
mL/min and the residence times experimentally derived for PCMKSB3, where the X-ray beam 
is situated at 8.88 m, compared to measurement of the tubing of 8.7 m. .............................. 197 
Table 5.20 – Experiment identifier corresponding with each of the data sets processed for the 
unseeded crystallisation runs analysed at 8.7 m and 6.7 m along the length of the KRAIC-S.
................................................................................................................................................ 200 
Table 5.21 – Reflection statistics corresponding with each of the datasets processed for the 
unseeded crystallisation runs analysed at 8.7 m and 6.7 m along the length of the KRAIC-S. 
*Denotes the starting frame employed for unit cell finding. #Frame was indexed but not enough 
reflections were available for refinement. †Frame required unit cell finding again. **Each 
diffraction run corresponds with a different single crystal, where five datasets corresponding 
with five different single crystals were analysed. .................................................................. 201 
Table 5.22 – Reflection statistics of the indexed spots obtained from manual spot finding of 
adjacent frames in CrysAlisPro, corresponding with each of the datasets for the unseeded 
crystallisation runs analysed at 8.7 m and 6.7 m along the length of the KRAIC-S. ............ 204 
Table 5.23 – DIALS data processing progress for each of the ten datasets as those analysed in 
CryAlisPro at both 8.7 m and 6.7 m crystalliser length scale. Green denotes that the data 
processing stage was successfully completed, whilst red denotes that the data processing stage 
was unsuccessful. ................................................................................................................... 206 
Table 5.24 – Reflection statistics of the indexed spots obtained from spot finding, 
corresponding with each of the datasets processed using DIALS for the unseeded crystallisation 
runs analysed at 8.7 m and 6.7 m along the length of the KRAIC-S. .................................... 206 
xliii 
 
Table 5.25 – Merging statistics for dataset 1 at 8.7 m and dataset 5 at 6.7 m, that achieved the 
full DIALS processing procedure including the successful completion of the merging 
algorithm. ............................................................................................................................... 210 
Table 5.26 – Reflection statistics corresponding with each of the datasets processed for the 
PCM form II seeded crystallisation runs in the KRAIC-S. *Denotes the starting frame 
employed for unit cell finding................................................................................................ 211 
Table 5.27 – Crystal sizing parameters of standard datasets 1 and 2. ................................... 213 
Table 5.28 – Integrated intensity values for the complete rocking curve across six hkl reflection 
sets for standard datasets 1 and 2. .......................................................................................... 213 
Table 6.1 – CSD Refcodes for the four profen targets. ......................................................... 220 
Table 6.2 – CSD Refcodes for the existing co-crystals of the four profen targets. ............... 220 
Table 6.3 – Matrix of conditions to be investigated for the materials discovery of the profen 
family *Classified as GRAS by the Select Committee on GRAS substances (SCOGS). ..... 223 
Table 6.4 – Crystal data and structural refinement parameters for IBU-ISO. ...................... 232 
Table 6.5 – Comparison of IR stretching frequencies of key functional groups in IBU-ISO 
compared to the constituent IBU and ISO starting materials. ............................................... 234 
Table 6.6 – Quantities of each component and overall concentration of IBU_ISO 1:1 in 1 mL 
of 60:40 HI used in the initial cooling crystallisation trials at 1 mL in the CRD Polar Bear Plus 
crystalliser. ............................................................................................................................. 252 
Table 6.7 – Flow parameters for the continuous co-crystallisation of IBU-ISO in the KRAIC / 
KRAIC-D platforms, identified by IBU-ISOK and IBU-ISOKD respectively. .................... 264 
Table 6.8 – Experimental parameters for offline KRAIC and online KRAIC-D experiments, 
identified by IBU-ISOK and IBU-ISOKD respectively. *Temperature was reduced to 40 ℃, 
10 minutes into the crystallisation process. **Water bath set to 35 ℃ initially, increased to 40 
℃ at 15 minutes. .................................................................................................................... 264 
Table 6.9 – Crystal data and structural refinement parameters for OXA-ISO. ..................... 270 
xliv 
 
Table 6.10 – Comparison of IR stretching frequencies of key functional groups in OXA-ISO 
compared to the constituent OXA and ISO starting materials. .............................................. 272 
Table 6.11 – Crystal data and structure refinement parameters for OXA-IMID. ................. 287 
Table 6.12 – Variation in N2-H, O1-H and O1-N2 bond distances in the OXA-IMID molecular 
complex through the application of temperature. .................................................................. 290 
Table 6.13 – Comparison of IR stretching frequencies of key functional groups in OXA-IMID 






List of Abbreviations 
a.u. – Arbitrary Units 
ACE – Acetone 
ALS – Advanced Light Source 
API – Active Pharmaceutical Ingredient 
ATR – Attenuated Total Reflection  
ATR-FTIR – Attenuated Total Reflectance Fourier Transform Infrared 
BCS – Biopharmaceutics Classification System 
CBZ – Carbamazepine 
CCD – Charge Coupled Device 
CCDC – Cambridge Crystallographic Data Centre 
CFD – Computational Fluid Dynamics 
CIF – Crystallographic Information File 
CNT – Classical Nucleation Theory 
COBC – Continuous Oscillatory-Baffled Crystalliser 
CQA – Critical Quality Attribute 
CRD – Cambridge Reactor Design 
CSD – Cambridge Structural Database 
Cu Kα – Copper K alpha 
DAWN – Data Analysis WorkbeNch 
DCM – Double Crystal Monochromator 
DH – Dihydrate 
DIALS – Diffraction Integration for Advanced Light Sources 
DLS – Diamond Light Source  
DSC – Differential Scanning Calorimetry 
EH – Experimental Hutch  
EPICS – Experimental Physics and Industrial Control System 
EtOH – Ethanol 
FBRM – Focused Beam Reflectance Measurement  
FDA – Food and Drug Administration 
FEP – Fluorinated Ethylene Propylene 
FLU – Flurbiprofen 
xlvi 
 
FP – Filter Paper 
Fps – Frames per second  
FTIR – Fourier Transfer Infrared 
FWHM – Full Width Half Maximum 
GDA – Generic Data Acquisition 
GRAS – Generally Regarded as Safe 
H2O:IPA – water:isopropanol solvent mixture 
HI – water:isopropanol solvent mixture (H2O:IPA) 
HIV – Human Immunodeficiency Virus 
HR – Harmonic Rejection 
HSM – Hot-Stage Microscope 
HT – High Temperature (37.5 ℃) 
IBU – Ibuprofen 
IBU_ISO – Ibuprofen Isonicotinamide physical mixture 
IBU-ISO – Ibuprofen Isonicotinamide co-crystal 
ID – Internal Diameter 
IMID – Imidazole 
IPA – Isopropanol 
IQR – Interquartile Range 
IR – Infrared 
ISO – Isonicotinamide 
KETO – Ketoprofen 
KRAIC – Kinetically Regulated Automated Input Crystalliser 
KRAIC-D – Kinetically Regulated Automated Input Crystalliser for  Diffraction  
KRAIC-S – Kinetically Regulated Automated Input Crystalliser – Single Crystal 
KRAIC-T – Kinetically Regulated Automated Input Crystalliser – Temperature Cycling 
LAG – Liquid Assisted Grinding 
LINAC – Linear Accelerator 
max abs – maximum absorbance 
MeOH – Methanol  
min abs – minimum absorbance 
Mo-Kα – Molybdenum K alpha 
MS – Mass Spectrometry 
xlvii 
 
MSZ – Metastable Zone 
MSZW – Metastable Zone Width 
MX – Macromolecular Crystallography 
N2 – Gaseous nitrogen 
NG – Neat Grinding 
NICO – Nicotinamide 
NS – Neutral Solvent  
NSAIDs – Non-Steroidal Anti-Inflammatory Drugs 
Obs – Observation  
OD – Outer Diameter 
OXA – Oxaprozin 
OXA_IMID – Oxaprozin and Imidazole physical mixture 
OXA_ISO – Oxaprozin and Isonicotinamide physical mixture 
OXA-IMID – Oxaprozin Imidazole co-crystal 
OXA-ISO – Oxaprozin Isonicotinamide co-crystal 
PAT – Process Analytical Technology 
PCM – Paracetamol 
PFPE – Perfluoropolyether 
PMMA – Polymethylmethacrylate 
Pos. – Position 
PP – Polypropylene 
PSD – Particle Size Distribution 
PSD – Position Sensitive Detector 
PTFE – Polytetrafluoroethylene 
PVC – Polyvinyl Chloride 
PVM – Particle Visualisation Measurements 
PXRD – Powder X-ray Diffraction 
QbD – Quality by Design  
R1 – Rotation 1 
R2 – Rotation 2 
R3 – Rotation 3 
RBF – round bottom flask 
RF – Radiofrequency 
xlviii 
 
RH – Relative Humidity  
rpm – Revolutions Per Minute 
RT – Residence Time  
RT – Room Temperature 
RTD – Residence Time Distribution 
SAXS – Small Angle X-ray Scattering 
SCGOGS – Select Committee on GRAS Substances 
SCXRD – Single Crystal X-ray Diffraction  
SMPT – Solution Mediated Phase Transformation 
SSHB – Short strong hydrogen bond 
TCI – Tokyo Chemical Industry 
TGA – Thermogravimetric Analysis 
TNT – Two-step Nucleation Theory 
UBA – Urea-barbituric Acid 
UV-Vis – Ultraviolet-Visible 
v/v – volume by volume 
VOF – Volume of Fluid 
VT-PXRD – Variable Temperature Powder X-ray Diffraction  
W1 – Window 1 
W2 – Window 2 
W3 – Window 3 
Wt % – Weight Percent 
X-FEL – X-Ray Free-Electron Lasers 
X-piece – Cross-piece 
XRD – X-ray Diffraction 






Chapter 1 – Introduction 
1.1 Context of Research  
Crystallisation is a complex, multi-step process involving a sequence of competitive nucleation 
and growth events, where there is potential for various solid forms, known as polymorphs, to 
crystallise from solution.1 In the context of crystalline pharmaceutical solids, the distinct 
differences in the molecular packing arrangements of the various polymorphic forms influences 
the physicochemical properties of the Active Pharmaceutical Ingredient (API), including 
solubility, dissolution, bioavailability and compressibility.1-5 This variability in physical 
attributes dictates the need for additional excipients in the drug product, such as binders, 
glidants and disintegrants. Moreover, an in depth understanding of the polymorphic landscape 
of an API is vital in ensuring the correct form can be reproducibly manufactured and 
administered to patients. Control over polymorphism is paramount in overcoming production 
problems associated with polymorphism, such as the phenomenon of the ‘‘disappearing 
polymorph’’, as in the case of the HIV protease inhibitor Ritonavir.6, 7 Manufactured by Abbott 
Laboratories, Ritonavir was introduced to the market in 1996, but just two years later was 
temporarily removed, as the original crystalline form could no longer be accessed. Instead, an 
unexpected more stable form (II) was produced in the crystalline product.5 The significant 
drawback to the formation of form II was its lower solubility (as it is the thermodynamically 
stable form), which resulted in a reduced oral bioavailability, affecting the therapeutic effect 
of the drug.8 This led to product withdrawal and a delay during reformulation before the drug 
was reintroduced to the market.1, 6 Importantly, the prediction of the crystallisation route in 
yielding a particular crystalline form is difficult considering that post-crystallisation offline 
analysis reveals information on the outcome but not the route of the crystallisation process and 
without considering down-stream processing requirements such as filtration and drying.9-12  
1.2 Types of Crystalline Compounds  
Pharmaceutical compounds can exist in various solid forms, which can be broadly categorised 
as amorphous or crystalline. Crystalline materials contain a regular ordered array of 
components, whereas amorphous materials are not ordered in regular arrays; these solids are 
much more difficult to gain control over and are much less reproducible than their crystalline 
counterparts, so are rarely employed in the pharmaceutical industry.13 The crystal structure 
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may be manipulated to improve physicochemical properties by exploiting the various single-
component or multi-component crystal forms known as polymorphs, or the generation of novel 
molecular materials containing multiple components, which comprise the API crystallised with 
another molecular entity. In these multi-component materials the API is present in the crystal 
structure with solvent molecule(s), co-former molecules or ionised with another ionic 
component to produce solvates, co-crystals and salts respectively (Figure 1.1).14-17 
                                                         
Figure 1.1 – Representation of crystalline forms including polymorphs and multi-component crystal systems 
compared to amorphous solids. 
1.2.1 Polymorphism  
Polymorphism is the ability of a single molecule or combination of different compounds to 
crystallise in multiple crystal forms, whilst still exhibiting the same chemical composition.13, 
18, 19 Polymorphism can be categorised into two types: conformational and packing.   
Conformational polymorphism arises from the ability of flexible molecules to adopt more than 
one conformation in the solid state, with many examples in the literature. One well known 
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example is the multiple polymorphs formed by the molecule “ROY”, due to its conformational 
flexibility.20 
A good example of packing polymorphism is present for the pharmaceutically important drug 
paracetamol (PCM), which exists in two main structural forms under standard conditions: 
monoclinic PCM form I with a herringbone packing arrangement of molecules and 
orthorhombic PCM form II with parallel layers of molecules (Figure 1.2). PCM form I is the 
structural form formulated and administered, usually in tablet form, to ease mild to moderate 
pain. The layered structure of PCM form II enables the molecular layers to slide over each other. 
This structural feature leads to enhanced compressibility and solubility and as a result improved 
manufacturing and bioavailability of this API.16, 21 PCM form II is metastable and must be 
formed in 100 % purity to avoid a polymorphic transition to the more stable PCM form I; 
presence of even trace form I causes the form II to form I transition. Crystallisation of pure form 
II has been highly challenging (though recent work has discovered new templated routes to its 
production),22, 23 and as a result the form administered for low level pain relief is the less 
bioavailable form I. As PCM form I has a lower compressibility than form II, tablets of PCM 
are necessarily large due to the high percentage of excipients required to form a tablet.  
 
 
Figure 1.2 – The packing arrangements of the two main polymorphic forms of paracetamol (PCM) under 
standard conditions: PCM form I (left) and PCM form II (right), with CSD refcodes of HXACAN30 and 
HXACAN31 respectively.24 
1.2.1.1 Thermodynamics of Polymorphism 
The overriding goal of the development of any solid-state form is to establish the solid with 
optimal characteristics for the intended use,21 which usually is the most thermodynamically 
stable polymorph.13 This is because the thermodynamic polymorph is the only form, which 
does not tend to be susceptible to polymorphic transformation. On the other hand, a significant 
disadvantage of using the thermodynamic polymorph for a pharmaceutical application is that 
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the most stable polymorph is the least soluble due to its high crystal packing density and hence 
issues with low bioavailability are possible.  
The relative stability of polymorphs can be attributed to their corresponding Gibbs free 
energies, where the most stable thermodynamic polymorph will possess the lowest free energy 
(Figure 1.3). Metastable polymorphs are thermodynamically unstable with higher free energies 
than the thermodynamic polymorph and thus are often formed under kinetic conditions.18 Over 
time, metastable polymorphs will have the tendency to transform into the thermodynamically 
stable polymorph, where this polymorphic transition is driven by a reduction in free energy of 
the system, provided that the activation energy to polymorphic transformation can be 
overcome.18, 25 This is captured in the concept of Ostwald’s Law of Stages in which it is 
postulated that the system passes consecutively through each metastable polymorph en route 
to the stable form. The presence of even trace amounts of the thermodynamic polymorph will 
often seed the polymorphic transformation from the metastable to stable polymorph (as seen in 
the above example of PCM).  
 
Figure 1.3 – The energy landscape of stable and metastable polymorphs. 
Phase diagrams can be used to compare between monotropic and enantiotropic polymorphic 
systems, providing insight to the effect of temperature on the polymorphic form obtained 
(Figure 1.4). In a monotropic system, which is dimorphic, the relative orders of the solubility 
of polymorphs is independent of temperature and hence the solubility curves of the two 
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polymorphs do not cross. In an enantiotropic system, the relative solubilities of the two 
polymorphs are temperature dependent and therefore the solubility curves intersect at Tt, the 
transition temperature. At the point of intersection, a reversible solid-solid transition occurs 
between polymorph I and polymorph II. The enantiotropic phase diagram in Figure 1.4 shows 
that below the transition temperature, polymorph I is most stable, but after the transition 
temperature the relative stabilities of the two polymorphs have switched and now polymorph 
II is more stable. If the transition temperature exists below the melting point of both 
polymorphs, a transition from form I to form II will be observed upon heating.9, 11, 13, 25 
                      
Figure 1.4 – Solubility curves in monotropic (left) and enantiotropic systems (right). 
1.2.2 Solvates  
In solute-solvent systems, it is possible for solvates to arise, where the solvent molecule is 
incorporated within the crystal structure and is present with the crystallising molecule in the 
unit cell. A solvate exhibits different physicochemical properties (melting point, bioavailability 
and compressibility properties) from those of the unsolvated form, which is important in the 
design of a drug product with specific requirements. Solvates are sometimes given the term 
pseudopolymorphs, but this is misleading as polymorphs occur in a unary system, whereas 
solvates belong to a binary system; it is therefore possible to differentiate between polymorphs 
and solvates by their position on the phase diagram.  
1.2.3 Salts  
A salt is a crystalline solid comprising of more than one type of ion; in pharmaceutical salts at 
least one of these ionic components includes an API. These charged entities are often generated 
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through proton transfer, leading to two oppositely charged components, held in the crystal 
lattice through both electrostatic attractions and intermolecular interactions. 
The development of pharmaceutically important molecules in salt form is a common 
occurrence in the pharmaceutical industry, because of the frequently low aqueous solubility of 
neutral active molecules. In fact, around 90 % of potential APIs are classified as exhibiting low 
aqueous solubility. According to the Biopharmaceutics Classification System (BCS), drug 
substances can be categorised in terms of permeability and solubility: high permeability / high 
solubility, high permeability / low solubility, low permeability / high solubility and low 
permeability / low solubility.14, 26 Introducing ionic components into the crystal lattice with the 
active molecule improves aqueous solubility as charged species dissolve more effectively in 
water, compared to the pure API form(s). The fundamental drawback to the formation of salts 
in pharmaceutical systems is that this relies on the active molecule being ionisable and thus 
restricts the choice of the API for pharmaceutical salt development.17, 18, 27  
1.2.4 Co-crystals  
Co-crystals are multi-component molecular materials comprising an API and co-former 
molecule or a second API in the crystal lattice, which exist as separate neutral entities and both 
of which are solids under ambient conditions. For pharmaceutical co-crystals the co-former 
should be benign and ideally a GRAS (Generally Regarded as Safe) molecule.14-16 
1.2.4.1 Crystal Engineering and Multi-Component Crystallisation  
Crystal engineering is an approach in which multi-component functional solid-state materials 
are designed through attempted prediction of intermolecular interactions with the aim of 
improving physicochemical properties with respect to those of the parent material. Co-
crystallisation is a method for achieving crystal engineering goals through multi-component 
crystallisation whereby two or more molecules crystallise within the same crystal lattice 
(Figure 1.5).16, 28-30 In co-crystallisation, the co-former molecule is utilised to direct the bonding 
and improve crystal packing to impart favourable physicochemical properties.16, 31  
Molecular complexes designed in this way are seen as increasingly beneficial in the 
pharmaceutical industry where co-crystallisation can be used to prepare APIs with the potential 
of providing enhanced properties of existing materials; such co-crystals can also be patented 
as a new material. An example of a pharmaceutical co-crystal used in a drug product on the 
market is Betachlor, which was employed for its improved thermal stability over pure chloral 
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hydrate as an anti-inflammatory to treat diseases with a decreased adrenal gland function. In 
the crystal structure, the co-former molecule betaine forms tetramers of charge-assisted diol-
carboxylate supramolecular motifs (heterosynthons) with the chloral hydrate API (Figure 
1.6).32  
 
Figure 1.5 – Schematic representation of multi-component co-crystallisation involving API and co-former 
molecules. 
 
Figure 1.6 – Co-crystal formation of the pharmaceutical co-crystal Betachlor, with hydrogen-bonded chains of 
betaine and chloral hydrate molecules, forming a herringbone arrangement of molecules.24, 33 
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1.2.5 Intermolecular Interactions in the Solid State 
1.2.5.1 Hydrogen Bonding 
Hydrogen bonds often dominate the intermolecular interactions present in a molecular crystal 
structure, where molecules orient themselves to maximise the strength of the hydrogen bonding 
interactions. As a result of their directionality, hydrogen bonds largely govern the structure of 
extended materials.34  A hydrogen bond is defined as an attractive electrostatic interaction 
between a hydrogen atom with a resulting partial positive charge, 𝐻𝛿+, by virtue of being 
covalently bonded to an electronegative atom A such as oxygen (O), fluorine (F) or nitrogen 
(N). The strength of the hydrogen bond is increased with increasing electronegativity of atom 
A.35, 36 As a result of the partial positive charge associated with the hydrogen atom, the H atom 
is attracted to another electronegative atom B, containing a partial negative charge arising from 
polarisable π-electrons or a lone pair of electrons. A hydrogen bond A-H⋯B is a donor-
acceptor bridging interaction, where H acts as a bridging atom between atom A and atom B. 
Atom A is the hydrogen bond donor, atom B the hydrogen bond acceptor.36  
The strength of a hydrogen bonding interaction ranges from very strong, of comparable 
magnitude to a covalent bond, to much weaker interactions similar to the strength of van der 
Waals forces (Table 1.1). Most hydrogen bonds possess bond strengths between these two 
extremes. Electrostatic interactions dominate weak and moderate hydrogen bonds, as the 
hydrogen atom is more strongly attracted to atom A than atom B, whereas with increasing 
hydrogen bond strength, the nature of the hydrogen bond becomes more covalent as a more 
equal attraction exists between atom A and the hydrogen atom and the hydrogen atom and atom 
B. This equal atom attraction is indicative that the system may be close to undergoing hydrogen 
transfer; although in solution this is dictated by the p𝐾𝑎 values of the donor and acceptor 
molecules, this is not so clearly the case in the solid state. The closer the A-H⋯B bond angle 
to 180°, the stronger the hydrogen bond; linear hydrogen bonds of this type with very short 







Table 1.1 – Properties of hydrogen bonds.36 
Hydrogen bond property Strong Moderate Weak 
A-H⋯B interaction Largely covalent Largely electrostatic Electrostatic 
H⋯B bond length (Å) ~1.2-1.5 ~1.5-2.2 2.2-3.2 
A⋯ ⋯B bond length (Å) 2.2-2.5 2.5-3.2 3.2-4.0 
A-H⋯B bond angle (°) 175-180 130-180 90-150 
Bond energy (𝑘𝑐𝑎𝑙𝑚𝑜𝑙−1) 14-40 4-15 1-4 
Directionality Strong Moderate  Weak 
 
1.2.5.2 Supramolecular Synthons and the Cambridge Structural Database (CSD) 
Crystal engineering requires an understanding of intermolecular interactions; these 
intermolecular interactions are rationalised by the functionalities of the molecules present in 
the crystal structure.37 The use of intermolecular interactions in the design strategy coupled 
with identification of the so-called supramolecular synthons that could potentially form, targets 
the prediction and control of the crystal structure.34, 38, 39 A supramolecular synthon is employed 
to simplify the description of the crystal packing by only including those atoms important to 
the intermolecular interactions, allowing for a logical and regular route to understanding how 
the overall packing assembly in the crystal structure is built up.14 
Information on how such units form can then be used in an attempt to predict the structures of 
other materials containing similar functionalities. This is the principle underlying the use of the 
Cambridge Structural Database (CSD)24 in this area, which contains all reported crystal 
structures, including co-crystals, from the literature. The Cambridge Crystallographic Data 
Centre (CCDC) has developed search functions within the Mercury programme for exploring 
the wealth of structural information available in the CSD. The CSD is a valuable tool when 
designing new co-crystals in materials discovery, as trends in the interactions of existing co-
crystals in the database can be used in the design strategy of new co-crystallisation attempts 
with the same targets involving alternative co-former molecules containing similar functional 
groups.  
Assessing crystal structures directly based upon the molecular components is a simplification. 
The intermolecular interactions present in a crystal structure not only depend on the functional 
groups present in the molecules, but also the location and presence of other functionalities in 
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the local environment. Therefore, the use of the CSD in the design approach is rather as a guide 
as opposed to a rule for future attempts in crystal engineering. 
Carboxylic acid moieties are utilised heavily in crystal engineering owing to their diverse 
hydrogen bonding potential; they also feature in the molecular structure of many 
pharmaceuticals.30, 31 The formation of hydrogen bonding interactions between two carboxylic 
acid groups leads to the formation of a homosynthon. However, a CSD study carried by Steiner, 
found that instead of the formation of carboxylic acid homosynthons, carboxylic acids would 
instead preferentially bind to non-oxygen acceptors, such as pyridyl nitrogen atoms, provided 
these alternative sites are available. This leads to the formation of a heterosynthon, offering a 
suitable route to the formation of co-crystals (Figure 1.7).40  
 
Figure 1.7 – Examples of a supramolecular homosynthon (left) and heterosynthon (right). 
1.3 Crystallisation 
Crystallisation is a phase change where randomly organised molecules, ions or atoms within a 
saturated solution condense to a regular and ordered crystalline solid. Crystallisation 
encompasses key areas of chemistry as well as chemical and process engineering, not only being 
useful as a purification and separation technique, but also as a means of producing new solid-
state materials and functioning as a branch of particle technology.25, 41, 42 Crystallisation is an 
important operation particularly in the pharmaceutical industry where the large majority (> 
80 %) of commercially available APIs are delivered as a solid dosage form and thus require 
crystallising post-synthesis.43 
Designing a crystallisation process to meet required product specification is a challenge. The 
pharmaceutical industry employs solution-based crystallisation for achieving desired product 
quality attributes including size, shape, purity and polymorphic form, where the control of these 
properties is paramount in subsequent down-stream processing such as granulation and 
tabletting.44 Control over these aspects relies on an in-depth knowledge of the solubility and 
metastable zone widths (MSZWs) of each of the polymorphic forms in a variety of solvents. To 
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add to the variables requiring control, MSZWs will vary with scale of operation, intensity of 
mixing and the type of crystalliser employed. Control of the crystallisation process is governed 
by gaining control over both the nucleation and growth steps of crystallisation; thus, to gain 
fuller control the poorly understood process of nucleation requires improved understanding.9, 11 
1.3.1 Solubility and Supersaturation 
The starting point in the design of any solution-based crystallisation process is a thorough 
understanding of the solubility of the API in a given solvent. Solubility is defined as the 
maximum amount of solute able to dissolve in a given solvent or solvent mixture at a specified 
temperature.11 A solution is classed as saturated when the solute concentration reaches the 
solubility limit; at which point dissolved and undissolved solute establish a thermodynamic 
equilibrium, illustrated by the equilibrium solubility curve in Figure 1.8.11 Below the solubility 
limit, the solution is undersaturated and stable with respect to crystallisation. Above the 
solubility limit, the solution is considered to be supersaturated, where there is a greater amount 
of solute dissolved in the solution than the equilibrium value for saturation and therefore 
spontaneous nucleation can occur.  Inside the metastable zone (MSZ), bounded by clear and 
cloud points in the turbidity method of solubility determination, primary nucleation cannot 
occur, however secondary nucleation can occur, in addition to crystal growth. Once the 
solubility of a solute-solvent system has been established at various temperatures, it is possible 
for the MSZW for that particular solute-solvent system to be established, shown as the distance 
between the equilibrium solubility and metastable boundary curves in Figure 1.8.11, 25, 39 The 
temperature dependence of solubility can be represented on a phase diagram of concentration 
versus temperature (Figure 1.8).  
The region in which a system can be classified as supersaturated but if undisturbed nucleation 
will not take place is known as the MSZ. For spontaneous nucleation to proceed, the system 
must pass beyond the MSZ via an increase in supersaturation of the system in to the so-called 
labile region. Nucleation is governed by kinetics, which dictates the size of the MSZ, which in 
turn dictates the extent of increase in supersaturation required to generate nuclei. Therefore, 
the nucleation and MSZW of a system exhibit innate variability with crystallisation 
environment, whereby experimental factors such as stirring and scale of crystallisation, as well 




Figure 1.8 – Solubility curve (solid line), metastable boundary (dashed line) and MSZW highlighted as the 
region between the two curves. 
The equilibrium solubility of a system is governed by thermodynamics and thus for a given 
solute-solvent system, the solubility behaviour will not be influenced by the crystallisation 
environment. Although the equilibrium solubility is a thermodynamic property, the metastable 
region is governed by kinetics. Importantly, until the crystallising system passes through the 
metastable region, the spontaneous nucleation occurring in the supersaturated region cannot 
proceed; this is known as the kinetic barrier to crystallisation. Supersaturation is the driving 
force of crystallisation as the solid and solute are no longer in equilibrium. To return the system 
back to equilibrium, solid material precipitates out of solution.41 
Supersaturation can be expressed mathematically in a number of ways using the terms solution 
concentration (c) and the equilibrium solubility concentration (c*). Equation 1.1 considers the 
supersaturation (∆C) as the difference between the solution concentration (c) and the 
equilibrium solubility concentration (c*) as the driving force for crystallisation, whereby the 
larger the value of ∆C, the greater the driving force for crystallisation. Equation 1.2 considers 
the same terms of solution concentration and the equilibrium solubility concentration but 
expressed as a ratio of the two terms, known as the supersaturation ratio, S. The value of S 
must be greater than 1 for the system to be supersaturated and thus for crystallisation to occur. 




∆𝐶 = 𝑐 − 𝑐∗  
Equation 1.1 – Supersaturation expressed in terms ∆C – the difference between c – the solution concentration 
and c* – the equilibrium solubility concentration. 




Equation 1.2 – The Supersaturation ratio, S. 
  
𝜎 =  
∆𝐶
𝑐∗
= 𝑆 − 1 
Equation 1.3 – The relative supersaturation, σ. 
1.3.2 Nucleation 
The initial step in the process of crystallisation is the formation of crystal nuclei within the 
system, referred to as nucleation. These minute crystal nuclei are the centres for crystallisation. 
Once these nuclei have formed, their growth into crystallites can occur. Various mechanisms 
for nucleation exist; these are grouped as primary and secondary nucleation (Figure 1.9). 
Primary nucleation occurs without the presence of any crystalline particles (homogeneous 
seeds). Primary nucleation can be further categorised into homogeneous and heterogeneous 
depending on whether the nucleation is spontaneous or is induced by a foreign particle, 
respectively. Homogeneous primary nucleation can only be achieved once the concentration of 
the solution has moved through the MSZ and passed into the supersaturated region of the phase 
diagram. This type of spontaneous nucleation allows for little control to be exerted on the 
system, which will subsequently undergo crystal growth.  
Heterogeneous nucleation can exist in both primary and secondary nucleation, dependent on 
whether nucleation occurs in the presence of foreign particles such as silica particles or seed 
crystals of the solute, respectively. Unlike homogeneous primary nucleation, heterogeneous 
primary nucleation can occur within the MSZ as the presence of these additional particles 
provide a surface for nucleation. The presence of a compatible surface within the solution 
reduces the Gibbs free energy barrier and thus the barrier to nucleation; therefore, it is possible 
for nucleation to proceed at lower levels of supersaturation than those required for spontaneous 
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nucleation. The presence of seed crystals of the desired solid form in secondary heterogeneous 
nucleation provides interfaces for nucleation from solution and growth of their crystalline 
polymorphic form in preference to other crystalline forms that could also be crystallised from 
the system. Outside of the intentional introduction of the desired polymorphic form through 
the use of seeds of polymorphic purity, the contact mechanism is the most common model 
proposed for secondary nucleation, where crystal-crystal, crystal-impeller and crystal-wall 
collisions create secondary nuclei.9  
Secondary nucleation is a heterogeneous process whereby seed crystals of the desired 
polymorphic form are deliberately introduced into the system to promote crystallisation of this 
polymorphic form; 10, 11, 25 as an approach, seeding is thus more amenable to control.  
 
Figure 1.9 – The mechanisms of Nucleation.11 
How nucleation occurs is poorly understood, however theories for the process by which nuclei 
are formed from a homogeneous solution exist. This ambiguity stems from the challenge in 
analysing nuclei, where the number of molecules contributing to the nuclei may range from as 
low as ten to several thousand individual molecules. It is unlikely that such number of nuclei 
in a cluster would evolve from a single collision, as the probability of so many molecules 
colliding simultaneously is low. Therefore, a more plausible suggestion to the formation of 
such nuclei containing so many molecules is a sequential addition of preferred orientation from 
a bimolecular collision, which builds step-wise; this is known as Classical Nucleation Theory 
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(CNT). As the size of the cluster reaches the critical cluster size (rc), the intermolecular 
interactions within the cluster begin to be more favourable than the intermolecular interactions 
with surroundings in the system. Once the critical cluster size has been reached, the free energy 
of the nuclei decrease such that growth can occur and eventually a crystalline lattice has 
formed.9-11, 45 
The free energy diagram for nucleation (Figure 1.10) indicates the critical nucleus size at which 
point the nuclei are stable and will not re-dissolve. This critical nucleus has an associated Gibbs 
free energy requirement, ∆GCritical. The outcome of whether particles re-dissolve or grow is 
governed by a resultant decrease in the Gibbs free energy of the particles.9, 10, 45  
 
Figure 1.10 – Free energy diagram for nucleation, indicating the presence of the ‘critical nucleus’ size, rc.45 
Any nuclei which do not reach the critical cluster size simply re-dissolve in solution as they 
are unstable due to the large surface area / volume ratio, whereas once the clusters are at least 
equal to the critical cluster size or greater, the surface area / volume ratio has decreased to a 
point where the nuclei are stable and thus will not re-dissolve. The composition of this critical 
cluster is not known due to its minute size and short-lived nature, it is possible it is a well-
defined crystallite or a more diffuse less-defined state.10 CNT has limitations, such as the basic 
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presumption that one molecule is added to the growing cluster at a time. This seems unlikely 
considering that clusters have the tendency to aggregate and rearrange their orientations whilst 
building up to the critical cluster size. In fact, it is likely that the rate of molecular addition is 
greater than the ability of these molecules to orient themselves favourably, leading to regions 
of the solid exhibiting an amorphous nature. This effect can however be reduced through the 
introduction of seeds, which predetermines the crystal lattice of the saturated solution. 9, 10, 45 
This fundamental limitation to the CNT is the premise for the other nucleation theory, known 
as the two-step nucleation theory (TST). Although this TST model was initially proposed as 
the mechanism by which proteins crystallise, since then both theoretical and experimental 
studies have proven that the TST model is as applicable to small organic molecules as to 
macromolecules, highlighting its broad relevance to solution-based crystallisation.45, 46 In the 
TST model, a cluster of sufficient size, much like that of CNT, is required to act as the centre 
for crystallisation, however in TST the particles within the cluster will rearrange themselves 
into a more favourable ordered structure larger than the critical nucleus size. This second step 
of cluster reorganisation is the rate-limiting step, where more complex structures take longer 
to reorganise themselves into the preferred arrangement (Figure 1.11).  
 
Figure 1.11 – Diagram comparing classical nucleation theory (CNT) and the two-step nucleation theory 
(TST).45 
1.3.3 Crystal Growth 
Once the nucleation process has occurred, the stage of crystal growth can proceed. Crystal 
growth involves the expansion of the stable nucleation centres formed in nucleation into 
macroscopic crystals. Exposing a crystal surface to a supersaturated solution causes the rate of 
movement of material to the crystal surface to exceed the rate of movement away from the 
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crystal surface, the net effect yielding crystal growth.25 The ability of a crystal surface to attract 
this material within the supersaturated solution and use it for crystal growth is dependent on 
the level of attachment and the relative strengths of these interactions.  
The basic principle for crystal growth relies on a build-up of layers, where new material, 
whether a molecule or cluster nucleus, first sheds its layers of solvent before bonding with the 
pre-existing crystal layers. The structure of a growing crystal surface may be categorised by 
the number of attachments: flat surface (F), growing step (S) and kink sites (K), which 
correspond to one, two and three attachments respectively (Figure 1.12).9, 47 The greater the 
number of potential attachments the growth unit can make with the existing crystal surface, the 
greater the affinity of the growth unit to adsorb to the crystal surface and lead to crystal growth. 
This results in kink faces being the fastest growing and flat faces being the slowest crystal 
growth surfaces. The slowest growing flat faces determine the final morphology of the crystal.  
 
Figure 1.12 – Crystal surface structure containing flat (F), step (S) and kink (K) faces.11 
Crystal growth is entropically an unfavourable process; a system will not preferentially drive 
to become more ordered, as this process exhibits a decrease in entropy. The crystal growth will 
only occur if growth sites with higher interaction energies can be created. The parameter α is 
defined to indicate which surfaces are likely to facilitate growth and develop multiple sites of 
interaction (Equation 1.4).25 




Equation 1.4 – The α factor used to predict the relative ease of crystal growth, where ∆E = energy change, k = 
Boltzmann constant and T = temperature. 
A low value of α corresponds to a surface with multiple growth sites available to facilitate 
crystal growth, whereas crystal surfaces with a large associated α term indicate that crystal 
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growth is difficult to achieve; in this case, special growth mechanisms are necessary. There are 
three common pathways with an increasing tendency for multiple site formation: continuous 
growth, surface nucleation and spiral growth.9, 10, 25 
It is possible for a crystalline system to have a comparable affinity to the formation of the 
higher binding sites, such as kinks and steps. In these crystalline systems, the continuous 
growth mechanism is adopted and the α-factor must be less than 3. This continuous growth 
mechanism indicates that every solute molecule arriving at the crystal surface will find a 
growth site as the energy requirement to form a step feature is low. Hence, the growth rate for 
the continuous growth mechanism is linear and extends throughout the range of 
supersaturation. Crystalline systems rarely adopt the continuous growth mechanism as these 
materials do not possess sufficient roughness. In this case, rather than binding directly the 
majority of material approaching potential growth surfaces will either return to the solution 
phase of the system, or adsorb to previously deposited crystalline species already bound to a 
growth site; this preferential adsorption causes the formation of surface islands or nuclei 
(Figure 1.13).  
Surface nucleation requires a larger α-factor than the continuous growth mechanism, in the 
range between 3 and 5. These surface islands eventually spread across the crystal surface as 
more solute molecules approach from solution leading to perpendicular growth in relation to 
the plane of the face. Surface islands produce both steps and kinks on the original crystal 
surface, which provide attachments for new crystalline material approaching the growth sites 
(Figure 1.13).  
 
Figure 1.13 – Formation of surface nuclei / islands. 
At α-factor values greater than 5, spiral growth or screw dislocation becomes the dominant 
mechanism and the formation of higher interactions such as kinks or steps is extremely difficult 
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(Figure 1.14). In this case, intermolecular interactions at the surface are increased, reducing the 
probability of surface nuclei formation, which ensures that the surface is flat. This growth 
mechanism utilises the fact that no crystal is perfect and therefore without defects, resulting in 
crystal surfaces which feature a self-generated step. Inherent lattice defects such as screw 
dislocations, a misalignment of the crystal lattice, permit spiral growth. These lattice defects 
could arise from heterogeneous growth via the addition of seeds crystals, additives or 
impurities to the crystalline system, each of which can impart stress during the growth process, 
leading to misalignment and in turn, points of emergence seen as steps. These vertical steps 
provide multiple binding sites for growth to occur.25 
 
Figure 1.14 – The mechanism of spiral growth. 
1.3.4 Crystal Morphology  
In addition to the internal crystal structure, the crystal morphology or crystal habit – the external 
shape of the crystal system – is also of great importance.10 The relative growth rates of the 
various crystal faces, which feature in a growing crystalline system, dictate the resultant 
morphology observed. The crystal morphology is described in terms of the set of 
crystallographic planes that show on the crystal surface, defined by their corresponding Miller 
indices, where the distance from the origin is proportional to the growth rate.48 As an example, 
the (001) Miller index describes a face that grows parallel to both the crystallographic a- and 
b-axis and intercepts the c-axis.25 
Crystal morphology influences both the crystallisation process and crystalline product. Crystal 
morphology can have a detrimental effect on secondary processing, where needles and plate-
like crystals exhibit a low packing density, leading to blockages in the filtration steps due to 
the formation of an impervious layer (Figure 1.15). These undesirable morphologies influence 
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the viability of the crystallisation process. Crystal morphology also affects the end use of 
crystalline products, as crystal habit can modify the bioavailability of the drug product.  
 
Figure 1.15 – Cuboid and plates/needle morphology comparison for filtration processing.25 
1.3.5 Crystallisation Methods 
The most common method of crystallisation employed in the pharmaceutical industry is 
solution-based crystallisation approaches.46 In the pharmaceutical industry, early phase drug 
development involves version selection, in terms of exploring salts and co-crystals of an API, 
followed by a polymorph screen, an automated screening, which targets the thermodynamic 
form of the API material and aims to understand the polymorphic landscape.49 ‘Fit for purpose’ 
crystallisation development is then carried out, ensuring that the crystallisation method will 
produce acceptable purity and yield, as well as the correct version and polymorph.   
The choice of the crystallisation method is largely governed by the dependence of the solubility 
of the solute-solvent system on temperature. For instance, if the solubility of the system is only 
weakly dependent on temperature, then evaporative crystallisation or precipitation methods 
such as reactive or anti-solvent crystallisation methods are the most suitable choices. For 
systems that produce a steep solubility curve for concentration versus temperature dependence, 
then cooling crystallisation should be employed, in order to achieve sufficient yield.11, 50  
1.3.5.1 Evaporative Crystallisation  
In evaporative crystallisation methods, supersaturation of the solution is achieved via 
evaporation of the solvent. Initially the solution will be undersaturated; once the solution is left 
to evaporate at a suitable temperature, the concentration will increase due to evaporation of the 
solvent, the solution reaches the MSZ and eventually becomes labile (Figure 1.16). Once the 
solution has increased in concentration enough to meet the metastable boundary, the solution 
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is considered supersaturated (in the so-called labile region beyond the MSZ), at which point 
spontaneous nucleation can occur followed by crystal growth, whereby precipitation of 
crystalline material out of the solution causes a simultaneous decrease in the solution 
concentration, causing the system to returns towards the solubility curve. If the system is left 
to further evaporate, the saturation point will be reached once more and further crystal growth 
observed; this cycle continues until all the solvent in the solute-solvent system has evaporated. 
During evaporative crystallisation, the system is kept at constant temperature and the 
concentration of the solution is dependent on the solubility of the solute in the solvent. The 
crystallisation profile is dependent on the temperature and the volatility of the solvent.9, 11, 25, 50  
 
Figure 1.16 – Schematic of an evaporative crystallisation profile. 
1.3.5.2 Cooling Crystallisation  
A more advanced and controlled technique than evaporative crystallisation methods is cooling 
or temperature-controlled crystallisation, a favoured method of crystallisation for batch 
production.51, 52 In cooling crystallisation, the system is cooled from the undersaturated to the 
supersaturated region. Much like in evaporative crystallisation, when the system reaches the 
metastable limit, nucleation and crystallisation is triggered and there is a subsequent decrease 
in concentration of the solution as some of the solute has precipitated out of the solution; this 
takes the system to within the MSZ. In the design of cooling crystallisation experiments it is 
important to ensure that the cooling of the system once it has achieved nucleation is controlled 
such that it remains in the metastable region to ensure no further primary nucleation may 




Figure 1.17 – Schematic of a cooling crystallisation profile. 
As the MSZ is a kinetic phenomenon, its size varies with the crystallisation conditions, such as 
cooling rate, stirring rate and scale of the crystallisation. Under a faster cooling rate the system 
will not have the opportunity to reach equilibrium conditions and therefore the crystallisation 
occurs under kinetic control and thus is more likely to lead to the production of less stable 
polymorphs as opposed to the thermodynamic polymorph that is more likely in cases where 
the system has been allowed to reach equilibrium when slower cooling rates are employed.  
1.3.5.3 Seeded Crystallisation  
In seeded crystallisations, seed particles of the desired product either in dry form or as a seed 
slurry are added to the crystallisation to overcome the stochastic nature of nucleation by 
avoiding spontaneous nucleation in the system. The seeds are introduced when the growth 
solution is in the MSZ; the addition point must be carefully positioned, if the seeds are added 
when the temperature of the solution is too high the seeds will simply dissolve, however if seed 
addition occurs too close to the metastable boundary, then the increase in solute concentration 
(via seed crystal addition) risks spontaneous nucleation. Once the seeds are added, the solution 
is then cooled, maintaining stability within the MSZ. Seeding is commonly employed in the 
pharmaceutical industry to gain control over solid form and produce a narrower particle size 
distribution (PSD) than non-seeded crystallisations. 9, 11  
1.3.5.4 Anti-solvent Crystallisation  
In anti-solvent crystallisation, a solvent in which the solute in the system displays poor 
solubility is added to an undersaturated solution. This anti-solvent addition increases the 
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supersaturation of the solution by essentially lowering the solubility curve so that the 
supersaturated region can be achieved at lower concentrations leading to crystallisation (Figure 
1.18). The effect of dilution by addition of the anti-solvent is outweighed by the reduction in 
solubility caused by the addition of the anti-solvent to the system. 
 
Figure 1.18 – Schematic of an anti-solvent crystallisation profile. 
1.3.5.5 Reactive Crystallisation  
Reactive crystallisation occurs when two or more compounds react within solution and the 
resultant product of the reaction is less soluble than the constituent starting components in the 
solvent system. Similar to anti-solvent crystallisation, this decrease in solubility and resultant 
increase in supersaturation causes crystallisation. The rate at which reactive crystallisation is 
achieved is dependent on the rate of reaction of the starting materials.  
1.3.5.6 Slurrying Crystallisation 
Solution mediated phase transformations (SMPTs) can be investigated via solution-mediated 
crystallisation techniques, known as slurrying. This method of crystallisation is a suspension 
technique, whereby an excess of solid is added to solvent and stirred for a period of time 
without complete solid dissolution. Some solid dissolution may occur in polymorphic systems, 
whereby dissolution of the metastable form and subsequent crystallisation of the stable form 
occurs during a SMPT. This method of crystallisation can be used to identify new polymorphic 
forms, to identify the thermodynamic form from concomitant polymorphs, or for screening for 
novel multi-components systems, such as co-crystals. The desired polymorph, obtained from 
slurrying crystallisations, can be tuned by varying experimental parameters such as slurrying 
time, stirring rate, temperature, solid loading and scale of operation.8  
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Systems that exhibit polymorphism in solution will undergo SMPTs, dictated by Ostwald’s 
Law of Stages: first, the metastable phase will undergo dissolution, second, nucleation of the 
stable phase, third, growth of the stable phase will occur. This implies that a low-energy route 
to interconversion between polymorphic forms exists.53  This transformation from the 
metastable to stable polymorph can be facilitated in solution as a result of the number of degrees 
of freedom molecules possess in this phase. Therefore, molecules in solution have the 
opportunity to re-orientate and re-align themselves so that as the molecules crystallise the free 
energy of the system is minimised. The SMPT is thermodynamically driven by the solubility 
difference between polymorphs.  
If a dimorphic system contains monotropic polymorphs, where form I is the thermodynamic 
form and form II is the metastable form, the use of slurrying to facilitate SMPTs can transform 
form II into form I in solution. The SMPT can be achieved by addition of an excess of form II 
to a solvent, yielding a slurry suspension of form II. As the thermodynamic form is the least 
soluble, form I will be less soluble than form II and thus the solution will be supersaturated 
with respect to form I. Once form I crystallises from solution, the concentration of the solution 
decreases, which simultaneously allows additional form II to dissolve in solution. In turn this 
causes more nucleation and growth of the stable form I. This cycle proceeds until full 
conversion from form II to form I is complete.54-56,57 
The same principle can also be applied to the formation of multi-component systems, such as 
co-crystals. The co-crystal A-B is comprised of single component A and single component B, 
where the co-crystal A-B exhibits a lower solubility in the particular solvent compared to the 
solubility of the individual components A and B in the same solvent. The thermodynamic 
relationship between the single components and multi-components facilitates the formation of 
the co-crystal (Figure 1.19). The co-crystal A-B could be accessed via a SMPT from a slurry 
containing an excess of the pure starting components A and B in the chosen solvent. The system 
is considered supersaturated with respect to component A and component B; the system will 
therefore be supersaturated with respect to the co-crystal A-B, provided the co-crystal exhibits 
a lower relative solubility in the chosen solvent. Once the system reaches supersaturation, 
nucleation of the co-crystal A-B can proceed in preference to crystallisation of either individual 
component. This cycle proceeds until full conversion from the starting components A and B to 




Figure 1.19 – Schematic of solubility curves of single components A and B, compared to the solubility curve of 
the multi-component co-crystal A-B. 
1.3.5.7 Mechanochemical Crystallisation  
Mechanochemistry refers to chemical reactions, typically of solid-state materials, achieved 
through the application of mechanical energy to the reaction system, either through neat 
grinding or the inclusion of minimal solvent, known as liquid assisted grinding (LAG). This 
approach can be applied particularly in the area of co-crystallisation, with the notable benefit 
of being less solvent intensive than solution-based crystallisation approaches. In addition, 
mechanochemical crystallisation is less dependent on the effects of solubility and solvent 
competition within a crystallising system compared to other crystallisation approaches.  
Mechanochemistry can be applied to the crystallisation of organic molecular materials, as 
mechanical energy can overcome the intermolecular interactions present within crystal 
structures allowing the opportunity for other intermolecular interactions, perhaps between the 
target and co-former molecule in attempted co-crystallisations to be achieved. The high 
molecular mobility achieved through the application of mechanical energy to the crystallising 
system, offers the opportunity to manipulate polymorphic form as well as produce new 
molecular materials.58-60 Both neat and LAG methods can be achieved using a traditional 
mortar and pestle or an automated mechanical ball mill apparatus.  
In the case of LAG, minimal solvent is introduced along with the solid starting materials in 
preparation for grinding, to aid the formation of co-crystals. The incorporation of a small 
amount of solvent in the grinding of solids has been shown to increase the rate of solid-state 
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crystal formation.61 The use of LAG can also encourage co-crystal formation in cases where 
the components have significantly different solubilities with respect to solution-based methods.  
1.3.6 Continuous Manufacturing 
Traditionally within the pharmaceutical industry, crystallisation is carried out via batch 
manufacturing methods. This standard approach utilises large stirred tank reactors, in which 
large volumes are being produced at one time.42 Process steps in batch manufacturing are 
usually not fully integrated, leading to long lead times and large associated inventory costs. 
They are also generally energy intensive and use large amounts of solvent. 
A technological shift to continuous production offers the opportunity to improve product 
quality and variety, reduce inventories, lower production costs in terms of time, energy usage 
and waste, as well as producing drug products on a variety of scales and enabling affordable 
personalised drugs to become a reality. However, a key drawback to the implementation of 
continuous processing is the complex and expensive regulatory procedure required to alter the 
current manufacturing methods (Table 1.2).62 Although some pharmaceutical companies are 
employing continuous processing to produce drug products, the uptake of continuous 
crystallisation and manufacturing of pharmaceuticals and fine chemicals remains limited. 
Table 1.2 – Opportunities for and barriers to Continuous Manufacturing.62 
Opportunities for Continuous Barriers to Continuous 
1. Cost 
 Reduced capital investment due to 
smaller facilities and plant footprint 
 Operating costs are lower, due to 
reduced labour requirements, increased 
asset utilisation, cheaper development 
costs, lower energy requirements 
 Reduced inventory costs (less material 
handling and transport costs) 
 
2. Product and Volume Flexibility 
 System can be easily altered to change 
product mix (Product Flexibility) 
1. Regulatory 
 Process Analytical Technology (PAT) 
and Quality by Design (QbD) not yet 
compliant  
 No regulatory body approval 
 No quality validation procedure 
 Sterility issues 
 
2. Social 
 Perception that it is only suitable for 
large scale 




 System can be easily altered to respond 




 Improved process control (>5σ, right-
first-time) 
 Less product rejection (in situ quality 
testing) 
 Integration of quality control and 
compliance (QbD) 
 Process safety and control 
 
4. Responsiveness 
 Move towards ‘made-to-order’ supply 
chain 
 Reduced time to market 
 Easier recycling 
 Minimised reaction time through better 
process parameter control 
 Little or no scale-up development 
required 
 Accelerated introduction of APIs to 
market 
 
5. Rapid scale-up 
 Ease of scale-up post clinical trial 
 
 
3. Process and Technology 
 Lack of process and technology 
understanding 
 Unknown process development 




 Resource availability 
 High initial start-up costs 
 Specialised equipment costs 
 Specialised personnel requirements 
 
When shifting to the uptake of continuous processing methods, a range of fundamental 
differences must be considered. The key characteristics of stoichiometry, reaction time, 






Table 1.3 – Comparison  of the fundamental characteristics of batch and flow processing methods.63 
Characteristic Batch Flow 
Stoichiometry Defined by the concentration and 
molar ratio of the starting 
components 
Determined by the concentration of 
the reagents and the ratio of their 
flow rates 
Reaction time Time spent under the reaction 
conditions 
Time spent in reactor – dependent on 




Time spent in reaction vessel Dependent on distance travelled 
along reactor length 
Steady-State Uniform concentration of 
components throughout reaction 
vessel  
Reactant concentration is steady with 
time but varies along reactor length 
1.3.7 Flow Chemistry and Flow Crystallisation  
The traditionally accepted advantages of flow chemistry include improved mixing and heat-
mass transfer enabling precise control of both reaction and process parameters,64, 65 but in 
addition the ability to carry out challenging chemistry not easily attainable in batch, such as 
photochemistry and reactions involving unstable intermediates, can also benefit from the 
adoption of flow chemistry.66 
Furthermore, the ability to handle potentially hazardous materials within, for example, a 
microreactor, align well with the ‘12 Principles of Green Chemistry’, emphasising safety as a 
key driver to the deployment of flow chemistry. The improved heat-mass transfer also means 
that this technology contributes to these ‘Sustainable Development Goals’ for greener and more 
sustainable chemistry solutions.64, 66, 67  
Flow technologies can be used as a means to direct the synthesis and assembly of materials for 
which the crystalline structure is important for the resultant properties, whereby some of the 
conditions, such as very slow or very fast mixing and the use of very small volumes of reagents 
can be achieved in flow environments but not via batch methods. These conditions are inherent 
to the nature of flow environments; for instance, reproducible control over particle size is a 
direct result of a combination of homogeneous mixing conditions as well as temperature 
control.65 Flow technologies can control the resultant structure through careful design of the 
ordering of reagents.65 
In flow crystallisation the key attribute in confirming reactor efficacy is by the particle size 
distribution (PSD) of the crystalline product; the narrower the PSD, the higher the level of 
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homogeneity experienced within the reactor, which typically is the goal in crystallisation to 
meet critical quality attributes (CQAs) criteria. 
1.3.7.1 Residence Time (RT) 
In batch processing, the reaction time is determined by how long the batch reactor is held under 
a set of reaction conditions. In continuous processing, the reaction time is instead described by 
the residence time (RT), which refers to how long the reactants reside in the reactor. The RT 
depends on the volume of the reactor and the flow rates of the reactants.63, 68 
In a tubular flow reactor, the RT can be calculated by the diameter and length of the tubing, 
along with the flow rate (s) (Figure 1.20 and Equation 1.5). The RT of a reaction can be varied 
through alterations to the size of the reactor, including bore size of the tubing, which alters the 
cross-sectional area, increasing the length of the tubing or adjusting the flow rates. There is an 
inversely proportional relationship between the flow rates employed and the RT, where at low 
flow rates this contributes to a longer RT in the reactor. 
The RT with respect to chemical reactions and crystallisation processes requires optimisation; 
if the RT is too low, the chemical reaction may not have reached completion and similarly for 
a crystallisation process, without sufficient RT in the crystalliser crystal growth may not have 
time to happen, a desired polymorphic transformation may be incomplete resulting a 
polymorphic mixture, or the transition may not have even started to proceed. On the contrary, 
if the RT is too long undesirable phase transformations could occur, or simply the solution is 
occupying the crystalliser for no benefit. In any flow system, a distribution of residence times 
will exist as a result of the fluid dynamics of the system, not all molecules that enter the reactor 
spend the same time period in the reactor.69, 70 This variance from the ideal residence time is 
known as the residence time distribution (RTD). During flow process optimisation, the RTD is 
minimised in order to maximise the consistency of the process. Strategies to reduce the RTD 
include enhanced mixing, alteration to the reactor geometry, reduction in solution viscosity and 













Equation 1.5 – Residence Time, RT calculated using r – radius of tubing (cm), l – length of tubing (cm), V – 
volume of tubing (mL) and Q – flow rate (mL/min). 
1.3.7.2 Steady-State Operation 
In a continuous flow reactor, the system can be considered to be operating at steady-state, 
provided at a given set point the concentration of a chemical species remains constant with 
time (Figure 1.21); however, in the event of precipitation or reaction, the concentration may 
differ with spatial point along the reactor.73 Steady-state operation can only be achieved once 
the system has completed a start-up period at the desired flow conditions (including 
temperature and flow rate (s)), to allow the system to reach equilibrium. Similarly, the system 
will move into an unsteady-state after any alterations in process variables are made and thus 
the stage of start-up will need repeating in order to return the system to steady-state.42, 70 Flow 
crystallisation processes, which suffer from blockages and issues with encrustation, will 
therefore experience disturbances to the pressure in the system, which causes the system to 
move from a steady to an unsteady-state. When continuous processes are operating at steady-
state, in contrast to batch processes, which consistently operate under non-steady-state 
conditions, the continuous flow process has the capability to impart much more control over 
the particles in the system and therefore control over CQAs is significantly more achievable in 




Figure 1.21 – Schematic of a single spatial point of a continuous flow process operating at steady-state, between 
the stages of start-up and shutdown. 
In order to establish whether a flow system has reached steady-state operation, an inert trace 
material can be employed to monitor the progress of the reaction by measuring, for instance, 
the concentration of a dye trace using a spectrometer. The system is confirmed to be operating 
at steady-state once the concentration of the dye remains constant with time.70  
1.3.7.3 Mixing, Mass and Heat Transfer 
The adoption of continuous processing can accomplish improvements in mixing, mass and heat 
transfer, as a result of the improved surface area-to-volume ratio, compared to the low surface 
area-to-volume ratio in traditional batch methods. Typically, in batch, the large stirred tank 
reactor requires an outer heating jacket to regulate temperature, in which the transfer of heat 
within the reactor is inefficient, where components at the edge of a reactor are heated to a 
greater extent than particles in the centre. Similarly, the impeller employed at the centre of the 
reactor to facilitate mass transfer and mixing in the system, will provide a greater degree of 
mixing to particles at the centre of the reactor, but poor mixing to particles at the walls of the 
container.68 The use of continuous processing methods imparts homogeneity on the system, 
which ensures that all particles experience similar conditions, in terms of RT, mixing, mass 
and heat transfer. 
In continuous processing, a system can benefit from approaching the adoption of plug flow 
conditions (Figure 1.22), in which particles experience the same conditions over the same time 
period, due to a narrow RTD. Plug flow conditions such as uniform concentration, velocity and 
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temperature profiles can be achieved in a plug flow reactor (PFR). The PFR model assumes 
there is no mixing in the direction of the flow (no back-mixing), whereby only radial mixing 
occurs transverse to the flow, allowing the flow to travel through the reactor as a single ‘plug’ 
from the inlet to the outlet. A system operating under plug flow conditions is an idealised 
situation; however, designing a system that can maintain conditions close to plug flow is 
sufficient for the assumption to be held.70  
The mixing behaviour in fluids can be broadly categorised into laminar, transitional and 
turbulent flow. The Reynold’s number, Re is a dimensionless mass transfer coefficient used to 
describe flow patterns in fluids, whereby the magnitude of Re can be used to describe the type 
of flow present. The magnitude of Re for a fluid can be determined from Equation 1.6. 
68 A low 
Re of < 2300 results in laminar flow dominating the fluid dynamics, an intermediate value of 
Re, between 2300 < Re < 4000 results in transitional flow and large Re values > 4000 correspond 
with turbulent flow. 63 Laminar flow features a radial distribution of velocities, where the 
maximum velocity and shortest residence time is achieved in the centre of the tubing, whilst 
the slowest moving particles with the longest residence times are those, which travel close and 
interact with the inside of the tubing.  
The size of the reactor influences the flow regime accessible at a particular scale (Table 1.4). 
In microreactors and nanoreactors laminar regimes can provide efficient mixing, whilst at 
larger scale, turbulent flow is necessary to maintain the quality of the heat and mass transfer, 
which is obtainable from this intense and random motion of fluid. To achieve plug flow in a 
tubular reactor, a high velocity flow rate is necessary to generate turbulent mixing; however, 
this causes a reduction in the RT, which could be insufficient for completion of the reaction or 
polymorphic transformation. An alternative strategy to maintain sufficient mixing at larger 
scale is to employ segmentation into the flow based on the premise of immiscibility of different 
media (Figure 1.23), which allows plug flow conditions to be achieved irrespective of flow 





Figure 1.22 – Fluid flow profiles for the different types of fluid flow: plug flow, laminar flow, transitional flow 





Equation 1.6 – Reynold’s number, Re, where ρ – density of the fluid (kg m-3), υ – net flow velocity (m s-1), d – 
diameter of the tube (m) and μ – dynamic viscosity (kg m-1 s-1). 
 
Figure 1.23 – Segmented flow comprising three immiscible media: media 1 (green), media 2 (blue) and media 3 
fills the inside of the tubing (off-white). 
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Table 1.4 – Scale of reactor and corresponding flow regime.63 
Scale Characteristic size (m) Flow regime 
Nano 10-7-10-9 Laminar 
Micro 10-7-10-5 Laminar 
Meso 10-5-10-3 Laminar 
Macro  10-3 and larger Turbulent 
1.4 Aims of Research 
This work will focus on solid-state molecular materials discovery and crystallisation in a 
manufacturing context. These materials discovery and delivery methodologies were developed 
across the areas of flow crystallisation, materials science, analytical chemistry and reactor 
engineering. This research is relevant to the development of new pharmaceutical formulations 
with enhanced physical properties and continuous processing methods to manufacture these 
high value materials in an efficient, scalable and cost-effective manner.  
The area of continuous crystallisation is in its infancy, with relatively limited understanding 
into how crystallisation occurs in a flow environment and thus its potential capabilities are also 
unknown. This PhD project has implemented flow crystallisation platforms at various 
beamlines on the Diamond Light Source (DLS) synchrotron. The major benefit with 
synchrotron studies is that the high intensity available for data collection times on these 
beamlines makes it possible to measure evolving crystalline materials as they grow in the 
reactor, allowing in situ characterisation to be carried out in flow as a function of crystallisation 
time. The pivotal importance of this is that online X-ray diffraction (XRD) analysis will 
facilitate this augmented understanding of crystallisation processes in a flow environment that 
the pharmaceutical industry requires, where presently understanding of the crystallisation 
process through diffraction is generally limited to analysis of the final crystalline product.  
The project presented in this thesis looks at the development of capabilities for in situ 
diffraction of flow processes at Diamond Light Source (DLS), using segmented flow 
crystallisation platforms known as the KRAIC-D (Kinetically Regulated Automated Input 
Crystalliser – for Diffraction) and KRAIC-S (Kinetically Regulated Automated Input 
Crystalliser – Single Crystal). The design of these continuous platforms were developed and 
optimised for implementation on the Diamond beamlines I11 (High Resolution Powder 
Diffraction) and I19 (Small Molecule Single Crystal Diffraction). Studies of the crystallisation 
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of highly polymorphic and pharmaceutically relevant model systems were investigated in the 
KRAIC-D and KRAIC-S platforms both offline and online.   
Another area of research presented in this thesis is the use of crystal engineering for the 
discovery of new multi-component materials, notably co-crystals of the profen family, using a 
range of crystallisation methods and techniques to evaluate the physical properties of these 





Chapter 2 – Theory of Diffraction Methods 
2.1 X-ray Crystallography  
Knowledge of chemical structure is the fundamental basis to understanding a material’s 
behaviour; in the solid state, it is also vital to understand the crystal structure. The study of 
crystal structure is termed ‘crystallography’, a fundamental analytical technique for structural 
determination of molecular materials.75  
The technique of X-ray crystallography relies on the fact that distances between atoms in a 
molecule are of the same magnitude as the wavelength of X-rays, which are of the order of 
magnitude 1 Å.  X-rays are diffracted by electrons within the atoms in the crystal structure and 
thus the resulting diffraction pattern allows for the relative position of atoms and the bonding 
behaviour between the different types of atoms in the molecular structure to be determined.75, 76 
X-ray diffraction analysis can be carried out using a range of diffraction techniques, most 
notably powder X-ray diffraction (PXRD) and single crystal X-ray diffraction (SCXRD), 
which comprise the diffraction analysis presented in this thesis.  
2.1.1 The Crystal  
A crystal is defined as a solid comprising of atoms or molecules, which are arranged in a 
systematic repeating manner that extends in three dimensions, where long-range order is 
exhibited throughout the solid. This repetition is effectively infinite on the atomic scale. This 
long-range order is also the origin of a number of well-defined properties of crystals, which 
allows for such properties to be designed in the crystallisation process. The building blocks are 
arranged symmetrically to maximise the level of interactions between the molecules, stabilising 
the crystal. The arrangement of the building blocks present within the crystal also affects the 
macroscopic crystal shape, known as morphology. The ordering of molecules of a particular 
substance can vary within the solid state, leading to the phenomenon of polymorphism. Both 
morphology and polymorphism are of pivotal importance within the crystallisation process in 
ensuring the desired physicochemical properties are achieved.11, 75  
2.1.2 The Unit Cell  
The unit cell is the simplest repeating unit that reflects the long-range order achieved in a crystal 
lattice. The unit cell can comprise a single molecule, part of a molecule, or a motif comprising 
of two molecules or more. The crystal lattice is built by displacements of the unit cell in three 
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dimensions. Restrictions on the unit cell parameters (Figure 2.1), with spatial dimensions (a, 
b, c) and angles (α, β, γ) leads to the seven crystal systems (Table 2.1 below).  
 
Figure 2.1 – Unit cell parameters labelled on unit cell axis. 
In a crystal lattice, comprising of an ordered array of atoms, ions or molecules, a reference 
point can be selected and all points identical to this reference point are considered lattice points. 
All lattice points possess the same surroundings and their position relative to the repeating 
pattern / motif is identical, assuming that these points are in the bulk of the crystal and not at 
the crystal surface (Figure 2.2).75, 77, 78 
 
Figure 2.2 – A repeating array of lattice points found in a crystal lattice, where the orange cross represents a 
molecule and the red points are the lattice points, shown in two dimensions. 
The arrangement of lattice points within the unit cell gives rise to four lattice types. Unit cells 
with lattice points only at the corners of the unit cell are referred to as Primitive (P). It is also 
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possible for lattice points to be positioned in the centre and on the faces of unit cells, leading 
to Body-Centred (I), Base-Centred (C) and Face-Centred (F) lattice types (Figure 2.3). These 
cell centrings lead to different numbers of lattice points per unit cell. The four lattice types 
combined with the seven crystal systems lead to fourteen unique Bravais lattices. 
 
Figure 2.3 – Four lattice types: Primitive (P), Body-Centred (I), Base-Centred (C) and Face-Centred (F). 
Table 2.1 – The seven crystal systems, ordered from highest to lowest symmetry. 
Crystal System Unit Cell Parameters: Restrictions on Unit 
Cell 
Lattice Types 
Cubic 𝑎 = 𝑏 = 𝑐 𝛼 = 𝛽 = 𝛾 = 90° P, I, F 
Hexagonal 𝑎 = 𝑏 ≠ 𝑐 𝛼 = 𝛽 = 90°            𝛾 = 120° P 
Trigonal (Rhombohedral) 𝑎 = 𝑏 = 𝑐 𝛼 = 𝛽 = 𝛾 ≠ 90° P 
Tetragonal 𝑎 = 𝑏 ≠ 𝑐 𝛼 = 𝛽 = 𝛾 = 90° P, I 
Orthorhombic 𝑎 ≠ 𝑏 ≠ 𝑐 𝛼 = 𝛽 = 𝛾 = 90° P, I, F, C 
Monoclinic 𝑎 ≠ 𝑏 ≠ 𝑐  𝛼 = 𝛾 = 90°               𝛽 ≠ 90° P, C 
Triclinic 𝑎 ≠ 𝑏 ≠ 𝑐    𝛼 ≠ 𝛽 ≠ 𝛾 P 
2.1.3 Crystal Symmetry  
Symmetry also exists inside the unit cell, leading to the concept of space groups that describe 
the spatial symmetry of molecules within the unit cell of a crystal lattice. The unit cell is 
generated from smaller asymmetric units related to one another by a combination of symmetry 
operations. There are six symmetry element types, which can be classified into translational 
and non-translational symmetry elements. There are four types of non-translational symmetry 
operations, which include rotation about an axis (n-fold = 2, 3, 4 and 6), reflection through a 
mirror, inversion through an inversion centre and rotary-inversion involving the rotation about 
an axis and inversion through a point (n-fold = 1̅, 2̅ and 3̅). The translational symmetry 
operations are compound operations, which comprise of a translation and non-translational 
symmetry element, which includes reflection or rotation. A glide plane involves a translation 
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followed by a reflection, whereas a screw axis involves a translation followed by a rotation 
operation. There are 230 unique space groups, arising from a finite number of possible 
symmetry element combinations, which are unevenly distributed across the fourteen Bravais 
lattices.78, 79 
2.1.4 Lattice Planes  
Two-dimensional planes (lattice planes) can be defined within the unit cell, in terms of their 
intercepts (x, y, z) with respect to the three cell axes (a, b, c), which gives insight into the 
orientation of a plane. The Weiss notation describes these points of interception, where these 
indices have values of integers or fractions of unit lengths. If a plane runs parallel to a, b, or c, 
the lattice plane does not intercept the particular axis and thus the Weiss notation is described 
by infinity, ∞. A more convenient notation, which unlike the Weiss indices does not contain 
fractions or infinities, is the use of Miller indices (h, k, l). Miller indices are related to Weiss 
indices, by a reciprocal relationship with any fractions cleared. For example, the plane 
intersecting the unit cell edges at a/2, b/2, c/2 would have Miller indices (2, 2, 2) (i.e. a/h, b/k, 
l/c). A group of lattice planes are each separated by the same spacing, known as the d-spacing 
and are situated parallel to each other. These lattice planes are described by the same Miller (h, 
k, l) set and are referred to as a family of crystal planes hkl of characteristic spacing dhkl.
76 
2.2 Diffraction of X-rays by crystals  
2.2.1 Generation of X-rays  
The generation of X-rays may be achieved by accelerating electrons through a potential 
difference of 40-60 kV and colliding the electrons with a water-cooled metal anode target. 
These electrons are initially generated from a heated filament supplied by an alternating 
current. The majority of the kinetic energy of the electrons is wasted as heat, whilst a small 
proportion generates X-rays by collision with the metal atoms within the metal target.  
X-rays emerging from a laboratory source are generated in an evacuated X-ray tube, in which 
collision of these high-energy electrons upon the metal target causes ionisation of an electron 
from a core atomic orbital. Subsequently, an electron from an excited state can lose energy to 
replace this core level electron, the energy difference between the electron in the higher level 
orbital and the core level is characteristic of the element used in the anode; the most frequent 
characteristic radiation used comes from the Kα and Kβ transitions. These X-rays possess 
characteristic energies and are generated alongside a continuous spectrum of white radiation. 
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Usually monochromatic X-rays are employed and the Kα wavelength is selected preferentially. 
The X-ray wavelengths generated are characteristic of the metal of the anode target; the most 
common metals employed for X-ray tubes are copper (Cu-Kα) and molybdenum (Mo-Kα), with 
wavelengths of 1.5418 Å and 0.7107 Å respectively.75, 80  
2.2.2 Scattering of X-rays by crystallographic planes  
X-ray diffraction is widely used to characterise the structure of crystalline solids. X-ray 
diffraction employs the principle that in order to ‘see’ an object, the wavelength of the light 
radiation being utilised must be of similar magnitude to the size of the object. X-ray 
wavelengths (of the order of Angstroms (Å)) coincide with the order of magnitude for 
interatomic spacings, meaning that X-rays are the suitable choice for probing the internal 
structure to ‘see’ crystalline solids at the atomic scale.76  
X-rays are scattered by electron clouds, whereby the strength of the scattering varies with the 
number of electrons present, relating to the atomic number of the element. A crystal of good 
quality yields a diffraction pattern of spots with varied intensity, produced by the scattering of 
X-rays. The diffraction pattern exhibits three features, which provide information on the 
properties of the crystal structure. The geometry of the pattern of spots gives insight to the 
lattice and unit cell geometry of the crystal. The diffraction pattern also exhibits symmetry, in 
both the positions of the diffraction spots, but more notably in the diffraction intensities of the 
spots in the pattern, which relates directly to the symmetry of the unit cell and thus gives 
information on the space group of the crystal lattice. Great variation in intensities of individual 
spots is apparent; these intensities hold all the available information about the relative positions 
of the atoms in the molecules that build up the crystal lattice.75  
The underlying principle of X-ray diffraction geometry is expressed in Bragg’s law, which 
determines the conditions by which diffraction is observed. Bragg’s law regards X-ray 
diffraction as a reflection from sets of parallel lattice planes within the three dimensional lattice. 
The orientations of these lattice planes are described by the Miller indices: h, k, l. The 
perpendicular distance between the parallel lattice planes is denoted by the d-spacing, which 
can be mathematically related to the Miller indices (for an orthogonal unit cell with α = β = γ 















Equation 2.1 – d-spacing for an orthogonal unit cell represented in terms of Miller indices (h, k, l) and unit cell 
axes (a, b, c). 
W. L. Bragg determined the conditions required for diffraction of X-rays and found that 
diffraction can be considered to behave like reflection from parallel planes constructed through 
lattice points, when the crystal is appropriately orientated in the X-ray beam. The angle of the 
incident X-ray beam (θ) must equal the angle of the ‘reflected’ X-ray beam for the diffraction 
to emerge from the scattering of the X-rays. In addition, to ensure that the waves from adjacent 
parallel planes will emerge in phase and constructively interfere (Figure 2.4), the path 
difference between X-ray beams must be an integral number (n) of the wavelength of the X-
ray beam (λ), where θ is the angle of incidence on the lattice plane (Equation 2.2).  
 
Figure 2.4 – The Bragg condition for the diffraction of X-rays from a set of parallel crystal planes. 
𝑛𝜆 = 2𝑑ℎ𝑘𝑙𝑠𝑖𝑛𝜃 
Equation 2.2 – Bragg’s equation: the path difference requirement to observe X-ray diffraction. 
2.2.3 The Reciprocal Lattice 
An alternative approach to describing the ‘direct’ crystal lattice is to consider the reciprocal 
lattice. Instead of a set of parallel crystallographic planes hkl, situated in a particular 
orientation, which are separated by a particular d-spacing, the reciprocal lattice is built in 
reciprocal space through the use of vectors. The vectors normal to these families of 
crystallographic planes hkl are represented by lengths d*1 and d*2, which are inversely related 
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to the d-spacings d1 and d2 respectively (Figure 2.5). A family of crystallographic planes is 
therefore represented by a reciprocal lattice point positioned at the end of the reciprocal lattice 
vector of length d* and whose direction relative to the reciprocal space origin, O is given by 
the normal to the corresponding hkl lattice plane. Each of the reciprocal lattice vectors 
represents a reflection from a diffraction pattern arising from a specific set of Miller planes. 
Assuming all of these vectors are related by the common reciprocal space origin, then the 
corresponding reciprocal lattice points will form a regular three dimensional array, known as 
the reciprocal lattice.81 
 
Figure 2.5 – Two families of parallel crystallographic planes hkl labelled as planes 1 and 2 separated by d-
spacings of d1 and d2 respectively (left) and the normal to these families of planes from a common origin, O 
with lengths d*1 and d*2.81 
The reciprocal lattice vector is a diffraction or scattering vector, containing information on both 
the magnitude of the interplanar d-spacing and the orientation of the Miller planes, which 
confirms whether the family of planes are in a diffracting position. The scattering vector bisects 
the incident and diffracted beams. Rearrangement of Bragg’s Law (Equation 2.2), highlights a 
directly proportional relationship between the sine of the diffraction angle, θ, and the inverse 
of the d-spacing (
1
𝑑ℎ𝑘𝑙
). As a diffraction pattern exists in reciprocal space, whilst a unit cell 
exists in real space, a large unit cell with larger d-spacings will have a compressed diffraction 
pattern.81 
The crystal lattice in direct space is described by a, b, c, the corresponding reciprocal lattice is 
described by a*, b*, c*. The relationship between direct and reciprocal lattice vectors is 






        𝒃∗ =
𝒄×𝒂
𝑽




Equation 2.3 – The mathematical relationship between direct (a,b,c) and reciprocal lattice (a*,b*,c*), with unit 
cell volume, V. 
2.2.4 The Ewald construction 
The Ewald construction is a geometrical expression of Bragg’s Law, which can be used to 
determine when the Bragg diffraction conditions are satisfied for a crystallographic set of hkl 
lattice planes (Figure 2.6, left). In the Ewald construction, the limits of the Ewald sphere (E) 
are define by a sphere radius of  
1
𝜆
, where λ is the wavelength of the incident X-ray beam passing 
through the middle of the sphere, with a crystal situated at the centre of sphere (E). The origin 
of the reciprocal lattice, O, is positioned at the point of intersection of the limits of sphere (E) 
with the emerging direct X-ray beam.  The reciprocal lattice vector is perpendicular to the set 
of hkl crystallographic planes and has a magnitude of 
1
𝑑ℎ𝑘𝑙
. The conditions required for 
diffraction to be observed at point P are to rotate the reciprocal lattice about point O until a 
reciprocal lattice point cuts the sphere at point P; the magnitude of this distance OP is the 
magnitude of the normal to the set of the hkl lattice planes d*. A limited number of reciprocal 
lattice points exist around sphere (E) corresponding with the limited number of observed 
reflections. The rotation of the Ewald construction about the reciprocal lattice centre O, leads 





Figure 2.6 – The Ewald construction (E) (left) and the limiting sphere (L) of observable reflections (right).81 
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2.2.5 Scattering of X-rays by atoms 
The scattering of X-rays by a crystal is from the electrons in the atoms, whose extent is of the 
same order as the X-ray wavelength. The path difference between X-rays scattered from 
different parts of the same atom thus results in destructive interference, leading to an angular 
dependence of the scattering as the X-rays become increasingly out of phase at higher 
scattering angles. This atomic scattering is expressed by the atomic scattering factor, f 
described in Equation 2.4, which considers the sum of the electrons from an atom, the 
contribution of which varies with scattering angle, θ (Figure 2.7).  
Atomic scattering factor,  f = 
𝐴𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒 𝑠𝑐𝑎𝑡𝑡𝑒𝑟𝑒𝑑 𝑏𝑦 𝑡ℎ𝑒 𝑎𝑡𝑜𝑚
𝐴𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒 𝑠𝑐𝑎𝑡𝑡𝑒𝑟𝑒𝑑 𝑏𝑦 𝑎 𝑠𝑖𝑛𝑔𝑙𝑒 𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑛
 
Equation 2.4 – Expression for the Atomic scattering factor, f. 
 
Figure 2.7 – Scattering factor functions fA and fB from atoms A and B, showing the relative fall-off of scattering 
with angle, θ for a heavier (A) and lighter (B) atom. 
The intersection of the atomic scattering factor at the y-intercept, coinciding with a scattering 
angle of zero, indicates that X-rays are in phase and thus the atomic scattering amplitude 
equates to the atomic number of the atom, Z.80  
The rate of fall off in scattering intensity with scattering angle is also impacted by the thermal 
motions of atoms, which effectively increases the extent of the electron density depending on 
the extent of the thermal motions and the type of atom; the associated thermal parameters 
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describing the atomic vibrations are an important aspect of a crystal structure determination. 
As can be seen in Figure 2.7, the fall-off of scattering with angle is more pronounced for lighter 
than heavier atoms; this, together with the intrinsically weaker scattering of atoms with fewer 
electrons, explains the difficulty that can be experienced in locating a hydrogen atom resulting 
from the single electron within the electron cloud as its X-ray scattering ability is low. 
2.2.6 A single crystal diffraction experiment  
In a single crystal X-ray diffraction experiment, a crystal is mounted onto a goniometer on a 
diffractometer and the crystal rotated about a fixed point, whilst being immersed in the X-ray 
beam. This rotation facilitates the maximum number of possible reciprocal lattice points to cut 
the Ewald sphere, resulting in the number of observable reflections to be maximised. This 
extent of rotation is achieved using a goniometer on a four-circle diffractometer set to Eulerian 
geometry with three possible axes of crystal rotation (ϕ, χ, ω). A fourth axis of rotation is 
achieved by a sweep of the detector along a 2θ vertical range used to observe the diffracted X-
rays (Figure 2.8).82  
 
Figure 2.8 – Schematic representation of a four-circle goniometer with Eulerian geometry. 
X-ray diffraction for structural determination via single crystal X-ray experiments is typically 
measured at low temperatures, whereby the single crystal is typically cooled to 100 K or 150 K 
by a cold nitrogen gas stream provided by a device such as a Cryostream. Low temperature 
sample environment is used for structural determination to reduce the thermal motion of atoms, 
which supresses the reduction in fall off of the atomic scattering factor with scattering angle. 
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A range of detectors can be employed to collect the diffraction data, including charge coupled 
devices (CCD)83 and PILATUS hybrid pixel array detectors.84 In a two-dimensional (2D) 
diffraction pattern produced from a single crystal experiment, the diffracted X-rays are 
observed as diffraction spots, which contain information about the crystalline material under 
analysis. 
2.3 Crystal structure determination using X-ray diffraction  
Measuring the diffraction of X-rays from a crystalline material, allows for the crystal structure 
to be determined, on the premise that the diffraction pattern is the Fourier Transform of the 
crystal structure. 
2.3.1 Pattern geometry  
2.3.1.1 Unit cell determination 
The arrangement of the diffraction spots on a diffraction image is related to the geometry of 
the unit cell and the symmetry of the crystal. During cell indexation, the unit cell is determined 
through use of the orientation matrix, which includes information on both the (reciprocal) unit 
cell (through the determined dhkl* values) and the diffractometer geometry. Using the 
diffraction positions of a relatively small number of reflections and their geometric 
relationship, the unit cell can be determined from a limited number of diffraction scans.78 
Further discussion of the orientation matrix is detailed in Chapter 5.
 
2.3.1.2 Symmetry and Space Group determination 
Once the unit cell parameters have been determined, the crystal symmetry can usually be 
selected. The crystal symmetry and space group may be assigned by comparing the intensities 
of reflections which are equivalent by symmetry,75 also taking into account the systematic 
absences in the diffraction pattern.   
These systematic absences arise as a result of the fact that in the presence of certain symmetry 
elements, scattering due to symmetry related parts of the structure combine out-of-phase, 
resulting in reflections with zero intensity, such that they are considered ‘absent’. The absence 
of certain reflections can be attributed to lattice centring, which are referred to as general 
absences. For a primitive lattice type, no general absences arise, whilst reflections are absent 
in an I-centred lattice when the sum of h + k + l is odd, in a B-centred lattice when h + l is odd, 
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in a C-centred lattice when the sum of h + k is odd and in an F-centred lattice when hkl integers 
are either all odd or all even integers.  
Systematic absences in selected parts of the diffraction pattern occur due to the presence of the 
translational symmetry elements of glide planes and screw axes in the crystal structure, which 
result from the translation components of these symmetry elements. For example, the presence 
of a 21 screw axis along b means that reflections will be absent from the 0k0 planes when k is 
an odd integer.76 
2.3.2 Reflection intensities  
This relationship between diffraction pattern spots and the position of the atoms in the unit cell 
can be defined through information about the reflection intensities and how these relate to the 
electron densities of the atoms. In data collection, the intensities, 𝐼ℎ𝑘𝑙, of the diffracted X-ray 
beam are measured at reciprocal-lattice points that arise from each set of Miller planes (hkl)). 
The diffraction pattern produced from experimental methods is related to the arrangement of 
the atoms in the unit cell of the crystal through Fourier transformation, whereby the Fourier 
transform (FT) defines the important quantity known as the structure factor, 𝐹ℎ𝑘𝑙. The 
magnitude of the structure factor, 𝐹ℎ𝑘𝑙 is equal to the square root of the intensity of each 
reflection, 𝐼ℎ𝑘𝑙 (Equation 2.5). The structure factor, 𝐹ℎ𝑘𝑙 is defined as the resultant of the waves 
scattered by all atoms in the unit cell in the hkl direction and is dependent on the scattering 
factor fj and position (xj, yj, zj) of each atom (Equation 2.6).  
𝐼ℎ𝑘𝑙 = (𝐹ℎ𝑘𝑙)
2 
Equation 2.5 – Square relationship between the intensity, Ihkl and structure factor, Fhkl. 
𝐹ℎ𝑘𝑙 = ∑ 𝑓𝑗𝑐𝑜𝑠2𝜋(ℎ𝑥𝑗 + 𝑘𝑦𝑗 + 𝑙𝑧𝑗) + 𝑖 ∑ 𝑓𝑗𝑠𝑖𝑛2𝜋
𝑗=𝑛
𝑗=1




Equation 2.6 – Mathematical relationship between the structure factor, Fhkl and the atomic scattering factor, fj, 
atomic positions, xj, yj, zj of each atom and the Miller indices hkl. 
Fourier transformation of the structure factor, 𝐹ℎ𝑘𝑙 (Equation 2.7) in turn produces the electron 
density map, which allows the discovery of the atom locations in terms of electrons per cubic 
Angstrom (e 𝐴−3) at all locations x, y and z in the unit cell, where V is the volume of the unit 
cell.76 Atoms with higher atomic numbers will consequently be more prominent and be more 
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accurately determined within the unit cell. The structure factor for reflection hkl contains 
information on both the amplitude and phase of a wave diffracted from planes of the single 
crystal.17  
𝜌(𝑥, 𝑦, 𝑧) =  
1
𝑉




Equation 2.7 – Mathematical relationship between the electron density ρxyz and the calculated structure factor, 
𝐹ℎ𝑘𝑙
𝑐𝑎𝑙𝑐, atomic positions, xj, yj, zj of each atom, the Miller indices hkl and volume of the unit cell, V. 
Equation 2.5 gives rise to the phase problem: the experiment measures 𝐼ℎ𝑘𝑙 and from this the 
magnitude of 𝐹ℎ𝑘𝑙 can easily be obtained. However, the sign (+/-) or phase of the structure factor 
cannot be obtained from experimental measurements. The phase problem must be overcome as 
a lot of important information for the determination of electron density is contained within the 
phase. Each 𝐹ℎ𝑘𝑙 value contains information about the positions of all atoms present from all 
symmetry related objects within the unit cell as stated by the space group. In order for the phases 
of the structure factors to be calculated, atomic positions must be known. Determination of these 
atomic positions can be carried out by a number of methods, including Direct methods and 
Patterson methods. The method should be chosen according to the atomic masses of the atoms 
present in the unit cell. For instance, for a structure containing heavy atoms, such as an 
organometallic crystal, the Patterson method approach should be adopted, whereas, for a purely 
organic molecule, direct methods should be chosen. It should be noted that direct methods could 
also be employed for heavy atom structures.76  
In the Patterson methods approach, the observed structure factors are squared to produce a 
Patterson map (Equation 2.8), which does not require knowledge of the phases. A Patterson 
map contains peaks that correspond to vectors between pairs of atoms and shows the positions 
of atoms relative to each other. These peaks are proportional to the square of the atomic numbers 
of the atoms present, and so vectors between the heavier atoms will dominate the Patterson map 





2𝑐𝑜𝑠2𝜋(ℎ𝑥 + 𝑘𝑦 + 𝑙𝑧)
𝑙𝑘ℎ
 
Equation 2.8 – Mathematical relationship between the electron density ρxyz and the experimental structure 
factor, Fhkl , atomic positions, xj, yj, zj of each atom and the Miller indices hkl and volume of the unit cell, V. 
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Direct methods are a trial and error method, whereby the phases of some of the structure factors 
are estimated according to the relationship between the phases of certain groups of reflections. 
If some strong reflections are assigned certain phase values this has implications for other strong 
reflections present. A restriction on the electron density is then imposed (ρ(x,y,z) must be 
positive everywhere) and the resulting trialled phases from different permutations of the 
assigned phase values input into Equation 2.7 to produce an electron density map. The electron 
density map usually contains a recognisable fragment; the positions of this fragment can be 
input into the structure factor equation (Equation 2.6). The peaks in the electron density map 
are then interpreted to form an initial structural model; to generate approximate phases. Once 
this initial step is complete most non-hydrogen atoms have been accounted for and this process 
is then iterated (Fourier recycling) to generate all the atoms in the structure. Direct methods is 
best used for structures where the atoms present have similar scattering characteristics.76  
2.4 Crystal structure refinement 
Fourier recycling methods are used together with structural refinement to locate any missing 
atoms and to optimise the determined parameters for all atoms. For good quality data this should 
include the hydrogen atoms within the structure.  
Fourier analysis on the calculated values of the structure factors produces an electron density 
map. This calculated electron density map is subtracted from the electron density map obtained 
from experimental data. From this, any further atomic positions not yet present in the model 
will appear as contours of electron density. These new atomic positions may now be used to 
recalculate structure factors and an updated electron density map; this iterative process 
continues until all atoms have been accounted for.  
To minimise errors in the initial structural model, structural parameters, such as atom types, 
atom positions and displacement parameters require optimisation. Crystal structure refinement 
is carried out using least squares iterations on F2. During the refinement process the structure 
factors resulting from the model (Fc) are compared to those from the experiment (Fo); the aim 
of the least squares refinement is to minimise the difference between the calculated and 
observed structure factors by use of a weighting approach (Equation 2.9). In this minimisation, 
each reflection is assigned a weight (w) reflecting the confidence in the accuracy of the 
measured intensity. The weight (w) of a reflection is inversely proportional to the estimated 
variance (σ) of the amplitude of the observed structure factor, Fo (Equation 2.10). Only the 
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magnitudes of Fo and Fc are compared as the corresponding phases of the structure factors are 











Equation 2.10 – The weight (w) reflecting the confidence of an observed structure factor. 
The progress of the refinement is monitored using the R-factor, a calculation of the agreement 
between the calculated and observed electron density maps, evaluated through the magnitudes 
of the structure factors (Equation 2.11). Throughout the refinement process the R-factor will 





Equation 2.11 – Mathematical relationship between R factor, R and observed and calculated structure factors, 
FObs and FCalc respectively. 
2.4.1 Constraints and Restraints  
The optimisation of structural parameters in order to improve the structural model and reduce 
the corresponding R-factor may require the use of constraints or restraints. Constraints in least-
squares refinement act to reduce the number of parameters involved in the refinement, either 
by expressing one parameter in terms of others, or by fixing the value of a parameter to a 
predefined value. For example, when proton disorder is present across a hydrogen bond, in 
order to refine the ratio of the site occupancy factors for each proton site, their sum is 
constrained to unity. On the other hand, the addition of restraint information to crystallographic 
least-squares refinement acts as extra information, leading to an increase in the overall number 
of observations. Restraints use a minimisation function involving a target value for a parameter 
which the actual restrained parameter will approach during refinement. For example, restraints 
may be applied to bond distances.85   
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2.5 Powder X-ray Diffraction (PXRD) 
X-ray diffraction analysis can be used to analyse polycrystalline powders, whereby each 
individual, randomly oriented, crystallite yields its own diffraction pattern, which are 
superimposed on one another during powder averaging to yield an overall diffraction pattern 
representative of the bulk sample. Powder X-ray diffraction is usually carried out using a fixed 
wavelength (λ) method with a varying angle (θ). As powder samples are comprised of many 
randomly oriented crystallites, on exposure to X-rays, the Bragg condition is satisfied for a 
number of different hkl crystal planes simultaneously. For each diffraction peak the 2 value 
is the same, however the direction of the diffracted X-rays will vary. This results in the 
diffracted X-rays being observed as Debye Scherrer cones, as a result of diffraction occurring 
from the same hkl crystal plane in a number of crystallites.81 The intensity of these rings of 
diffraction may vary in intensity due to preferred orientation effects, which increases the 
intensity of certain peaks; the sample is often rotated during data collection to mitigate this 
issue. Preferred orientation effects can arise from a powder sample comprised of many plate-
like crystals. 
The cones or cone slices accessed by the detector are integrated to give the characteristic 1D 
PXRD pattern of intensity against 2θ (°), containing peaks for reflections from particular hkl 
crystal planes at 2θ positions related to the dhkl, with intensity Ihkl (Figure 2.9). The position of 
peaks in a PXRD pattern are unique to each crystal structure and are determined by the unit 
cell parameters; these can therefore be used as fingerprinting tools when compared to the peak 
positions from crystal structures of polymorphic purity.75, 81 
 




2.6 Synchrotron Crystallography  
Laboratory X-ray sources are appropriate for most offline routine diffraction analysis, however 
the use of synchrotron radiation at a synchrotron source is necessary for in situ X-ray diffraction 
techniques. Synchrotron radiation comprises electromagnetic radiation spanning the range 
from infrared (IR) radiation to X-rays, whereby synchrotron sources can generate tunable 
beams of electromagnetic radiation with intensities defined by ‘flux’ or ‘brilliance’ many 
orders of magnitude more intense than a laboratory source.86, 87 The exceptionally bright X-ray 
beams obtainable at synchrotrons facilitates data collection of a quality and resolution not 
attainable through use of conventional X-ray sources. The brightness accessible at synchrotron 
sources has been further increased at third generation low-emittance light sources, through use 
of additional magnets known as insertion devices, such as undulators or wigglers. High 
brightness is fundamental for low bandpass detection and to achieve high angular and thus d-
spacing resolution, whereby closely situated diffraction peaks, or those with weaker intensities, 
have the opportunity to be resolved.87  
2.6.1 Synchrotron Radiation at Diamond Light Source (DLS) 
Diamond Light Source (DLS) is the national synchrotron in the UK (Figure 2.10), it utilises 
highly accelerated electrons to produce extremely bright light in the form of intense and highly 
collimated X-ray beams. The electrons are generated in the electron gun from where they are 
accelerated to kinetic energies above the MeV range, corresponding to a speed approaching the 
speed of light, through a series of three particle accelerators, the linear accelerator (LINAC), 
the booster synchrotron and the storage ring. Once at speed, the electrons are injected in 
bunches into the storage ring, which is an evacuated ring shaped chamber.  
 




Figure 2.11 – The production of synchrotron X-ray radiation at Diamond Light Source, including the electron 
gun, linear accelerator, booster ring and electron beam around the synchrotron ring.88 
The storage ring is not circular, but made of forty-eight straights connected with forty-eight 
bending magnets, to bend the electron beam. This bending causes the electrons to emit energy 
in the form of X-rays (Figure 2.11). These magnets work on the principle that if a moving 
electron intersects a magnetic field, which is perpendicular to the direction of travel, then the 
electron will experience a force perpendicular to both the direction of travel and the magnetic 
field. This force generates a centripetal acceleration causing the electron to move along a 
circular path and emit electromagnetic radiation. Radio frequency (RF) cavities are also present 
in sections along the storage ring to boost electron energy and momentum that has been lost 
due to the bending of electrons and electron collisions.  
Insertion devices known as undulators or wigglers are also installed on the straight sections of 
the storage ring at Diamond (Figure 2.12), a third generation synchrotron – these are arrays of 
magnets that offer enhanced intensity and tunability of the generated X-ray beams. A wiggler 
can be considered as a series of bending magnets that alternate the direction of travel of the 
electrons to the left and right, causing a periodically ‘wiggling’ of the electron path. Undulators 
differ from bending magnets and wigglers, whereby these magnets comprise of alternating low 
field magnetic poles and thus as the electron beam passes through these magnets these electrons 
experience a series of inward and outward acceleration where radiation is emitted on each 
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‘undulation’. Downstream of the undulator, the emitted radiation may overlap constructively 
or destructively, which results in a ‘lumpy’ spectrum, which consists of a fundamental 
frequency plus a series of higher harmonics. Undulators therefore can produce very intense 
single wavelength radiation by magnet parameter tuning.86  
 
Figure 2.12 – Insertion devices: wiggler (left) and undulator (right) in principle differ only in the size of the 
excursions from a straight path that these insertion devices force the electrons to execute.86 
The beamlines run off tangentially to the storage ring containing the bending magnets, whilst 
the beamlines are positioned parallel to the axes of the insertion devices.86 A typical beamline 
set-up comprises an optics hutch, experimental hutch and control room. The synchrotron 
radiation emitted by the wiggler or undulator initially passes through the optics hutch, which 
carries out ‘tuning’ of the radiation by monochromation to the desired wavelength of radiation, 
whilst also ‘focusing’ the beam to the desired size and position for a particular diffraction 
experiment. Monochromation of the synchrotron beam is achieved using two crystal 
monochromators, whereby one of the crystals uses Bragg’s law to filter out a narrow band of 
radiation, whilst the other redirects the beam in parallel to the incident beam back to its original 
path.86 The monochromated beam is focused in both the horizontal and vertical direction using 
mirrors. The next section of a beamline is the experimental hutch where diffraction of the 
synchrotron X-rays from a crystalline sample is measured and the final section is the control 
room where the diffraction experiment is controlled and monitored.86 
Chapter 3 – Experimental Techniques and Instrumentation 
Chapter 3 details the range of techniques and instrumentation used for the preparation and 
characterisation of the materials under study in this research project in order to achieve the 
research goals outlined at the end of Chapter 1. This chapter provides a general overview whilst 




The carrier fluid used in the segmented flow crystallisation experiments was a fluorinated 
perfluoropolyether (PFPE), commercially known as Galden SV110, which was sourced from 
Solvay. 
In Chapter 4, urea (U) and barbituric acid (BA) were purchased from Sigma Aldrich 
(Steinheim, Germany) and carbamazepine (CBZ) was purchased from Molekula (Darlington, 
UK). All reagents were used without further purification. Laboratory grade solvents (methanol 
(MeOH) and ethanol (EtOH)) purchased from Sigma Aldrich were used for all crystallisations. 
In Chapter 5, paracetamol (PCM) was purchased from Sigma Aldrich and used without further 
purification. Laboratory grade isopropanol (IPA) purchased from Sigma Aldrich was used in 
the solvent mixture 60:40 water:isopropanol (HI) for all crystallisations.  
In Chapter 6, the four profen targets were sourced from TCI UK Ltd (Oxford, UK). All co-
former molecules and laboratory grade solvents were purchased from Sigma Aldrich. All 
reagents were used without further purification. 
In Chapter 7, ibuprofen (IBU) was sourced from TCI UK Ltd. The isonicotinamide (ISO) co-
former molecule and laboratory grade IPA were purchased from Sigma Aldrich. All reagents 
were used without further purification. 
3.2 Solubility and Metastable Zone Width (MSZW) Measurements  
In Chapter 6, solubility measurements of the IBU and oxaprozin (OXA) pure target materials 
in 60:40 HI and acetone (ACE) respectively, a physical mixture of IBU and ISO (1:1 and 1:2 
molar ratios) in 60:40 HI, as well as the pre-prepared co-crystal of IBU-ISO in 60:40 HI were 
carried out. 
To establish the ability of a solid to dissolve in a solvent, solubility measurements were carried 
out, which allow for the concentration / temperature dependence of the solid material in a 
particular solvent to be understood. Solubility was measured by either turbidity or by visual 
observation. Turbidity measurements using the Technobis Crystal16® or Crystalline® at 1 mL 
and 5 mL scale respectively were performed at the University of Strathclyde. The Crystalline® 
also features particle viewer technology to allow real time imaging alongside the temperature 
and turbidity measurements. In situ images were acquired every minute, allowing for 
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visualisation of the complete crystallisation process. Visual observation measurements were 
conducted using the Cambridge Reactor Designs (CRD) Polar Bear Plus apparatus at the 
University of Bath. 
3.2.1 Turbidity 
Both the Crystal16®  (Figure 3.1) and Crystalline®  platforms operate by measuring the 
transmissivity of a laser through a sample in order to determine clear and cloud points through 
various heat and cool cycles respectively. The clear points are the temperatures at which the 
transmission reaches 100 %, marking full dissolution, whilst the cloud points correspond with 
when the transmission drops off from 100 % as nucleation and subsequent crystal growth 
occurs.   
Solutions of varying concentration were prepared in 1.5 mL and 8 mL vials respectively for 
insertion into the Crystal16®  and Crystalline®  platforms. The vials were prepared by weighing 
a known amount of a pure or physical mixture of the constituent starting components under 
solubility investigation with 1 mL or 5 mL of solvent for the Crystal16® and Crystalline®  
platforms respectively. A concentration range for each system was investigated to yield a 
solubility curve. Vials were cycled through temperature cycles, where samples were heated 
from 20 ℃ to 70 ℃ and then cooled from 70 ℃ to 5 ℃, via a Peltier thermoelectric device, 
using a heating and cooling rate of 0.3 ℃ min-1 with magnetic bottom stirring of 800 rpm to 
provide agitation to the system.  
 
Figure 3.1 – The Technobis Crystal16®. 
For each concentration of a solid in solvent system, one replicate was conducted and the 
average cloud and the average clear point calculated across the three heat-cool cycles, to yield 
a single cloud and a single clear point temperature at that particular concentration. The clear 
and cloud points denoted by the red and green circles respectively, mark the intersection of the 
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temperature versus time and transmission (%) versus time plots superimposed in Figure 3.2. 
The clear points denote the solubility points leading to a solubility curve when investigated 
over a concentration range. The region between the cloud curve and clear curve is referred to 
as the metastable zone (MSZ).  
 
Figure 3.2 – Temperature (℃) versus time (seconds) plot (blue) superimposed with transmission (%) versus 
time (seconds) plot (orange) for repeat heat-cool cycles in the Crystal16®  and Crystalline®  platforms. Clear and 
cloud points are highlighted by red and green circles respectively. 
3.2.2 Visual Observation  
For these experiments, the CRD Polar Bear Plus crystalliser was used to allow for controlled 
heating and mixing of the sample to ascertain the dissolution temperature when a known 
amount of solid was added to the solution (Figure 3.3). A 50 mL round bottom flask with a 
working volume of 20 mL of the chosen solvent was allowed to equilibrate at 0 °C for 10 
minutes before any solid was added. Magnetic bottom stirring was set to a stirring rate of 
700 rpm. Once the solvent had equilibrated at 0 °C, small increments of solid of known mass 
were added and allowed to dissolve and the corresponding temperature noted.  The solution 
was heated at a rate of 0.2 °C min-1 and further increments of solid were added to the solution. 
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As the temperature of solution increased the additional solid dissolved and the corresponding 
temperature of solid dissolution was noted before subsequent increments of solid were added. 
This process was repeated until the solution reached a temperature of 50 °C. The masses added 
were used to calculate the concentration of solution and this, coupled with the observed 
dissolution temperatures, yielded solubility curves of concentration versus temperature. In 
cases where the solution turned into a cloudy emulsion as the concentration was increased 
(similarly observed with in-line cameras during turbidity measurements in the Crystalline®) 
the solubility measurements were stopped before the 50 ℃ final heating temperature was 
reached. The visual observation experiments were repeated three times for each solid in solvent 
combination to ensure statistical reproducibility.  
 
Figure 3.3 – The Cambridge Reactor Designs (CRD) Polar Bear Plus Crystalliser, featuring overhead stirring. 
3.3 Crystallisation Methods  
A range of crystallisation methods were investigated: evaporative, mechanochemical including 
neat grinding (NG) and liquid assisted grinding (LAG), slurrying and cooling crystallisations 
in both batch and continuous platforms were investigated for a range of systems. The various 
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crystallisation methods were employed to control polymorphic form or investigate co-crystal 
formation for materials discovery.   
3.3.1 Evaporative Crystallisation  
In Chapter 6, for the evaporative screen aimed at multi-component material formation, the four 
profen family materials were investigated with a range of co-formers. The solubilities of the 
two components are similar in the particular solvent, to result in a symmetric ternary phase 
diagram, otherwise the crystallisation outcomes do not reflect the input materials. A mass of 
20 mg of the profen family target with initially the corresponding mass of co-former, calculated 
from a 1:1 molar ratio of target:co-former was weighed into a 7 mL vial with 1-2 mL of solvent. 
The use of sonication was employed to promote dissolution. If complete dissolution had not 
been achieved after 30 minutes of room temperature sonication in a sonic bath, heat was applied 
to the sonicator or more solvent was added to achieve complete dissolution. Once the solid was 
fully dissolved, plastic caps which had four small holes pierced in them were placed on the 
sample vials. The samples were then left undisturbed to allow for solvent evaporation and 
subsequent crystallisation. All crystallisations conducted in this way were set up to contain 
both starting materials, with the intention of forming a multi-component system. In addition to 
the different stoichiometries of starting materials, a variety of different evaporation 
temperatures were also investigated: 5 °C (placed in fridge), room temperature, 30 °C, 40 °C 
and 50 °C. For the elevated evaporation temperatures a hot-plate with a DrySyn attachment 
were used for temperature control.  The samples were observed for any crystallisation and the 
crystals were harvested before complete evaporation of the solvent, in an aim to keep any 
unwanted impurities in the solution phase. The crystals were analysed via polarised optical 
microscopy as well as Powder X-ray Diffraction (PXRD) and Differential Scanning 
Calorimetry (DSC) in order to determine if a new phase had been accessed, when compared to 
the PXRD patterns and DSC traces of the starting materials.   
3.3.2 Mechanochemical Crystallisation 
In Chapter 6, mechanochemical crystallisations investigate the use of mechanical energy in 
achieving desired phases, either through multi-component formation or obtaining the desired 
polymorph. For materials discovery, initial experiments investigated a 1:1 molar ratio of 
target:co-former using 40 mg of the profen family target, where the components were ground 
by hand for 5 minutes using a mortar and pestle, either neat (NG) or using a few drops of 
solvent (LAG). When an excess of one or both of the starting components was evident in the 
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PXRD and DSC data, the grinding time was increased to 30 minutes to provide additional 
mechanical energy to favour co-crystal formation. An alternative strategy to yield a pure co-
crystal from grinding approaches would be to alter the stoichiometric ratio of the starting 
components by decreasing the relative molar ratio of the component present in excess in the 
PXRD data.  
3.3.3 Slurrying Crystallisation 
Slurry crystallisations are a suspension technique used to investigate solution-mediated phase 
transformations (SMPTs) in solution. Slurry techniques can be used for multi-component 
material formation or establishing the thermodynamic form from concomitant polymorphs 
through competitive slurrying.  
3.3.3.1 Multi-component Slurrying Experiments 
In Chapter 6, small-scale slurries were prepared by a 1:1 molar ratio of a physical mixture of 
the starting components using ~200-400 mg of the profen target and the chosen co-former. A 
small amount of solvent was then added to the solid materials in 7 mL or 20 mL vials for 
slurries mediated in 2 mL and 10 mL of solvent respectively. The 20 mL vials were placed in 
the CRD Polar Bear Plus crystalliser and the 7 mL vials in a hot-plate with a DrySyn attachment 
for temperature control at 20 ℃ and 30 °C respectively. Magnetic bottom stirring (250-
350 rpm) was used for agitation. A variety of solvent media were used (ACE, EtOH, IPA, H2O 
and 60:40 HI), depending on the specific study being undertaken. Once the sample was 
prepared and under agitation, it was important to ensure that not all the solid dissolved and an 
excess remained, maintaining the suspension. If the slurry dissolved, a pre-weighed post 
addition of solid was added to the solution to establish a slurry that would remain a suspension 
after equilibration. The systems were left slurrying for a predetermined amount of time, for 24 
hours and 1 week for 10 mL and 2 mL slurry investigations respectively, before being filtered 
and dried at room temperature. The slurry product was then analysed for solid form identity by 
PXRD and DSC. Full experimental parameters can be found in Chapter 6.   
In Chapter 7, to investigate potential short-lived crystal phases undergoing SMPTs, in situ 
slurrying in capillaries was carried out at beamline I11. To investigate early stage slurrying 
crystallisation of IBU and ISO 1:1 in a physical mixture compared to the pre-prepared IBU-
ISO co-crystal, slurrying crystallisations were carried out in 1-2 mL of 60:40 HI for 5 minutes, 
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to ensure the physical mixture was homogeneously mixed before loading the slurry into a 
borosilicate capillary. The precise sample preparation is detailed in Chapter 7.  
3.3.3.2 Competitive Slurrying  
In Chapter 4, competitive slurrying experiments using two polymorphic forms in a 1:1 molar 
ratio in the solid mixture were slurry mediated in solvent for a slurrying time of 4 minutes, in 
which the slurry time represents the residence time between adjacent windows in the KRAIC-
D under the flow conditions employed in the experiments. These experiments aimed to 
establish whether a polymorphic transformation would occur between adjacent windows when 
a mixture of polymorphic forms were present in solution slugs. For the CBZ model system, 
competitive slurrying of the metastable CBZ form II and thermodynamic CBZ form III slurry 
mediated in EtOH were investigated, whilst for the UBA model system, the concomitant UBA 
form I and UBA form III slurry mediated in MeOH were investigated. A mass of ~150-200 mg 
of this mixture was placed into 7 mL glass vials and 1-2 mL of the chosen solvent (CBZ in 
EtOH, UBA in MeOH) was added. A hot-plate with a DrySyn attachment was used to allow 
for both magnetic bottom stirring set at 350 rpm and temperature control at 20 °C. After 
slurrying the polymorphic mixtures for 4 minutes, the slurries were then filtered via vacuum 
filtration and left to dry at room temperature before being analysed by PXRD. Full details can 
be found in Chapter 4.  
3.3.4 Cooling Crystallisation  
Cooling crystallisation was investigated by both batch and continuous processing methods. In 
Chapter 6, batch crystallisations were carried out in the CRD Polar Bear Plus crystalliser, whilst 
a range of platforms were investigated for continuous processing: KRAIC (Chapters 4, 5 and 
6), KRAIC-D (Chapter 4 and Chapter 6) and KRAIC-S (Chapter 5) platforms. 
3.3.4.1 Batch Cooling Crystallisation 
In Chapter 6, small-scale cooling crystallisations with a working solvent volume of 1 mL were 
carried out in 1.5 mL vials using the CRD Polar Bear Plus crystalliser with magnetic bottom 
stirring. For co-crystallisation experiments, the two components were weighed into vials and 
the appropriate amount of the chosen solvent added. The vials were placed in the appropriate 
insert in the Polar Bear Plus crystalliser and stirred at a rate of 400 rpm. Cooling profiles were 
designed based on the solubility behaviour of the solid in the particular solvent. The vials were 
initially heated to the start temperature at a heating rate of 10 ℃ min-1 and dwelled at 
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temperature for an hour to ensure complete dissolution. Once the starting components had 
completely dissolved, the temperature programme switched to controlled linear cooling, 
initially at a cooling rate of 0.05 ℃ min-1, which was increased to more appropriate cooling 
rates adopted in industry of 1 ℃ min-1. The final temperature was chosen between 20 ℃ and 
5 ℃, depending on the temperature of crystallisation, the vials then dwelled at the final 
temperature for a specific amount of time before being filtered via vacuum filtration, dried at 
room temperature and then analysed by PXRD and DSC for solid form identity.  
For cooling crystallisations at scale, between 20 mL and 200 mL working volume of solvent 
was placed in round bottom flasks (RBFs) inserted into the CRD Polar Bear Plus crystalliser. 
Overhead stirring was provided by an external motor and shaft, to ensure efficient mixing and 
mass transfer. The starting components were weighed and added to the solvent in the RBF and 
heated at 10 °C min-1 to the starting temperature. The cooling rate adopted for these larger scale 
crystallisations was 1 ℃ min-1. Similar to the small-scale batch crystallisations, the vials 
dwelled at the initial temperature for 1 hour before commencing the cooling programme to 
ensure complete dissolution. The vials also dwelled at the final temperature to ensure sufficient 
crystalline material was available for analysis, with the dwell time the same across all the scales 
to allow for direct comparison between the various batch scales. Full experimental details on 
individual systems are provided in the relevant sections in Chapter 6. 
3.3.4.2 Continuous Cooling Crystallisations in the KRAIC / KRAIC-D / KRAIC-S 
platforms 
Continuous cooling crystallisations of model systems CBZ in EtOH and UBA in MeOH 
(Chapter 4), as well as continuous co-crystallisation of the novel material IBU-ISO in 60:40 
HI (Chapter 6) were investigated in the KRAIC (Kinetically Regulated Automated Input 
Crystalliser) (Figure 3.4) and KRAIC-D (Kinetically Regulated Automated Input Crystalliser 
– for Diffraction) platforms (Figure 3.5, left).  
In Chapter 5, the KRAIC-S (Kinetically Regulated Automated Input Crystalliser – Single 
Crystal) was used as a cooling crystallisation platform suitable for in situ Single Crystal X-ray 
Diffraction (SCXRD) characterisation in flow at beamline I19 (Figure 3.5, right). The cooling 
crystallisation process of paracetamol (PCM) in 60:40 HI in the KRAIC-S platform allowed 
for single crystals within solution slugs to be grown in situ. Optimisation of a slug triggering 
mechanism was used to achieve indexation from a single diffraction frame and after refinement 
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and integration of a series of images; the images could be scaled and merged allowing for full 
structural solution, via a serial-crystallography type approach. 
The cooling crystallisation processes were optimised offline in the KRAIC platform, to yield 
powder and single crystals crystallising in solution slugs suitable for appropriate analysis. For 
in situ X-ray diffraction (XRD) analysis, the KRAIC-D and KRAIC-S were installed at the 
high-resolution powder diffraction beamline I11 (Figure 3.5, left) and the small molecule single 
crystal beamline I19 respectively at Diamond Light Source (DLS) (Figure 3.5, right). 
 
Figure 3.4 – Bath-developed KRAIC platform. 
 
Figure 3.5 – Installation of the KRAIC-D at I11 (left) and installation of the KRAIC-S at I19 (right). 
Segmented flow employed in the KRAIC, KRAIC-D and KRAIC-S platforms incorporates 
three phases: two liquid components, the carrier fluid and the crystallising solution, with one 
gas phase (air) to achieve tri-segmented flow (Figure 3.6). To achieve segmentation, a cross-
piece (X-piece) was utilised, whereby the three separate streams combine at the mixer piece / 
segmentor; on the premise of immiscibility this combination results in a segmented net flow.   
64 
 
Segmentation facilitates plug flow operation in these flow crystallisation platforms, where 
particles experience good mixing conditions and are well suspended. Plug flow operation helps 
mitigate some of the inherent issues associated with moving solid particles in a flowing 
environment. For instance, the opportunity for sedimentation was reduced and the loss of 
homogeneity caused by adhesion of particles to the reactor walls was also reduced. This liquid-
liquid segmentation prevents any back mixing within the crystalliser and thus all particles 
experience the same conditions, imparting homogeneity as a result of this steady-state 
operation. For instance, particles spend the same amount of time within the reactor, which 
varies depending on the reactor length, flow conditions and was quantified by the residence 
time (RT). The immiscible carrier fluid was a perfluoropolyether (PFPE) with favourable 
wetting properties to prevent the crystallising solution nucleating on the solid surface by 
physically removing the solution flow from the reactor walls and thus preventing unwanted 
secondary nucleation from occurring during the crystallisation.72 
 
Figure 3.6 – Schematic of tri-segmented flow through the combination of three separate streams at the X-piece. 
The three phases were independently pumped under temperature control to the point of 
combination at the X-piece; the use of temperature control prevents crystallisation from 
occurring before segmentation was achieved. The X-piece was contained in a custom-made 
glass segmentation water bath sat on a hot-plate to provide temperature control. The 
temperature of the system until the water bath was maintained at the temperature of the 
crystallising solution feed, using jacketed tubing, which was controlled by an external 
circulator. The crystallising solution and priming solvent feeds were contained separately in 
2 L RBFs each on a hot-plate with a DrySyn attachment. The hot-plates provide heating and 
stirring of the solutions to ensure the crystallising solution was completely dissolved and if the 
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priming solvent was a solvent mixture, the mixing ensured the priming solvent was 
homogeneous ready for delivery. Once segmentation was achieved and the net segmented flow 
emerged from the heated water segmentation bath, no additional temperature control was 
imparted on the system. The system was left to cool on its own accord, resulting in 
crystallisation via air-cooling. 
The crystallising solution (or priming solvent during equilibration of the system) was pumped 
using an SF-10 peristaltic pump designed to lessen the effects of pulsation. The air and carrier 
fluid were each pumped using gear pumps. Employing separate pumps for each of the 
components in the tri-segmented flow allows complete control over the platform and facilitates 
flexibility in both crystallisation and reaction-based experiments. Variation in pump speeds 
and the reactor length, allows for kinetic regulation to be imparted in the system and the RT 
(time for a particular crystallisation volume segment to transit the device from establishing 
segmentation to the end-piece) to be optimised. Importantly, this allows for solution-mediated 
kinetic changes, particularly polymorphic transitions, to be optimised or removed as required.72  
The body of the KRAIC platform comprises a single extruded length of Fluorinated Ethylene 
Propylene (FEP) 15 m in length, with an internal diameter (ID) of 3.6 mm, resulting in a total 
crystalliser volume of 121 mL. As a result of the segmentation employed in the KRAIC 
crystalliser, only 61 mL of the total crystalliser volume comprises the crystallising solution. 
The net flow rate of the segmented flow through the KRAIC was typically 8.3 mL/min, 
contributing 2 mL/min from the crystallising solution, 4.18 mL/min and 2.1 mL/min for the air 
and carrier fluid flow rates respectively. This means that a 1 L crystallising solution feed will 
enable a 2 hour operation time, which was markedly longer than traditional flow crystallisation 
platforms such as a Continuous Oscillatory-Baffled Crystalliser (COBC), which for the same 
feed volume, would only facilitate a crystallisation run for 25 minutes.72  
An end-piece was seamlessly attached to the FEP tubing outlet ready for product recovery via 
vacuum filtration. The downward slope introduced by the widening of the end-piece was 
designed to achieve both recovery of carrier fluid from the solution via recovery holes and 
propulsion of crystals towards the filtration unit. These carrier fluid recovery holes were simply 
a number of holes at the bottom of the tubing, which allow the preferentially wetting carrier 
fluid to pass through, but not the crystallising solution. Recovery of the carrier fluid will reduce 
the overall net flow of the system, which could lead to blockages, so this was mitigated by the 
66 
 
incorporation of a neutral solvent (NS) towards the outlet (Figure 3.7). The NS was employed 
upstream of the carrier fluid recovery system using a gear pump, to maintain the net flow, as 
the velocity of the solution was increased at the point of addition and will therefore prevent 
encrustation in the pipeline and reduce contact time of particles with the reactor walls. The NS 
must be miscible with the crystallising solution and will not alter the solubility properties of 
the solution. Thus, the NS will not dissolve any of the solid particles in the crystallising 
solution, or lead to precipitation of particles from the filtrate, such as impurities, or more 
crystals of the target material, which will negatively affect the particle size distribution (PSD). 
The NS selected was usually the pure solvent used in priming (and the solvent used in the 
crystallising solution), cooled in an ice bath.72 
 
Figure 3.7 – End-piece set-up in the KRAIC, KRAIC-D and KRAIC-S platforms including the carrier fluid 
recovery holes and the NS inlet, adapted from Robertson et al.72 
For each KRAIC, KRAIC-D and KRAIC-S run, the experimental RT was measured to 
ascertain the crystallisation time, whilst also ensuring that the various pumps were operating at 
the desired programmed rates. Particular attention was taken to the flow rate of the air pump, 
which had the tendency to lessen over time as air is compressible. To mitigate this reduction in 
flow rate over time, the air gear pump was primed with the solvent used for priming to wet the 
inside of the pump.  
To ensure the KRAIC, KRAIC-D and KRAIC-S platforms were operating at steady-state, the 
system requires priming with pure solvent in place of the crystallising solution before any 
crystallisation run commences. The flow rates and temperature conditions utilised during 
priming were identical to those employed in the crystallisation run. The system will typically 
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require a couple of residence times to reach steady-state operation; this will also ensure any 
impurities from the inside of the tubing were removed. As a result of the steady-state operation 
obtained in the segmented flow, the solution passing a set point along the reactor length will 
always be at the same stage of the crystallisation process irrespective of the experiment time, 
enabling in-depth investigations into events that evolve with time, such as polymorphic 
transitions.  
The materials from which the KRAIC-D was constructed were compatible with in situ 
operation on synchrotron radiation beamlines. For instance, the X-ray beam was focused at the 
hydrophobically coated Kapton® viewing windows, which were incorporated into the KRAIC-
D design to facilitate X-ray penetration and minimise background interference at set points 
along the length of the crystalliser (Figure 3.8). The distance between windows was 2.623 m, 
to ensure the residence time was sufficient from when segmentation was established at the X-
piece and between analytical points, so that crystallisation events such as polymorphic 






Figure 3.8 – Schematic of KRAIC-D showing segmented flow and position of viewing windows. 
The body of the KRAIC-D tubular reactor was constructed of FEP, which is flexible and 
transparent to allow for visual monitoring of the crystallising solution, allowing identification 
of potential blockages. The Kapton® windows and Polytetrafluoroethylene (PTFE) unions 
comprise the viewing section of the KRAIC-D. The PTFE unions providing a join between the 
Kapton® analysis points and the rest of the FEP body.  
Use of X-ray transparent Kapton® windows incorporated into the KRAIC-D at I11 was not 
employed for the KRAIC-S at I19 and instead the scattering resulting from the reactor was 
subtracted during data processing. Thus, the entirety of the KRAIC-S was built from a single 
68 
 
extruded length of FEP to set up a single coil of tubing for the main body of the KRAIC-S. The 
viewing section, where the X-ray beam focusses on the single crystal in the solution slugs, is 
comprised of FEP supported by a motorised stage, employed to oppose the net segmented flow, 
such that a single crystal can be artificially ‘held’ in the X-ray beam for sufficient time to obtain 
enough diffraction spots for indexing from a single frame. As a single crystal is held in the X-
ray beam during data collection, due to the self-mixing provided by the bolus flow in the 
solution slugs the crystal is rotating, which allows for data across a range of orientations with 
respect to the X-ray beam to be obtained. A pump-probe approach is employed, based on a slug 
triggering mechanism, whereby a laser / diode is continually monitoring the segmented flow, 
coupled with the known net flow rate and distance from the laser trigger to the X-ray beam is 
known. The motorised stage can be prompted to translate as a single crystal in a solution slug 
passes the X-ray beam, whereby the X-ray beam can be switched on / off to only collect data 
on crystallising solution slugs. The developmental work and set-up associated with the slug 
triggering mechanism is detailed in Chapter 5.  
The experimental conditions including concentration and temperature control, together with 
the flow parameters, varied greatly for the various KRAIC-D experiments (and corresponding 
KRAIC experiments), the detail of which can be found in Chapter 4 and Chapter 6. Similarly, 
the experimental detail for the various KRAIC-S (and the associated KRAIC) runs can be found 
in Chapter 5.  
3.3.5 Seeded Cooling Crystallisation 
To investigate the impact of introducing a controlled solid interface into the cooling 
crystallisation within the KRAIC-D platform, an additional T-piece inlet was inserted into the 
platform at pre- and post-nucleation stages of the crystallisation process. The introduction of a 
seed addition port allowed for a seed slurry to be transferred using an SF-10 peristaltic pump 
into the KRAIC-D. The slurry of seeds of polymorphic purity were introduced into the cooling 
crystallisation at room temperature. The detail of the slurry preparation, including slurry 
stability testing, as well as stability testing of the slurry through an SF-10 peristaltic pump was 
detailed in Chapter 4. The seeding cooling crystallisation experiments of the KRAIC-D 
installed at I11 DLS investigated the model systems CBZ in EtOH and UBA in MeOH. The 
seed slurry introduced into the cooling crystallisation of CBZ in EtOH was the thermodynamic 
CBZ form III delivered in EtOH. The impact of seeding on the cooling crystallisation of UBA 
in MeOH looked at the concomitant form UBA form III in polymorphic purity, introduced at 
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pre- and post-nucleation stages, whilst the dominant form UBA form I was only introduced at 
the pre-nucleation seeding port. Both UBA form I and III slurries were mediated and delivered 
in MeOH. The solvents employed in the delivery of the slurries were selected to match the 
solvent employed within the cooling crystallisation. The seeded KRAIC-D experimental set-
ups are illustrated and described in detail in Chapter 4. 
Seeding of the metastable PCM form II using an FEP coil into the cooling crystallisation of 
PCM in 60:40 HI in the KRAIC-S is detailed in Chapter 5. For seed solution delivery into the 
KRAIC-S, instead of an SF-10 pump as detailed for delivery into the KRAIC-D, a syringe 
pump coupled with a piston connected through a T-piece was used upstream of the sample 
loop. The net flow was delivered at room temperature using the syringe pump, while the piston 
provided oscillation to the system. The PCM form II seeds suspended in the carrier fluid were 
pre-loaded into the coil before delivery into the KRAIC-S. The seeded experimental set-up is 
illustrated and described in detail in Chapter 5. In Chapter 4 and Chapter 5, for each seeding 
experiment, the seed solutions were prepared immediately before use.  
3.4 Analytical Methods 
3.4.1 Powder X-Ray Diffraction (PXRD) 
Laboratory Diffraction Analysis 
PXRD was used in this work as a “fingerprinting” tool to characterise the crystal structure of 
polycrystalline solid products, including potential co-crystals produced during the 
crystallisation trials. Pattern comparison is used as the main approach; matching (of peak 
positions and hence of unit cell parameters) was expected for experiments targeting optimised 
production of known solid phases, while mismatched patterns were targeted in the case of 
materials discovery (the observed PXRD should not match those of either starting materials or 
known products containing these, indicating a product with a distinct unit cell).  
Bruker D8 Advance Diffractometer 
For the majority of laboratory powder diffraction analysis, a Bruker D8 Advance 
Diffractometer set in flat plate mode, equipped with monochromatic Cu-K𝛼 (𝜆 = 1.54056 Å) 
radiation in reflection geometry at 298 K was used to analyse powder samples. The crystalline 
samples were lightly ground and placed onto a glass slide, which was then mounted onto a 
glass flat-plate with a non-diffracting adhesive substance. The diffraction pattern of the powder 
sample was obtained between 2θ = 5 – 40°.  
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STOE STADI P Diffractometer 
Later laboratory work conducted at the University of Bath (in 2019) used a STOE STADI P 
diffractometer with Cu-Kα1 radiation ( = 1.54045 Å). The samples were prepared by placing 
some crystalline powder onto a transparent, zero-diffracting acetate foil in the sample holder. 
A secondary acetate foil was placed over the top of the sample, before being secured in the 
sample holder. The samples were evaluated at room temperature (298 K) and a diffraction 
pattern was obtained between 2 = 2 – 75°.  
In Chapter 4, the crystalline material resulting from CBZK and CBZKD experiments was not 
ground during sample preparation in order to avoid evoking a polymorphic transformation 
resulting from grinding of the sample.  
Synchrotron Diffraction Analysis 
Beamline I11, the High-Resolution Powder Diffraction beamline at DLS (Chapter 4 and 
Chapter 7) 
The High Resolution Powder Diffraction Beamline I11 at DLS was used for the powder 
synchrotron studies presented in Chapter 4 and Chapter 7 of this research project. Beamline 
I11 utilises a combination of very high angular resolution, high count rates and controlled 
environmental conditions to achieve detailed structural analysis of polycrystalline materials.  
The synchrotron X-ray radiation supplied to I11 is provided by an in-vacuum U22 undulator 
insertion device located in the main electron storage ring. The undulator is 2 m in length, 
comprising of an array of 90 permanent magnets, exhibiting a period length of 22 mm. This 
insertion device produces an X-ray beam energy ranging from 5-30 keV, where the highest 
flux was achieved at medium energies between 11-20 keV, decaying quickly beyond 20 keV.89  
The optics hutch at I11 contains various components: primary slits designed to trim the white 
beam from the undulator, a cryo-cooled Double Crystal Monochromator (DCM) equipped with 
a pair of Si(111) crystals, double bounce harmonic rejection (HR) mirrors, two sets of 
monochromatic slits and an embedded intensity monitor (Figure 3.9). The distance between 
the two crystals comprising the DCM was altered to maintain the fixed-exit beam geometry 




Figure 3.9 – A schematic of the beamline I1I layout at DLS, which shows the main components along with the 
approximate distances from the undulator X-ray source, adapted from Thompson et al.89 
The two experimental hutches downstream of the optics hutch take beam controlled by an X-
ray shutter. They house different experimental setups designed to support complementary areas 
of structural science. Synchrotron Powder XRD studies of highly polymorphic model systems 
and novel multi-component materials in this research project have been carried out in both 
experimental hutches (EH1 and EH2). Both EH1 and EH2 are designed for high-resolution and 
time-resolved diffraction data whilst EH2 offers the additional benefit of having physical 
capacity to house non-routine experiments, which require advanced experimental set-ups, such 
as the KRAIC-D. The key benefit in EH2 being situated downstream of EH1, allows 
experimental set-up to be carried out whilst EH1 is still taking beam (Figure 3.10).  
     
Figure 3.10 – A schematic of the beamline I1I layout at DLS.90 
In Chapter 4, EH2 was utilised for in situ XRD characterisation of cooling crystallisations in 
the KRAIC-D, to investigate crystallisation events that evolve with crystallisation time. This 
was made possible due to the design and steady-state operation mode of the KRAIC-D, in 
which the reactor provides highly reproducible reaction conditions. A 15 keV X-ray beam 
energy, corresponding to a wavelength of 0.8265 Å, was employed to maximise flux. The beam 
size employed was 1 mm x 1 mm, compatible with a typical 7 mm plug length. The diffraction 
was detected using a 2D CCD (Charge Coupled Device) Pixium RF4343 detector, operating at 
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10 frames per second (fps), which was sufficient to isolate scattering from plugs in a proportion 
of frames.  
In Chapter 7, EH1 was utilised for the in situ XRD characterisation of slurrying crystallisations 
in capillaries to benefit from both high-resolution and rapid data collection to monitor time-
resolved changes in solution phases over a range of crystallisation periods. The wavelength of 
X-ray radiation used was 0.8265 Å, equating to a beam energy of 15 keV. The beam size of 
0.5 mm x 2.5 mm was compatible with the sample size, where slurry samples were loaded into 
1 mm borosilicate capillaries. The experimental capillary set-up was traditional for PXRD data 
collection at I11, whilst the sample state, whereby a slurry was loaded directly into a capillary, 
was non-routine and novel. Chapter 7 provides a demonstration for protocol development for 
in situ characterisation of slurrying crystallisation. As these slurrying investigations were time-
resolved, a wide-angle PSD (Position Sensitive Detector) Mythen detector was employed due 
to its fast data acquisition rate of < 1 s per pattern. The diffraction patterns of the slurry samples 
were obtained between 2θ = 2 – 92° at room temperature. Variable temperature powder X-ray 
diffraction (VT-PXRD) measurements were investigated across the same 2θ (°) range, within 
the temperature range 293-400 K through use of a Cryostream Plus. The heating / cooling rate 
employed was 0.8 ℃ min-1, with each 5 ℃ incremental change in temperature accompanied 
by a 3 minute equilibration period before data collection. 
The data collection process was controlled through the in-house Generic Data Acquisition 
(GDA) software whilst the data processing for the KRAIC-D EH2 work and the EH1 slurrying 
in capillaries investigations were carried out using Matlab® and DAWN91 (Data Analysis 
WorkbeNch ) software packages respectively.  
3.4.2 Single Crystal X-ray Diffraction (SCXRD) 
SCXRD was used in two ways in this work.  For potential new co-crystals, SCXRD gives a 
rapid route to the determination of unit cells from single crystal samples resulting from 
crystallisation trials.  For structures that were confirmed by unit cell screening to be novel, 
SCXRD was the method then used to allow for full structural determination, revealing molecular 
geometry and packing. Potential co-crystals were initially screened and the unit cell parameters 
from the pre-screening experiment compared with the unit cell parameters of the starting 
materials, including various polymorphic forms, found in the Cambridge Structural Database 
(CSD).24 Provided the unit cell parameters were different, indicating a new crystal phase has 
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been discovered, and where the single crystal was of sufficient quality to yield quality diffraction 
data, a full data collection to yield structure solution could be carried out. A crystal of good 
diffraction quality has reflections that have a good intensity and occur to a high resolution 
(typically dmin < 0.84 Å), that do not overload at low angle and which are not split. The novel 
crystal structures presented in Chapter 6 were determined using SCXRD, conducted using both 
laboratory and synchrotron sources. The choice of X-ray source was selected on the basis of the 
quality of the crystals produced in the evaporative crystallisation trials; crystallisation products 
which yielded very small crystallites or weakly diffracting single crystals required a synchrotron 
source for structure solution.  
SCXRD analysis was also used in this work to investigate structural solution of single crystals 
grown in situ in solution slugs in a segmented flow crystalliser known as the KRAIC-S. 
Synchrotron X-rays on I19 were employed as a non-invasive in situ characterisation technique 
to monitor tumbling crystals within moving droplets, the use of a high flux source with fast data 
collection times that a synchrotron source provides was fundamental for this in situ XRD single 
crystal analysis.  
3.4.2.1 Optical Microscopy 
The selection of quality single crystals for traditional laboratory and synchrotron single crystal 
diffraction studies was carried out using polarised light microscopy. A single crystal of suitable 
quality for analysis exhibits well define crystal edges and faces, whilst also being free from 
cracks or any additional tiny crystallites attached to the single crystal surface.  A microscope 
fitted with a polarising lens was used to determine the crystallinity of the solid. When viewed 
under polarised light, a single crystal will ‘extinguish’ when rotated as the high degree of order 
within the crystalline structure causes the crystal to act as a polariser. Optical microscopy was 
also a useful tool for assessing a crystal’s size and shape (morphology), which can give an 
indication of solid form, provided the various polymorphs exhibit distinct differences in habit. 
The crystal size also indicates the extent of crystal growth.  
Laboratory Diffraction Analysis 
Two in-house X-ray diffractometers were used in the SCXRD studies of the multi-component 
materials discovered in this research project. SCXRD data were recorded on the Rigaku Oxford 
Diffraction92 (previously Agilent Technologies) SuperNova and Gemini A Ultra CCD 
diffractometers. Both of these diffractometers have a dual source sealed tube with both Cu-Kα1 
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( = 1.54045 Å) and Mo-Kα1 radiation ( = 0.71073 Å) with microfocus sources allowing for 
high X-ray flux to be delivered to the sample. Both of the single crystal diffractometers utilise 
a graphite monochromator and have a four-circle kappa goniometer, with an Agilent93 Eos S2 
and Atlas CCD detectors for the SuperNova and Gemini A diffractometers respectively.  
Although the specific components vary across diffractometers, the general experimental set-up 
remains the same (Figure 3.11). The four-circle κ goniometer allows for movement of the single 
crystal through each of the three diffractometer axes (κ, ϕ, ω), as well as the 2 of the detector, 
allowing for a complete set of diffraction data to be collected. 
 
Figure 3.11 – The experimental set-up for a laboratory SCXRD diffractometer, pictured is the Rigaku Oxford 
Diffraction SuperNova diffractometer.92 
All single crystals were isolated from the bulk sample, cleaned in a viscous oil, Fomblin®, and 
the crystal mounted onto the looped Kapton® filament attached to a magnetic mount. Once the 
temperature of the diffraction experiment was set at the desired temperature, the magnetic mount 
was then placed on the diffractometer goniometer head. The crystal was centred in the X-ray 
beam position by adjustments to the vertical and horizontal axes of the goniometer head.  Once 
screening of the mounted single crystal of good diffraction quality is complete, full structural 
determination can be performed. A recommended data collection strategy is suggested at the 
end of the pre-experiment used for crystal screening. The strategy suggests the required 
exposure time per diffraction image necessary to obtain diffraction data to the required 




the data collection. These parameters are typically a d-spacing 0.8 Å resolution, an I/σ of 15, a 
redundancy of five and a completeness of 98 %. The extent of reciprocal space to be sampled 
during the data collection is also to be decided, in terms of the requirements of the unique data 
for the particular crystal system. If time permits, collection of a full hemisphere of data is 
recommended to access all unique reflections. 
The sample temperature was controlled by a flow of liquid nitrogen using an Oxford Diffraction 
Cryojet apparatus. VT-SCXRD measurements can be achieved by altering the temperature 
controlled by this liquid nitrogen flow device. The exposure times were dependent upon the 
system being studied, the details of which can be found in the relevant results chapters.  
Both the Supernova and the Gemini A Ultra CCD diffractometers were equipped with the 
Rigaku-Oxford diffraction software CrysAlisPro,94 which was used to collect, index and 
prepare data for structural interpretation. This was then analysed in the SHELXT (structure 
solution using a dual-space iteration starting from a Patterson superposition, through use of the 
charge flipping algorithm to generate more random phases) and SHELXL (least squares 
refinement) programs, used to solve and refine the crystal structure respectively. Both 
programmes were executed as part of the GUI Olex2 (version 1.2.10) software package from 
OlexySys Ltd. Visualisation and analysis of the crystal structures produced was then conducted 
in Mercury (version 4.2.0). 
Synchrotron Diffraction Analysis 
Single crystal synchrotron X-ray diffraction studies of crystalline material in this research 
project were carried out at two synchrotron facilities: Diamond Light Source (DLS), UK88 on 
beamline I19, at Harwell and the Advanced Light Source (ALS), USA95 on beamline 12.2.1, 
at the Lawrence Berkeley National Laboratory. The theory of synchrotron crystallography was 
described in Chapter 2. The high intensity of synchrotron X-rays is advantageous for 
demanding crystalline systems, with a high degree of structural disorder or where 
crystallisation trials produce weakly diffracting samples, or extremely small crystallites where 
laboratory sources could not provide structural solution.  
Beamline I19, the Small Molecule Single Crystal beamline at DLS (Chapter 5) 
Beamline I19 was used predominately for the single crystal synchrotron studies in this research 
project. I19 offers high-flux, along with tuneable-wavelengths dedicated to single crystal 
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structure determination of small-molecule systems, including under a variety of conditions and 
sample environments, such as high pressure.96 
Beamline I19 is located on a 5 m straight-section of the storage ring, where an in-vacuum U21 
undulator source provides the highly intense 5-28 keV energy range, with an associated 0.44-
2.48 Å wavelength range (Figure 3.12). Wavelength selection of the synchrotron X-rays 
emerging from the storage ring was achieved using a cryo-cooled double crystal 
monochromator (DCM) situated in the optics hutch, equipped with a Si(111) crystal set. The 
double crystals select the 5-28 keV synchrotron radiation range, whilst also maintaining the 
fixed-exit beam geometry. The X-ray beam was focused downstream of the DCM in the optics 
hutch using a pair of bimorph mirrors, which independently focus the beam in the horizontal 
and vertical axes. Once focused, the beam was directed towards the experimental hutches, 
where the sample was situated, ready for data collection. The dimensions of the mirrors were 
matched to the beam divergence and the beam’s 3 mrad incidence angle, which ensures the 
beam footprint was maximised over the mirrors. The focused beam exhibits a Gaussian profile 
with a Full Width Half Maximum (FWHM) of 90 m horizontally by 60 m vertically and 
185 m horizontally by 130 m vertically for the first and second experimental hutches (EH1 
and EH2), respectively. The beam size can be altered by defocusing / refocusing the bimorphs, 
which provides opportunity to optimise for a range of sample sizes. The beam size was selected 
to ensure that the sample was completely immersed in the primary beam. The experimental 
hutches were able to take beam, by opening an X-ray shutter.96  
 




EH2 offers the physical capacity to house non-routine experiments, which require advanced 
experimental set-ups, such as the KRAIC-S. The key benefit in EH2 being situated downstream 
of EH1, is to allow experimental set-up to be carried out whilst EH1 is still taking beam.  
Data were collected in EH2 using Si(111) monochromated radiation at the Ag edge (0.4859 Å) 
on a Newport98 four-circle diffractometer in κ geometry equipped with a DECTRIS99 
PILATUS 2M hybrid pixel detector (Figure 3.13). The diffraction data was collected by the in-
house GDA software. Image data from the PILATUS 2M detector was displayed and analysed 
using the data visualisation and image manipulation software Albula.100 Data processing trials 
were carried out ‘by hand’ using the CrysAlisPro (Version 40.53) software package, whilst 
automated data processing was carried out using the in-house software DIALS (Diffraction 
Integration for Advanced Light Sources )101, 102 and Xia2 using a pre-package of DIALS.  
 
Figure 3.13 – The experimental set-up of the KRAIC-S at EH2, I19 DLS, featuring 1) Newport98 four-circle 
diffractometer and 2) DECTRIS99 PILATUS 2M detector. 
To ascertain crystal growth at various set points along the length of the KRAIC-S platform 
where crystals were grown in situ, standard data collections of known crystallite sizes were 
analysed in EH2 as a reference. The integrated intensity values of the PCM form I and PCM 
form II crystallites of known sizes were collected via the traditional SCXRD data collection 
methodology and compared to the integrated intensity values of single crystals in solution slugs 
captured in flow in the KRAIC-S.  
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Beamline 12.2.1, the Small Molecule Crystallography beamline at ALS (Chapter 6) 
A recently upgraded superbend beamline 12.2.1 with wavelength ranges of 0.5-2 Å, coinciding 
with a beam energy of 6-24 keV, suitable for chemical crystallography was installed at the 
ALS.95 Beamline 12.2.1 features a parabolic collimating mirror where the X-rays were directed 
into a Kohzu double crystal Si(111) monochromator followed by a second toroidal mirror, 
which focuses the beam at the sample positioned in the X-ray hutch. An extremely small beam 
focus spot of 30 m x 80 m was available. Beamline 12.2.1 employs a Bruker D8 laboratory 
diffractometer with a PHOTON II CPAD detector, in which temperature control was achieved 
using an Oxford Cryostream 800+.  Transmission filters were applied to the incoming beam 
dependent on the attenuation / diffraction characteristics of the sample, the details can be found 
in Chapter 6.103, 104 The data were collected using the Bruker AXS Apex2 software and 
processed using the Bruker AXS Apex2 with SADABS-2014/5 software packages.  
The exposure times for each SCXRD data collection were dependent on both the analytical 
approach and the material under analysis (full details can be found in the relevant results 
chapters). 
Thermal analysis  
3.4.3 Differential Scanning Calorimetry (DSC)  
DSC is used to determine the thermal properties of the solid material under study. The 
information obtained includes melting point, phase transitions, desolvation, decomposition 
among others. Comparing the thermal events of the profen family co-crystals, with those of the 
constituent starting components can indicate co-crystal formation when the thermal events 
differ from the starting materials or confirm the presence of pure or excess starting material 
when the DSC traces match the DSC traces of the starting materials. This DSC trace 
comparison is similar to the pattern comparison approach used in the PXRD analysis.  
For DSC measurements, between 1-10 mg of powdered sample was weighed and placed into a 
Tzero aluminium pan and then sealed with a Tzero aluminium lid by the use of a crimping 
device. The pan containing the powdered sample under study was placed next to an empty 
reference pan, within a Thermal Advantage (TA) Instruments Q20 DSC. This DSC instrument 
was equipped with Thermal Advantage Cooling System 90 and operated with a dry nitrogen 
purge gas at a flow rate of 18 cm3 min-1. The average heating rate was 10 K min-1. The DSC 
procedure was devised with TA software whereby specific heating and cooling programmes 
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could be set including heating and cooling rates, in addition to temperature limits. The data 
were collected using the software Advantage for Qseries. The resultant endothermic and 
exothermic events that occurred during the heat-cool cycles were recorded and the Universal 
Analysis software was used to evaluate the resulting DSC traces. 
3.4.4 Thermogravimetric Analysis (TGA) coupled with Mass Spectrometry (MS) 
Thermogravimetric (TG) analysis coupled with Mass Spectrometry (MS) allows for the 
thermal decomposition pathway of a material to be understood, by measuring the weight loss 
of a sample as a function of temperature. TG is often coupled with MS to allow the identity of 
the components lost during sample heating to be confirmed. TGA is used to monitor the 
desolvation of a sample and additionally the stoichiometry of a solvate can be quantified. TGA 
was used in Chapter 6 to analyse the Oxaprozin-Imidazole (OXA-IMID) solvate structure.  
Thermogravimetric Analysis (TGA) was conducted using a Setsys Evolution TGA 16/18 in 
tandem with a Mass Spectrometer (MS). Once the instrument had been calibrated and a 
background sample of an empty aluminium crucible run under air, a small powdered sample 
(1-5 mg) was placed into a 170 μL aluminium crucible which was placed onto the internal 
instrument balance. The sample was then subject to a pre-programmed heating profile, 
5 ᵒC min-1 between 20 ℃ and 400 ℃ and the mass loss of the sample was recorded with respect 
to the temperature. The data collection and processing were carried out using Calisto. Any 
evolved gas was run through the attached MS for analysis. 
MS was coupled with the TG analysis using an OmniStar GSC 320 from Pfeiffer Vacuum, 
under an argon atmosphere (2.3 bar outlet pressure) controlled using Pfeiffer Vacuum Quadera 
software. In the experimental set up, the MS was programmed to detect the first four significant 
MS peaks of the ethanol solvent used in the evaporative crystallisation experiment. The signals 
of these peaks were recorded throughout the temperature regime and plotted alongside the TG 
curve, as a function of temperature; this allowed the solvent mass loss step to be identified and 
the stoichiometry of the OXA-IMID solvate to be quantified. 
3.4.5 Hot-Stage Microscopy (HSM)  
Hot-Stage Microscopy (HSM) combines microscopy with thermal analysis to allow the thermal 
behaviour of crystalline materials to be visualised as a function of temperature and time. The 
basic configuration of the hot-stage microscope includes an optical microscope equipped with 
a digital camera, a heating stage sample chamber coupled to a digital programmable temperature 
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controller and a computer with software to record HSM images and videos from the digital 
camera. HSM was used in Chapter 6 to analyse the OXA-IMID solvate structure and monitor 
solvent evolution from the sample.  
A single crystal or a small quantity of the crystalline material produced from an evaporative 
crystallisation experiment was mounted onto a glass slide with the use of a low-diffracting oil, 
Fomblin®, which was then placed into a Mettler Toledo FP82 hot stage set up equipped with a 
Leica DM1000 Microscope. The crystalline sample was subject to specified heat programmes 
using the FP90 Processor whereby it was possible to define the initial and final temperature as 
well as the heating rate. The resultant thermal activity, such as melting of, or solvent evaporation 
from, the sample was recorded using an Infinity 2 microscopy camera.  
3.4.6 Spectroscopy  
3.4.6.1 Fourier Transform Infrared Spectroscopy (FTIR)  
Infrared (IR) spectroscopy uses the IR region of the electromagnetic spectrum to probe the 
rotations and vibrations of molecular bonds in organic molecules. The IR radiation is absorbed 
by molecules at characteristic resonant frequencies that are directly related to the bond 
vibrations in the molecule and hence are characteristic of a particular functional group.105 
Fourier transform IR (FTIR) increases the sensitivity of IR measurements by employing an 
interferometry approach in which the interference pattern generated by recombination with the 
reference beam can be Fourier transformed to produce the IR spectrum. The use of FTIR 
spectrometers is adopted as the standard approach in modern IR spectroscopy. The benefit of 
using an FTIR spectrometer include decreasing the sample size required for analysis and 
decreasing the time required for acquisition of the spectrum. In Chapter 6, FTIR spectroscopy 
was used as an approach to monitor co-crystal formation by comparison to the spectra of the 
starting profen targets, as well as the hydrogen bonds produced in the co-crystal formation, 
evident from the visualisation of the co-crystal in Mercury after SCXRD analysis. 
The FTIR spectra were recorded at room temperature using a Perkin Elmer FTIR Spectrometer 
in the range 4000-500 cm-1 with an ATR (Attenuated Total Reflection) sampling accessory. 
Multi-component co-crystal formation can be established by comparison with the constituent 
starting materials prepared by the same crystallisation method. The functional groups of focus 
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were C=O and N-H due to their hydrogen bonding capabilities often observed during co-crystal 
formation.    
3.4.7 Process Analytical Technology (PAT) 
3.4.7.1 Inline Ultraviolet Visible Spectroscopy (UV-Vis) monitoring 
Ultraviolet-Visible (UV-Vis) spectroscopy uses the UV and visible regions of the 
electromagnetic spectrum to interact with matter, which causes electronic transitions, in which 
electrons are promoted from the ground state to a high-energy state. UV-Vis absorption is 
principled on the Beer-Lambert law, which states that the attenuation of light is related to the 
properties of the material through which the light is travelling (Equation 3.1), including the 
concentration.  
A = ɛcl 
Equation 3.1 – The Beer-Lambert law, where A = Absorbance, ɛ = molar extinction coefficient, c = 
concentration and l = path length. 
Chapter 4 looks at UV-Vis monitoring to investigate dye addition into solution slugs as a 
technique to optimise seeding addition into the KRAIC-D. An Ocean Optics UV-Vis 
spectrometer with an in-line z-path flow cell monitored the concentration of dye via the 870 nm 
peak with a data step value of 5 ms. The intensity of wavelength 870 nm was followed as it 
gave the most discernible difference from the air spectra. As the absorbance value for the dye 
spectrum at this particular wavelength was lower than that for the air and carrier fluid media, 
local minima were monitored during the UV-vis analysis. The local minima absorbance values 
and time difference taken over a 1 minute time period were then compared for consistency of 






Chapter 4 – In situ X-ray Diffraction (XRD) Analysis of 
Continuous Segmented Flow Cooling Crystallisation in KRAIC-D 
at High Resolution Powder Diffraction Beamline I11 Diamond 
Light Source – Urea-barbituric acid (UBA) and Carbamazepine 
(CBZ) 
The research presented in Chapter 4 comprises a research collaboration between the Wilson 
Group at the University of Bath with the Kapur and Meldrum groups at the University of Leeds. 
The other researchers who contributed to various aspects of this work include: Dr. Mark 
Levenstein (University of Leeds),106 Dr. Pierre-Baptiste Flandrin,107 Dr. Daniel Scott and Dr. 
Ruth Lunt (University of Bath).  
The work presented in this chapter has been published in Analytical Chemistry: Dynamic 
Crystallization Pathways of Polymorphic Pharmaceuticals Revealed in Segmented Flow with 
Inline Powder X-ray Diffraction. 
Mark A. Levenstein#, Lois Wayment#, C. Daniel Scott, Ruth Lunt, Pierre-Baptiste Flandrin, 
Sarah J. Day, Chiu C. Tang, Chick C. Wilson, Fiona C. Meldrum, Nikil Kapur, and Karen 
Robertson (#These authors contributed equally). 
Analytical Chemistry 2020 92 (11), 7754-7761, DOI: 10.1021/acs.analchem.0c00860 
4.1 Introduction and Aims 
In order to gain more control over crystallisation processes, an improved understanding of these 
processes is required. The use of more controllable and reproducible crystallisation 
methodologies, coupled with a means of continually monitoring the process through in situ 
analysis techniques, provides a means to achieve this. For example, in situ monitoring of a 
solution-mediated polymorphic transformation (SMPT) from form II to form I of the 
pharmaceutically relevant rifampicin in a 100 mL jacketed glass crystalliser in three solvents 
at 30 ℃ was investigated. The SMPT of rifampicin was monitored online using Focused Beam 
Reflectance Measurement (FBRM) and Raman spectroscopy. It was found that the factors 
controlling the polymorphic transformation differed with solvent selection. The transformation 
process was controlled by dissolution of form II in heptane, whilst in hexane and octane the 
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process was initially controlled by dissolution of form II and then by the growth of form I. This 
in situ study thus provided mechanistic insight.108  
More relevant to this results chapter, in situ synchrotron powder X-ray diffraction (PXRD) 
studies have been used to monitor the SMPT of the potent anti-inflammatory agent flufenamic 
acid from the metastable form I to the stable form III during the wet granulation process. The 
resulting experimental data obtained from this study were used to test and validate a predictive 
model for polymorphic transformations during the wet phase of granulation, based on mass 
transport and crystallisation kinetics. Real time monitoring provided the opportunity for real-
time control of the granulation process; altering the granulation time can alter the polymorphic 
outcome.109 In a study by Ouyang et al., the polymorphic transformation from α-glycine to γ-
glycine during an ionic liquid-mediated crystallisation process was achieved through 
evaporation of water. Droplets of the target solution were spotted in the middle of the cavity of 
the glass sample holder and the crystallisation process of glycine was monitored via in situ 
PXRD by monitoring the change in intensity of characteristic diffraction peaks.110 
Online PXRD analysis was employed to investigate chemical and structural transformations of 
coordination polymers and metal-organic frameworks carried out by mechanochemical 
reactions. The mechanochemical reactions were carried out in an in-house built milling vessel 
and analysed by in situ synchrotron X-ray diffraction (XRD) monitoring, whereby the real-
time characterisation was achieved without disturbing the milling process.111, 112  
Online PXRD analysis was employed to monitor the formation and growth of nanoparticles, 
as well as to monitor phase transitions and to determine crystallite size. The formation and 
growth of CoSb2O4 nanoparticles using different precursor stoichiometries were followed in 
real time using in situ synchrotron PXRD. The crystallite size can be fine-tuned between 14 
nm and 17.5 nm under nonstoichiometric conditions, whilst crystallites twice as large are found 
in stoichiometric ratios. A similar study employed in situ synchrotron XRD analysis to study 
the formation, growth and phase transformation of colloidal monodisperse spherical copper 
sulfide nanocrystals synthesised in dodecanethiol. For these studies of the CoSb2O4 
nanoparticles and the copper sulfide nanocrystals, the precursor was injected into a custom-
made sapphire capillary set-up, which was subsequently pressurised and heated to the desired 
temperature, whilst time-resolved XRD patterns were acquired at 5 seconds and 9 seconds 
intervals respectively. These studies demonstrate the use of in situ synchrotron XRD analysis 
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to provide information on how to control the size and phase of these nanoparticle systems as a 
function of time and temperature.113, 114  
These online PXRD studies have been limited to batch processing methods. Batch 
environments exhibit limitations such as inhomogeneity, with respect to mixing and heat 
transfer. In addition, for large stirred-tank reactors, it is only possible for a fraction of the vessel 
to be probed and thus the analysis may not necessarily be representative of the bulk sample.  
Flow technologies offer the potential for the area of analysis (for example, the size of the X-
ray beam), to be compatible with the size of the reactor, resulting in representative sampling of 
the crystallisation process compared to traditional batch reactors. At the micro and nanoscale, 
the flow of fluids is confined such that turbulence is essentially suppressed, which leads to 
predictable flow paths and controlled mixing conditions, where polymorphic form can be more 
reliably predicted and thus the desired form can be accessed for manufacture.115 However, 
milliscale crystallisers operate over a more suitable scale of production of crystallisation 
processes in the pharmaceutical industry to facilitate high-throughput screening at scale. In 
increasing the scale of operation from nanoscale to milliscale, dramatic changes in flow 
behaviour are apparent, whereby the flow of fluids in milliscale crystallisers exhibit turbulent 
behaviour. This turbulent flow results in unpredictable crystallisation pathways compared to 
nanoscale systems and emphasises the importance of in situ XRD for improved understanding. 
Although the area of continuous crystallisation is not in its infancy, relatively little 
understanding into how crystallisation occurs in a flow environment has been achieved to date 
and thus its potential capabilities are also unknown.  
In the work presented, a flow crystallisation platform based upon the KRAIC,72 known as the 
KRAIC-D (Kinetically Regulated Automated Input Crystalliser for Diffraction), which 
employs tri-segmented flow and achieves crystallisation through cooling, was installed on the 
High Resolution Powder Diffraction beamline I11 at the Diamond Light Source (DLS) 
synchrotron. In this segmented flow environment, each droplet of crystallising solution only 
equates to a volume of ca. 0.2-0.4 mL; coupled with the corresponding flow rate and the 
associated data acquisition time per slug this means that observing crystallisation in situ is not 
to date accessible with laboratory-source diffractometers due to the small volume of diffracting 
material passing the beam at any given time. This problem with analysis is rectified through 
the use of the high flux available at synchrotrons. The use of synchrotron radiations rectifies 
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the inherent issues with low intensity of diffraction and a high signal:noise ratio. The higher 
intensity of X-rays available at synchrotron facilities allows diffraction from crystallites to be 
discerned above the scattering of the solvent, whereby solution slugs contain a significant 
solvent contribution compared to the low density of crystallites in solution slugs passing the 
X-ray beam. Furthermore, segmented flow provides highly reproducible environments for 
crystallisation, such that at a given set point along the length of the crystalliser, once steady-
state operation has been reached, the crystallisation process will always be at the same stage of 
the crystallisation irrespective of the experiment time. This reproducibility in nucleation and 
crystal growth times allows events that evolve with time, such as polymorphic transformations, 
to be captured without time constraint.  
Two pharmaceutically relevant and highly polymorphic systems of interest, which comprise 
the materials focus for this study, are the model systems urea-barbituric acid (UBA) and 
carbamazepine (CBZ).  
CBZ is the API in Tergetol®, which is used as an anti-seizure medication and to relieve 
neuropathic pain (Figure 4.1). CBZ has five anhydrous polymorphic forms, as well as solvates 
and co-crystals;116 the various polymorphs possess distinct habits.117 CBZ form III is the 
thermodynamic form under ambient pressure, whilst CBZ form II is often formed from 
solution-based crystallisations.1 According to Ostwald’s rule of stages, the less stable 
polymorph will often nucleate first and will subsequently undergo polymorphic 
transformation(s) before reaching the most stable polymorph.118 As a result of Ostwald’s step 
rule, it can be postulated that a polymorphic transformation from CBZ form II to CBZ form III 
could be observed in the crystallisation process, where the initial polymorphic outcome is 
largely dictated by the mixing conditions.1    
 
Figure 4.1 – Chemical structure of carbamazepine (CBZ). 
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UBA is a co-crystal of urea and barbituric acid (Figure 4.2). It exhibits improved solubility 
from barbituric acid, which is a precursor material to the barbiturate family of compounds. The 
barbiturates such as phenobarbital act as central nervous system depressants providing 
anaesthesia and used in the treatment of epilepsy and migraines.119 UBA is a polymorphic co-
crystal with four known forms, three of which have been fully characterised, two of which have 
very similar Gibbs Free energies and exist concomitantly; a mixture of these two, UBA form I 
and UBA form III, are often obtained as a mixture from cooling crystallisations.51, 120 It has 
been previously reported that UBA form I is the stable form crystallised from cooling under 
ambient conditions,51 whilst charge density calculations reported from Gryl et al.121, 122 suggest 
otherwise. Thus, the use of in situ XRD characterisation could provide evidence to unravel the 
true stability relationship between UBA form III and UBA form I during crystallisation.  
 
Figure 4.2 – Chemical structure of the components urea (left) and barbituric acid (right), which comprise the 
co-crystal system urea-barbituric acid (UBA). 
This chapter investigates the relative stabilities of the various polymorphic forms for both the 
CBZ and UBA model systems, via unseeded and seeded cooling crystallisation via flow 
methodologies. This work will elucidate the crystallisation pathways for CBZ in ethanol 
(EtOH) and UBA in methanol (MeOH). As well as polymorphic transitions during unseeded 
crystallisation, the effect of introducing a controlled solid interface through the use of seed 
crystals of polymorphic purity, added at various set points along the length of the crystalliser, 
will be presented. The use of seeds in a range of pure polymorphic forms will augment the 
understanding of the polymorphic landscape by establishing whether seeding dictates the 
polymorphic outcome. In addition to analysing the final crystalline product, in situ monitoring 
via XRD characterisation will allow the crystallisation processes to be continually monitored, 
allowing the various phases and transformations during the processes to be revealed.  
The pivotal importance of investigating flow crystallisation processes via online XRD analysis 
is to contribute to the augmented understanding of crystallisation processes in a flow 
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environment required by the pharmaceutical industry. In situ XRD analysis of continuous 
segmented flow milliscale crystallisation in the KRAIC-D platform at I11 is thus reported here 
for the pharmaceutical compounds CBZ and UBA. 
4.2 KRAIC-D Design and Overview 
The custom designed KRAIC (Kinetically Regulated Automated Input Crystalliser) is a 
milliscale continuous crystalliser, which employs liquid-segmented flow to achieve plug flow 
conditions and mixing throughout the reactor length, in order to optimise critical quality 
attributes (CQAs), such as form and particle size distribution (PSD). The liquid-segmented 
flow employed in the KRAIC platform comprises the crystallising solution to achieve 
crystallisation through cooling, carrier fluid to coat the inside of the tubing and prevent 
crystallisation on the reactor walls and air to improve mixing and slug regularity.72  
An adaptation of the KRAIC developed by Dr. Karen Robertson at the University of Bath, to 
ensure the segmented-flow crystalliser was suitable for in-beam operation at DLS, led to a 
collaboration with the Kapur and Meldrum groups at the University of Leeds. Dr. Karen 
Robertson, Dr. Mark Levenstein and Dr. Pierre-Baptiste Flandrin conceptualised, designed and 
built the KRAIC-D. The design and materials used to construct the KRAIC-D are selected to 
ensure compatibility for in-beam operation at beamline I11, DLS. The two cylindrical supports 
in Figure 4.3a provide a means to add length to the crystalliser as the fluoroethylene propylene 
(FEP, 3.18 mm internal diameter (ID)) body of the KRAIC-D is wrapped around the cylinders. 
These cylinders are positioned to provide distance and, as a result of steady-state operation, 
choice of residence time between the various analytical set points along the crystalliser length. 
Wrapping the FEP tubing around the two columns provides a slight but constant upward 
gradient for the segmented flow, which is beneficial for the controlled fluid dynamics within 
the system. These plastic cylinders also provide heat insulation for the tubing coils and as a 
result prevent heat sink effects. The cylinders are set far enough apart such that unnecessary 
strain is not put upon the viewing section where the custom polytetrafluoroethylene (PTFE) 
unions provide a join between the viewing section (consisting of short lengths of Kapton® 
tubing) and the rest of the FEP body (Figure 4.3a). A constant ID is maintained throughout the 




The viewing section comprises X-ray transparent Kapton® windows, to ensure minimal 
background diffraction results from the tubing. The windows are strategically placed along the 
length of the crystalliser to monitor the crystallisation process at various stages, where a given 
distance equates to a specific crystallisation time, irrespective of the experiment time due to 
the steady-state operation of the flow crystalliser. For the experiments reported here, the 
Kapton® analysis tubes are positioned at 6.4 m, 9.0 m and 11.7 m for windows 1, 2 and 3 
respectively along the crystalliser length. Data are acquired by translation of the KRAIC-D 
platform on a motorised XYZ stage, which facilitates movement between windows in the Z-
direction (Figure 4.3a). The motorised stage also allows traversing in the X-direction, along 
the windows, to allow multiple scans to be acquired at each window position, whilst also 
maximising the operational lifetime of each Kapton® window before damage of the coating 
from the X-ray beam renders them unusable. The Kapton® windows are hydrophobically 
coated with a commercially available water repellent, known as Aquapel®, to ensure 
preferential wetting of the carrier fluid (perfluoropolyether, PFPE (Galden®)); the treatment 
procedure is detailed in Section 4.3.1. This window treatment ensures that crystallisation occurs 
away from the inner walls of the tubing, removing the solid interface, which ensures that 
nucleation proceeds spontaneously by primary homogeneous nucleation (in an unseeded 




Figure 4.3 – (a) Diagram of the KRAIC-D by Dr. Mark Levenstein, operating in transmission mode with X-ray 
penetration initiated behind the window section, (b) enlarged view of a single analysis window comprising a 
Kapton® tube and two PTFE unions (inset shows the triphasic (solution, air, and carrier fluid) plug flow), (c) 
accumulation of 2D diffraction pattern frames from 100 ms exposures which are combined to achieve (d) the 1D 
diffraction plot (shown here is a combined scan of CBZ form II). 
4.2.1 Union Detail 
The PTFE unions designed by Dr Mark Levenstein provide a join between the viewing section 
containing the Kapton® windows (Kapton®, 3.188 mm ID, 3.38 mm OD) and the rest of the 
FEP body of the KRAIC-D (FEP, 3.175 mm ID, 4.76 mm OD). The joining of the Kapton® 
windows within the unions is improved by the use of a silicone sealant used to prevent leakages. 
The PTFE unions are designed to ensure a continual ID of 3.19 mm) with little to no 




Figure 4.4 – Computer-aided drawing (CAD) of PTFE unions by Dr. Mark Levenstein, with all measurements 
set to mm, with the ID of the union equalling the ID of the KRAIC-D body, highlighted in red. 
4.2.2 Experimental Set-up 
Segmentation is achieved on the premise of immiscibility of the three phases, where separate 
streams of crystallising solution, air and carrier fluid are all transferred under temperature-
controlling jacketed tubing to ensure a constant, well-defined temperature start point before the 
flows combine at a glass cross-piece (X-piece, 3 mm ID) (Figure 4.5a).  
A circulator bath is used to control the temperature of the tubing jackets and transfer tubes 
(Figure 4.5d). The X-piece sits in a temperature-controlled segmentation water bath comprising 
a custom glass water bath via a hot-plate with magnetic bottom stirring. The temperature is 
actively regulated until segmentation is achieved to prevent crystallisation occurring before 
segmentation; once the flow is segmented heated temperature control is removed to allow the 
cooling crystallisation to proceed via air cooling of the solution within the crystalliser tubing. 
Depending on how rapidly nucleating the crystallising system is, coupled with the 
concentration and temperature conditions, further temperature controlled tubing such as a 
section of sub-ambient jacketed crystalliser tubing (represented by the nucleation promoter) 




Figure 4.5 – (a) KRAIC-D schematic highlighting X-ray transparent windows and seed inlet positions. (b-d) 
Photographs of the KRAIC-D in experimental hutch 2 (EH2) of beamline I11 at Diamond Light Source showing 
(b) KRAIC-D analysis section with beam outlet behind, (c) detector and trolley positioning, (d) trolley with 




Figure 4.6 – Schematic of KRAIC-D unseeded experiments. 
A peristaltic pump (Vapourtec SF-10), designed to lessen pulsation with respect to standard 
peristaltic pumps whilst maintaining compatibility with crystallising solution transfer, was 
employed for the crystallising solution, whilst the air and carrier fluid were transferred using 
gear pumps (Ismatec ISM895E). For seeding crystallisation runs, an additional SF-10 
peristaltic pump was utilised to introduce the seed slurry into the crystallisation at the pre-
nucleation and post-nucleation seeding ports (Figure 4.5a). 
4.2.3 Seeding Inlets 
For experiments where the influence of introducing a controlled solid interface through seeding 
was investigated, the experimental set-up required adaptation to accommodate this addition.  
4.2.3.1 Seed Inlet Geometry and Flow Rate ratio Optimisation  
The previously optimised unseeded crystallisation set-up required development to allow for an 
additional inlet to introduce the seed slurry into the system. The considerations for this 
development include the type of connector component used to introduce the slurry, with 
consideration to the material of which it is composed, the bore size of the component and the 
orientation of the connector. The component that facilitates the introduction of the seeds must 
be a 3-way connector, such as a Y-piece or a T-piece, where the net-segmented flow emerging 
from the X-piece can combine with the seed stream, resulting in a seeded net-flow. The material 
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from which this connector is made, such as glass or polypropylene (PP), will affect the 
wettability and in turn the segmentation. The flow conditions also require optimisation, as the 
relative flow rates of the various streams will affect the seed dosage into a solution slug. The 
incorporation of additional material within the segmented flow also relates back to the bore 
size of the connector. For instance, a connector with a smaller bore size, whilst maintaining the 
same flow rates and thus the same volume of fluid passing through in a given time, maximises 
the chance of incorporation of the seed material into the solution slug rather than the generation 
of separate slugs comprising only the seed slurry. The generation of novel solution slugs during 
seed addition assumes the immiscible activation barrier, which depends on the surface tension 
of the segmented media in the tubing, is overcome. 
4.2.3.2 Seed Addition Monitoring using inline UV-vis Spectroscopy 
The use of a dye allows for the addition of the seed stream to be evaluated not only visually 
but also using UV-Vis spectroscopy. For the purpose of UV-Vis analysis, the seed slurry 
comprised an ethanolic solution containing ~0.8 g/L of Eosin Y in ethanol, which was 
continually stirred via round bottom stirring with a magnetic stirrer. The dye solution was 
introduced into the segmented flow system via one of three connectors under trial: PP T-piece 
(2 mm ID), PP Y-piece (3 mm ID) and glass T-piece (3 mm ID). The different connector 
geometries allow for connector material, connector design and orientation, as well as bore size 
to be evaluated for optimal seed delivery (Figure 4.7). The seed connector was introduced 
directly after the X-piece where segmentation is established by adopting the same in-series 
configuration illustrated in the unseeded experiments (Figure 4.6), using a short section of 
Marprene® tubing, chosen both for its chemical resistance and for the fact that the semi-rigid 
Marprene® provides a strong join between the glass X-piece and the seed connector.  
For the purpose of this developmental study, rather than the segmented flow entering the 
KRAIC-D platform, instead a 1 m length of FEP tubing (ID 3.18 mm) was connected to the 
end of the segmentor and dye inlet using a short section of Marprene® to the 3-way seed 
connector. To monitor the dye incorporation into the segmented flow, an Ocean Optics UV-
Vis spectrometer connected to an in-line z-path flow cell was attached directly to the outlet of 
the 1 m length of FEP tubing using a PP screw thread connector and ferrule. The tri-segmented 
flow emerging from the X-piece comprised ethanol for the solution slugs, carrier fluid 
(Galden® SV 110) and air delivered at flow rates of 2.1 mL/min for ethanol and 4.18 mL/min 




Figure 4.7 – Images of segmentation X-piece connected to (clockwise) PP T-piece, glass T-piece and PP Y-
piece seed / dye inlet connectors for seeding optimisation studies. 
To ascertain the identity of each of the components of the segmented flow featuring in the UV-
Vis spectra, background spectra of each of the pure components (ethanol, air, carrier fluid and 
Eosin Y in ethanol solution) were recorded separately and background subtraction carried out 
(Figure 4.8).  The UV-Vis spectrometer was set to scan across a range of wavelengths (200-
1000 nm), to determine the single wavelength most appropriate for analysis of Eosin Y in 
relation to the other media. A wavelength of 870 nm was selected as the spectrum at this 
wavelength shows the most discernible differences in absorption between air and Eosin Y, 
given potential issues with detector blackout due to absorbance values of >1 at 250 nm and 
590 nm.  
The UV-Vis spectrum of carrier fluid was not observed from the spectra obtained during 
segmented flow; this can be attributed to the high density of the carrier fluid meaning sufficient 
volume of carrier fluid does not pass the laser beam path for identification.  
The flow conditions investigated in these experiments are summarised in Table 4.1, with each 
flow rate combination trialled for the X-piece connected to either a PP T-piece, glass T-piece 
or PP Y-piece connector. This allowed flow rate optimisation, as well as connector material 
optimisation and choice of geometry to yield the best segmentation in terms of slug size 




Figure 4.8  – Full UV-Vis spectra of all three phases in dye studies of seeding inlet optimisation (ethanol trace 
measured to confirm background subtraction). 
Table 4.1 – Flow rates for the dye and solution feeds used in seed optimisation study. 
Flow rate of dye /mL/min 1 2 
Flow rate of solution /mL/min 1 1.2 1.4 1.6 1.8 2 2.5 3 2 
Comparing the relative absorbance trends for the pure air and Eosin Y spectra, at 870 nm the 
air absorbs more strongly than Eosin Y and thus it was decided to focus on local minima of the 
absorbance values for monitoring the delivery of the dye (Figure 4.9).  
The time interval between the local minima absorbance values gives an indication of the dosing 
from the resulting concentration of dye within a solution slug, but this will also be dictated by 
the slug sizes of the various media and the consistency of the segmentation. It is important 
therefore to make comparisons between the spectroscopic data and visual observations of the 
segmentation to make reliable judgements on the optimal seed delivery set-up. Regularity in 
segmentation and thus slug distances is observed as a horizontal line for the time interval (in 




Figure 4.9 – 870 nm peak absorbance versus time (5 ms increments) for 1 mL/min seed flow rate, with 1.0, 1.2 
or 1.4 mL/min solution flow rate, with a PP T-piece (used for optimal seeding configuration). N.B. orange 
vertical bars show location of detected local minima (left) and the corresponding slug analysis chart for each 
flow rate combination featuring solution troughs (blue) and slug distances (orange) (right). 
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The visual observation of the segmented flow corresponding with the UV-vis data presented in 
Figure 4.9 for the various flow rate combinations using the PP T-piece connector is presented 
in Table 4.2.  Image 3 in Table 4.2 corresponding with a solution flow rate of 1.4 mL/min and 
seed flow rate of 1 mL/min exhibits the most homogeneous segmentation coupled with the 
lowest dosage addition of the dye to each solution slug, whilst mitigating against sedimentation. 
The PP T-piece set-up yields the lowest dosage of dye into the solution slugs consistent across 
all flow rate combinations, compared to the glass T-piece and PP Y-piece configurations; the 
corresponding UV-vis data and segmentation images for the same flow rate combinations are 
presented in Appendix 4.2 and 4.3 respectively. As a result of the low and consistent dosing of 
dye into solution slugs provided by the PP T-piece, this was selected as the most appropriate 
connector for this application.  
As the flow rate of the solution feed is increased, the size of the solution slugs proportionally 
increases, which subsequently results in the segmented flow appearing less homogeneous, 
which is reflected in both the UV-vis data and corresponding slug analysis plots (Figure 4.9) 
as well as by visual observations (Table 4.2). This inverse relationship between the magnitude 
of the flow rate and segmentation homogeneity is consistent across all the connectors, as 
evident from the data presented in Appendix 4.1, 4.2 and 4.3.  The absorbance data for all the 
seed inlet geometries and flow rate ratios are detailed in Appendix 4.4.  
Table 4.2 – Images of segmentation corresponding with a range of flow rate combinations for the solution feed 




4.2.4 Seed Generation and Slurry Stability Studies 
4.2.4.1 CBZ Seed Generation and Feed Slurry Stability  
A study of pure CBZ form III seeds and seed solution stability was performed through a range 
of slurry densities (altered by CBZ in EtOH concentration), stirring rates and slurrying times 
(Table 4.3). This allows for the elucidation of form delivery parameters in order to access CBZ 
form III in polymorphic purity, allowing the form of seeds delivered into the KRAIC-D to be 
established reliably and to be reproducibly accessed.   
The slurry is prepared and delivered at room temperature into the cooling crystallisation during 
in situ analysis experiments and therefore this study only considers a slurry temperature of 
20 ℃. Importantly the temperature of the experimental hutch (EH2) at beamline I11 varies 
greatly depending on the outside temperature, the circulator bath, water bath and feed solution 
will all emit heat, additionally contributing to the temperature of the room. The temperature 
will affect the slurry density through change in solubility and therefore investigating a 
concentration range helps account for these slight variances in temperature. The CBZ stock 
used in the crystallisations is the thermodynamic form CBZ form III (Appendix 4.5 (CBZ 
starting material)). 
Table 4.3 – Experimental parameters for seed stability testing of CBZ form III in EtOH. 








40 1 300 20 





Concentration of CBZ in EtOH 
Varying concentrations of CBZ slurry mediated in EtOH at a stirring rate of 300 rpm for 1 hour 
yielded CBZ form III. A representative CBZ DH peak at 9° 2θ is also evident in the PXRD 
patterns for 40, 50 and 55 mg/mL CBZ in EtOH (Figure 4.10), while concentrations of 45 and 
60 mg/mL CBZ in EtOH produce CBZ form III in polymorphic purity. Slurrying CBZ in EtOH 
at a stirring rate of 300 rpm for 2 and 3 hours across the same concentration range each 
produced CBZ form III in polymorphic purity. Obtaining seeds of polymorphic purity at these 
longer timescales is beneficial, particularly considering that even though the slurries are made 
99 
 
just before use, the nature of in-beam operation including blockage mitigation result in slurry 
preparation and delivery timeframes typically of hours.  
 
Figure 4.10 – PXRD patterns showing CBZ form III stability in EtOH at 300 rpm for a slurrying time of 1 hour 
at 20 ℃. 
Slurrying Time 
To access the metastable CBZ form II, Ostwald’s rule of stages would suggest that shorter 
slurrying times could yield CBZ form II forming initially, which may be isolated provided the 
metastable form can be isolated before transforming to the thermodynamically stable CBZ 
form III. Formation of the metastable CBZ form II will be kinetically driven, thus an increase 
in stirring rate may promote the formation of this metastable form (Table 4.4). Slurrying CBZ 
in EtOH at an increased rate of 400 rpm for 10, 20 and 30 minutes before filtration, yielded 
CBZ DH (Figure 4.11). Experiments at these various slurrying times were investigated over 
the full 40-60 mg/mL CBZ in EtOH concentration range. The results for the 40 mg/mL CBZ 
in EtOH are reported here, but the polymorphic outcome was the same across the full 
concentration range and over the various slurrying times (Figure 4.11 and Appendix 4.5).  
The stirring rate and slurrying time have a greater impact on polymorphic outcome compared 
to concentration. When CBZ in EtOH is slurried at a stirring rate of 500 rpm, a polymorphic 
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transformation is observed from CBZ DH to the thermodynamic CBZ form III between 10 and 
20 minutes respectively (Figure 4.12 and 4.13) consistent across the full concentration range. 
A complete summary of all the CBZ seeding stability testing including the experimental 
conditions and the corresponding polymorphic outcome is given in Table 4.5.  
Table 4.4 – Experimental parameters for CBZ form II slurry stability testing. 
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Figure 4.11 – PXRD patterns for CBZ form II slurry testing at 400 rpm over various slurrying times at 20 ℃. 
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Figure 4.12 – PXRD patterns of varying concentrations of CBZ in EtOH at 500 rpm for 10 minutes slurrying 
time. 
 
Figure 4.13  – PXRD patterns of varying concentrations of CBZ in EtOH at 500 rpm for 20 minutes slurrying 
time. 
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Table 4.5 – Summary of CBZ seeding stability testing. 
Concentration 
of CBZ in 
EtOH 
/mg/mL 
Stirring Rate /rpm 
300 400 500 
Slurrying Time /mins 
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4.2.4.2 Pumping Stability Testing 
Slurry delivery uses the SF-10 peristaltic pump from Vapourtec UK to transfer the slurry 
suspension from the slurry feed, through the pump to the filtration unit, or in the case of seeded 
KRAIC-D runs, towards the KRAIC-D. Slurry delivery experiments were used to ensure that 
the solid form of the CBZ does not change as the seed suspension is pumped through the SF-
10, where the movement of the slurry through the flexible tubing inside the SF-10 pump or the 
action of the rotor resulting in compression of the flexible tubing could cause a grinding effect 
leading to a change in polymorphic form. It is important to establish that the seeds of 
polymorphic purity obtained from the seeding experiments maintain form and purity when the 
slurry is delivered through the SF-10 pump towards the pre- and post-nucleation seeding inlets 
in the KRAIC-D. Achieving precise control over the form of CBZ introduced into the KRAIC-
D allows reliable comparisons with the unseeded KRAIC-D runs, as well as understanding the 
effect of introducing a controlled solid interface into the crystallisation process.  
In addition to solid form, it is important to establish the weight percent (wt %) of solid delivery 
from the pump and thus the seed dosing in the KRAIC-D experiments. The stability of CBZ 
samples through the SF-10 was investigated using the set-up in Figure 4.14. The slurry 
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suspension is pumped through the SF-10 pump at a flow rate of 1 mL/min, in order to collect 
a 5 mL aliquot, each sample is collected over 5 minutes through Buchner funnel filtration. 
The slurry is produced by overhead stirring of a seed solution of 50 mg/mL CBZ in EtOH 
(prepared at 100 mL scale), stirred at a rate of 500 rpm for 2 hours. Once equilibration of the 
slurry suspension was established for 5 minutes, the slurry was delivered through a SF-10 pump 
and subsequently collected via vacuum filtration. The slurry delivery parameters and wt % 
solid loading of CBZ in each sample aliquot are summarised in Table 4.6 and 4.7 respectively.  
            
Figure 4.14 – Schematic of experimental set-up for CBZ form III seed solution pumping stability studies. 
 
Table 4.6 – CBZ slurry delivery parameters. 
Flow rate (mL/min) 1 
Collection time (mins)  5 
Collection volume (mL) 5 
Predicted solid from excess from 50 g/kg 45.5 
Predicted wt% CBZ solid in CBZ slurry 2.93 
 
Table 4.7 – Slurry wt % of CBZ form III seed solutions used for pumping stability studies via collection of 5 
mL aliquots. 
Sample aliquot Mass on filter paper /g Wt 
% 
A1 0.1123 0.68 
A2 0.1561 1.40 
A3 0.1646 1.53 
A4 0.157 1.41 
A5 0.1629 1.51 
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A6 0.172 1.65 
A7 0.1771 1.74 
A8 0.1416 1.16 
The PXRD data confirms solid form consistency across the eight aliquots collected for offline 
analysis, where CBZ form III was crystallised with a representative CBZ DH peak also evident 
at 9° 2θ for the majority of the aliquots (Figure 4.15). Aliquots A2 and A6 yielded CBZ form 
III in polymorphic purity and thus as there is no obvious transformation point between prepared 
slurry form and obtained aliquot it can be confirmed that passing the CBZ slurry mediated in 
EtOH through the SF-10 peristaltic pump does not impact form and the slurry remains stable 
over the full collection time.  
The wt % solid loading remains relatively consistent throughout, only resulting in a blockage 
within the pump 44 minutes 30 seconds into the slurry delivery experiment, at A9 where no 
solid was drawn through the line and the experiment was stopped. Consistent with this, during 
the beamtime experiments it was found that a slurry would not be continually delivered into 
the KRAIC-D for more than 45 minutes. 
 
Figure 4.15 – PXRD result of CBZ form III seed solutions pumping stability studies. 


























4.3 Platform Development and Optimisation 
4.3.1 Kapton® Window Treatment  
The surface of the Kapton® windows are inherently slightly hydrophilic and thus modification 
by surface activation with a plasma cleaner, followed by the application of a commercial 
fluorinated water repellent (Aquapel®) is required, to match the hydrophobic surfaces of the 
PTFE unions and FEP body of the KRAIC-D.123  
The Kapton® windows were made hydrophobic using a chemical treatment process with 
Aquapel® adapted from Mazutis et al.124 Kapton® tubes were prepared by initially cleaning the 
tubes thoroughly with acetone (ACE) or EtOH, followed by drying the tubes with an air or 
nitrogen (N2) stream. A Kapton
® tube was placed in the plasma cleaner with the plasma stream 
pointing down the tube. A negative glow discharge with a 20 mA current was applied to the 
tubing for 15 seconds. After activating the surface of the tubing with the plasma cleaner, the 
tubing was placed in a centrifuge tube, which contained 7 mL of Aquapel®. The tubing was 
soaked in the hydrophobic treatment for 1 minute with rotation to ensure the tubing was 
completely coated. The tubing was removed from the Aquapel®, dried again with an air or 
nitrogen (N2) stream and subsequently washed once more with ACE or EtOH. Water was run 
down the tubing to check the coating was complete and no beading occurred. 
4.3.2 Aquapel® Coating Deterioration 
The hydrophobic coating was shown to deteriorate after overexposure to the X-ray beam, 
where the Aquapel® was susceptible to beam damage and beading was observed on the inside 
of the Kapton® tubing. To combat this, beam exposure at any given tube location was reduced 
and limited to 51 frames of a 0.1 second exposure before traversing by 1 mm increments along 
the length of a Kapton® window using the X-translation stage. The translation increment along 
the Kapton® tubing is compatible with the size of the 1 mm x 1 mm X-ray beam.107  
4.3.3 Blockage Mitigation 
Blockage mitigation must be considered when crystallisation is occurring in flow. Strategies to 
deal with blockages include providing a seamless join when tubing, unions and mixer pieces 
are connected to prevent perturbation to the flow, which could cause encrustation. The 
wettability of the carrier fluid to the inner wall of a tubular reactor / crystalliser must be 
optimised to ensure crystallisation is occurring away from the solid interface by ensuring the 
crystallising solution does not come into contact with the crystalliser walls. As the crystallising 
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solution does not ordinarily interact with the crystalliser walls, a solid surface to allow for 
nucleation does not exist and thus the solution slugs exist in a highly metastable state until 
crystallisation is achieved; a tiny perturbation to the flow could thus cause interaction with a 
solid surface and in turn could lead to encrustation.  
Strategies to deal with potential blockages during crystallisation in the KRAIC-D platform 
include by-pass tubes of 3.18 mm ID FEP tubing of similar length to the Kapton® windows, 
connected to the rest of the FEP body with zero volume unions, comprising of FEP of slightly 
larger bore size, which provide a seamless join. This approach improves the crystallisation run 
time and maximises time for data collection. During process optimisation the mitigation of 
blockages originating from the PTFE union joins was investigated via the removal of the unions 
(Figure 4.16). To provide a seamless join between the Kapton® windows and the FEP body, 
the FEP ends required heat treatment. 
 
Figure 4.16 – Removal of PTFE unions as part of blockage mitigation strategy. 
Heat treatment of the FEP ends altered the surface chemistry of the inside of the FEP tubing, 
altering the preferential wetting of the carrier fluid, which led to perturbation of the segmented 
flow at the FEP ends and thus this blockage mitigation strategy is not a suitable alternative to 
the PTFE union set-up. In addition, due to beam damage of the Kapton® windows in the 
KRAIC-D set-up, it is necessary to retain the PTFE unions to allow window replacement.  As 
the unions had to be retained, other methods were employed for blockage mitigation.  These 
were minimising X-ray exposure time at a given analysis point to avoid X-ray damage to the 
hydrophobic coating at the exposure point and also ensuring the Kapton® windows contain 
flush edges through a developed cutting procedure (Section 4.3.4). 
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4.3.4 Thin Wall Tubing Cutting Procedure 
The polyimide (Kapton®) tubing (3.38 mm OD, 3.188 mm ID) from American Durafilm 
(Moorseville, NC) was extruded rather than wound and required cutting into approximately 
7.5 cm lengths for the Kapton® windows. The use of Kapton® tubing wound in preparation is 
not appropriate in this case as winding produces subtle joins in the tubing, which can alter the 
surface properties and prevent the carrier fluid preferentially wetting the inside of the tubing.  
A 3.18 mm metal rod was filed to fit neatly within the 3.188 mm Kapton® tubing to prevent 
distortion of the delicate tubing during cutting. A radial cutting pattern was then employed 
using a tubing cutter to guide a straight cut in the tubing, whilst ensuring a flush finish. A flush 
finish to the Kapton® tubing is necessary to provide as seamless a join as possible with the 
PTFE unions (Figure 4.17). 
 
Figure 4.17 – Photograph of Kapton® tube cutting set-up. 
4.4 Cooling Crystallisations 
All continuous crystallisation runs are initially cleaned and primed with segmented flow 
comprising carrier fluid, air and the pure solvent used in the crystallising solution. During 
priming the conditions such as flow rates and temperature are matched to those adopted in the 
crystallising run to ensure the system is allowed to perform at steady-state operation. All 
transfer tubing jackets and the segmentation bath were usually set to the same temperature as 
the feed solution.  The system usually requires at least one residence time (the time taken for 
the media to travel from the point of segmentation to the end-piece) to reach steady-state 
conditions. The time taken to reach steady-state operation can be attributed to the flow 
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conditions adopted by the pump. The pumps do not operate under the same plug flow 
conditions as the rest of the system, instead the pumps operate under laminar flow and thus 
time is required for the concentration to reach equilibrium, which then must pass through the 
whole crystalliser to outlet, which is dependent on the residence time.  
At the end of the KRAIC system, before filtration employed for offline analysis, the segmented 
flow undergoes carrier fluid recovery and the resulting loss in flow rate due to this recycling 
of the carrier fluid results in the need for an additional inlet to maintain the overall flow rate 
and prevent a build-up of material at the end-piece. This additional inlet flow is termed the 
neutral solvent (NS), comprising the solvent used in the crystallising solution chilled in an ice 
bath. The NS is selected on the basis that its introduction into the system (using a Gear pump, 
Ismatec ISM895E) will not cause further crystallisation or dissolution.72 Crystal recovery via 
vacuum filtration was only used for supporting offline analysis. For most of this work where 
in situ diffraction analysis was carried out, the NS was often not chilled in an ice bath and thus 
was not considered neutral and contributed to dissolution. Therefore, the NS employed in the 
beamtime experiments was used to aid carrier fluid rather than solid recovery.  
After any major blockages or detrimental changes in segmentation, such as issues with 
wettability, are observed, the system was washed with pure hot solvent to dissolve any 
crystalline material and impurities on the inside of the crystalliser. Removing the segmentation 
and operating at high flow rates of approximately 10 mL/min cleans the inside of the tubing 
most effectively.  
During priming, the feed solution (CBZ in EtOH or UBA in MeOH) is prepared and allowed 
to reach dissolution at the set temperature for approximately an hour. For all experiments 
additional temperature-controlled tubing of 1.07 m length of FEP (hereafter termed ‘nucleation 
promoter’) is connected directly after the segmentation water bath and prior to the air-cooled 
15 m FEP, should additional cold temperature be required to aid nucleation.  
In the case of CBZ in EtOH, additional temperature control using the nucleation promoter set 
to 10 ℃ was required, whilst for UBA in MeOH the conditions were optimised without the 
need for the additional temperature control, so the jacket of the nucleation promoter was left 
air-filled and under ambient temperature.  
109 
 
4.4.1 Seeded Cooling Crystallisations 
Seeded cooling crystallisations operate similarly to an unseeded run, but with an additional 
inlet to which the seed is introduced in a slurry using a PP T-piece (see Section 4.2.3). The 
seeding ports are positioned either pre-nucleation in a T-piece after the X-piece (0.05 m) in the 
segmentation bath, or post-nucleation in a T-piece positioned after window 2 (9.1 m). The 
seeding port positions relating to two distinct stages of pre- and post-nucleation in the 
crystallisation process were determined from an unseeded crystallisation run.  
4.4.1.1 Pre-nucleation Seeding 
When seeding was introduced before primary nucleation, the seed inlet comprised a PP T-piece 
(2 mm ID) connected shortly after the glass X-piece through compressed flexible tubing 
(Marprene®, 3.18 mm ID) held flush on either side of the T-piece to limit any perturbation to 
the segmented flow (Figure 4.18).  
 
Figure 4.18 – Schematic of KRAIC-D showing seeding position for pre-nucleation seeding experiments. 
4.4.1.2 Post-nucleation Seeding 
When seeding was introduced after primary nucleation, the pre-nucleation seed inlet was 
capped and an additional seed inlet comprised a joined section of 3.18 mm FEP tubing with a 
2 mm hole on the top and a Marprene® sheath to seal the port connected shortly after window 




Figure 4.19 – Schematic of KRAIC-D showing seeding position for post-nucleation seeding experiments. 
The difference in material between the pre- and post-nucleation seeding ports can be attributed 
to where the crystallising solution sits on the concentration / temperature dependent solubility 
curve. For post nucleation stages in the crystallisation process, the solution slugs exist in a 
highly metastable state where any changes in material from the Kapton® or FEP body could 
cause changes in preferential wetting and thus nucleation upon the walls of the crystalliser, 
which in turn could lead to blockages. As a result, instead of the PP T-piece, the use of an FEP 
union with a comparable inlet bore size to the PP T-piece was chosen for the seeding port to 
mitigate against these issues. For pre-nucleation stages, the PP-T piece was chosen for the 
connector as the best material to achieve preferential wetting of the carrier fluid.  A change in 
material from FEP to PP at this early stage in the crystallisation process was possible as the 
solution slugs had just been segmented and are at a higher temperature so have not yet reached 
the metastable zone from cooling. 
4.5 Data Capture and Analysis Procedure 
4.5.1 Data Capture 
Powder diffraction data were collected in a serial crystallography-like approach, where 
diffraction data from a range of scans, obtained from a range of slugs at the same analytical 
residence time (RT) position were integrated to build a statistical average of crystalline form 
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and growth at a set point along the length of the crystalliser.125 As the system is operating at 
steady-state and the crystalline material in the solution slugs is grown in situ, different set 
points can be related to the different stages in the crystallisation process, imparting knowledge 
on the crystallisation pathway adopted with time.  
In situ XRD characterisation was performed at Diamond beamline I11, using an X-ray beam 
of 15 keV energy, corresponding with a wavelength of 0.82437 Å with a 2D CCD detector 
(Pixium RF4343) operating at 10 frames per second (fps). The energy of the X-ray beam was 
chosen to maximise flux, which is particularly beneficial for poorly diffracting samples. As the 
stream of crystallisation media passes the X-ray beam continually, the X-ray damage caused 
to each crystallite by the high flux X-ray beam is minimised. The size of the X-ray beam used 
was 1 mm x 1 mm to maximise the area probing crystallite detection, whilst the beam remained 
compatible with the sample size, by being completely immersed in the average 7 mm to 1 cm 
slug length and 3.18 mm slug diameter. The net flow resulting from the flow rates of the three 
separate streams produced an average slug velocity of between 12 and 22 mm/s equating to a 
dwell time in the beam of 455 to 830 ms calculated from a 1 cm average slug size. 
The background was an important consideration as the sample, in addition to not being static, 
also comprises three separate media: air, carrier fluid and the solvent background from the 
crystallising solution. The frame collection rate was designed to be faster than the net flow, 
ensuring that most frames contain only one of the three components in the tri-segmented flow.   
As a result, each scan comprised 51 frames of a 0.1 second exposure; a short exposure time 
was selected for each frame to maximise the signal-to-noise ratio. 
4.5.2 Data Analysis Procedure 
To process and analyse the high volume of diffraction data obtained during synchrotron 
experiments, collaborator Dr. Mark Levenstein developed an automated Matlab® script to 
interrogate each frame and determine the origin of the scattering.106, 123 An empirical approach 
to background subtraction was adopted, whereby within each scan a frame of solvent scattering 
without crystalline diffraction was selected for use in background subtraction. Careful 
background subtraction was carried out ‘by hand’ to ensure the background was representative 




These processed frames are then combined and azimuthally integrated to generate a composite 
1D diffraction pattern (Figure 4.3c and d). Finally, this process is repeated with data from each 
window, where five 10.1 s scans (each of 51 individual 100 ms frames with 100 ms dead-time 
between frames) per window are combined to obtain a picture of the average diffraction from 
crystals present at that particular residence time in the crystallising solution slugs. Five scans 
were chosen to be statistically relevant, recognising that not all scans will contain diffraction, 
particularly those at earlier analysis points along the length of the crystalliser where sufficient 
growth may not have been achieved. It is therefore possible to estimate the diffraction ‘hit rate’ 
at a given set point by considering how many of the five scans contain diffraction. The five 
scans included for each window were selected to span the full range of scans taken from 
different times in an individual experimental run to be representative of the entire 
crystallisation and avoid data being skewed by a potential short-lived flow instability. Each 
diffraction pattern presented in this chapter from an in situ experiment will comprise 255 
frames of a 0.1 second exposure. Diffraction patterns are presented at the Cu K characteristic 
wavelength (1.5406 Å) for comparison to reference data. 
When comparing diffraction patterns, it is important to consider the uncertainty in 2θ resulting 
from the 3.19 mm ID of the Kapton® window analysis points, within which depth the observed 
crystals can reside at any distance as they pass the incident X-ray beam. The sample-to-detector 
distance was calibrated by mounting a ceria sample on the centre of the Kapton® tubing, thus 
there is an error margin of 1.6 mm either side of the calibration centre. Thus a crystal passing 
through the analysis window residing close to the tubing wall is situated at a different sample-
to-detector distance to a crystal passing through the centre of the tubing and there is an 
associated angular uncertainty in 2θ due to the width of this milliscale flow channel. This 
uncertainty has an angular dependence, which reaches a maximum value at 45°, which equates 
to a 2θ drift of approximately ±0.14 for diffracted X-rays with a sample-to-detector distance 
of 324 mm. An inverse relationship exists between the sample-to-detector distance and the 
associated uncertainty in angle; as the sample is moved further from the detector, the 
uncertainty in the angle reduces.  
In addition to the uncertainty in 2θ due to the variance in sample-to-detector distance resulting 
from the ID of the Kapton® windows, there is also a smaller effect due to the finite pixel size 
on the detector. For these in situ experiments on I11, the detector was chosen to operate in the 
faster detector mode, whereby groups of pixels are merged into a single pixel, binned into 
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296 x 296 μm blocks of 2 x 2 pixels. With increased pixel size, the uncertainty in angle also 
increases, with a maximum uncertainty of 0.025. The uncertainty associated with the size of 
the pixels on the detector is thus significantly smaller than the error associated with the variance 
in the sample-to-detector distance.  
4.6 Growth Studies 
Within the Matlab® script, an integrated intensity value for each scan is produced. To express 
the crystal growth at a set point along the length of the crystalliser, the five integrated intensity 
values can be illustrated in a box and whisker plot. The limits of the box express the upper and 
lower quartile, while the median is highlighted by a red line. The whiskers denote the highest 
and lowest integrated values amongst the five values. The default Matlab® box plotting method 
is adopted, which extends the whiskers to any data that falls within 1.5 x interquartile range 
(IQR). Any data outside this region is instead plotted with a red cross.   
Representing the spread of the integrated intensity values, or area under the diffraction pattern 
at each window with a box and whisker plot, indirectly allows for the crystal growth in a 
crystallisation process to be interpreted visually. The diffraction intensity can be correlated to 
the number of nuclei and the relative crystal growth of the system at a set point along the 
crystalliser length. The growth profile can therefore be mapped and compared across unseeded 
and seeded crystallisation runs. It is important to consider that in the case of seeded 
crystallisations, additional crystalline material with an associated integrated intensity is 
injected into the system, so the crystal growth between windows will not be quantifiable 
(Appendix 4.6). 
4.7 Polymorphic Monitoring of Carbamazepine (CBZ) 
CBZ exists in five anhydrous polymorphic forms, as well as a dihydrate (DH) form (Figure 
4.20).116, 126 The metastable CBZ form II is known to crystallise from solution and CBZ form 
III is the thermodynamic form,1 therefore these two forms can be expected in this study. It is 
important to recognise that even though absolute ethanol is the solvent utilised in these cooling 
crystallisations, once absolute ethanol is exposed to the atmosphere, the ethanol will uptake 




Figure 4.20 – PXRD patterns of the five anhydrous forms of CBZ and CBZ DH reference patterns simulated in 
Mercury33 (Refcodes: CBMZPN11 (CBZ form I), CBMZPN03 (CBZ form II), CBMZPN01 (CBZ form III), 
CBMZPN12 (CBZ form IV), CBMZPN16 (CBZ form V) and FEFNOT (CBZ DH, orthorhombic interpretation 
of space group)). The intense peaks between 5-13° 2θ for CBZ DH have been truncated to ensure clarity of less 
intense peaks for comparison. 
CBZ form III is the stable form at room temperature (RT), which is enantiotropically related 
to form I; form I can be produced by holding form III at 185 °C for 10 minutes to induce the 
phase transformation.128 CBZ form I is the preferred CBZ polymorph at high temperature.129 
CBZ form II can be accessed by cooling crystallisation from ethanol, propan-1-ol, 
isopropylbenzene and dichloromethane.1, 128, 130, 131 CBZ form IV has not been reported from 
solution based crystallisation techniques, but instead this metastable form has been accessed 
by spray drying.132 A computationally assisted approach was adopted to selectively produce 
CBZ form V through calculations of structurally similar molecules, which indicated their 
potential to act as a solid-state template. The calculations and subsequent experimental trials 
found that CBZ form V could be accessed by templating the growth of CBZ from the vapour 
phase onto the surface of a dihydrocarbamazepine form II crystal.133 
Sypek et al. investigated the influence of experimental conditions on polymorphic outcome, as 
well as possible polymorphic transformations during the cooling crystallisation of CBZ from 






















anhydrous EtOH. The study showed that stirring was the most notable controlling factor in 
dictating the initial polymorphic outcome of CBZ, where quiescent conditions yielded CBZ 
form II crystals, which subsequently underwent slow transformation to the stable form III.1  
The phase transformation between CBZ form II and form III during cooling crystallisation 
from propan-1-ol was investigated by Zhao et al., through use of in-line PAT techniques: 
Attenuated Total Reflectance Fourier Transform Infrared (ATR-FTIR), Focused Beam 
Reflectance Measurement (FBRM) and Raman.134, 135 This study confirmed an enantiotropic 
relationship between forms II and III, with an associated transition temperature of 34 ℃. A 
similar study carried out by Liu et al. using in situ FBRM and PVM confirmed a transition 
temperature of 40 ℃ from the same solvent system.130 The paper reported that the cooling rate 
affected the polymorphic outcome, whereby an increase in cooling rate from 0.2-0.5 K min-1 
reduced the quantity of CBZ form II in the crystalline product.130  The polymorphic 
transformation of the metastable CBZ form II to the thermodynamic form III is not dependent 
on the solvent choice of crystallisation, as studies have shown the transformation proceeding 
from both EtOH and propan-1-ol solvents.1, 130 However, the rate of transformation can be 
altered by solvent choice and purity of the CBZ starting material.1 
Guidelines for solvent selection on the premise of ‘Black’s rule’, which states that the solubility 
of a solvent-solute system will double in concentration every 20 ℃ increase in temperature, 
have been proposed.136  Adhering to this rule for solvent selection during the design of a cooling 
crystallisation process, will ensure an adequate yield. Other selection criteria exist including a 
maximum temperature (Tmax) of approximately 60 ℃, to minimise solvent loss due to 
evaporation, highlighting the importance of Tmax reaching a temperature at least 5-10 ℃ below 
the boiling point of the solvent. Criteria for a cooling crystallisation with respect to 
concentration are also factors for consideration, where the solubility should be equal to 50-
150 g/L at Tmax to ensure the final slurry remains mobile. Equally, if the final solubility is less 
than 5 g/L, the precipitation of impurities is deemed more likely than the solute.136 On the basis 
of these selection criteria, the evidence of polymorphic transformations from cooling CBZ in 
EtOH, as well as the impact of mixing conditions on polymorphic outcome, EtOH was selected 
as the most suitable solvent for the in situ monitoring of the cooling crystallisation of CBZ. 
The temperature dependence and enantiotropic relationship between CBZ polymorphs make 
this a suitable model system to investigate via cooling crystallisation in the KRAIC and 
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KRAIC-D platforms. The benefit of using the KRAIC-D platform here is that an understanding 
of the polymorphism of CBZ in EtOH as a function of crystallisation time can be gained, by 
installing the KRAIC-D and monitoring this system on beamline I11. 
4.7.1 Offline KRAIC / KRAIC-D Experiments: CBZ in ethanol (EtOH) (CBZK/KD) 
To develop the flow crystallisation process of CBZ in ethanol (EtOH) for in-beam operation in 
the KRAIC-D, developmental work optimised offline was carried out in the KRAIC and 
KRAIC-D platforms. The KRAIC and KRAIC-D are operationally identical with one 
exception; the KRAIC comprises a single extruded length of 15 m of FEP tubing, whilst the 
KRAIC-D requires Kapton® windows and PTFE unions to connect the various lengths of FEP 
tubing (total 14 m).  
                                                                                                                                            
Figure 4.21 – CBZ in EtOH solubility curve adapted from N. Briggs thesis.137 Avantium: turbidity data 
collected on 8 mL parallel crystallisation system. Optimax: collected in a 1 L stirred tank crystalliser with ATR-
FTIR as the method of detection. Literature curve: laser monitoring technique determined by the synthetic 
method.138 The data from each of the methods defined are overlaid. 
Initial concentrations of CBZ in EtOH and corresponding temperature conditions were based 
upon the solubility curve of CBZ in EtOH.137 The concentration used for the unseeded CBZ in 
EtOH KRAIC (CBZK1) and KRAIC-D runs (CBZKD1-2 and CBZKD6), as well as seeded 
KRAIC-D runs (CBZKD3-5) was based on the solubility curve at 50 ℃ (feed temperature), 
equating to a concentration of 66.6 g/kg (52.5 g/L) CBZ in EtOH (Figure 4.21). The 
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crystallisation parameters used in the unseeded 52.5 g/L CBZ in EtOH KRAIC (CBZK1) and 
KRAIC-D (CBZKD1-2 and CBZKD6) runs as well as CBZ form III seeded KRAIC-D offline 
runs (CBZKD3-5) are summarised in Tables 4.8 and 4.9. 
Table 4.8 – Flow rates (in mL/min) used for all KRAIC (CBZ unseeded), as well as (offline and online) 
KRAIC-D runs: unseeded, † ‘pre-seed pos.’ and ‘post-seed pos.’ refer to the flow rates prior to and after the 
post-nucleation seeding inlet. 










CBZ unseeded 2.1 4.18 12.5 2.4 N/A 8.68 8.68 
CBZ III pre-
nucleation seeded 
2.1 4.18 12.5 1.4 1 8.68 8.68 
CBZ III post-
nucleation seeded 
2.1 4.18 12.5 2.4 1 8.68 9.68 
The experimental set-up for the unseeded CBZ in EtOH KRAIC (CBZK1) run is illustrated in 
Figure 4.22. The experimental set-up for offline unseeded CBZ in EtOH KRAIC-D (CBZKD1 
and CBZKD5) runs is represented in Figure 4.23.  
 





Figure 4.23  – Schematic of the experimental set-up for the offline unseeded CBZ crystallisation in EtOH runs 
in the KRAIC-D. 
The experimental conditions including platform set-up, feed concentration and seed wt % solid 
loading are summarised in Table 4.9, as well as experimental residence times at various 
analytical points for the offline CBZK1 and CBZKD1-6 runs in Table 4.10. CBZKD2 
investigated the impact of the removal of the PTFE unions on the crystallisation product and 
process, whilst all other CBZKD runs employed the PTFE unions.  
Table 4.9 – Experimental parameters including feed concentration, seed loading and experimental set-up for 
CBZ offline experiments in the KRAIC and KRAIC-D are identified by CBZK and CBZKD respectively. 





CBZK1 52.5 N/A No T-piece, unseeded KRAIC Fig. 4.22 
CBZKD1 52.5 N/A No T-piece, unseeded KRAIC-D Fig. 4.23, 
with unions 
CBZKD2 52.5 N/A No T-piece, unseeded KRAIC-D Fig. 4.23), 
without unions 
CBZKD3 52.5 2.9  Pre-nucleation seeded KRAIC-D, Fig. 4.18 
CBZKD4 52.5 2.9  Pre-nucleation seeded KRAIC-D, Fig. 4.18 
CBZKD5 52.5 2.9  Pre-nucleation seeded KRAIC-D, Fig. 4.18 




Table 4.10 – Experimental residence times for various analytical set points along the length of the KRAIC-D 
for CBZ offline experiments (CBZKD). N.B No residence time measurements were taken for CBZKD2. The 
difference between CBZKD1 and CBZKD2 is attributed to the removal of the unions, which would reduce the 
length of the crystalliser slightly for CBZKD2. 













Length 1.07 m 6.47 m 9.07 m 11.77 m 14 m 
CBZK1 N/A N/A N/A N/A 16:27 
CBZKD1 1:10 5:51 8:33 11:40 14:46 
CBZKD3 1:02 5:23 7:52 10:31 12:48 
CBZKD4 - - - - 13:03 
CBZKD5 - - - - 12:51 
CBZKD6 - 8:28 12:09 16:05 19:06 
CBZK1 
Initial temperature control of the feed, circulator and segmentation bath was set to 55 ℃. Even 
after reductions in temperature of the segmentation bath from 50 ℃ to 35 ℃ in 5 ℃ increments 
to promote nucleation, no crystallisation was observed after 1 hour into the crystallisation run. 
Ice was then introduced into the segmentation water bath, as a crude way to provide insight as 
to whether additional temperature control in the form of a nucleation promoter could promote 
crystallisation at this concentration. Ice in the water bath led to a reduction in temperature of 
the water bath to 13-15 ℃, which resulted in crystallisation observed in the first coil, where 
agglomerates of needle crystals appeared in the solution slugs, which would suggest 
crystallisation of CBZ form II; however, the PXRD data for CBZK1 also shows the presence 
of CBZ DH (as shown in Figure 4.24 below). CBZKD experiments after CBZK1 required the 
use of the nucleation promoter, thus the use of additional cold temperature control introduced 
after the segmentation water bath was the key finding from experiment CBZK1.  
Offline measurements by PXRD of CBZ produced in the KRAIC platform (CBZK1) from 
EtOH indicated that CBZ DH was the resultant form with additional diffraction peaks attributed 
to CBZ form III, whilst crystallisation in the KRAIC-D yielded CBZ form III when unions 
were present (CBZKD1) and CBZ form II without the use of unions (CBZKD2) (Figure 4.24). 
The CBZ in EtOH KRAIC-D run (CBZKD1) with PTFE unions experienced a leakage between 
a Kapton®-union join and thus evaporation of EtOH at this join could have caused 
crystallisation of CBZ form III and led to seeding of the evaporation product through the 
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crystalliser. It has been reported that evaporation of CBZ in EtOH yields CBZ form III,128 
which could explain the formation of the thermodynamic form in this run. Experiment 
CBZKD6 of unseeded CBZ in EtOH yielded CBZ form II. The CBZ in EtOH form III pre-
nucleation seeded KRAIC-D (CBZKD3-5) runs trialled offline produced CBZ form III, 
indicating that seeding largely dictates polymorphic outcome, whilst CBZKD3 does not yield 
CBZ form III in purity, due to additional peaks at 8° 2θ (Figure 4.24).  
 
Figure 4.24 – PXRD patterns of CBZ in EtOH in KRAIC and KRAIC-D platforms identified as CBZK and 
CBZKD respectively compared to the reference patterns simulated in Mercury33 (Refcodes: CBMZPN03 (CBZ 
form II), CBMZPN01 (CBZ form III) and FEFNOT (CBZ DH)). 
To ascertain the yield achieved by the various crystallisation runs, sample collection via 
vacuum filtration was carried out over a residence time (Table 4.10 above), summarised by the 
various yields in Table 4.11. The collection time is presented with the corresponding yield, as 






























Table 4.11 – Yield and polymorphic outcome of crystallisation for CBZ offline experiments (CBZK and 
CBZKD). 
Experiment Crystallisation? Mass Collected (g) 
(Collection Time) 
% Yield Polymorphic 
Form 
CBZK1 Yes – after cooling 
segmentation bath 
below RT 
- - CBZ DH 
CBZKD1 Yes  FP1: 0.1955 (7 min) 
 
FP1: 22.2 Impure CBZ 
form III with 
CBZ DH 
CBZKD2 Yes FP2: 0.1957 (10 min) FP2: 15.5 CBZ form II  
CBZKD3 Yes FP1: 0.0814 (10 min) 
FP2: 0.2024 (15 min) 





form III with 
CBZ DH 
CBZKD4 Yes FP1: 0.0716 (35 min 
48 sec) 
FP1: 1.6  CBZ form III 
CBZKD5 Yes FP1: 0.073 (unknown 
collection time) 
- CBZ form III 
CBZKD6 Yes FP1: 0.0379 (17 min) FP1: 1.8 CBZ form II 
The yields presented in Table 4.11 show great variance between crystallisation runs and also 
between different collections (FP1 and FP2), within the same experiment. Accurate 
determination of the yield for a given run proved difficult, as common blockage problems and 
flow rate adjustments in regards to the air pump, particularly evident for CBZKD4 and 
CBZKD5, resulted in inaccurate collection times and yields. Encrustation problems were 
experienced at unions, inside the SF-10 pumps used for both the seed and solution lines and in 
the FEP tubing if this was distorted. Offline ex situ analysis carried out using a laboratory 
source X-ray diffractometer have shown the metastable CBZ form II is crystallised from 
unseeded KRAIC-D (CBZKD2 and CBZKD6) runs. Offline measurements from pre-
nucleation seeded CBZ form III (CBZKD3-5) KRAIC-D runs yields CBZ form III, indicating 
that seeding dictates polymorphic outcome. These offline investigations highlight the potential 
of CBZ in EtOH cooling crystallisation for online X-ray monitoring at Beamline I11. 
4.7.2 Online KRAIC-D Runs at Beamline I11: CBZ in EtOH (CBZKDB)  
The preliminary offline KRAIC (CBZK1) and KRAIC-D (CBZKD1-6) experiments presented 
in Section 4.7.1 provide a suitable start point for online CBZ KRAIC-D experiments at I11, 
which are presented by CBZKDB identifiers.  A range of online cooling crystallisations were 
investigated during the beamtime, including unseeded (CBZKDB1 and CBZKDB2), pre-
nucleation (CBZKDB3) and post-nucleation (CBZKDB4) seeded crystallisation experiments. 
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The experimental set-up, along with feed and seed slurry concentration for each of these 
CBZKDB beamtime experiments are summarised in Table 4.12, as well as temperature 
conditions and residence times at the three analytical set points (W1, W2, W3) (Table 4.13). 
Table 4.12 – Experimental set-up, as well as concentrations of feed and seed solutions for the various CBZKDB 
beamtime experiments. 
Experiment  Set-up Feed solution concentration 
CBZ in EtOH g/L 
Seed Solution 
(wt%) 
CBZKDB1 T-piece Unseeded 
KRAIC-D (Fig. 4.7) 
52.5 Unseeded (N/A) 
CBZKDB2 T-piece Unseeded 
KRAIC-D (Fig. 4.7) 
56.7 Unseeded (N/A) 
CBZKDB3 Pre-nucleation Seeded 
KRAIC-D (Fig. 4.13) 
52.5 3.0 
CBZKDB4 Post-nucleation Seeded 
KRAIC-D (Fig. 4.14) 
52.5 3.0  
 
Table 4.13  – Crystallisation parameters for all CBZ runs, with temperature until segmentation and nucleation 
promoter defined in Figures 4.6, 4.18 and 4.19 ‡denotes RTs which are extrapolated from observed values. 














W1 W2 W3 End 
CBZ 
unseeded 










52.5 3.0 55 10 8.7 12.6 16.3‡ 18.6‡ 
 
4.7.3 Unseeded CBZ in EtOH KRAIC-D at I11 (CBZKDB1 and CBZKDB2) 
The initial concentration of 52.5 g/L CBZ in EtOH used in experiment CBZKDB1 with the 
temperature of the experimental hutch at 26 ℃ did not crystallise sufficient material for 
analysis, particularly at window 1 (W1) which is the earliest analysis point in the crystallisation 
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process. As a result, the concentration of the feed solution was increased to 56.7 g/L CBZ in 
EtOH for experiment CBZKDB2. The data obtained from online analysis of experiment 
CBZKDB2 is presented in Figure 4.25.  
 
Figure 4.25 – PXRD patterns of CBZKDB2 unseeded CBZ in EtOH at W1, W2 and W3 in the KRAIC-D at 
I11. The scale of the experimental diffraction patterns has been adjusted for clarity (W1 scaled by a factor of 8 
relative to W2 and W3) and converted into Cu Kα wavelength for comparison to the reference CBZ form II 
simulated in Mercury33 (Refcode: CBMZPN03 (CBZ form II)). 
For an unseeded CBZ in EtOH run in the KRAIC-D, the metastable CBZ form II is crystallised 
from the solution slugs at window 2 (W2) and window 3 (W3), indicated by representative 
CBZ form II peaks at 8°, 13° and 24° 2θ. W1 contains only two diffraction peaks, which also 
coincide with representative CBZ form II peaks (at 15° and 24° 2θ). The observation points 
equate to 8 mins 30 secs (6.4 m), 12 mins 20 secs (9.0 m) and 16 mins 20 secs (11.7 m) for 
W1, W2 and W3 respectively.  
At W1, crystallisation is at much earlier stages within the crystallisation process, which 
explains the weak diffraction signal obtained at that point. A method was developed to 
determine the ‘hit rate’ at a given position to gauge the likelihood of observing diffraction at 
different crystallisation times. The hit rates, which quantify the probability of observing 




















diffraction in the total number of scans collected for each crystallisation run, are summarised 
for CBZKDB1 and CBZKDB2 in Table 4.14.  
Diffraction was not observed for the beamtime experiment CBZKDB1, as indicated by the hit 
rate fractions and integrated intensity values at the analytical points of W1, W2 and W3. For 
experiment CBZKDB2, the hit rate and integrated intensity values increase from W1 to W3 as 
would be expected from the occurrence of crystal growth, the probability of the X-ray beam 
hitting crystallites in a solution slug increases. Importantly, the spread of the five integrated 
intensity values involved in the integration to produce a diffraction pattern are selected to 
reflect the hit rate when the number of scans collected exceeds five scans. This ensures that the 
five scans under analysis are representative of all of the data collected at a set point.  





Hit rate of total 
number of scans 
collected 
Integrated Intensity for 5 
scan statistical sampling 
CBZKDB1 1 0/5 0 
2 0/5 0 
3 0/5 0 
CBZKDB2 1 2/5 0.062 / 0.044 / 0 / 0 / 0 
2 4/5 0.822 / 3.394 / 5.887 / 0.028 / 
0 
3 5/5 11.13 / 13.05 / 17.17 / 3.589 / 
5.693 
Growth plots represented by box and whisker plots at various set points (W1, W2, W3), provide 
an alternative visual approach to comparing crystal growth across the crystallisation process. 
The growth plots for the unseeded CBZ in EtOH KRAIC-D run convey the widely accepted 
exponential crystal growth mechanism. An increase in intensity was seen between the first 
(0.02 a.u. average intensity) and second (2.03 a.u. average intensity) windows with an even 
greater increase seen between the second and third (10.13 a.u. average intensity) windows 
(Figure 4.26). It should be noted that such comparisons are only semi-quantitative; CBZ form 
II exhibits needle-like morphology and thus dependent on the movement of the needles within 
the solution slugs and the high aspect ratio diffraction data may only capture a particular face 




Figure 4.26 – Growth plots for CBZKDB2 unseeded CBZ in EtOH KRAIC-D run at I11. 
4.7.4 Pre-nucleation Seeding of CBZ form III (CBZKDB3) 
For CBZ form III seeded runs where pure CBZ form III is introduced as a slurry into the CBZ 
in EtOH cooling crystallisation at the pre-nucleation stage (CBZKDB3) (0.05 m, Figure 4.18 
in Section 4.4.1), CBZ form III is observed across all windows, highlighting that pre-nucleation 
seeding with the thermodynamic form of CBZ dictates the polymorphic outcome (Figure 4.27).  
 
Figure 4.27  – PXRD patterns of  CBZKDB3 pre-nucleation seeded CBZ in EtOH at W1, W2 and W3 in the 
KRAIC-D at I11, which have been converted into Cu Kα wavelength for comparison to the reference CBZ form 
III simulated in Mercury33 (Refcode: CBMZPN01 (CBZ form III)). 





































Window 2 Window 3 
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The growth plots for the pre-nucleation seeded CBZ form III (CBZKDB3) cooling 
crystallisation in EtOH analysed in the KRAIC-D platform show consistency in integrated 
intensity values for CBZ across the three windows, implying the system reached equilibrium 
prior to W1 (Figure 4.28).  
 
Figure 4.28 – Growth plots for CBZKDB3 pre-nucleation seeded CBZ form III in EtOH KRAIC-D run at I11. 
4.7.5 Post-nucleation Seeding of CBZ form III (CBZKDB4) 
For CBZ form III seeded runs where pure CBZ form III is introduced as a slurry at a post-
nucleation stage, (CBZKDB4) after W2 (9.1 m, 16 mins 30 secs RT, Figure 4.19 in Section 
4.4.1), into the crystallisation stream, CBZ form II is observed to have crystallised at W2, 
whilst only CBZ form III is detected at W3 (Figure 4.29).   
For a post-nucleation seeded CBZ form III (CBZKDB4) crystallisation, a pronounced increase 
in integrated intensity is observed between W2 and W3, which is to be expected as additional 
crystalline material is injected between the two analytical windows (Figure 4.30).  
Visually observing solution slugs passing W3, it was found that two habits could be observed 
to be physically separated based upon their different resulting interactions with the turbulent 
flow within the slugs. The crystal habits for CBZ form II and form III are distinctly needles 
and prismatic blocks respectively. The separation of form in a single solution slug could be 
rationalised by CBZ form II needles forming a cluster, which presents a higher drag force for 
the bolus flow and thus result in the clusters being pushed towards the rear of the slug. The 
blocks of CBZ form III have a correspondingly lower drag surface, which can overcome the 
bolus driving forces and take position in the front of the solution slug.  





















Figure 4.29 – PXRD patterns of CBZKDB4 post-nucleation seeded CBZ in EtOH at W2 and W3 in the 
KRAIC-D at I1. W2 is scaled by a factor of 20 relative to W3 for clarity and the diffraction patterns are 
converted into Cu Kα wavelength for comparison to the references CBZ form II and CBZ form III simulated in 
Mercury33 (Refcodes: CBMZPN03 (CBZ form II) and CBMZPN01 (CBZ form III)). 
 
Figure 4.30 – Growth plots for CBZKDB4 post-nucleation seeded CBZ form III in EtOH KRAIC-D run at I11. 
Both of these polymorphs do, however position themselves within the centre of the fore and 
rear eddy centres, the positions of which were predicted by computational fluid dynamic (CFD) 
simulations (Figure 4.31) performed by P.-B. Flandrin.107  























Figure 4.31 – (a) Photograph of CBZ form II needles and CBZ form III blocks separated by flow patterns in 
slugs, (b) CFD volume of fluid (VOF) image with flow streamlines overlaid, (c) CFD velocity contour image. 
N.B. CFD calculations were performed with Ansys Fluent by P.-B. Flandrin.139 
4.7.5.1 Single exposure polymorph identification 
Contrary to the visual observations of distinct habits, preliminary diffraction analysis only 
indicated the presence of CBZ form III after seeding. This could be because the diffracting 
power of CBZ form III is anticipated to be higher than that of the high aspect ratio needles of 
CBZ form II which, dependent on the needle orientation with respect to the X-ray beam, could 
reduce the observed diffraction intensity of CBZ form II with respect to form III. Furthermore, 
the empirical approach adopted for background subtraction during the data processing could 
also be reducing the chance of observing CBZ form II depending on the threshold chosen.  
To investigate whether CBZ form II could be isolated not only visually but in the diffraction 
data, single frame analysis was investigated. As each frame is collected by a 100 ms exposure 
at intervals of 100 ms, the probing point within a solution slug is random and thus any position 
within a solution slug could be probed. Each frame that exhibited diffraction at W3 was 
analysed and in each case only CBZ form III emerged (Figure 4.32b), despite the visual 
observations that clearly showed needles and blocks physically separated within a single 
solution slug. The single frame analysis was also investigated at W2 before the CBZ form III 
seed solution was introduced and confirmed that sufficient diffraction data was collected within 
these frames to elucidate the presence of CBZ form II in this window (Figure 4.32a).  
Investigation of individual frames did not isolate CBZ form II, which was postulated to be 
observed visually separated from CBZ form III in a single solution slug. However, the single 
frame analysis has highlighted that polymorphic identity of CBZ form II and CBZ form III 
could be clearly ascertained from single 100 ms exposures from W2 and W3, respectively 
(Figure 4.32). At W3, the vast majority of habit observed in the solution slug was needle and 
thus it is unlikely that diffraction data from these needles would not have been acquired during 
the data collection. 
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To address this, it is noted that in some studies CBZ form III has been found to exist as needles 
under certain conditions, via crystallisation in isopropanol140 or in the presence of 
surfactants.141 This may explain the separation of CBZ crystalline material on the premise of 
habit, whereby the needle and block morphologies are separated based on their different 
interactions with the flow paths in the solution slug.  The lack of observation of CBZ form II 
in the PXRD patterns can be attributed to this unusual case of crystallising two different 
morphologies of CBZ form III in this segmented flow environment in the KRAIC-D. 
 
Figure 4.32 – PXRD patterns of CBZ obtained from post-nucleation seeded cooling crystallisation in the 
KRAIC-D at windows (a) W2 and (b) W3 comparing the data obtained from the combined scan method (5 
scans), a single scan with a total of 51 exposures and a single 100 ms exposure (frame). The dotted lines are a 
guide to the eye for the identification of selected characteristic peaks of CBZ II and III in (a) and (b), 
respectively. The experimental diffraction patterns have been  converted into Cu K wavelength for comparison 
to reference data. (Refcodes: CBMZPN03 (CBZ form II) and CBMZPN01 (CBZ form III)).33 
4.7.5.2 Offline slurrying of CBZ form II and CBZ form III  
The initial visual observation of CBZ form II and CBZ form III potentially co-existing within 
a single solution slug evident from post-nucleation seeding of pure CBZ form III after window 
2 prompted investigation into competitive slurrying of the two forms. To ascertain whether 
conversion between CBZ form II and CBZ form III would be expected between W2 and W3. 
Slurrying experiments were carried out wherein a slurry containing both polymorphs was 
stirred for the time between windows (4 minutes) and then filtered and analysed offline via 




Offline slurrying experiments of CBZ II and III seed mixtures (Figure 4.33) indicate that a 
slight polymorphic transition can occur within the 4 minutes timeframe between the seeding 
inlet and W3. Importantly, the mixing conditions in the offline slurrying batch experiments 
using a round bottomed flask with magnetic bottom stirring differ from the mixing experienced 
within the solution slugs in the KRAIC-D. In the KRAIC-D experiment, this could result in a 
reduction in the amount of CBZ form II present at W3 to below detectable limits accessible by 
this in situ XRD characterisation and data processing technique. Alternatively, since the needle 
habit of CBZ form II shows consistency in shape and thus position within the solution slug is 
well defined, it is plausible that the random exposure rate of the solution slugs simply resulted 
in no exposures of the rear portion of the slug containing CBZ form II needles.  
 
Figure 4.33 – PXRD plots of offline slurrying experiments of CBZ form II and III mixture showing some 
transformation towards CBZ form III in the 4 minute slurrying experiment. 
4.7.6 Conclusions of CBZ in situ XRD Characterisation 
An unseeded CBZ in EtOH cooling crystallisation yields the metastable CBZ form II across 
all analytical points. Seeding with the pure thermodynamic CBZ form III dictates the 
polymorph outcome at both pre- and post-nucleation stages. Visual analysis of post-nucleation 
seeding of CBZ form III suggested the presence of both CBZ form II needles and CBZ form 
III blocks in solutions slugs at W3, but this was not reflected in the diffraction data, where only 
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CBZ form III was identified from all diffraction from flowing droplets at W3.  This could be 
explained by the fact that CBZ form III has been found also to exist in needle morphology 
under certain conditions. 
4.8 Polymorphic Monitoring of Urea Barbituric acid (UBA) 
The co-crystal system urea-barbituric acid (UBA) has four polymorphic forms at atmospheric 
pressure. UBA form I and form III exist concomitantly, whilst UBA form II is highly 
metastable and thus is not expected in this study.122 The fourth polymorph UBA form X has 
been discovered recently during slurry experiments utilising urea and barbituric acid in a 2:1 
ratio slurry mediated in 2 mL of methanol or ethanol stirred at a rate of 250 rpm maintained at 
20 ℃.120 Concomitant production of polymorphs UBA form I and III is expected in the study 
described here. The concomitant nature of the UBA polymorphs has led to some debate 
regarding the identity of the thermodynamic form of UBA,122 and this study aims to provide 
additional insight to the relative stabilities of UBA form I and III.  
4.8.1 Offline KRAIC Experiments: UBA in methanol (MeOH) (UBAK1) 
Experiments performed by a previous member of the group using the KRAIC platform without 
inline analytical capability72 were reproduced here and similarly ascertained that a mixture of 
UBA form I and III were obtained from crystallisation in MeOH.  
The crystallisation parameters for unseeded and seeded (both pre- and post-nucleation) 
experimental runs for UBA in MeOH are summarised in Table 4.15; the temperature zones 
controlled by the jacketed tubing and residence times dictated by the flow parameters are also 
highlighted.  
The flow parameters used in the unseeded UBA in MeOH crystallisation runs (13.21 g/L and 
14.09 g/L for urea and barbituric acid in MeOH respectively) in the KRAIC (UBAK1) and 
subsequent KRAIC-D (UBAKDB1), UBA form III (UBAKDB2 and UBAKDB3) and form I 





Table 4.15  – Crystallisation parameters for all UBA in MeOH runs with temperature until segmentation and 
nucleation promoter defined in Figures 4.6, 4.18 and 4.19, ‡denotes RTs which are extrapolated from observed 
values.  

















Urea 13.21 - 60 - 4.1 6.9 9.0 10.8 




Urea 13.21 0.2 60 - 4.1 6.9 9.0 10.8 





Urea 13.21 0.2 60 - 4.1 6.9 9.0 10.8 





Urea 13.21 0.2 60 - 4.1 6.9 8.8‡ 10.4‡ 
BA 14.09 
 
Table 4.16 – Flow rates (in mL/min) used for all KRAIC and KRAIC-D runs, † ‘pre-seed pos. and ‘post-seed 
pos’ refer to the flow rates prior to and after the post-nucleation seeding inlet. 



























The experimental set-up for unseeded UBA in MeOH KRAIC (UBAK1), which does not 
feature any additional temperature control after the segmentation water bath, is illustrated in 
Figure 4.22 in Section 4.7.1.  
 
Figure 4.34 – PXRD of material collected from an unseeded offline KRAIC UBA in MeOH experiment 
(UBAK1) showing a mixture of UBA form I and III in the final product. 
Offline PXRD analysis after filtration of the crystalline product emerging from the KRAIC 
platform (UBAK1) yields a mixture of UBA form I and III (Figure 4.34), which has also been 
reported in previous crystallisation studies of UBA.72 This coexistence of UBA form I and III 
confirms UBA in MeOH shows the potential for a polymorphic transformation during 
crystallisation, which can be monitored by in situ XRD characterisation (UBAKDB).  
4.8.2 Online KRAIC-D Runs at Beamline I11: UBA in MeOH (UBAKDB) 
The preliminary offline KRAIC (UBAK1) experiment presented in Section 4.8.1 provides a 
suitable start point for online UBA KRAIC-D experiments at I11, which are presented by 
UBAKDB identifiers.  A range of online cooling crystallisations was investigated during the 
beamtime, including unseeded (UBAKDB1), pre-nucleation (UBAKDB2 and UBAKDB4) and 
post-nucleation (UBAKDB3) seeded crystallisation experiments. The experimental set-up, 




















along with feed and seed slurry concentration for each of these UBAKDB beamtime 
experiments are summarised in Table 4.17.  
Table 4.17 – Experimental set-up, as well as concentrations of feed and seed solutions for the various 
UBAKDB beamtime experiments. 
Experiment  Set-up Feed solution concentration 
UBA in MeOH g/L 
Seed Solution 
(Wt %) 







UBAKDB2 Pre-nucleation form 





UBAKDB3 Post-nucleation form 





UBAKDB4 Pre-nucleation form I 






4.8.3 Unseeded UBA in MeOH KRAIC-D at I11 (UBAKDB1) 
For the unseeded UBA in MeOH KRAIC-D (UBAKDB1) run at I11, UBA form III was 
accessed in polymorphic purity at W1 (4.6 mins, 6.4 m), whilst W2 and W3 also show UBA 
form III, but a dominant UBA form I representative peak at 28.9° 2θ (3.09 Å; (114̅)) begins to 
emerge at W2 (6.9 mins, 9.0 m). This representative UBA form I peak increases in intensity at 
W3 (9.0 mins, 11.7 m) (Figure 4.35). This progression in polymorphic form and dominance of 
the UBA form I polymorph signifies that a polymorphic transformation from UBA form III to 
I is occurring as the crystallisation process proceeds and UBA form I is the thermodynamic 
form in methanolic solution.  
The growth plots for the unseeded UBA in MeOH KRAIC-D (UBAKDB1) run conveys a 
linear relationship between the average integrated intensity and position along the crystalliser 





Figure 4.35 – PXRD patterns of UBAKDB1 unseeded cooling crystallisation of UBA in MeOH in the KRAIC-
D showing a progression of UBA form III to form I in patterns obtained from W1 to W3. The scale of the 
experimental diffraction patterns has been adjusted for clarity (W1 scaled by a factor of 40, W2 by 3 relative to 
W3); the synchrotron data has been converted into Cu K wavelength for comparison to reference data. 
(Refcodes: EFOZAB (UBA form I) and EFOZAB02 (UBA form III)). 
 
Figure 4.36 – Growth plots for a UBAKDB1 unseeded UBA in MeOH KRAIC-D run at I11. 
4.8.4 Pre-nucleation Seeding of UBA form III (UBAKDB2) 
For UBA form III seeded runs where pure UBA form III is introduced as a slurry at pre-
nucleation stages (UBAKDB2) (0.05 m, Figure 4.18 in Section 4.4.1) into the UBA in MeOH 























cooling crystallisation, UBA form III is observed across all windows, but the dominant UBA 
form I peak emerges again at ~29° 2θ for W2 and W3 set points along the KRAIC-D (Figure 
4.37). Although small and apparently slightly shifted in 2, the intensity of this peak can be 
enhanced by combining 10 rather than 5 scans (Appendix 4.7). This demonstrates that seeding 
does not dictate polymorphic outcome and again implies that UBA form I is the thermodynamic 
polymorph.  
 
Figure 4.37 – PXRD patterns of UBAKDB2 pre-nucleation UBA form III seeded cooling crystallisation of 
UBA in MeOH in the KRAIC-D showing a progression of UBA form III to form I in patterns obtained from W1 
to W3. The scale of the experimental diffraction patterns has been adjusted for clarity (W1 scaled by 5, W2 by 
2.5 relative to W3); the synchrotron data has been converted into Cu K wavelength for comparison to 
reference data. (Refcodes: EFOZAB (UBA form I) and EFOZAB02 (UBA form III)). 
The growth plots for the pre-nucleation UBA form III seeded UBA in MeOH KRAIC-D run 
conveys a linear relationship between the average integrated intensity and position along the 
crystalliser length (Figure 4.38), implying steady-state is not reached within the timeframe 
investigated. This crystal growth behaviour for a pre-nucleation seeded UBA in MeOH 
KRAIC-D run is similar to the crystal growth observed in the unseeded UBA in MeOH 
KRAIC-D experiment. The crystal growth results for UBAKDB2 show an increase in 
integrated intensity over the crystalliser length, in contrast to CBZKDB3 where CBZ form III 






















introduced at pre-nucleation stages led to a constant integrated intensity value over the 
crystalliser length.  
 
Figure 4.38 – Growth plots for UBAKDB2 pre-nucleation seeded UBA form III in MeOH KRAIC-D run at 
I11. 
4.8.5 Post-nucleation Seeding of UBA form III (UBAKDB3) 
Post-nucleation seeding with UBA form III after window 2 (UBAKDB3) (i.e. positioned after 
where UBA form I emerged at W2 in the unseeded experiments, Figure 4.19 in Section 4.4.1) 
further indicates a close relative stability of the two polymorphs with UBA form I emerging at 
W3 (Figure 4.39). However, unlike the unseeded cooling crystallisation of UBA in MeOH 
(UBAKDB1) presented in Section 4.8.3, UBA form I has not emerged at the analytical set 
point W2 for UBAKDB3, the polymorphic transformation occurs at a later stage in the 
crystallisation process and instead emerges at W3 (Figure 4.39).  
For post-nucleation seeded UBA form III crystallisation (UBAKDB3), a pronounced increase 
in integrated intensity is observed between W2 and W3, which is to be expected as additional 






Figure 4.39 – PXRD patterns of UBAKDB3 post-nucleation UBA form III seeded cooling crystallisation of 
UBA in MeOH in the KRAIC-D showing a partial transformation of UBA form III to form I in the pattern 
obtained at W3. The scale of the experimental diffraction patterns has been adjusted for clarity (W2 scaled by 50 
relative to W3); the synchrotron data has been converted into Cu K wavelength for comparison to reference 
data. (Refcodes: EFOZAB (UBA form I) and EFOZAB02 (UBA form III)). 
 
Figure 4.40 – Growth plots for UBAKDB3 post-nucleation seeded UBA form III in MeOH KRAIC-D run at 
I11. 























4.8.6 Pre-nucleation Seeding of UBA form I (UBAKDB4) 
For UBA form I seeded runs where pure UBA form I is introduced as a slurry at pre-nucleation 
stages (UBAKDB4) (0.05 m, Figure 4.18 in Section 4.4.1) into the UBA in MeOH cooling 
crystallisation, pure UBA form I is observed across W1 and W2, highlighting that seeding with 
the thermodynamic form in solution dictates the polymorphic outcome. Characteristic UBA 
form I peaks are evident across each of the analytical set points in the KRAIC-D (Figure 4.41).  
 
Figure 4.41 – PXRD patterns of UBAKDB4 pre-nucleation UBA form I seeded cooling crystallisation of UBA 
in MeOH in the KRAIC-D showing UBA form I at W1 and W2. The experimental diffraction patterns have 
been converted into Cu K wavelength for comparison to reference data. (Refcode: EFOZAB (UBA form I)). 
For pre-nucleation seeded UBA form I crystallisation (UBAKDB4), a pronounced increase in 
integrated intensity is observed between W1 and W2 (Figure 4.42). Pre-nucleation seeding with 
UBA form I results in a greater increase in apparent crystal growth between W1 and W2 
(increase of almost factor 20 in average intensity), when compared to pre-nucleation seeding 
with UBA form III. This implies UBA form I adopts a faster crystal growth mechanism 
compared to UBA form III, with average integrated intensity increase of factor ~5 between W1 
and W2. This difference in relative growth rates of the two forms could be attributed to 
polymorphic conversion from UBA form III to I, which is occurring during the analysis time 
period for seeded form III crystallisations but not UBA form I seeded crystallisation runs.  





















Figure 4.42 – Growth plots for UBAKDB4 pre-nucleation seeded UBA form I in MeOH KRAIC-D run at I11. 
4.8.7 Stability of UBA Seeds 
The polymorphic form of the UBA seeds used in the trials were tested after dry storage for over 
12 months in a vial under standard laboratory conditions. Additionally, to ascertain whether 
conversion from UBA form III to UBA form I would be expected between windows, a slurry 
containing equal quantities of UBA form I and form III seeds was stirred in MeOH for 4 
minutes, which equates to the residence time between adjacent windows.  The UBA slurry was 








Figure 4.43 – PXRD plots of UBA form I and III seeds before and after dry storage for over 12 months and 
XRD pattern obtained from slurrying a UBA form I and III 50:50 mixture in MeOH for 4 minutes. N.B. UBA 
form I and III stock t=0 data taken on a Bruker D8 Advance, t=14/15 months and slurrying experiment taken on 
a STOE STADI P diffractometer. 
Interestingly, the relative stability of the concomitant forms of UBA form I and III varies 
depending on whether the sample is dry or exists in solution. Under dry storage conditions 
within a 12 month period, it was found that UBA form I undergoes complete polymorphic 
transformation to UBA form III, whilst upon slurrying UBA form III for 4 minutes in MeOH, 
there is an incomplete conversion to UBA form I (Figure 4.43). The dry UBA form III seeds 
remained stable, maintaining form over the storage period. These findings clarify the 
discrepancy reported in the stability of UBA polymorphs; solid state transformation from UBA 
form I to form III,120-122 but solution state transformation of UBA form III to form I.51  
4.8.8 Conclusions of UBA in situ XRD Characterisation 
In situ XRD has provided the first proof of a polymorphic transformation from UBA form III 
to UBA form I over the course of the crystallisation process in MeOH. Experiments seeded 
with UBA form I or UBA form III reinforce this finding. Seeding experiments with UBA form I 
at pre-nucleation stages yield UBA form I throughout analysis, whilst seeding at either pre- or 
post-nucleation stages with UBA form III shows a partial transformation from UBA form III 
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to form I emerging from W2 onwards along the length of the crystalliser. UBA form I is 
dominant in solution as seeding with UBA form III does not dictate the polymorphic outcome; 
partial transformation to UBA form I will occur. In contrast, dry samples of UBA form I 
showed a solid-state transformation to UBA form III from analysis after a one-year time period.   
4.9 Comparison and Conclusions of model systems: CBZ and UBA 
In situ powder XRD has been used to augment the limited understanding gained from offline 
analysis of the pharmaceutically relevant and highly polymorphic systems CBZ in EtOH and 
UBA in MeOH.  
For CBZ in EtOH, an unseeded crystallisation run yielded the metastable CBZ form II. 
Unseeded crystallisation experiments of UBA in MeOH initially crystallises as UBA form III 
which, over the crystallisation process, undergoes incomplete transformation to UBA form I.  
Introduction of a controlled solid interface in the form of pure polymorphic seed crystals 
dictated the polymorphic outcome of CBZ in EtOH but this was not the case for UBA form III 
seeded crystallisations in MeOH, whereby UBA form I emerged over the crystallisation time. 
Addition of the thermodynamic form of CBZ (CBZ form III) into the crystallisation at pre-
nucleation stages produced pure CBZ form III throughout the observed crystallisation time. 
Whilst post-nucleation addition produced only CBZ form III from the diffraction data, visual 
observation confirmed the continued presence of CBZ form III needles separated in the same 
solution slug from the CBZ form III blocks. This finding has demonstrated the potential of 
segmented flow to be used as a polymorph separation technique, provided the polymorphs 
display distinct differences in habit. Seeding UBA in MeOH with pure UBA form III seeds did 
not dictate the polymorphic outcome, much like the unseeded UBA in MeOH run, UBA form 
I showed resilience and emerged over the length of the crystalliser. This gives indication to the 
relative stabilities of UBA form I and III, where there has been some contradictory views in 
the literature.51, 120-122 The repeated incomplete transformation to UBA form I in seeded form 
III and unseeded runs, highlights that UBA form I is the thermodynamic form in methanolic 
solution. This finding is reaffirmed in UBA form I pre-nucleation seeding runs, where UBA 
form I is observed throughout the length of the crystalliser.  
Whilst a combined scan method was preferred to encompass data from across many exposures 
to ensure a proportional representation of the crystallisation environment, where data across 
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five scans was selected to be statistically relevant, further diffraction analysis ascertained that 
polymorph identification could be achieved from individual 100 ms exposures. Table 4.18 
summarises the phases of CBZ and UBA obtained from each experiment using the five-scan 
combined approach, listing the representative peaks identified in the diffraction patterns. 
From the diffraction integrated intensity data, it was possible to gain insight into the different 
growth kinetics of the two crystallising systems from both unseeded and seeded environments. 
For an unseeded CBZ in EtOH run (CBZKDB2), the growth plots at the three analysis points 
along the length of the crystalliser are in agreement with the widely accepted exponential 
crystal growth mechanisms. In contrast, UBA in MeOH (UBAKDB1) shows less substantial 
growth with a linear dependence with respect to the crystalliser length. The differences in 
growth profiles for the unseeded runs of CBZ in EtOH and UBA in MeOH highlight the 
differences in MSZWs for the two solute-solvent systems and thus UBA did not require the 
additional temperature control provided by the 10 ℃ nucleation promoter, resulting in different 
cooling profiles for UBA and CBZ (Figure 4.44). The exponential crystal growth of CBZ in 
EtOH (Figure 4.45) relates to the delay in achieving nucleation and subsequent growth. The 
two crystallisation processes will also have different kinetics, different flow rates and 
corresponding residence times and thus the different analytical set points, which remain 
consistent across all experiments, are probing different stages in the growth kinetics of the two 
processes. In addition, during the unseeded UBA and form III seeded UBA crystallisations a 
polymorphic transformation was observed, whilst a transformation was not observed during 









Table 4.18 – Qualitative summary of polymorphic expression observed in all KRAIC-D experiments. †A 




Experiment Window Form Representative 2θ 
peaks 
CBZ Unseeded CBZ 
(CBZKDB2) 
2 and 3 CBZ form II 8.7°, 13.3°, 18.4°, 24.4° 
Seeded form III pre-
nucleation (CBZKDB3) 
2 and 3 CBZ form III 15.3°, 15.8°, 17.1°, 
24.9°, 27.5° 
Seeded form III post-
nucleation (CBZKDB4) 
2 CBZ form II 13.3°, 18.4°, 24.4° 
3 CBZ form III† 15.3°, 15.8°, 26.7°, 27.6° 
 
UBA Unseeded UBA 
(UBAKDB1) 
1 UBA form III 27.3°, 25.0° 
2 UBA form I 
and form III 
27.3°, 29.0° 
3 UBA form I 





1 UBA form III 27.2° 
2 UBA form I 
and form III 
27.2°, 29° 
3 UBA form I 





2 UBA form III 27.2° 






1 UBA form I 17.6°, 27.7°, 28.9° 
2 UBA form I 17.6°, 27.7°, 28.9° 
The crystallisation behaviour of UBA in MeOH is reaffirmed by the growth plots for the seeded 
runs of UBA in MeOH. UBA form I pre-nucleation seeded runs have a much greater increase 
in apparent crystal growth between W1 and W2, compared to UBA form III pre-nucleation 
seeded runs, implying a faster crystal growth mechanism for form I over form III (Figure 4.46). 
This could be attributed to the polymorphic conversion of UBA form III to I which is taking 
place during the analysed time period for UBA form III seeded runs, but not for UBA form I 




Figure 4.44 – Measure temperature profiles across KRAIC-D for CBZ and UBA experiments. 
 
Figure 4.45 – Box plots of diffraction intensity for (a) unseeded (CBZKDB2), (b) pre-nucleation form III 
seeded (CBZKDB3), and (c) post-nucleation form III (CBZKDB4) seeded CBZ KRAIC-D experiments. N.B. 
red lines indicate the median intensity found in all frames containing non-solvent diffraction, boxes encompass 




Figure 4.46 – Box plots of diffraction intensity for (a) unseeded (UBAKDB1), (b) pre-nucleation form III 
seeded (UBAKDB2), (c) pre-nucleation form I seeded (UBAKDB4), and (d) post-nucleation form III seeded 
(UBAKDB3) UBA KRAIC-D experiments. N.B. red lines indicate the median intensity found in all frames 
containing non-solvent diffraction, boxes encompass upper to lower quartiles, and the absolute maximum and 
minimum intensity values are represented as whiskers. 
4.10 Overall Discussions and Conclusions 
As a result of the steady-state operation of the KRAIC-D, an analytical set point will be at the 
same stage of the crystallisation process irrespective of the experiment time, which allows 
events that evolve with the crystallisation time, such as polymorphic transformations, to be 
investigated. Using both unseeded and seeded (pre- and post-nucleation) cooling crystallisation 
methodologies, the evolving crystal structures of the pharmaceutical compounds: CBZ in EtOH 
and UBA in MeOH were uncovered as a function of residence time by probing different set 
positions along the length of the tubular flow crystalliser, KRAIC-D.  
In CBZ experiments, unseeded CBZ in EtOH crystallisations yielded the metastable CBZ form 
II. For seeded crystallisation runs, the seed addition point determined whether single or 
multiple polymorphs were observed throughout the crystallisation. Pre-nucleation seeded 
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crystallisations with the thermodynamic form CBZ form III produced CBZ form III throughout 
the length of the crystalliser, whereas addition of CBZ form III post nucleation once CBZ form 
II crystallised, yielded a mixture of morphologies, suggesting co-existence of CBZ form II and 
III. Only CBZ form III could be evaluated from the diffraction data, whereas visual observation 
suggested a potential mixture of the two forms in a single solution slug (distinguished by their 
characteristic morphologies, in which a significant proportion of crystalline material in the 
solution slug exhibited needle morphology). To examine the possible existence of the two 
forms from the diffraction data an alternative strategy to the five-scan combined method was 
examined, in which polymorph identification could be achieved from a single 0.1 second 
exposure. CBZ form II could still not be isolated from the single diffraction frames, in spite of 
the appearance of a significant proportion of needles in the visual observations. In the absence 
of diffraction evidence for CBZ form II, this can be explained by the fact that under some 
conditions, CBZ form III can exist in needle morphology.  
The visual observation of the two morphologies and their separation in the slugs, however, 
showed that segmentation has the potential to facilitate polymorph separation on the premise 
that various forms might have different morphologies and thus different habits will interact 
differently in the bolus flow. The investigation of single frame analysis prompted by this 
observation has also highlighted that polymorph identification can be achieved from a single 
100 ms exposure from flowing droplets.  
It was observed that for an unseeded crystallisation of UBA in MeOH, a progression of 
polymorphs from UBA form III to form I occurred. In seeded UBA experiments, a single 
polymorph was observed throughout the process when seeded with UBA form I but in 
experiments seeded with UBA form III there was still an incomplete transformation into UBA 
form I, as observed in the unseeded run. The resilience of UBA form I in the presence of UBA 
form III seeds and the corresponding suppression of UBA form III in the presence of form I 
seeds suggests a preference for UBA form I in methanolic solution. Together, these results 
highlight the importance of coupling real-time structural analysis with the crystallisation of 
polymorphic pharmaceutical crystals and co-crystals. 
The ability to investigate diffraction at different analytical length scales using this technique 
increases the number of materials and solution conditions that could benefit from this in situ 
characterisation. There is also the potential to extend this analytical method to augment the 
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crystallisation pathway understanding of other types of crystallisation methods, such as anti-
solvent, reactive and slurrying crystallisations, in the KRAIC-D. The utility of the KRAIC-D 
thus potentially expands beyond fundamental research in academic laboratories to industrial 





Chapter 5  – In situ X-ray Diffraction (XRD) Analysis of 
Continuous Segmented Flow Cooling Crystallisation in KRAIC-S 
at Small Molecule Single Crystal Beamline, I19 Diamond Light 
Source – Paracetamol (PCM) 
The research presented in Chapter 5 comprises a research collaboration between the Wilson 
Group at the University of Bath with Dr. Mark Warren at Beamline I19 the Diamond Light 
Source. The other researchers who contributed to various aspects of this work include: Dr. 
Daniel Scott, Miss Pollyanna Payne, Dr. Lauren Hatcher (University of Bath), as well as Dr. 
Lucy Saunders, Dr. Graeme Winter and Dr. Ben Williams (Diamond Light Source).  
5.1 Introduction and Aims 
Serial Crystallography (the collection of data from a series of individual crystals to make a 
complete data set) is a method recently established to study the structures of macromolecules 
using synchrotron or X-FEL (X-Ray Free-Electron Lasers) sources. The intense synchrotron 
X-ray source and more intense X-FEL pulse of second and femtosecond timeframes 
respectively, can result in the destruction of any exposed microcrystal, in cases where larger 
single crystals cannot be grown, making serial data collection mandatory. This method of data 
collection requires a high-throughput serial approach to sample delivery. Of relevance to the 
present work, and the potential extension of the method to small molecule systems, this 
delivery of samples can be achieved using a microfluidic platform that has the ability to 
generate large numbers of identical droplets; this creates defined reaction chambers allowing 
continual sample replenishment during data collection.123, 142  
Serial crystallography has received much attention in the field of protein crystallography, as a 
means to overcome the rate-limiting steps of obtaining diffraction quality crystals and handling 
crystals during transfer to the X-ray diffractometer.143 Gerard et al. reported a microfluidic 
platform employed to address these issues. The crystallisation of a protein of pharmaceutical 
interest was achieved via tubing microfluidics, which facilitated both in situ and ex situ X-ray 
diffraction (XRD) analysis.143  
The increasingly focused and brilliant X-ray beams available at synchrotron facilities reduce 
the requirements for both sample volume and data acquisition time, whilst high-resolution 
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diffraction data can be collected even from weakly diffracting crystals.142, 144 Importantly, the 
rapid data acquisition times accessible at synchrotron sources allows a diffraction pattern to be 
collected before the onset of radiation damage, which is particularly beneficial to radiation 
sensitive samples.142, 143 The requirements necessary for the serial sample delivery into the X-
ray beam are imposed by both the experimental set-up and the properties of the sample. The 
sample must be compatible with the size of the X-ray beam, such that the sample is fully 
immersed in the X-ray beam. The sample must be reliably delivered to this X-ray interaction 
area at a constant and appropriate rate, to allow sufficient data to be collected while avoiding 
excessive radiation damage.142  
Microfluidic techniques are appropriate for reducing sample volume, automation and high-
throughput crystallisation approaches.143 Microfluidics has the ability to produce hundreds to 
thousands of droplets with identical composition, compatible with serial crystallography 
approaches.143 Most of the microfluidic devices used for in situ synchrotron studies have 
focused on the characterisation of protein crystals and small angle X-ray scattering (SAXS) of 
soft matter, such as surfactants145 and biomolecules.144 The majority of these studies have been 
performed with continuous flow146 or static systems;144 the analysis of flowing droplet systems 
is limited to SAXS to monitor the formation of nanoparticles147 and protein assembly.148, 149  
The millifluidic droplets or slugs achieved via segmentation of the flow in a milliscale 
crystalliser, such as the KRAIC-D reported in Chapter 4, offer reproducible crystallisation 
environments. Issues with radiation damage are also effectively eliminated by the short 
residence time of each droplet / slug in the X-ray beam.123 
The use of serial crystallography approaches applied to structural solution using single crystals 
of small organic molecules grown in situ is unprecedented. This chapter investigates the use of 
segmented flow in a milliscale crystalliser to grow small organic molecule single crystals in 
situ through cooling crystallisation, coupled with in situ single crystal XRD analysis to achieve 
structural solution from single crystals contained in flowing droplets. 
5.1.1 Data Requirements 
One of the most notable challenges with this work is ensuring the appropriate crystallisation 
conditions to access a single crystal in a single solution slug. This is in contrast to the slurries 
crystallised in solution slugs in the KRAIC-D monitored at I11 presented in Chapter 4.  
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From the in situ XRD powder experiments presented in Chapter 4, individual diffraction 
images recorded from the polycrystalline sample within the solution slugs were converted 
relatively directly into 2D powder patterns for analysis. The KRAIC-D has been optimised for 
these in situ powder diffraction studies. In contrast, single crystal diffraction studies require 
the diffraction pattern to be indexed before any useful information can be extracted; achieving 
indexation from a single image of a small molecule system is challenging. This can be mitigated 
by obtaining multiple images from multiple orientations from a single crystal tumbling within 
a solution slug, which has to reside in the X-ray path (Figure 5.1) for a significant period (1-
4 seconds). The tumbling of a single crystal in a solution slug presents multiple orientations 
with respect to the X-ray beam, a necessary requirement in diffraction experiments to sample 
a sufficient portion of reciprocal space, the extent of which is dependent on the crystal 
symmetry. To be able to “suspend” the crystal in the X-ray beam a re-design of the set-up is 
essential. The adaptation of the KRAIC platform for single crystal measurements on I19 will 
hereafter be known as the KRAIC-S (Kinetically Regulated Automated Input Crystalliser – 
Single Crystal). 
 
Figure 5.1 – Principles of the KRAIC-S flow cell implemented at I19. 
Adaptations of the segmented flow apparatus for non-invasive single crystal structure 
determination is driven by the data requirements for this novel technique. As the X-ray source 
is in a fixed position and the segmented flow through the crystalliser cannot be stopped (as this 
would cause sedimentation and disrupt the mixing conditions within each slug), the only way 
to artificially “hold / suspend” the tumbling crystal in the X-ray beam is to use a motorised 
stage to translate the tubing in the opposite direction to the flow. The speed must equal and 
oppose the net flow rate within the KRAIC-S and the translation time / distance must be long 
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enough so the resulting diffraction data on a single diffraction image is sufficient for 
indexation. 
Using data collected via standard methods, the typical minimum angular rotation required to 
index a crystal can be determined.  This will then give an indication into how long each solution 
slug needs to reside in the X-ray beam; a suitable motorised stage can then be employed to 
move the tubing in the opposite direction to the segmented flow. A wedge of data is defined as 
a small sweep, which samples a small portion of reciprocal space.150 Each wedge of data (range 
of angular rotation of the single crystal) will obtain a small slice of reciprocal space. For 
structure solution, hundreds of wedges at different orientation must be successfully scaled and 
merged. The longer the solution slug containing the crystals stays in the X-ray beam, the larger 
the wedge of data that can be collected, meaning fewer wedges need to be combined for 
structural solution.  
5.1.2 Model System: Paracetamol (PCM) 
Paracetamol (acetaminophen, PCM) is a common analgesic and antipyretic active 
pharmaceutical ingredient (API); the chemical structure is presented in Figure 5.2. PCM exists 
in five polymorphic forms, two of which can be accessed under high pressure conditions. The 
two forms of interest in this work are PCM form I, the thermodynamic form, and the metastable 
PCM form II. PCM form I (CSD Refcode: HXACAN3024) crystallises in the monoclinic space 
group P21/n, whilst PCM form II (CSD Refcode: HXACAN31
24) crystallises in the 
orthorhombic space group Pbca. The different space groups associated with these polymorphs 
result from differences in packing which in turn results in differences in physiochemical 
properties of the solid forms of PCM. PCM form I adopts a herringbone arrangement of PCM 
molecules, whilst PCM form II adopts a layered structure (Figure 5.3).151, 152 The layered 
structure of PCM form II means that the layers of molecules have the ability to slide over each 
other, resulting in a more soluble API, which is more easily compressible into a tablet.152, 153  
 




Figure 5.3 – The crystal structures of PCM form I (left) and PCM form II (right), displaying their distinct 
differences in packing arrangements of the two forms, adapted from Agnew et al.151, 152 
The thermodynamic PCM form I and metastable PCM form II are easily distinguishable by 
single crystal X-ray diffraction (SCXRD) analysis due to distinct differences in space group 
and unit cell parameters (Table 5.1). In this study, crystal data including unit cell parameters 
are monitored to ascertain polymorphic form of single crystals grown and analysed in situ.  
Table 5.1 – Crystal data including unit cell parameters of PCM form I and form II obtained from the CSD.24 
Polymorph PCM form I PCM form II 
CSD Refcode HXACAN30 HXACAN31 
Lattice type Monoclinic Orthorhombic 
Space group P21/n Pbca 
a /Å 7.091 (<1) 7.188 
b /Å 9.211 (<1) 11.765 
c /Å 11.597 (<1) 17.68 
α /° 90.00 90.00 
β /° 97.84 (<1) 90.00 
γ /° 90.00 90.00 
Volume /Å3 750.387 1451.799 
Z 4.0 8.0 
Z′ 1.0 1.0 
These two polymorphs have also been shown to exhibit distinct differences in habit, where 
PCM form I displays octahedral geometry, whilst PCM form II produces needle-like 
morphology, when crystallised from ethanol.154  
PCM was selected as the model system to be utilised as a proof of concept for this technique; 
it has been extensively studied in the solid state153, 155-157 and the metastable PCM form II can 
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be selectively accessed in polymorphic purity;22, 151, 152 the influence of introducing a controlled 
solid interface in the form of seeds introduced into the crystallisation can thus be understood.  
5.2 Data Processing Trials  
Data processing trials on previously collected datasets of strongly diffracting small organic 
molecules captured using a 0.2 second exposure per image were employed as standard test 
datasets to establish the minimum amount of data that could be used to achieve indexation and 
to obtain an instrument model used for all datasets. Two previously collected datasets were 
investigated: one from the small organic molecule cytidine (of size 40 x 30 x 20 m3), 
collected on the PILATUS 300K detector using a wavelength of 0.6889 Å at I19 EH2; the 
second from PCM (of size 90 x 50 x 20 m3), collected on the PILATUS 2M detector using a 
wavelength of 0.4859 Å at I19 EH2. 
This information can then be used to predict how long the single crystal needs to be retained in 
the X-ray beam for successful indexation, and thus the length of translation needed from the 
motorised stage. Once this information is established, the experimental set-up can be designed 
and optimised.  
5.2.1 CrysAlisPro Data Processing Trials 
The aim of this work was to trial indexing of decreasing wedge sizes by processing existing 
data with known unit cells, which have previously been collected and solved at I19. These data 
processing trials investigated 180° (corresponding with a full dataset), 90°, 20°, 10°,  5°, 2°, 1° 
and 0.4° wedges of data. Each diffraction image corresponds to an angle of 0.2°, so for the 20° 
wedge, this coincides with 100 images. The wedge of data of the required width was selected 
during peak finding using CrysAlisPro (Version 40.53), with automated unit cell determination 
enabled. In cases where the unit cell was not found automatically, the unit cell parameters were 
input manually during cell indexation. The results of the data processing trials across the 
various data wedges, including unit cell parameters, total number of reflections and number of 
indexed reflections for the cytidine and PCM datasets are given in Tables 5.2 and 5.3 
respectively.  
Wedges of data of width 2° and above were successfully indexed in CrysAlisPro, finding the 
unit cell automatically without manual input. Wedges of at least 2° per frame collected from a 
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single crystal within a solution slug were thus assumed to be required for indexation from a 
single frame to be achieved. 
Table 5.2 – Cytidine: the full 124° dataset was collected on a PILATUS 300K diffractometer and processed 
across a range of wedge sizes using CrysAlisPro. 
Parameter Wedge of Data 
90° 20° 10° 5° 
Unit cell finding (Auto) Yes Yes Yes Yes 
a /Å 5.2287(12) 5.236(6) 5.236(10) 5.228(17) 
b /Å 14.291(3) 14.388(19) 14.45(2) 14.55(4) 
c /Å 15.118(3) 15.14(2) 15.15(2) 15.15(4) 
α /° 89.967(16) 
89.76(11) 
89.56(14) 90.7(2) 
β /° 89.972(17) 89.78(10) 89.74(15) 90.2(3) 
γ /° 89.943(17) 89.62(10) 89.48(15) 89.7(3) 
Volume /Å3 1129.6(4) 1140(2) 1147(3) 1152(6) 
Total number of reflections 338 65 36 16 
Reflections indexed 319 61 33 15 
% of indexed reflections 94.38 93.85 91.67 93.75 
 
Table 5.3 – PCM: the full 180° dataset was collected on a PILATUS 2M diffractometer and processed across a 
range of wedge sizes using CrysAlisPro. 
Parameter Wedge of Data 
180° 90° 20° 
Unit cell finding (Auto) Yes Yes Yes 
a /Å 7.1039(4) 7.1039(6) 7.1022(17) 
b /Å 9.3829(5) 9.3820(7) 9.380(2) 
c /Å 11.7100(8) 11.7102(10) 11.708(3) 
α /° 89.992(5) 90.020(7) 
90.031(19) 
β /° 97.402(5) 97.393(7) 97.405(19) 
γ /° 90.010(5) 89.990(6) 89.973(19) 
Volume /Å3 774.02(8) 773.98(11) 773.5(3) 
Total number of reflections 1600 820 177 
Reflections indexed 1303 672 142 
% of indexed reflections 81.44 81.95 80.23 
Parameter Wedge of Data 
10° 5° 2° 1° 
Unit cell finding (Auto) Yes Yes Yes Yes 
a /Å 7.100(3) 7.103(5) 7.091(9) 7.077(16) 
b /Å 9.386(4) 9.388(6) 9.394(12) 9.40(2) 
c /Å 11.711(5) 11.714(7) 11.704(14) 11.718(11) 
α /° 89.93(4) 90.04(5) 89.90(10) 89.86(13) 
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β /° 97.39(4) 97.41(5) 97.39(10) 97.27(13) 
γ /° 90.00(4) 90.03(5) 90.07(11) 90.15(19) 
Volume /Å3 774.0(6) 774.6(8) 773(2) 773(3) 
Total number of reflections 83 36 11 5 
Reflections indexed 64 29 10 5 
% of indexed reflections 77.11 80.56 90.91 100 
 
5.2.2 Automated Data Processing Trials via DIALS 
DIALS (Diffraction Integration for Advanced Light Sources) is a software suite for the analysis 
of crystallographic X-ray diffraction data, developed across synchrotron facilities including 
Diamond Light Source (DLS) and the Lawrence Berkeley National Laboratory in which the 
Advanced Light Source (ALS) is situated. The DIALS software encompasses spot finding, 
indexing, refinement and integration.158  
DIALS was initially developed to process data from pixel-array detectors. The DIALS project 
provides an interface to the analysis of standard rotation datasets, as well as still-shot diffraction 
data of biological macromolecules, such as proteins, collected at synchrotron sources. Whilst 
DIALS was initially developed for analysis in macromolecular crystallography (MX), it can 
also be employed in chemical crystallography for the analysis of small organic molecules.158 
DIALS has previously been employed to process protein crystals randomly rotating within a 
droplet via the creep indexing routine. Protein crystals have corresponding large unit cells 
producing many diffraction peaks on a single image and thus indexing from a single image is 
facilitated, compared to small organic molecules in which much smaller unit cells produce 
significantly fewer diffraction spots on a single image.159 The utilities that DIALS offer may 
be ideally suited for the processing of data collected from single crystals of small organic 
molecules randomly rotating within a solution slug in the KRAIC-S. Once a routine for DIALS 
processing has been established, each step can be automatically triggered after data collection, 
this can lead to full automation of processing. This improves on CrysAlisPro, which although 
user friendly can be slow (manual processing procedures can take days for a single collection 
run); the DIALS routine has the potential to process the same dataset in minutes.  
Before the DIALS routine can be optimised, the data processing requirements for the KRAIC-
S experiments need to be understood through use of data processing trials on existing data with 
a known unit cell. A comparable study to the CrysAlisPro work in Section 5.2.1 was carried 
out using DIALS (Version 2.1) to identify the minimum wedge of data that can be indexed 
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from a single image. These DIALS data processing trials investigated the same decreasing 
wedge widths for comparison with the CrysAlisPro data processing trials. In cases where the 
unit cell was not found automatically, the unit cell parameters were manually input during cell 
indexation. The results of the data processing trials across the various wedges of data, including 
unit cell parameters, total number of reflections and number of indexed reflections for the 
cytidine and PCM datasets are summarised in Table 5.4 and 5.5 respectively.  
Table 5.4 – Cytidine: the full 124° dataset was collected on a PILATUS 300K diffractometer and processed 
across a range of wedge sizes using DIALS. Attempts to index a 1° wedge of data via manual input of unit cell 
parameters failed.  
Parameter Wedge of data 
90° 20° 10° 5° 2° 
Unit cell finding Yes Yes Yes Yes Manual 
a /Å 5.11896(6) 5.12581(11) 5.11742(15) 5.09039(15) 5.131(3) 
b /Å 13.9854(8) 13.9430(19) 13.880(3) 13.746(3) 13.80(4) 
c /Å 14.7781(8) 14.807(2) 14.794(3) 14.699(3) 14.908(19) 
α /° 89.975(4) 89.941(12) 89.990(19) 90.31(2) 90.00 
β /° 89.997(3) 90.162(6) 90.246(8) 90.253(9) 90.00 
γ /° 89.964(3) 90.101(5) 89.803(8) 90.190(8) 90.00 
Reflections 
unindexed 
1055 48 28 13 6 
Reflections indexed 231 223 110 59 19 
% indexed 
reflections 













Table 5.5 – PCM: the full 180° dataset was collected on a PILATUS 2M diffractometer and processed across a 
range of wedge sizes using DIALS.  
Parameter Wedge of data 
180° 90° 20° 10° 5° 
Unit cell finding Yes Yes Yes Yes Yes 
a /Å 7.10506(11) 7.1079(5) 7.1147(2) 7.1169(3) 7.1125(4) 
b /Å 9.3846(2) 9.3860(6) 9.3969(4) 9.3990(7) 9.3965(8) 
c /Å 11.7122(2) 11.7149(6) 11.7273(5) 11.7270(7) 11.7239(10) 
α /° 89.9942(15) 90.014(2) 89.936(4) 89.934(6) 89.917(9) 
β /° 82.5863(13) 82.598(3) 82.650(4) 82.642(6) 82.660(8) 
γ /° 89.9889(14) 89.998(3) 90.046(4) 90.060(5) 90.059(7) 
Reflections unindexed 566 286 65 27 13 
Reflections indexed 2483 1291 287 138 65 
% indexed reflections 81.4 81.9 81.5 83.6 83.3 
Parameter Wedge of data 
2° 1° 0.4° 0.2° 
Unit cell finding Yes Yes Manual Manual 
a /Å 7.1245(10) 7.103(2) 7.108(3) 7.077 
b /Å 9.402(2) 9.380(7) 9.370(11) 8.894 
c /Å 11.743(4) 11.708(6) 11.704(9) 11.534 
α /° 89.81(2) 90.0 90.0 90.000 
β /° 82.70(2) 97.40(4) 97.42(6) 98.459 
γ /° 90.101(17) 90.0 90.0 90.000 
Reflections unindexed 5 3 0 0 
Reflections indexed 25 12 8 5* 
% indexed reflections 83.3 80.0 100.0 100 
 
5.2.3 Automated Data Processing Trials via Xia2 
Xia2 uses a pre-package of DIALS, whereby the various algorithms for the stages of spot 
finding, indexation, refinement, integration and scaling are achieved in a single command on 
behalf of the user.159 The Xia2 data processing trials investigated the same decreasing wedge 
widths for comparison with the CrysAlisPro and DIALS data processing trials. In cases where 
the unit cell was not found automatically, the unit cell parameters were again manually input. 
Similar results were obtained as for the DIALS runs, with the full results across the various 
wedges shown in Appendix 5.1. However, Xia2 did not achieve indexation with as small a 
wedge of data as DIALS. 
5.2.4 Data Processing Trials Conclusions 
Using CrysAlisPro and DIALS via Xia2 processing methods, the smallest wedge of data that 
can be indexed is between 1-2°, whilst running the algorithms step-wise allowed DIALS to 
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index a wedge width of as small as 0.2° using manual input of the unit cell parameters to reduce 
the number of variables compared to reflections. The processing of multiple 2° datasets was 
attempted using DIALS, but this required further optimisation (see Section 5.5.2.2). The data 
produced from a randomly tumbling single crystal within a solution slug can benefit from the 
DIALS method of creep-indexing, following the orientation matrix in time as the crystal 
tumbles. The software can also be automated to process thousands of wedges and calculate the 
best set of wedges to merge for structure solution.   
These initial data processing trials used diffraction data obtained on the PILATUS 300K and 
PILATUS 2M detectors. Whilst commissioning runs employed the PILATUS 300K detector, 
the beamtime experiments employed the PILATUS 2M detector for data collection. The larger 
PILATUS 2M detector results in more photons detected per image, thus allowing a wedge of 
data less than those accessed using the PILATUS 300K detector, resulting in finer slicing whilst 
also achieving indexation from a single image as a result of this larger detector.  
5.3 KRAIC-S Design and Overview 
The development of the KRAIC-S was carried out in collaboration with Dr. Mark Warren at 
the Diamond Light Source. As discussed above in Section 5.1.1, the set-up needs to facilitate 
translation to artificially “hold / suspend” the tumbling crystal in the X-ray beam. The data 
requirements of this in situ XRD technique dictated the design requirements. To minimise 
weight and bulk within the analysis area, as well as weight restrictions of the motorised stage, 
a single coil of tubing positioned away from the X-ray beam was employed, in which the 
crystallisation tubing can be pulled through the set-up to probe difference time-periods in the 
crystallisation process. 
Although X-ray transparent Kapton® windows at various analytical points as featured in the 
KRAIC-D in Chapter 4 would be desirable to minimise background, a single extruded length 
of FEP (3.18 mm ID, 11 m length) was utilised for initial testing of the KRAIC-S. Although 
not optimal, a background subtraction can be performed to remove scattering resulting from 
the FEP before data processing.  A practical advantage of using a single extruded length for 
the KRAIC-S allows for the FEP tubing to be threaded to monitor different lengths along the 
length of the KRAIC-S crystalliser; these different lengths scales equate to different 
crystallisation times in the crystallisation process. The removal of PTFE unions between FEP 
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and Kapton® windows should reduce the frequency of blockages compared to the KRAIC-D. 
Background subtraction from the diffraction data should also be more straightforward.  
5.3.1 Experimental Set-up 
As for the KRAIC-D, segmentation is achieved on the premise of immiscibility in the KRAIC-
S. Separate streams of crystallising solution, air and carrier fluid are all transferred under 
temperature-controlling jacketed tubing to ensure a constant, well-defined temperature start 
point before the flows combine at a glass cross-piece (X-piece, 3 mm ID) (Figure 5.4). A 
circulator bath is used to control the temperature of the tubing jackets and transfer tubes. The 
X-piece sits in a temperature-controlled segmentation water bath comprising a custom glass 
water bath via a hot-plate with magnetic bottom stirring. The temperature is actively regulated 
until segmentation is achieved to prevent crystallisation occurring before segmentation; once 
the flow is segmented, heated temperature control is removed to allow the cooling 
crystallisation to proceed via air cooling of the solution within the crystalliser tubing. In 
contrast to the KRAIC-D, use of a temperature-controlled tubing segment as a nucleation 
promoter will be avoided in the experimental set-up of the KRAIC-S. Such a nucleation 
promoter could encourage the formation of multiple nucleation sites, which is not desirable 
when a single crystal is desired to crystallise per solution slug. 
 
Figure 5.4 – Schematic of KRAIC-S unseeded experiments, featuring the original laser diode slug triggering 
set-up employed in the commissioning time experiments. 
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A peristaltic pump (Vapourtec SF-10) was employed for the crystallising solution and the air, 
whilst the carrier fluid was transferred using a gear pump (Ismatec ISM895E). For seeding 
crystallisation runs, an additional syringe pump (Syrris Asia) was utilised to introduce the 
single crystal seeds into the crystallisation at the pre-nucleation stage.  
5.3.2 Seeding Coil Optimisation 
To seek to ensure regularity in observing single crystals in solution slugs, an optimised seeding 
approach was employed to controllably introduce single crystals into the KRAIC-S crystalliser. 
In addition, introducing single crystal seeds of the metastable PCM form II, offers the potential 
to yield a different polymorphic outcome to the unseeded cooling crystallisation of PCM in 
60:40 v/v water:isopropanol (HI). The challenge in introducing single crystals into the KRAIC-
S is achieving regularity in seed dosing into every solution slug, coupled with the challenge in 
moving single crystals in a homogeneous stream through a suitable pump, through the seeding 
coil to the point at which segmentation is achieved. 
The use of an orange dye pre-loaded into the sample loop facilitated visual observation of the 
seeding addition into the KRAIC-S. A water:isopropanol solvent mixture (60:40 HI), (~330 mg 
/ 500 mL) of Eosin Y was prepared and continually stirred during the experiments through 
bottom stirring using a magnetic stirrer. The Eosin Y solution was pre-loaded into the FEP coil 
and added to the solution flow through a needle using a single syringe pump. The seed and 
solution streams combine with the air and carrier fluid to yield the tri-segmented flow with a 
net flow rate of 6.2 mL/min, comprising air (2.5 mL/min), carrier fluid (1 mL/min) and solution 
(2.7 mL/min). For the seed addition, flow rates of 50, 80 and 100 μL/min were trialled and it 
was found that 100 μL/min resulted in the most consistent addition of dye into each slug, 
confirmed by visual observation. 
Initial seeding coil trials investigated the use of 1 mm ID FEP tubing resulting in a 2 mL volume 
with a single syringe pump. The delivery of the PCM form II suspended in 60:40 HI was 
successful using the single syringe pump, however the 2 mL volume only coincides with a 20 
minute residence time, which is too short a time period for crystallisation runs. The delivery 
system of the PCM form II seeds needed optimisation, as the PCM form II seeds had the 
tendency to dissolve in the tubing. Instead of suspending the PCM form II seeds in solvent, 
delivering the seeds in carrier fluid ensures that the seeds will not dissolve and the seeds can 
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be introduced at room temperature. Carrier fluid was employed for the dispersant to prevent 
dissolution of the PCM form II seeds. 
As part of the optimisation, the FEP tubing was replaced with a 1.5 mm ID, 12 mL volume 
tubing and seeds in carrier fluid were loaded into the FEP coil using a syringe. The seeds were 
then introduced from the sample loop into the KRAIC-S, at a rate of 100 μL/min, but did not 
progress along the tubing at all, as the larger bore size of the sample coil tubing did not provide 
sufficient back pressure to move the seeds along the tubing. This approach led to an uneven 
distribution of the PCM form II seeds and sedimentation within the FEP sample loop and thus 
an alternative approach was required. 
To mitigate this issue with delivery, segmentation of the seeds in the 25 ft, 0.79 mm ID seeding 
coil was required. Segmentation of the seed delivery will reduce the consistency of the addition 
but will stop blocking issues and help with the overall seed delivery to the KRAIC-S system. 
Instead, PCM form II seed loading was carried out by segmenting the carrier fluid PCM form 
II suspension to prevent sedimentation. The air segmentation was achieved by removal / 
immersion / removal of the sample loop inlet in and out of the conical flask containing the 
PCM form II suspension carried out by hand. A pump was attached to the seed sample loop 
outlet to draw the segmented flow through the coil, to completely fill the loop before a seeding 
crystallisation run. The use of air segmentation to load the PCM form II into the FEP sample 
loop showed an improvement compared to the original method, which used a syringe to load 
the coil. However, a blockage occurred in the tubing despite segmenting the flow with air. The 
segmented flow required increased movement without a large increase to the net flow rate. 
Oscillation was thus introduced, rectifying this problem by providing additional movement to 
prevent the PCM form II crystals adhering to the tubing, but not altering the net flow, which 
would negatively impact the dosing of the seeds into the solution slugs (Figure 5.5).  
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Figure 5.5 – Schematic of PCM form II seed addition via a carrier fluid suspension, in which the net flow is 
controlled by a syringe pump, whilst a piston provides an oscillation to the system. 
A piston was employed to superimpose oscillation to the net flow via a T-piece. The net flow 
rate of 100 μL/min provided by the syringe pump, together with oscillation from the piston of 
± 2 cm of 0.79 mm ID tubing maintains the overall flow rate from the seeding coil of 100 
μL/min contributing to the net segmented flow of the KRAIC-S (Figure 5.6). The volume of 
the seeding coil is 3.38 mL, this coupled with the overall flow rate of 0.1 mL/min, equates to a 
suitable seeding run time of 34 minutes. 
Once the PCM form II seeds were pre-loaded into the FEP sample loop before a crystallisation 
run, the outlet of the seed coil was passed through the segmentation water bath and introduced 
into the connector set-up in the segmentation water bath. Concerns with dissolution of the seeds 
at the raised temperature of the water bath were removed through the use of the inert carrier 
fluid, which will maintain the same solid loading at both room temperature and the raised 




Figure 5.6 – Piston attached to a motorised stage to provide oscillation, with a needle connected to the coil 
tubing. 
The connector set-up in the segmentation water bath comprised two polypropylene (PP) T-
pieces (both 2 mm ID) arranged in series, with a needle (0.08 mm ID) through the centre of the 
first T-piece. The needle facilitated the addition of the PCM form II seeds to the solution, 
together with the carrier fluid. The net flow after the first T-piece was then further segmented 
using air via a second T-piece. The optimised seeding addition into the KRAIC-S is represented 
in the schematic in Figure 5.7 and installed at EH2 I19 in Figure 5.8.  
5.3.3 Cooling Crystallisations 
All continuous crystallisation runs are initially cleaned and primed with segmented flow 
comprising carrier fluid, air and the pure solvent mixture used in the crystallising solution. 
During priming the conditions such as flow rates and temperature are matched to those adopted 
in the crystallising run to ensure the system is allowed to perform at steady-state operation. All 
transfer tubing jackets and the segmentation bath were usually set to the same temperature as 
the feed solution.  The system usually requires at least one residence time (the time taken for 
the media to travel from the point of segmentation to the end-piece) to reach steady-state 
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conditions. During priming, the feed solution (PCM in 60:40 HI) is prepared and allowed to 
reach dissolution at the set temperature for approximately an hour. 
 
Figure 5.7 – Schematic of seeded KRAIC-S experiments (PCMKSS). 
 
Figure 5.8 – Photograph of KRAIC-S installed in experimental hutch 2 (EH2) of beamline I19 at Diamond 
Light Source during the beamtime. 
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5.4 Slug Triggering 
KRAIC-D experiments detailed in Chapter 4 on beamline I11 used a continuous collect strategy 
followed by advanced data processing to carry out background subtraction to remove any 
patterns without diffraction. The continuous collect strategy cannot be employed for analysis 
of single crystals grown in situ in the KRAIC-S as single images will not contain sufficient 
diffraction data for indexation and analysis. Triggering when a solution slug is passing the X-
ray beam is therefore required to initiate translation of the motorised stage accurately in order 
to artificially suspended a single crystal in a solution slug in the X-ray beam during data 
acquisition.  
Slug triggering testing was initially carried out offline in the KRAIC-D platform, looking at 
the effect upon a laser-photodiode pair when solution, air or carrier fluid passes through the 
laser beam, which changes the transmission and can be monitored on an oscilloscope read-out. 
A laser is focussed at a section of the FEP tubing containing the segmented media, which is 
flowing through the KRAIC-D platform (Figure 5.9). A photodiode reader (Canberra) is 
coupled to an oscilloscope (Tektronix) to measure the laser intensity (Beta CW 670 nm 
wavelength and 1 mW) through the tubing as segmented flow passes the laser beam.  
 
Figure 5.9 – The use of a laser on the segmented flow to provide an optical trigger. 
The resulting pattern on the oscilloscope can be used to identify the different media (air, carrier 
fluid, solution) involved in the segmentation at a given point. The solution used in this 
investigation is water; tests on other solvent systems and crystallising solutions will need to be 
carried out, but water is appropriate for these initial investigations as good segmentation is 
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established due to the surface tension of water. This will then be used to design a triggering 
mechanism to control the translation stage to effectively suspend a solution slug containing a 
single crystal in the X-ray beam to collect a sufficient wedge of reciprocal space to achieve cell 
indexation from a single diffraction frame (Figure 5.10). 
  
Figure 5.10 – Principles of the slug triggering testing. 
The purpose of this work was to determine what media contributed to each of the features in 
the resulting oscilloscope pattern. To establish an understanding of these features a number of 
slug to air ratios were employed. To change this ratio, variation in the flow rates of each of the 
constituents in the segmented flow (air, carrier fluid and solution) were investigated. The 
detailed investigation is presented in Appendix 5.2. 
The flow rate of the segmented flow is an accumulative effect of all pump rates. Combining 
the three separate flows using a X-piece connector, the speed of the motor would have to be 
14 mm/s under a typical set of flow conditions (2.1 mL/min each for air and carrier fluid, and 
1.6 mL/min for the solution). The tumbling / rotation speed of a single crystal within a solution 
slug is unknown. Assuming a single crystal rotates at 2° / second and a 2° wedge of data was 
required for indexation of a single frame, the time the crystal is required to be within the X-ray 
beam in order to obtain sufficient data to index a crystal would be one second, thus for the 
conditions described above, a motorised stage with the capability to travel a distance of 14 mm 
at a speed of 14 mm/s would be required.  
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This work established the basis for these signals to be used as an optical trigger for signalling 
when the X-ray beam should be on / off during data collection on I19.  
The benefit of exploring the fastest and slowest flow rates in this work means that the entire 
range of translation distances established should be sufficient for any investigation of 
crystallisation processes when installing the KRAIC-S on I19. When optimising the flow rates 
during offline developmental work, it is important to consider the relationship between 
tumbling rate and flow rate, where it is probable that the faster the flow rate the greater the 
tumbling rate, which causes great variance in lattice orientation between adjacent diffraction 
frames. This could negatively impact indexation of adjacent diffraction frames, where 
reindexation of the unit cell obtained from the previous frame will be carried out during data 
processing.  
5.4.1 In vitro Data Processing Optimisation 
The purpose of the offline EH2 run at I19 was to use the findings from the data processing 
trials and slug triggering testing (Section 5.2 and 5.4 respectively), applied to the experimental 
set-up installed on the beamline (Figure 5.11). The requirements of the motor were also 
assessed, to establish whether the motorised stage initially employed had the capability to reach 
the required speeds and sufficient displacement calculated in the slug triggering testing. The 
calculated motor requirements were initially utilised, which can be altered by eye to ensure that 
the slug is artificially suspended in the camera under the initial flow rates employed. This is a 
useful approach for monitoring and ‘following’ a single slug, before X-ray experiments. 
 
Figure 5.11 – Schematic of the initial translation / triggering set-up trialled for installation at EH2 I19. 
The flow rates of each of the three separate streams employed to establish the tri-segmentation 
were controlled by separate pumps; the solution was controlled by an SF-10 peristaltic pump, 
while gear pumps were utilised for the carrier fluid and air streams. The solution employed 
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during the initial offline EH2 run was water, once optimisation was complete without solids; a 
crystallising solution of PCM in 60:40 HI was introduced.  
The photodiode / laser assembly is placed upstream of the position where the FEP tubing 
crosses the X-ray beam. As the segmented flow passes the photodiode / laser assembly, the 
solution / air interface can be detected in advance, so that when that particular slug reaches the 
X-ray path the motorised stage (Figure 5.12) can be triggered.  
In the initial slug triggering mechanism design employed in the commissioning time 
(PCMKSC), the photodiode / laser assembly is in a static position, separated from the 
motorised stage by an excess of FEP tubing, ensuring that the FEP pipeline does not become 
too taught as the motor moves after the optical trigger has been instigated. 
 
Figure 5.12 – FEP tube holder and motorised stage (left) and photodiode / laser box (right). 
EPICS (Experimental Physics and Industrial Control System) was employed to continuously 
record the diode signals and was coupled with a Python script that plots the diode read-outs 
and monitors the diode plots by detecting when the signal goes above a specified threshold 
value. The larger the negative magnitude of the diode intensity, the higher the diode signal. 
This can then be used to trigger the motorised stage after a specified time-delay.  Sampling of 
the signals is important, to allow the leading-edge trigger to be well defined allowing for an 
accurate optical read-out (Figure 5.13). It is also important that the sampling of signals is 
sufficiently rapid to minimise the associated uncertainty in the position of each slug. An 
increased sampling frequency would decrease this uncertainty and improve the accuracy of the 
optical triggering. Monitoring these diode plots during data acquisition allows for the regularity 
of the segmentation to be monitored; irregularities or changes to the diode read-out give an 
indication of a drop-off in slug triggering efficiency and any changes to the experimental 
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conditions, which cannot be visually monitored in the experimental hutch during data 
collection.  
 
Figure 5.13 – Diode read-out produced from Python script, red data points correspond with the diode reading 
and the blue line corresponds with the leading edge detection. 
Optimisation of flow rates to match motorised stage limitations 
Both the individual flow rates of the three components, which contribute to the net flow and 
the size of the slugs, coupled with the speed and translation distance of the motorised stage, 
together need to ensure that a solution slug is artificially ‘suspended’ in the X-ray beam to 
collect sufficient data for indexing. A series of experiments were run to investigate this; the 
various parameters including the flow rates of the three media employed in the segmented flow, 
together with the slug separation and verdict of the trial are summarised in Table 5.6, with 
images of the resulting slugs in the Appendix 5.2. 
Table 5.6 – Flow parameters and segmentation separation for the three trial combinations employed in the in 
vitro data processing optimisations. 
Parameter Trial 1 Trial 2 Trial 3 
Flow rate 
/mL/min 
Air 4.18 4.18 2.1 
Carrier Fluid 2.1 2.1 2.1 
Solution (water) 3.2 1.6 1.6 
Net 9.48 7.88 5.8 
Distance between adjacent slugs /cm 3.2 4.2 2.6 
Time separation between adjacent slugs /s 1.5 2 2 
Motorised stage speed /mm/s 21 21 13 




With a translation distance of 38 mm and a translation speed of 10 mm/s under the optimal 
flow conditions from these tests: air pump (2.1 mL/min), carrier fluid pump (2.1 mL/min) and 
solution pump, water (1.6 mL/min), the solution slug remains in the X-ray beam for nearly 4 
seconds. This is sufficient for 38 images to be obtained, enough frames for unit cell 
determination. It would be possible to achieve a 4° to 8° wedge of data from this, depending 
on the speed of crystal tumbling. This is sufficient given that the data processing trials on 
CrysAlisPro and DIALS indicated a 2° and 0.2° wedge of data respectively would be required 
when the unit cell parameters are known.  
5.5 Data Capture and Analysis Procedure  
5.5.1 Data Capture 
The X-ray beam is triggered to operate continuously during translation of the motorised stage, 
which is signalled from the slug triggering mechanism; depending on the net flow rate of the 
segmented flow, the translation may occur over 4 seconds during data acquisition of 40 images, 
which equates to a 0.1 second exposure per image. Single crystal diffraction data were collected 
in a serial crystallography-like approach, where each scan comprised data from a range of runs, 
where each run comprised a range of frames. Each run captured diffraction data on a single 
crystal within a single solution slug and data from a range of frames within a single run were 
analysed. Five datasets corresponding to five different single crystals were analysed for each 
set of experimental conditions to ensure statistical relevance. The various experimental 
conditions under investigation include two different analytical residence time (RT) positions 
(8.7 m and 6.7 m crystalliser lengths) for the unseeded cooling crystallisation of PCM in 60:40 
HI, as well as PCM form II seeding experiments. For each of the five datasets analysed for 
each experiment, the diffraction frames were indexed and if this was achieved, refined to 
establish the extent of crystal rotation. Comparison of lattice rotations and intensity values for 
the unseeded crystallisation process at the two analytical RT points builds a statistical average 
of single crystal growth at a set point along the length of the crystalliser and allows crystal size 
to be compared with lattice rotations. As for other in situ experiments described, with the 
system operating at steady-state, different set points can be related to the different stages in the 
crystallisation process, imparting knowledge on the crystallisation pathway adopted with time.  
Initial diffraction data obtained in the commissioning time (PCMKSC) were collected on a 
Dectris 300K PILATUS detector, whilst for subsequent beamtime experiments (PCMKSB) a 
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larger detector known as Dectris 2M PILATUS (Figure 5.14) was employed. This change to 
the large detectors facilitated the sampling of a larger part of reciprocal space, resulting in more 
reflections, which made indexation easier from a single image.  
 
Figure 5.14 – Dectris 2M PILATUS detector employed for beamtime experiments (PCMKSB). 
5.5.2 Data Analysis Procedure 
5.5.2.1 CrysAlisPro 
The data analysis procedure using CrysAlisPro (Version 40.53) was created and optimised. 
The PILATUS images and instrument model were imported into CrysAlisPro. A frame within 
the diffraction data was selected as a starting frame for initial unit cell finding, on the premise 
the frame contained sufficient diffraction but not too many spots as this could indicate the 
presence of a ‘twinned’ / multi-crystal. Peak hunting was carried out for this starting frame 
where diffraction spots were added manually before cell indexation. Provided the unit cell was 
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accessed automatically, cell refinement was carried out, whereby all lattice parameters were 
refined but only for the starting frame. For the monoclinic PCM form I, the unit cell angles 
were constrained with  =  = 90, and for the orthorhombic PCM form II, all unit cell angles 
were constrained to 90°.  For all subsequent frames, cell indexation was reindexed from the 
previous image and refinement was only carried out on lattice rotations relative to the 
instrument (R1, R2 and R3). For frames where cell indexation was not achieved initially or 
from the previous frame, the unit cell parameters of the polymorphic form could be input 
manually.  
For each diffraction frame a range of information including the 2D diffraction image (Figure 
5.15), unit cell parameters and lattice rotations after refinement (Table 5.7), a peak table for 
each diffraction frame and distribution histograms with respect to the reciprocal lattice (a*, b* 
and c*-axes) (Figure 5.16) was collected. This information is useful for comparison with 
subsequent frames and subsequent runs, as well as between different types of experiment.  
5.5.2.2 DIALS  
The determination of the crystal orientation matrix from a single image requires tens of 
reflections, not always available from small unit cell materials. Improvements to the number 
of reflections per image can be achieved by employing a large pixel array detector.  Thus, as 
noted above, for the beamtime experiments, a larger PILATUS 2M detector with dimensions 
384 x 424 x 455 mm3 was employed to increase the number of diffraction spots per frame. The 
detector was installed especially for the beamtime experiments; the precise detector position 
was thus determined and included post data collection, prior to any data processing.   
The first attempt at processing the data using DIALS was to mimic the processing carried out 
previously in CrysAlisPro, whereby the same starting frames were selected. These starting 
frames in the various datasets were selected in CrysAlisPro data processing on the premise the 
image contains the most diffraction spots, whilst ensuring the diffraction coincides with a 
single crystal. The starting frame image is used for the initial indexing, then the rotation matrix 
of the next image is refined from this initial indexing. 
After header correction was applied to the raw images, the header corrected images were 
imported into DIALS and the background associated with each diffraction frame was removed 
in preparation for the spot finding procedure. This was to mitigate issues associated with the 
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threshold selected for the spot finding and was successful in giving reliable spot location 
(Figure 5.17), which was particularly important to ensure sufficient diffraction data was found 
from a single image in order to achieve indexation.  
 
Figure 5.15 – 2D diffraction image from a PCM form II seeded crystallisation run.  
Table 5.7 – Unit cell parameters (a, b, c, α, β, γ) and lattice rotations R1, R2, R3 after refinement from a PCM 
form II seeded crystallisation run.  
Unit cell parameters a /Å 11.6815 
b /Å 7.3393 
c /Å 16.9153 
α /° 90 
β /° 90 
γ /° 90 
Lattice rotations R1 /° 23.523 
R2 /° -77.111 
R3 /° -3.081 
 
In comparison to the peak tables corresponding to the same diffraction frames in CrysAlisPro, 
which achieved cell indexation, the DIALS indexing routine was not able to index the single 
image to extract the orientation. In order to increase the number of diffraction peaks to achieve 
cell indexation, neighbouring diffraction images were merged, resulting in a larger wedge of 
data and thus an increasing sampling of reciprocal space per dataset. The benefit with fine 
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slicing is that the minimal amount of diffraction data per frame can be used to achieve cell 
indexation, whereby if a diffraction frame does not contain sufficient diffraction for indexation, 
a larger slice can be achieved by merging the fine slices together. The limiting factor is the 
smallest increment of a wedge of data sampled from reciprocal space. 
For indexing, the unit cell parameters are fixed; reducing the number of parameters, and the 
detector distance is also constrained during cell indexation. The successfully indexed 
reflections are input into the refinement process.   
 
Figure 5.16 – Distribution histograms with respect to the reciprocal lattice: a*-axis, b*-axis and c*-axis from a 
PCM form II seeded crystallisation run.  
 
Figure 5.17 – Single diffraction frame after DIALS spot finding (background subtracted), with spots 
highlighted in pink. 
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With the increased number of peaks resulting from the merging of neighbouring images, it was 
possible to achieve indexation and obtain the orientation matrix from a single diffraction image. 
All the steps above were compiled into a Python script, facilitating complete automation of the 
DIALS processing procedure, which only takes a couple of minutes to complete.  
This initial DIALS method provided a proof of concept for the novel in situ single crystal X-
ray diffraction technique, however in contrast to CrysAlisPro, it was not possible to employ 
the starting frame to yield the first orientation matrix to then refine neighbouring images, as 
only single images were imported. The DIALS processing procedure was thus updated to 
import all of the data and only subtract a band of scattering from the FEP tubing as opposed to 
an entire background from the diffraction images. Background subtraction was also carried out 
around the beamstop and in this updated method, the spot finding, indexing, refinement and 
integration on the individual image occurs on the entirety of the datasets. A local indexing 
assignment method can be used on data that may not follow a conventional sweep about a given 
scan axis and is applied across all diffraction images in a dataset. After local indexing 
assignment, refinement, integration and scaling was carried out using DIALS. The integration 
stage was carried out using standard methods, generating p4p, hkl and ins files.  
5.6 Growth Studies  
Data from single crystals of known crystallite size measured on an optical microscope were 
collected via traditional single crystal data collection strategies at I19, using a 0.2 second 
exposure per image and subsequently processed using standard data processing procedures in 
CrysAlisPro (Version 40.53). Diffraction spots determined from a single crystal within a 
solution slug can be integrated and their intensities compared with the equivalent hkl reflections 
within the standard single crystal datasets. For a given hkl set of reflections, the intensity values 
corresponding with the single crystals of known crystal volume can be directly correlated, 
allowing estimation of the crystal size of the single crystals grown in situ in the KRAIC-S.  
The concept of sufficient sampling must be considered; the intensity magnitudes of the 
complete rocking curve represented by a normal distribution function are sampled (Figure 
5.18), as opposed to just the maximum average intensity value. The sampling is dependent on 
the fine slicing selected for data capture, illustrated by the red dotted lines in Figure 5.18, which 
causes the same hkl diffraction spot to reside on adjacent diffraction images and data from these 
spots in adjacent diffraction frames are accumulated to produce the total diffraction intensity. 
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For the single crystal slug datasets, the maximum average intensity coinciding with the centre 
of the hkl set was only accumulated with the intensity value of an adjacent frame ±1 either side 
of the maximum average intensity of the starting frame to mitigate the variabilities in intensity 
resulting from crystal rotation within the solution slug.  
 
Figure 5.18 – Complete rocking curve represented by a normal distribution function. 
5.7 Polymorphic Monitoring of Paracetamol (PCM) 
5.7.1 Offline KRAIC Experiments: PCM in 60:40 H2O:IPA (HI) (PCMK) 
To develop the flow crystallisation process of PCM in 60:40 (v/v) H2O:IPA (HI) to crystallise 
no more than one single crystal per solution slug, developmental work optimised offline was 
carried out in the KRAIC and KRAIC-S platforms. The KRAIC and KRAIC-S are 
operationally identical; unlike the KRAIC-D, these two platforms have a single extruded length 
of 15 m and 11 m of FEP tubing respectively. The only exception to this is that the KRAIC 
comprises three coils, one housed in a glass cylinder, whilst the other two coils are housed in 
aluminium cylinders, whilst the KRAIC-S is not housed and is instead wrapped around 
aluminium posts screwed into an aluminium breadboard base (ThorLabs). The difference in 
housing of the main FEP coil (s) may result in some differences in the residence time of 
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crystallisation through the length of the KRAIC and KRAIC-S crystallisers. It can be expected 
that crystallisation will occur at an earlier residence time in the KRAIC-S compared to the 
KRAIC as a result of increased air cooling. The crystallisation process required optimisation 
to ensure that crystallisation occurred by the residence time of the tubing holder positioned 
directly in front of the X-ray beam at I19 EH2, 6.7 m and 8.7 m for earlier stage and later stage 
crystallisation, respectively. The crystalliser length at the tubing holder / X-ray beam position 
was altered via threading of the FEP tubing. The standard crystalliser length at this analytical 
point was 8.7 m, which was used for all PCM form II seeded crystallisation experiments. 
Initial concentrations of PCM in 60:40 HI and corresponding temperature conditions were 
based upon the solubility curve of PCM in 60:40 HI.22, 152 The concentration used for the 
unseeded PCM in 60:40 HI KRAIC (PCMK) and KRAIC-S (PCMKS) runs, as well as seeded 
KRAIC-S runs (PCMKSS) was based on the solubility curve (y = 68.596e0.0334x) at 29 ℃ (feed 
temperature). Referring to the solubility curve in Figure 5.19, this equates to a concentration 
of 182 g/kg (200 g/L with the density of 60:40 HI at 0.914 g/mL) PCM in 60:40 HI.  
 
Figure 5.19 – Solubility curve of PCM form I in 60:40 (v/v) H2O:IPA (HI) using data from Agnew22, 152, fitted 
with an exponential trend curve.  
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The PCM in 60:40 HI cooling crystallisations in the KRAIC and KRAIC-S are categorised into 
offline experiments, identified as PCMK and PCMKS in the KRAIC and KRAIC-S platforms 
respectively. The online experiments are categorised into commissioning and beamtime 
experiments, denoted PCMKSC and PCMKSB, both carried out in the KRAIC-S, which is 
designed to be compatible with the size and data collection requirements of EH2 at I19.  
The experimental set-ups for the various KRAIC offline crystallisation runs are presented in 
Figures 5.20 and 5.21, with the difference between the KRAIC set-ups being the presence and 
absence of a nucleation promoter after the segmentation water bath. The concentration of the 
PCM feed, the temperature control, flow rates and experimental residence times for the various 
experiments are outlined in Table 5.8, 5.9, 5.10 and 5.11 respectively. The measured cooling 
profiles for the unseeded PCM in 60:40 HI KRAIC cooling crystallisation experiments 
PCMK2-4 are shown in Figure 5.22.  
 
Figure 5.20 – Schematic of the experimental set-up for the unseeded PCM in 60:40 HI run, without a nucleation 




Figure 5.21 – Schematic of the experimental set-up for the unseeded PCM in 60:40 HI runs, with a nucleation 
promoter in the KRAIC (PCMK2-4). 
Table 5.8 – Experimental parameters including feed concentration, seed loading and experimental set-up for 
PCM offline experiments in the KRAIC platform (PCMK). 
Experiment Feed Solution (g/L 60:40 
HI) 
Experimental Set-up 
PCMK1 200 Unseeded, no nucleation promoter, Fig. 5.20 
PCMK2 200 Unseeded, with nucleation promoter, Fig. 
5.21 
PCMK3 200 Unseeded, with nucleation promoter, Fig. 
5.21 







Table 5.9 – Set temperatures in the KRAIC platform *For PCMK1, the temperature of the water bath was 
reduced to 30 ℃ at 40 minutes into the run and subsequently the heating of the water bath was switched off and 
ice added to the bath (final temp 12.1 ℃) in attempt to promote nucleation. 
†
For PCMK2 the temperature of the 
nucleation promoter was reduced to 5 ℃ at 1 hour 20 minutes into the crystallisation run. 
‡
For PCMK4, the 
nucleation promotor was turned on (from RT) to 10 ℃. 
#
For PCMK4, 78 minutes into run the temperature of 
the tubing jackets was raised to 60 ℃. 
Experiment Set Temperature (℃) Temperature of 





water bath  
PCMK1 N/A 45 45 40 (30)* 23.2 
PCMK2 10 (5)† 50 45 40 22.9 
PCMK3 5 50 45 40 21.5 
PCMK4 RT (10)‡  50 50 (60)# 40 24.0 
 
Table 5.10 – Flow rates (mL/min) used for all KRAIC runs. *For PCMK1, the flow rate of the solution was 
reduced to 1.4 mL/min to allow more time for crystallisation to proceed. Later on in PCMK1 the flow rate of the 
carrier fluid was reduced to 2.1 mL/min.  #For PCMK2, the flow rate of the carrier fluid and feed were reduced 
to 2.1 mL/min and 1.5 mL/min respectively at 42 minutes, the flow rate of the feed was further reduced to 1 
mL/min at 1 hour 12 minutes. 
‡
For PCMK4, 78 minutes into run the flow rate of the solution pump was 
increased to 3.6 mL/min. 
Experiment Flow rate / mL/min 
Carrier fluid Air Neutral Solvent Solution 
PCMK1 4.18 (2.1)* 4.18 12.5 2.8 (1.4)* 
PCMK2 4.18 (2.1)# 4.18 12.5 2.8 (1.5, 1) # 
PCMK3 2.1 4.18 12.5 1.5 








Table 5.11 – Experimental residence times for various set points along the length of the KRAIC for PCM 
offline experiments (PCMK) *For PCMK1, total residence time before solution flow rate reduction is shown, all 
other residence times quoted in PCMK1 refer to the reduced 1.4 mL/min flow rate for the solution. For PCMK2-
4, residence times are measured before any alterations to the flow rates are carried out. 













PCMK1 N/A ~6 12:24 18:28 19:05 
13:45* 
PCMK2 1:00 5:38 9:50 14:10 14:35 
PCMK3 1:45 9:12 15:35 22:18 22:56 
PCMK4 1:33 9:01 15:27 22:11 22:42 
 
 
Figure 5.22 – Measured cooing profiles of temperature versus crystalliser length in the KRAIC for experiments 



























After 40 minutes into the crystallisation run, no crystallisation was observed so the temperature 
of the water bath was reduced to 30 ℃ in an attempt to promote nucleation. The flow rate of 
the solution pump was also reduced to 1.4 mL/min at 1 hour 13 minutes to increase the 
residence time within the KRAIC to 16 minutes, allowing more time for crystallisation to 
proceed. The flow rate of the carrier fluid was also reduced to 2.1 mL/min at 1 hour 31 minutes 
to increase the residence time further to 19 minutes.  
At 1 hour 37 minutes crystals were observed in the feed line and SF-10 solution pump. The 
lines were then switched to pure solvent and the system was cleaned / primed for 20 minutes 
before restarting the crystallisation run.  
No crystallisation was observed after 30 minutes into the re-started run so the heating supplied 
to the water bath was switched off and ice added to the segmentation water bath to promote 
nucleation. The final temperature of the water bath was 12.1 ℃. At 52 minutes into the 
crystallisation run the feed was switched to cleaning / priming as crystallisation was observed 
in the solution pump, which led to a blockage in the solution pump.  
The learnings obtained from PCMK1 was that a nucleation promoter maintained at sub-
ambient temperatures was required to promote nucleation and subsequent crystallisation. The 
feed solution concentration could equally be increased for the same result, however the 
tendency of the solution pump to block suggests this would not be the most appropriate 
alteration in conditions. As a result of the blockage observed in the solution pump, the solution 
flow rate needs to be maintained at a high flow rate to avoid crystallisation in the line. The 
temperature of the jacketed tubing could also be increased to avoid crystallisation in the lines 
before segmentation is achieved.  
PCMK2 
The PCM solution re-used from PCMK1 did not dissolve at 45 ℃, so the temperature was 
raised to 50 ℃ to aid dissolution; this increase in dissolution temperature can be attributed to 
evaporation of the solvent. The flow rates of the carrier fluid and feed solution were reduced 
to 2.1 mL/min and 1.5 mL/min, respectively, at 42 minutes to increase the residence time. At 
1 hour 12 minutes into the crystallisation run the flow rate of the solution feed was further 
reduced to 1 mL/min. Very sporadic nucleation and growth, equating to a single crystal in one 
single solution slug, was noted after 10 minutes of observations. The temperature of the 
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nucleation promoter was thus reduced to 5 ℃ at 1 hour 20 minutes to increase the extent of 
nucleation. Filtration to obtain yield from the crystallisation proved challenging as recovery of 
the carrier fluid was poor, which led to the formation of a filter cake resulting in filter clogging.  
The filter cake resulted from micro-crystals invisible to the naked eye in the slugs. 
At 1 hour 24 minutes into the crystallisation run, encrustation was observed in the feed lines 
and the flow rate of the feed solution was returned to 1.5 mL/min. The feed was also switched 
to priming to avoid a blockage in the lines.  The observation of single crystals after 1 hour 24 
minutes could be attributed to the introduction of the nucleation promoter or could result from 
the previous blockage in the feed line.  
PCMK3 
The PCM solution was re-used from PCMK2. During the crystallisation run, no obvious 
crystallisation occurred in solution slugs, even with the nucleation promoter set to 5 ℃. 
Crystallisation was observed very sporadically in the solution slugs, with the earliest 
observation of crystallisation seen at coil 3 rung 3 (11.5 m). The crystals sometimes appear 
single in nature, highlighting the potential of PCM in 60:40 HI as a suitable system for growing 
single crystals in situ in the segmented flow crystalliser. Solid recovery was facilitated by 
vacuum filtration over a collection period of 23 minutes, with a corresponding mass of solid of 
0.114 g, equating to a yield of 10.66 % for a measured outlet temperature of 27 ℃. The feed 
was switched to cleaning / priming at 1 hour 5 minutes into the crystallisation run. 
PCMK4 
The concentration of the PCM solution was increased to 225 g/L to increase the extent of 
crystallisation. Single crystals were observed exiting the KRAIC in irregular slugs; the first 
observable point of crystallisation occurred at coil 3 rung 4, 12 m along the length of the 
KRAIC. Solid was recovered from the outlet, where the crystallising solution exiting the 
KRAIC had a corresponding temperature of 24 ℃ obtained from readings measured using an 
internal temperature probe. During PCMK4, the first collection (FP1) was collected over 26.5 
minutes with an associated mass of solid of 0.2311 g, equating to a yield of 8.07 %. The second 
collection (FP2) was collected over 11.25 minutes, giving a mass of 0.1741 g equating to a 
yield of 14.33 %. FP2, commencing 75 minutes into the crystallisation run, was not collected 
over an entire residence time due to the formation of a filter cake resulting from poor recovery 
of the carrier fluid. The filtration samples recovered from the KRAIC were viewed under a 
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microscope, providing confirmation that single crystals are formed under these conditions 
during the cooling crystallisation of PCM in 60:40 HI in PCMK4 (Figure 5.23). 
It was noted that the single crystals did not appear to tumble sufficiently in solution slugs. Most 
of the crystals position themselves and grow at the back of a solution slug. This is a potential 
issue for data collection at I19, which uses ‘crystal creeping’ for indexing the crystal, based 
upon at least a 2° rotation angle. Conversely, substantial rotation is also undesirable, as between 
adjacent frames the orientation will alter so much that indexation may fail. A small 2° rotation 
angle may not be observable with the naked eye, so the minimal rotation of single crystals 
observed in the KRAIC runs offline may be sufficient for data processing requirements. The 
degree of rotation allowance was ascertained during the I19 commissioning time.  
At a crystallisation run time of 78 minutes, encrustation was observed in the feed line. The flow 
rate of the feed solution pump was increased to 3.6 mL/min and the temperature of the tubing 
jackets increased to 60 ℃. The pump had to be stopped and cleared as the blockage was too 
severe. The SF-10 pump was changed and the feed line switched to priming solvent to clear 
the line at a flow rate of 5 mL/min. 
The KRAIC crystallisation experiment PCMK4 showed that the flow rate adopted for the feed 
solution SF-10 pump was too low, which caused sedimentation and in turn encrustation in the 
pump and feed lines. As a result, the temperature of the feed requires increasing to avoid 
blockages observed before segmentation. Even though single crystals were clearly present in 
some of the solution slugs, their presence remained irregular and thus the concentration of the 




Figure 5.23 – Microscope images of FP1 (top) and FP2 (bottom) from PCMK4 vacuum filtration collections, 
with varying levels of magnification, lower (left) and higher (right) for each PCM collection sample. 
 
Conclusions from offline PCMK experiments conducted at the University of Bath 
The PCM single crystals have the tendency to position themselves at the back of solution slugs, 
knowledge of this is paramount in ensuring high precision from the slug triggering mechanism, 
as it is important that the position of where to suspend the slug in the beam is well understood, 
accurate and reproducible. 
The flow rate and the temperature of the feed may be too low, which could be causing the 
recurring issues with blockages in the SF-10 solution pump and transfer tubes leading to the 
segmentation water bath. To mitigate these recurring issues, an increase in the flow rate of the 
solution pump, as well as raising the temperature control of the feed and transfer tubes was 
required.  
The temperature of the laboratory varied by a few degrees between experiments PCMK1-4 
(Table 5.9), which can result in marked differences in crystallisation outcome. The metastable 
zone width (MSZW) of PCM in 60:40 HI in the KRAIC is not known as a result of the 
uncontrolled cooling within the segmented flow platform.  
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Experiment PCMK4 at the increased concentration of 225 g/L PCM in 60:40 HI, may result in 
more single crystals in solution slugs with the introduction of cooling in the tubing jackets of 
the nucleation promoter.  
Furthermore, the concentration of PCM in 60:40 HI may need to be raised further (250 g/kg 
PCM in 60:40 HI was employed by a previous group member to crystallise powder in solution 
slugs).152 This may also require adjusting the temperature of the feed solution and the flow rate 
of the SF-10 solution pump.  
5.7.2 Online KRAIC-S Runs at Beamline I19: PCM in 60:40 HI (PCMKSC and 
PCMKSB) 
5.7.2.1 Commissioning Time at I19 EH2 (PCMKSC) 
Offline KRAIC (PCMK) experiments presented in Section 5.7.1 yielded single crystals in 
solution slugs via visual observation, which highlights both the potential of PCM in 60:40 HI 
for in situ SCXRD monitoring and gives a suitable start point for online KRAIC-S experiments. 
The online KRAIC-S experiments at I19 are categorised into commissioning time and 
beamtime with unique identifiers PCMKSC and PCMKSB respectively.  
During the commissioning time (PCMKSC) experiments, the unseeded cooling crystallisation 
of PCM in 60:40 HI was investigated. The experimental set-up, along with feed concentration 
and X-piece geometry for each of these PCMKSC commissioning time experiments are 
summarised in Table 5.12. The temperature conditions, flow rates and residence times for the 




Table 5.12 – Experimental parameters including feed concentration and experimental set-up for the KRAIC-S 
platform used for the various experimental runs in the Commissioning time at EH2 I19 (PCMKSC). 
Experiment PCM Feed 
Solution (g/L 
60:40 HI) 
Experimental Set-up Glass X-piece 
PCMKSC1 225 Unseeded KRAIC-S, 
with nucleation 
promoter, Fig. 5.4 
Uneven bore size 3 mm ID for feed 
inlet, 2 mm ID for air and carrier 
fluid inlets, with the net segmented 
flow at 3 mm ID 
PCMKSC2 225 Unseeded KRAIC-S, 
with nucleation 
promoter, Fig. 5.4 
Uneven bore size 
PCMKSC3 225 Unseeded KRAIC-S, 
with nucleation 
promoter, Fig. 5.4 
Uneven bore size 
PCMKSC4 225 Unseeded KRAIC-S, 
with nucleation 
promoter, Fig. 5.4 
Even bore size (3 mm ID for all 
inlets / outlet) 
PCMKSC5 250 Unseeded KRAIC-S, 
with nucleation 
promoter, Fig. 5.4 
Even bore size 
 
Table 5.13 – Set temperatures in the KRAIC-S platform used for the various experimental runs in the 
Commissioning time at EH2 I19 (PCMKSC). *RT – room temperature. 







PCMKSC1 RT* (air filled) 50 50 40 
PCMKSC2 RT (air filled) 55 55 40 
PCMKSC3 RT (air filled) 55 55 40 
PCMKSC4 RT (air filled) 50 55 40 
PCMKSC5 RT (air filled) 50 55 40 
 
Table 5.14 – Flow rates (mL/min) used for the various experimental runs in the Commissioning time at EH2 
I19 (PCMKSC). *For PCMKSC3, the flow rates of the solution and air were altered to 2.1 mL/min and 2.5 
mL/min respectively at 50 minutes into the crystallisation run.  
Experiment Flow rate /mL/min 
Carrier fluid Air Neutral Solvent Solution 
PCMKSC1 2.1 4.18 12.5 1.5 
PCMKSC2 4.18 4.18 12.5 1.5 
PCMKSC3 2.1 1.5 (2.5)* 12.5 3.1 (2.1)* 
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PCMKSC4 2.1 3.1 12.5 1.5 
PCMKSC5 2.1 3.1 12.5 1.5 
 
Table 5.15 – Experimental residence times for various analytical set points along the length of the KRAIC-S in 
the various experimental runs in the Commissioning time at EH2 I19 (PCMKSC) N.B There are no residence 
times recorded for PCMKSC5, but they would be expected to be similar to PCMKSC4, which utilises the same 
flow rates. *A blockage in the solution feed was observed at this crystallisation time; as a result, the residence 
time may not be accurate. **The flow rate of the carrier fluid was briefly increased to 8.3 mL/min; therefore, the 
residence time of the outlet may not be accurate. 










Nucleation promoter 1:41 - 2:07 1:45 
Rung 1 3:25 - 3:46 2:38 
Rung 2 4:25 - 5:14 3:50 
Rung 3 5:16 6:40 6:45 5:20 
Rung 4 7:07 8:07 8:11 6:31 
Rung 5 8:30 9:36 9:42 7:45 
Rung 6 9:51 11:03 11:13 8:57 
Rung 7 - 12:32 12:43 10:03 
Rung 8 12:36 14:01 14:14 11:24 
Rung 9 13:57 15:29 15:42 12:23 
Rung 10 15:19 16:59 17:13 13:46 
Rung 11 16:42 18:29 18:44 14:57 
Rung 12 18:06 19:58 20:15 16:08 
Rung 13 19:29 21:25* 21:44 17:23 
Rung 14 20:51 22:55 23:13 18:33 
Rung 15 22:14 24:25 24:10 19:45 
Photodiode / Laser box 23:20 25:38 25:55 20:40 
Tubing holder (X-ray 
beam) 
23:28 26:22 26:42 - 
Outlet 28:24 31:39 31:40** - 
PCMKSC1 and PCMKSC2 
A blockage was observed 33 minutes into the crystallisation run in the SF-10 peristaltic 
solution pump. The temperature of the tubing jackets was increased from 50 ℃ to 55 C for 
PCMKSC2, together with the introduction of foil added to the inlet of the SF-10 pump for 





Some crystals were observed in the top of the KRAIC-S, but their presence was very irregular; 
some of the crystals comprised a single crystal within a single solution slug, whilst other 
solution slugs formed agglomerates of PCM. The PCMKSC3 experiment was ended 1 hr 10 
minutes into the crystallisation run. The increased experiment time with respect to previous 
experiments can be attributed to a change in the SF-10 inlet and outlet tubing, where the bore 
size of the tubing has increased, reducing blockage issues in the solution pump. 
PCMKSC4 
For experiments PCMKSC1-3, a glass X-piece with uneven bore size was used. The 
segmentation observed in these experiments showed irregularity therefore, for PCMKSC4, a 
change in glass X-piece with even bore size for each inlet / outlet was adopted, which greatly 
improved the homogeneity of the segmented flow.  
Some discrepancies in the slug triggering mechanism in terms of matching the translation of 
the motorised stage with the net flow rate of the segmented flow was observed; this could be 
altered experimentally by trialling different motor translation speeds to match and directly 
oppose the net flow. Inconsistency in which part of the solution slug was triggering the laser / 
photodiode box and thus held stationary in the camera / X-ray beam was experienced. This was 
attributed to a difference in height of the photodiode / laser box, which was at a lower position 
than the translation stage (calibrated to the X-ray beam), which was corrected. This in turn 
helped the consistency of the segmentation and also resulted in a reduction in the crystal 
tumbling of the single crystals in solution slugs.  
PCMKSC5 
Experiment PCMKSC5 used a higher concentration of PCM in 60:40 HI (250 g/L), to yield 
more single crystals in solution slugs. A single crystal within a solution slug was observed in 
the videos taken alongside the slug triggering mechanism to track these. The PCM single 




Figure 5.24 – 2D diffraction frame showing diffraction spots (left) with the corresponding solution slug held in 
the X-ray beam during data collection, captured by a camera positioned by the X-ray beam (right), the single 
crystal is positioned at the back of the solution slug highlighted by the red circle. 
5.7.2.1.1 Commissioning Time Data Processing using CrysAlisPro 
The lattice rotations with respect to the instrument corresponding to the PCM single crystal 
were found to be equivalent to a crystal rotation of 0.4° during data collection of each frame. 
This finding confirms previous data processing trials in Section 5.2.2 predicting that cell 
indexation could be achieved from a 0.2° wedge of data using the automated DIALS processing 
approach. The rotation is observed to be chaotic and not in a single direction, which is 
observable from the lattice rotations with respect to the instrument (Appendix 5.4). 
Conclusions from Commissioning time conducted at Diamond Light Source  
A fine balance exists between crystallising single crystals in enough solution slugs to index 
enough frames for full indexation, whilst also avoiding crystallisation of multiple crystallites 
within a solution slug. The key is to ensure that sufficient single crystals are crystallised in situ 
before the X-ray beam to allow around 20 datasets of single crystals to be collected, even if 
some solution slugs yield multiple crystallites as long as the latter can be processed.  
During the commissioning time, the temperature of the experimental hutch was not regularly 
monitored. It was observed that very small changes in temperature greatly impact the 
crystallisation process and thus to mitigate these issues with temperature fluctuations, during 
subsequent beamtime experiments, the experimental hutch door remained closed except for 
entry and exit of the hutch in order to maintain constant temperature conditions. For beamtime 
Direction of flow 
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experiments, the temperature and humidity conditions of the experimental hutch were thus 
constantly monitored using a humidity / temperature sensor. 
5.7.2.2 Slug Triggering Mechanism Optimisation  
Both the offline EH2 run for rig development (Section 5.4.1) and the commissioning time 
described above employed a photodiode / laser box separated from the FEP tubing holder 
situated at the X-ray beam. This separation in the position of the slug trigger to the slug data 
collection at the X-ray beam not only led to both a time delay between trigger and data 
collection, which negatively impacted data collection efficiency, but also reduced the accuracy 
of the trigger due to alterations in the flow rate over the slug trigger distance. In terms of hit 
rate, single crystals resided in 1 in 10 solution slugs and the slug triggering mechanism 
successfully accessed the correct position of a single crystal in a solution slug for 1 in 20 
attempts; the likelihood of obtaining data is thus only achieved 1 in 200 stage translations.  
To mitigate these issues, an optimised design of the slug triggering mechanism was established, 
whereby the photodiode / laser box was instead installed on the motorised staged with the 
tubing holder. To make this design geometrically possible without the photodiode and laser 
colliding with the beamline optics, mirrors were employed to reflect the laser beam to the 
photodiode (Figure 5.25). The optimised slug triggering mechanism also incorporated a longer 
translation range from 42 mm in the original design to 118 mm, with corresponding operating 
translation windows of 38 mm and 60 mm for the original and updated slug triggering designs 
respectively (Figure 5.26). In addition, to avoid reductions in the flow rate of the air over time, 
which was observed repeatedly when using the gear pump in the offline EH2 run, the air pump 
was switched to an SF-10 peristaltic pump, allowing for the net flow rate to be more accurately 
maintained. 
This updated slug triggering mechanism comprising of a single translation unit improved both 
the efficiency and efficacy of the slug triggering mechanism, as well as the single crystal hit 
rate. In the updated design, the delay time between slug triggering and X-ray data collection of 
a single crystal in a solution slug is significantly reduced from 44.63 seconds for the original 
slug triggering design (PCMKSC2) to 2 seconds for beamtime experiments with net flow rates 
of 9.86 mL/min and 6.2 mL/min for commissioning time and beamtime experiments 
respectively. This reduction in time delay from the original slug triggering set-up would have 
been greater if the net flow rate used in the commissioning time matched the lower flow rates 
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employed in the beamtime experiments. This design optimisation resulted in increased data 
collection efficiency. Furthermore, the slight variations in pump rates over the crystalliser 
lengths are mitigated in this new design as the trigger and analysis point are adjacent and thus 
the accuracy in accessing the single crystal in a solution slug after the optical trigger is much 
improved.  
                
Figure 5.25 – Side on view of the updated slug triggering mechanism set-up featuring the photodiode / laser box 
with mirrors. 
                               
Figure 5.26 – CAD drawings of updated slug triggering mechanism design, above (top) and side (bottom) view. 
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5.7.2.3 Beamtime at I19 EH2 (PCMKSB) 
Experimental conditions and observations for the various PCMKSB beamtime experiments, 
together with any changes to the flow rates, concentration and experimental set-up are 
presented and discussed in detail in Section 5.7.3 for CrysAlisPro and DIALS data processing. 
Investigations into the effect of primary and secondary heterogeneous nucleation using silica 
particles and PCM form II seeds respectively on the crystallisation outcome in terms of crystal 
singularity and polymorphic outcome was investigated in the KRAIC-S. Secondary 
heterogeneous seeding was investigated through the addition of PCM form II seeds pre-loaded 
in a seeding coil and introduced into the KRAIC-S by careful dosing into the solution slugs. 
Primary heterogeneous seeding was investigated through the use of silica particles, which 
through addition to the PCM in 60:40 HI feed solution and subsequent removal of the feed inlet 
filters provided an amorphous surface to promote primary heterogeneous nucleation.  
A range of online cooling crystallisations was investigated during the beamtime, including 
unseeded and homogeneous PCM form II seeded crystallisation experiments. The experimental 
set-up, including connector geometry, along with feed concentration for each of these 
PCMKSB beamtime experiments are summarised in Table 5.16. The temperature conditions, 
flow rates and residence times for the PCMKSB experiments are summarised in Table 5.17, 
5.18 and 5.19 respectively. Importantly, for beamtime experiments PCMKSB3-5, the X-ray 
beam was focussed at 8.7 m along the length of the KRAIC-S, whereas for PCMKSB6 the X-
ray analysis point focussed at 6.7 m along the KRAIC-S. To ensure platform versatility for the 
unseeded and seeded KRAIC-S experiments during the beamtime, the experimental set-up 
illustrated in Figure 5.27 was adopted, whilst the 8.7 m and 6.7 m analysis lengths were 
accessed by threading of the excess FEP.   
PCMKSB1 
During PCMKSB1 no active beam was present. For PCMKSB1 there is a difference in total 
residence time between priming and crystallisation of 42 seconds, however the time taken for 
a solution slug to travel from the start to the end of the tubing holder is the same. This travel 
time is the most fundamental part of the residence time for the slug triggering mechanism and 
the subsequent simultaneous trigger of the motorised stage and start of data collection for a 
single crystal.  
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The slug sizes were measured to be 2 cm during priming (without temperature control and with 
an empty water bath), which reduced to 1.5 cm during crystallisation. This can be attributed to 
the application of temperature control, which leads to a change in pressure and in surface 
tension as the viscosity of the media is reduced with an increase in temperature. In addition, 
there is a change from solvent to solution when moving from system priming to a crystallisation 
run, again changing the interfacial tension. The segmentation for PCMKSB1 is extremely 
regular, which is reflected in the associated photodiode / laser read-out (Appendix 5.5).  
The use of silica particles to promote primary heterogeneous nucleation did not impact the 
regularity of single crystals in solution slugs and thus future PCMKSB experiments focussed 
on unseeded PCM in 60:40 HI experiments without additional silica non-crystalline particles.  
Between experiments PCMKSB1 and PCMKSB2 the PILATUS 2M detector was installed; the 
chiller associated with this installation led to an increase in the room temperature of EH2 from 
22.7 ℃ to 23.1 ℃. The crystallisation conditions adopted in PCMKSB1 therefore correspond 
with a supersaturation ratio of 1.6. As a result of this slight increase in temperature, a 
corresponding increase in the concentration of PCM in 60:40 HI may be required to ensure that 
crystallisation occurs along the length of the crystalliser before the X-ray beam.  
 
Figure 5.27 – Schematic of KRAIC-S used for unseeded (where the sample loop is disconnected) and seeded 
(with the sample loop) experiments with T-pieces in series configuration, featuring optimised slug triggering 




Table 5.16 – Experimental parameters including feed concentration, seed loading and experimental set-up for 
the KRAIC-S platform used for the various experimental runs in the Beamtime at EH2 I19 (PCMKSB). 


















PCMKSB1 240 1 N Unseeded, Fig. 5.4 Even bore size 
Glass X-piece (3 
mm ID) 
PCMKSB2 245 N/A N Unseeded, Fig. 
5.27 
Two T-pieces in 
series with needle 
through centre of 
first T-piece 
PCMKSB3 245 N/A N As for PCMKSB2 As for PCMKSB2 
PCMKSB4 245 N/A N As for PCMKSB2 As for PCMKSB2 
PCMKSB5 245 N/A N As for PCMKSB2 As for PCMKSB2 
PCMKSB6 247 N/A N As for PCMKSB2 As for PCMKSB2 
PCMKSB7 245 N/A Y Seeded, Fig. 5.27 As for PCMKSB2 
 
Table 5.17 – Set temperatures in the KRAIC-S platform used for the various experimental runs in the Beamtime 
on I19 (PCMKSB). *For PCMKSB4 the temperature of the water bath was reduced to 35 ℃ at 1 hour 13 
minutes into the crystallisation experiment, the bath reached 38 ℃ and 35 ℃ at 1 hour 15 minutes and 1 hour 40 
minutes respectively. For PCMKSB4 the temperature of the water bath was further reduced to 32 ℃ at 2 hours 
32 into the crystallisation run. #For PCMKSB5, the temperature of the water bath was reduced to 30 ℃ at 54 
minutes. 
Experiment Set Temperature (℃) 
Feed Jacketed Tubing Segmentation water bath  
PCMKSB1 50 60 40 
PCMKSB2 50 60 40 
PCMKSB3 50 60 40 
PCMKSB4 50 60 40 (35, 32)* 
PCMKSB5 50 60 32 (30)# 
PCMKSB6 50 60 40 







Table 5.18 – Flow rates (mL/min) used for the various experimental runs in the KRAIC-S Beamtime on I19 
(PCMKSB). 





Solution Seed suspension 
PCMKSB1 1 2.5 2.1 2.7 0.1 
PCMKSB2 1 2.5 2.1 2.7 N/A 
PCMKSB3 1 2.5 2.1 2.7 N/A 
PCMKSB4 1 2.5 6.26 2.7 N/A 
PCMKSB5 1 2.5 6.26 2.7 N/A 
PCMKSB6 1 2.5 6.26 2.7 N/A 
PCMKSB7  1 2.5 6.26 2.7 0.1 
 
Table 5.19 – Experimental residence times for various analytical set points along the length of the KRAIC-S in 
the various experimental runs in the Beamtime on I19 (PCMKSB). The various lengths along the KRAIC-S 
were calculated from the speed of the motorised stage employed in PCMKSB3 employed to directly oppose the 
net segmented flow at a rate of 6.47 mL/min and the residence times experimentally derived for PCMKSB3, 













Rung 1 1.16 1:27 1:30 1:26 1:26 
Rung 2 2.30 2:45 2:52 2:46 2:49 
Rung 3 3.44 4:03 4:13 4:07 4:13 
Rung 4 4.55 5:19 5:33 5:27 5:35 
Rung 5 5.65 6:34 6:52 6:45 6:56 
Rung 6 6.73 7:48 8:10 8:03 8:16 
Rung 7 7.82 9:02 9:28 9:21 9:36 
Photodiode / 
Laser box 
8.84 10:11 10:40 10:33 10:51 
Start of tubing 
holder (X-ray 
beam) 
8.88 10:13 10:42 10:34 10:54 
End of tubing 
holder 
8.95 10:16 10:46 10:39 10:59 
Outlet 11.1 12:47 13:29 13:20 13:38 
 
PCMKSB2  
During PCMKSB2 no active beam was present. The crystallisation conditions adopted in 
PCMKSB2 correspond with a supersaturation ratio of 1.7. PCM crystals were observed 
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towards the back of solution slugs, where some of the crystals are singular and some are 
multiple. Crystal observations started at 27 minutes 50 seconds counted sequentially 1 in 34, 1 
in 13, 1 in 30 and 1 in 5 slugs, with crystals observed at the end of rung 7. A second set of 
crystal observations was noted between 56 minutes and 1 hour 1 minute, where crystals were 
seen in 1 in 22, 1 in 12, 1 in 53, 1 in 28, 1 in 2, 1 in 4 and 1 in 51 solution slugs. Not all 
observations were of slugs containing just one crystal.  
PCMKSB3 
The input delay time for the slug triggering mechanism to consistently probe the same part of 
the solution slug was partially optimised, however some wavering in the slug positioning 
remains as a result of the speed of the photodiode output. 
In addition, a build-up of crystals occurred at the end-piece; these were retrieved for crystal 
sizing to be used as standards for comparison to the crystal growth observed at various set 
points along the length of the crystalliser. To mitigate the blockages at the end-piece, the flow 
rate of the neutral solvent pump was increased to 6.26 mL/min. 
PCMKSB4 
The higher room temperature of EH2 appeared to be affecting the nucleation rate, as only two 
crystals were visually observed over a 20 minute period. The temperature of the water bath was 
therefore reduced from 40 ℃ to 35 ℃ at 1 hour 13 minutes, reaching the set 35 °C at 1 hour 
40 minutes into the crystallisation run. A further reduction in temperature was applied to the 
water bath, where the temperature was changed to 32 ℃ at a crystallisation time of 2 hours 32 
minutes. The statistics of crystal spotting at 2 hours 50 minutes was 1 in 133, 1 in 18, 1 in 33, 
1 in 26 and 1 in 38 solution slugs.  
PCMKSB5 
To promote nucleation, the temperature of the water bath was reduced to 30 ℃ at 54 minutes 
into the crystallisation experiment, which took a further 4 minutes to reach the desired 
temperature. The temperature of EH2 was measured to be 23.9 ℃, which corresponds to a 
supersaturation ratio of 1.6.  
PCMKSB6 
To increase the number of slugs containing crystals, the concentration of the feed of PCM in 
60:40 HI was increased to 247 g/L. To prevent the solution slugs producing multiple nucleation 
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sites yielding multiple crystals, the temperature of the water bath was returned to 40 ℃. The 
first crystal was observed passing the beam at 23 minutes into the crystallisation time. The 
extent of single crystal formation remained too low, so a further increase in concentration of 
PCM was required. A post addition of 0.7502 g of PCM was made to the remaining 250 mL of 
solution to yield a concentration of 250 g/L; sufficient crystallisation was still not observed 
after 45 minutes. A further addition of 0.5017 g of PCM was made to the remaining 125 mL 
of solution, resulting in a PCM solution concentration of 254 g/L, however this did not increase 
crystallisation. Post additions are recognised as not the most accurate method for altering the 
concentration of solution, but provide a rapid means to gauge the effect of increasing the 
concentration. Once the concentration of PCM in 60:40 HI has been optimised for single crystal 
production, new solutions are made for improved accuracy of the concentration.  
PCMKSB7  
A stock of PCM form II previously made by L. Agnew152 was used to investigate seeding of 
the metastable form into the cooling crystallisation of PCM in 60:40 HI in the KRAIC-S 
installed in EH2 at I19. The PCM form II sample preparation is detailed in Agnew et al.22 
This experiment investigated the effect of PCM form II seeding on the cooling crystallisation 
of PCM in 60:40 HI in the KRAIC-S. The PCM form II seeds were suspended in carrier fluid, 
which was then loaded into the FEP coil with the use of air segmentation. The feed was 
switched from priming to the unseeded PCM in 60:40 HI solution 10 minutes before the syringe 
pump employed for the PCM form II seed coil, to ensure the concentration of the solution slugs 
had equilibrated and the PCM form II would not dissolve.  
The increase in the net segmented flow arising from the additional 100 μL/min flow rate of the 
PCM form II seeds into the KRAIC-S resulted in the motorised stage operating at a speed too 
slow to directly oppose the net flow; this was thus altered. 
For a PCM form II seeded crystallisation run (PCMKSS), the hit rate was observed to be 1 in 
30, 6 in 50, 2 in 50, 1 in 9, 1 in 39, 11 in 13, 3 in 4, 2 in 2 and 2 in 5. Although these crystal hit 




5.7.3 Data Processing of Unseeded Cooling Crystallisations of Paracetamol (PCM) in 
60:40 H2O:IPA (HI) KRAIC-S at I19 
For each type of experiment, as well as each analytical set-point along the length of the KRAIC-
S (8.7 m and 6.7 m), five sets of data were processed and analysed to be statistically relevant, 
the corresponding experiment identifier for each of the datasets are summarised in Table 5.20.  
The reflection statistics for each frame which was successfully indexed and refined within these 
datasets are summarised in Table 5.21; this information is useful for rationalising any 
significant changes in lattice parameters between frames within an experimental run. The 
reflection statistics show that the datasets analysed at 8.7 m corresponding with a crystallisation 
time of 10.7 minutes, compared to 6.7 m corresponding with 8.2 minutes crystallisation time, 
have more reflections per frame and a higher percentage of reflections involved in indexation. 
Additionally, indexation and refinement can be achieved across a greater number of adjacent 
frames at 8.7 m compared to 6.7 m along the KRAIC-S. These comparisons can be rationalised 
by crystal growth, whereby the intensity of spots is greater at 8.7 m compared to 6.7 m and 
thus manual spot finding is easier at 8.7 m.  
Table 5.20 – Experiment identifier corresponding with each of the data sets processed for the unseeded 
crystallisation runs analysed at 8.7 m and 6.7 m along the length of the KRAIC-S. 
Experiment type Distance along length 







PCM in 60:40 HI 
8.7  10.7  1 PCMKSB3 
2-3 PCMKSB4 
4-5 PCMKSB5 








Table 5.21 – Reflection statistics corresponding with each of the datasets processed for the unseeded 
crystallisation runs analysed at 8.7 m and 6.7 m along the length of the KRAIC-S. *Denotes the starting frame 
employed for unit cell finding. #Frame was indexed but not enough reflections were available for refinement. 
†Frame required unit cell finding again. **Each diffraction run corresponds with a different single crystal, where 





Frames Number of 
reflections 
% of reflections 
indexed 




3, 4, 6, 7, 8, 9†, 
11, 12†, 25, 26, 
27, 28, 29, 30†, 
31#, 32, 33, 34, 
35, 36*, 37, 38, 
39, 40, 41, 42 
18, 16, 8, 8, 8, 7, 
12, 10, 19, 6, 10, 
12, 7, 9, 3, 13, 16, 
23, 20, 25, 25, 18, 
26, 30, 17, 18 
100, 100, 100, 100, 
100, 100, 92, 100, 
100, 100, 100, 100, 
100, 100, 100, 100, 
94, 91, 100, 100, 100, 
89, 100, 90, 100, 90 
2 
(PCMKSB4) 
6*, 7, 8, 9, 10, 
11, 12, 13, 14, 
15, 17†, 18, 19, 
22†, 24, 25 
13, 9, 5, 8, 11, 8, 
12, 12, 9, 8, 9, 13, 
21, 11, 11, 7, 6 
100, 100, 80, 100, 
100, 100, 92, 100, 
100, 100, 89, 77, 100, 
91, 100, 86, 100 
3 
(PCMKSB4) 
4, 5, 6, 7, 8, 9, 
10, 11*, 12, 13, 
14, 15, 19†  
18, 9, 11, 11, 10, 
8, 12, 15, 11, 14, 
22, 14, 10 
78, 100, 100, 100, 
100, 88, 100, 100, 91, 
93, 100, 93, 100 
4 
(PCMKSB5) 
5†, 7, 9, 10, 11, 
12, 13, 14, 15, 
16, 17, 18*, 19, 
20 
6, 9, 7, 11, 8, 8, 
12, 11, 8, 11, 6, 9, 
10, 8 
100, 100, 57, 100, 
100, 50, 92, 100, 100, 
82, 100, 100, 50, 88 
5 
(PCMKSB5) 
13, 14, 15, 16, 
17, 19, 20, 21, 
22, 23, 24, 25*, 
26, 27, 28, 29, 
30, 31, 32, 33, 
34, 35, 36, 37, 
38, 39, 40 
10, 4, 8, 7, 6, 9, 9, 
14, 10, 8, 8, 14, 
19, 14, 11, 8, 11, 
16, 8, 7, 7, 13, 10, 
5, 5, 8, 6 
90, 100, 89, 100, 100, 
100, 90, 100, 100, 80, 
100, 100, 79, 100, 
100, 88, 73, 100, 88, 
100, 100, 100, 60, 
100, 80, 80, 83 




13, 14, 15, 16, 
17, 18, 19, 20, 
21*, 22, 23 
6, 20, 27, 19, 17, 
21, 20, 14, 12, 8, 7 
100, 65, 74, 74, 65, 




28, 29, 30, 31, 
32, 33*, 34, 35, 
36, 37, 38, 39, 
40, 41 
17, 17, 15, 21, 23, 
17, 11, 9, 9, 8, 7, 
8, 13, 13 
35, 35, 60, 43, 48, 71, 
64, 67, 78, 100, 86, 
75, 100, 69 
3 
(PCMKSB6) 
27, 28, 29, 30*, 
31, 32, 33, 34, 35 
11, 12, 17, 15, 11, 
24, 9, 14, 6 
45, 50, 65, 87, 91, 63, 
67, 71, 83 
4 
(PCMKSB6) 
20*, 21, 22, 23, 
24, 25, 26, 27, 
28, 29, 30, 31, 
32, 33, 34, 35, 36 
11, 14, 15, 14, 13, 
19, 12, 9, 14, 19, 
18, 14, 7, 9, 7, 6, 6 
82, 64, 47, 57, 38, 53, 
67, 67, 57, 68, 39, 36, 
71, 56, 57, 67, 83 
5 
(PCMKSB6) 
35*, 36 9, 5 89, 100 
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5.7.3.1 Monitoring later stage crystallisation using CrysAlisPro: 8.7 m along crystalliser 
length, crystallisation time of 10.7 minutes 
Optimally the unit cell dimensions are fixed during the calculation of the rotation angles due 
to the very low data to parameter ratio (which can be as low as 1:1 for some frames; e.g. set 4, 
frame 9, which shows a large variance (Figure 5.28)). However, CrysAlisPro does not allow  
the unit cell dimensions to be fixed when refining rotation angles. The a-axis is shown to drift 
over time (Figure 5.28; the variance of the other unit cell parameters with time is presented in 
Appendix 5.6). This variance in unit cell parameters over time may be attributed to changes in 
the sample-detector distance as a single crystal rotates in a solution slug (± 1.59 mm).  
Monitoring R1, R2 and R3 with respect to the instrument over time, allows the extent of single 
crystal rotation to be considered independently along three different 1-dimensional planes. The 
rotations of the single crystal analysed in set 5 at 8.7 m are presented in Appendix 5.6. These 
show that the rotation behaviour tends to be random.  
5.7.3.2 Monitoring earlier stage crystallisation using CrysAlisPro: 6.7 m along crystalliser 
length, crystallisation time of 8.2 minutes 
The same analysis approach using CrysAlisPro was also carried out on five datasets from 
diffraction scans acquired at 6.7 m along the length of the KRAIC-S. Again the a-axis across 
each of the frames showed variance over time, but in this case the a-axis parameter was 
consistently underestimated with respect to the 7.09 Å axis for PCM form I (HXACAN30) in 
the CSD (Figure 5.29). This can be attributed to the reduction in the number of reflections and 
reflection intensity at this earlier stage in the crystallisation process.  
The R1, R2, and R3 lattice rotations of the single crystal analysed in set 5 at 6.7 m (Appendix  
5.7) again show essentially random variations, which appear to be systematically smaller than 
for the 8.7 m position. If confirmed in further experiment such a reduction in tumbling rotation 
would affect the capability to gain indexing in the KRAIC-S.  However, it must be noted that 





Figure 5.28 – a-axis lattice parameter over time for each of the five datasets at 8.7 m compared to the 
magnitude of the a-axis for PCM form I obtained from the CSD. 
 
Figure 5.29 – a-axis lattice parameter over time for each of the five datasets at 6.7 m compared to the 
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204 
 
5.7.3.3 Comparison of Lattice Rotations at earlier and later stage crystallisation (6.7 m 
and 8.7 m crystalliser lengths) 
Data acquisition at the different set points (6.7 m and 8.7 m) allows the extent of crystal growth, 
as well as the degree of lattice rotations with crystal size to be understood. Table 5.22 shows 
that the number of reflections and percentage of these reflections utilised in cell indexation 
increases with crystalliser length, as a single crystal grows between these two set points.  
Table 5.22 – Reflection statistics of the indexed spots obtained from manual spot finding of adjacent frames in 
CrysAlisPro, corresponding with each of the datasets for the unseeded crystallisation runs analysed at 8.7 m and 
6.7 m along the length of the KRAIC-S. 
Crystalliser length /m Dataset 
(Experiment Identifier) 
# Reflections % Indexed 
8.7 1 (PCMKSB3) 384 96 
2 (PCMKSB4) 173 93 
3 (PCMKSB4) 165 94 
4 (PCMKSB5) 124 85 
5 (PCMKSB5) 255 95 
6.7 1 (PCMKSB6) 171 88 
2 (PCMKSB6) 188 67 
3 (PCMKSB6) 119 69 
4 (PCMKSB6) 207 59 
5 (PCMKSB6) 14 95 
As the PCM form I single crystal grows between 6.7 m and 8.7 m along the KRAIC-S, 
corresponding with 8.2 minutes and 10.7 minutes into the crystallisation process, the crystal 
rotates to a greater degree (Figures 5.30-5.32). This finding of an increase in the degree of 
crystal rotation with increasing crystal size can be attributed to differences in the interaction of 
the single crystal with the turbulent flow and may be of relevance in future experiment design.   
 




Figure 5.31 – R2 rotation with respect to the instrument over time as the crystal grows between 6.7 m and 
8.7 m. 
 
Figure 5.32 – R3 rotation with respect to the instrument over time as the crystal grows between 6.7 m and 
8.7 m. 
5.7.3.4 DIALS Processing Results 
All data processing attempts from the various crystallisation runs were carried out manually 
using CrysAlisPro; the same analysis was also investigated via automated processing 
methodologies.  
The DIALS automated processing was only carried out on data collected from the unseeded 
cooling crystallisation of paracetamol in 60:40 HI beamtime experiments (PCMKSB); five 
datasets were collected for both 8.7 m and 6.7 m crystalliser lengths along the KRAIC-S 
platform. Three of the ten datasets completed the entire DIALS data processing procedure, 
using the automated routine, two of the datasets failed at all stages and the remainder achieved 
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partial completion of the various data processing steps (Table 5.23). After initial spot finding, 
> 90 % indexation of the diffraction spots was achieved (Table 5.24), similar to the indexation 
achieved via CrysAlisPro processing (Table 5.22).  
The DIALS data processing progress across the various datasets would proceed through the 
entirety of the process if the best processing routines for each of the algorithms were 
established. Merging of neighbouring datasets would also likely achieve a high success rate for 
completion of the DIALS process.  
Table 5.23 – DIALS data processing progress for each of the ten datasets as those analysed in CryAlisPro at 
both 8.7 m and 6.7 m crystalliser length scale. Green denotes that the data processing stage was successfully 





Indexation Refinement Integration Merging 
8.7  1 PCMKSB3     
2 PCMKSB4     
3     
4 PCMKSB5     
5     
6.7 1 PCMKSB6     
2     
3     
4     
5     
 
Table 5.24 – Reflection statistics of the indexed spots obtained from spot finding, corresponding with each of 
the datasets processed using DIALS for the unseeded crystallisation runs analysed at 8.7 m and 6.7 m along the 
length of the KRAIC-S. 
Crystalliser length /m Dataset # Indexed # Unindexed % Indexed 
8.7 1 323 5 98.5 
2 224 0 100 
3 164 2 98.8 
4 135 3 97.8 
5 153 0 100 
6.7 1 133 11 92.4 
4 103 4 96.3 
5 107 10 91.5 
Monitoring the spot count over each of the diffraction frames in a dataset allows for the 
behaviour of the single crystal within a solution slug with respect to the X-ray beam to be 
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monitored. The single crystals monitored in the various datasets are generally shown to move 
in and out of the X-ray beam (Figure 5.33).  In addition to monitoring the movement of the 
single crystal moving in and out of the X-ray beam through the spot count over the various 
frames, visual observations provide additional evidence of this behaviour.  
The video capturing the motorised stage artificially suspend the single crystal in the X-ray 
beam during data collection also shows single crystal movement in and out of the beam in the 
ESI detailed in Appendix 5.8 (20190726_1928_0010_Unseeded PCM_8_7m_Set 4_Video). 
The movement of the single crystal analysed in dataset 5 at 6.7 m is also captured by visual 
observations in the ESI detailed in Appendix 5.8 (20190728_1614_0001_Unseeded 
PCM_6_7m_Set 5 Video).  From the various observations, the correlation between crystals 
moving in and out of the beam and successful indexing was not established at this point. 
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Figure 5.33 – Varying movement of a single crystal in the X-ray beam: Crystal moving in and out of beam for 
dataset 1 at 8.7 m (top), crystal starts in beam and moves out of beam dataset 4 at 8.7 m (middle) and crystal 
remains in beam dataset 5 at 6.7 m (bottom). 
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In contrast to the lattice rotations extracted from CrysAlisPro, which showed increased rotation 
at the later stage in the crystallisation process (8.7 m, 10.7 minutes crystallisation time), 
suggesting that crystal rotation increases with crystal size, DIALS processing suggested the 
opposite finding (Figure 5.34).  
 
Figure 5.34 – Scan-varying orientation parameters for dataset 5 at 6.7 m and dataset 1 at 8.7 m, elucidating the 
relationship between the extent of crystal growth with lattice rotation using DIALS. 
The difference in the extent of lattice rotation with crystal size suggested from the data 
processing methods of CrysAlisPro and DIALS can be attributed to differences in the various 
stages of the processing procedures, notably the automated spot finding in DIALS and the fact 
that DIALS processing is not dependent on successive frames all being indexed successfully. 
In addition, the unit cell parameters are fixed and input into the processing for DIALS, whilst 
CrysAlisPro the unit cell parameters are not input nor fixed during refinement. The lattice 
rotations across the run are acquired after the refinement stage. 
To establish how the single crystal will tend to rotate in 3-dimensional dynamics, the sample’s 
angular displacement from its original orientation rather than along the displacement axis 
direction can be considered (Figure 5.35). The overall sample tumbling angle with frame 
number as the crystal grows, shows a reduction in rotation, similar to the finding in 1-




Figure 5.35 – Sample tumbling angle versus frame number for dataset 5 at 6.7 m and dataset 1 at 8.7 m, 
elucidating the relationship between the extent of crystal growth with overall lattice rotation using DIALS 
[combined rotration calculations courtesy of a Python script provided by Dr Ben Williams, DLS]. 
The merging statistics I/σ of 14 for dataset 1 at 8.7 m is of the magnitude required for standard 
collection datasets, typically of 15 (Table 5.25). Given the nature of the data collection strategy 
using the slug triggering mechanism, the completeness of a slug dataset was expected to be 
low, whilst dataset 1 at 6.7 m shows a reasonable completeness of 7 % considering the nature 
of the data collection. This completeness corresponds with one single crystal artificially 
suspended in the X-ray beam for 4.4 seconds and therefore it can be postulated that ~20 of 
these datasets would be required for full structure solution. 
Table 5.25 – Merging statistics for dataset 1 at 8.7 m and dataset 5 at 6.7 m, that achieved the full DIALS 
processing procedure including the successful completion of the merging algorithm. 
Merging Statistics Dataset 1 at 8.7 m  Dataset 5 at 6.7 m 
Resolution 2.86 – 0.54 5.33 – 0.54 
Observations 285 742 
Unique reflections 114 383 
Redundancy 2.5 1.9 
Completeness (%) 2.01 7.09 
Mean intensity 36219.1 1970.0 
Mean I/sigma(I) 14.1 1.8 
R-merge 0.121 0.172 




5.7.4 Data Processing of Seeded PCM form II Cooling Crystallisation of Paracetamol 
(PCM) in 60:40 H2O:IPA (HI) KRAIC-S (PCMKSS) at I19 using CrysAlisPro 
For the PCM form II seeded experiments (PCMKSS), only four yielded diffraction suitable for 
indexation and only three of those identified PCM form II, whilst the other identified PCM 
form I. Each of these four sets were obtained from experiment PCMKSB7 (Table 5.26). 
After indexation of the starting frame, none of the adjacent frames on any of the three sets from 
which PCM form II was positively identified could be either re-indexed from the current unit 
cell or indexed by manually inputting the PCM form II unit cell parameters. Furthermore, the 
adjacent frames to the starting frames selected for initial unit cell finding seldom contained 
diffraction on the 2D image. This indicates that the PCM form II crystals are moving in and 
out of the X-ray beam analysis region and thus it could be rationalised that the extent of crystal 
rotation for the PCM form II is much greater than the rotation found for the PCM form I single 
crystals; this may be a crystal morphology effect. This is further supported by visual 
observations (ESI in Appendix 5.8: 20190727_2355_0010_Seeded PCM form II_Set 2_Get 
Form II_Video).  As the extent of rotation is so significant and moves beyond the X-ray 
analysis area, it is not possible to quantify the single crystal rotation of the PCM form II single 
crystals.  
The fact that PCM form II was not produced in all seeded runs indicates that the PCM form II 
seed dosing efficiency could be improved. In addition, some of the datasets yielded multiple 
crystals in a single solution slug; therefore, the concentration of the seed could be reduced.  
Table 5.26 – Reflection statistics corresponding with each of the datasets processed for the PCM form II seeded 
crystallisation runs in the KRAIC-S. *Denotes the starting frame employed for unit cell finding. 
Set Frames Number of 
reflections 
% of reflections 
indexed 
Polymorph of single 
crystal 
1 3* 31 68 PCM form II 
2 2* 11 100 PCM form II 
3 3* 15 87 PCM form II 
4 3* 6 100 PCM form I  
 
5.7.5 Crystal Sizing and Crystal Growth at various set-points 
This work assesses whether it is possible to extract crystal size of single crystals grown in situ 
in the KRAIC-S, using a range of crystals of known size through the average intensity from a 
range of reflections manually integrated in CrysAlisPro. The assessment of crystal size would 
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ideally be carried out by merging fully processed and integrated data of the slug datasets 
compared to a range of standard datasets of suitable relative crystal sizes; however, these data 
are not generally available for the former.  
The success of this crystal size prediction is reliant on many variables, including the intensity 
of individual reflections, which will be dependent on the crystal morphology. The morphology 
of single crystals grown under plug flow conditions in the KRAIC-S will differ from the batch 
of PCM used for crystal sizing standards. During data collection, depending on the position, 
orientation and morphology of a single crystal in a solution slug relative to the X-ray beam, it 
is possible that the beam will only partially hit the single crystal, which impacts the observed 
intensity of certain reflections. Furthermore, it is possible that only part of the rocking curve 
may be obtained for a reflection from a single crystal in a solution slug. This also relates to the 
extent of rotation of the single crystal in the solution slug. It would also not generally be 
possible to apply scaling of data from a single image for the single crystals grown in situ, whilst 
scaling will have been applied to the standard single crystal data collections. 
Importantly, it is not possible to monitor crystal growth of the same single crystal in a solution 
slug at the various set points, but as the KRAIC-S is operating under steady state conditions, 
this analysis may provide a reasonable approximation for the size of the single crystals grown 
in situ in the KRAIC-S crystalliser. The growth profile of the crystallisations is not known 
under these conditions; fitting a linear trendline assumes a linear crystal growth mechanism, 
but an exponential crystal growth mechanism could be equally valid.  
The sizes of the single crystals analysed for the standard datasets 1 and 2 (Table 5.27) were 
measured on an optical microscope to yield a benchmark for comparison to those grown in situ 
in solution slugs in the KRAIC-S. Assuming that size measurements of the larger single crystal 
corresponding with dataset 1 are more accurate than the small single crystal corresponding with 
dataset 2, dataset 1 was therefore used as the basis for scaling. The scaling ratio determined for 
standard datasets 1 and 2 of 4.74:1 is in good agreement with manual spot integration in 





Table 5.27 – Crystal sizing parameters of standard datasets 1 and 2.  
Crystal sizing parameter  Standard dataset 1 Standard dataset 2 
Measured crystal dimensions /μm 150 x 120 x 20 90 x 50 x 20 
Measured crystal volume / μm3 360 000 90 000 
Ratio from scaling and merging datasets 
1 and 2 in XPrep 
4.7492 1 
Predicted crystal dimensions /μm 360 000 75 802 
 
Table 5.28 – Integrated intensity values for the complete rocking curve across six hkl reflection sets for standard 
datasets 1 and 2.  
Reflection 
set 
hkl Standard dataset 1 
(Rocking curve) 
Standard dataset 2 
(Rocking curve) 
Scale          
(Rocking curve) 
1 0 1 -8 2929.75 377.75 7.76 
2 -3 -2 -8 1659.25 322.5 5.14 
3 4 3 -8 856 162.25 5.28 
4 4 3 -9 1739.75 378.75 4.59 
5 6 1 3 417.25 78 5.35 
6 -5 -5 -5 396.25 71 5.58 
 Average = 5.62 
The crystal size prediction of single crystals crystallised in solution slugs in the KRAIC-S from 
standard single crystal datasets is slightly flawed as a result of the single crystals tumbling in 
and out of the X-ray beam, leading to inaccuracies in the observed intensity of reflections, and 
the assumption of a spherical crystal. The crystal size predictions could be improved by 
significantly increased sampling over a greater number of reflection sets, starting frames and 
standard datasets, whilst also comparing the growth results with the spot count statistics across 
the dataset. This increased sampling is not feasible using the manual crystal growth processing 
method used here; an automated crystal growth processing procedure would need to be outlined 
and optimised. Additionally, the size of the X-ray beam could be increased to immerse a 
solution slug, allowing for the single crystal to be continually monitored by the X-ray beam, 
however, additional background subtraction to remove the scattering from the 60:40 HI solvent 
in the solution slugs would also be required.  
The crystal growth mechanism of the unseeded cooling crystallisation of paracetamol in 60:40 
HI under these conditions is not known. Increasing the number of analytical set points could 
allow the crystal growth mechanism to be determined. Although the KRAIC-S operates under 
steady-state conditions, late nucleating crystals along the length of the KRAIC-S will be at an 
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earlier stage of the crystal growth process compared to earlier nucleating crystals monitored at 
the same set point. This would clearly affect estimates of crystal growth. 
5.8 Overall Discussions and Conclusions 
Data Processing Conclusions 
CrysAlisPro provided a useful start point for indexing and refining the in situ single crystal 
XRD data to obtain information on the polymorph crystallised through cell indexation of a 
single diffraction frame. Lattice indexation and refinement on adjacent frames to the starting 
frame chosen for cell indexation allowed for lattice rotations to be monitored over time. 
CrysAlisPro allowed for the number of useful reflections per diffraction frame to be realised. 
The key drawback to the use of CrysAlisPro is that the manual nature of the processing means 
that this data processing procedure is significantly time consuming, meaning that rapid data 
processing in parallel to beamtime experiments, which could potentially prompt alterations to 
experimental set-up and conditions, is not feasible. Furthermore, the unit cell parameters cannot 
be fixed and will shift after refinement; this greatly increases the number of variables and 
results in a poor data to parameter ratio. CrysAlisPro can only be employed for the single 
crystal data processing steps of indexation and refinement; it is not possible to carry out 
integration required for structural solution. 
DIALS has the capability to mitigate against these key drawbacks highlighted in CrysAlisPro, 
whereby the data processing procedure can be fully automated, facilitating data checks during 
beamtime experiments and also allows a wealth of data to be processed in relatively minimal 
time on a timeframe of minutes. The use of DIALS was thus investigated and developed 
significantly during the project, in collaboration with Dr Mark Warren (Diamond Light 
Source). The unit cell can also be fixed in DIALS, greatly reducing the number of variables 
and thus improving the data to parameter ratio, which is particularly important in these single 
diffraction frame methods via this serial crystallography-like approach.  
In contrast to CrysAlisPro, DIALS can carry out integration and image merging towards 
structural solution. Importantly, employing DIALS in this ‘proof-of-concept’ study allows the 
number of single crystals that need to be analysed to allow novel structure solution to be 
quantified, which is a fundamental question to be answered when selecting other crystallising 
systems in the future. The five datasets for each experimental condition investigated in this 
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study only resulted in a DIALS merging of one of the datasets, thus the merging of these 
integrated datasets for structural solution was not possible as a result of insufficient sampling. 
However, on the premise that the merged datasets at 8.7 m and 6.7 m achieved a completeness 
of 2 % and 7 % respectively, it would be expected that structural solution could be achieved 
from 20-50 of these datasets to sample the entire sphere, although due to symmetry of the 
lattice, this number of datasets could be reduced, whilst still achieving structural solution.  Data 
capture utilises a continuous sweep of the X-ray beam, with the single crystal residing in the 
beam for 4 seconds, followed by data analysis using the automated DIALS processing 
procedure with a corresponding data analysis time of ~3-4 minutes; this results in a data capture 
and analysis time of only 5 minutes required for each dataset.  
Experimental Set-up Conclusions  
The KRAIC-S crystalliser, which employs segmented flow to yield solution slugs with an 
identical and highly reproducible crystallisation environment, is a suitable platform to carry 
out serial-crystallography type experiments. The accessible flow rates are compatible with the 
motorised stage translations to artificially ‘‘hold / suspend’’ a single crystal in the X-ray beam 
for sufficient diffraction data to be acquired for indexation. The slug triggering mechanism has 
been optimised into a single optical trigger and analysis unit, which greatly reduces the 
downtime between data acquisitions from 44 seconds to 2 seconds, but also improves the 
accuracy in the slug triggering tracking the current part of the solution slug, while maintaining 
equal but opposing speed of the motorised stage. This led to great improvements in the 
successful hit rate of single crystals by the X-ray beam, with the likelihood of obtaining data 
increased by a factor of 10 (to 1 in 20 stage translations) in the new design. 
The cooling crystallisation process for PCM in 60:40 HI has been optimised to yield a single 
crystal within solution slugs. The crystallisation process is largely impacted by small 
fluctuations in temperature and therefore careful temperature control and maintenance 
mitigated this variability in the extent of crystallisation observed.  
The seeding delivery system for PCM form II seeds into the cooling crystallisation of PCM in 
60:40 HI in the KRAIC-S has been designed and optimised. Three diffraction runs were shown 
to yield PCM form II single crystals, whilst PCM form I was evident in a fourth run, indicating 
that the efficiency of seed dosing could be optimised further.  
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Future Work  
Although the use of FEP tubing throughout the entirety of the KRAIC-S, including the 
analytical set point where the X-ray beam is focussed successfully mitigated against blockages, 
the FEP tubing contributed significantly to the background of the diffraction data. Therefore, 
future KRAIC-S experiments on I19 may employ an X-ray transparent hydrophobically coated 
Kapton® window similar to those employed in the KRAIC-D presented in Chapter 4.  An 
alternative material to Kapton® would be Mylar®. Provided Mylar® can be prepared by 
extrusion, this is a more robust material and is colourless, allowing improved clarity of visual 
observations of single crystals in solution slugs. In addition, replacing the FEP with a material, 
which is transparent to X-rays will ensure that the tubing will not give rise to undue background 
in the diffraction patterns that would mask weak high resolution signals. 
The main source of blockages in the KRAIC-S results from crystallisation of the PCM in 60:40 
HI feed in the inlet / outlet of the SF-10 pump or inside the solution pump. To mitigate these 
sources of blockages, the use of positive displacement liquid transfer via Mass Flow 
Controllers (MFCs), which uses the transfer of pressure to accurately transfer media from the 
feed, is an alternative strategy to deliver the segmented flow through the KRAIC-S crystalliser.  
The work presented on PCM in 60:40 HI in this chapter demonstrates the potential of the 
technique in terms of data collection and the associated information obtained from the data 
processing for other systems in the future. The serial-crystallography approach to data capture 
will be employed for the analysis of X-ray and photosensitive samples.  
The use of the slug triggering mechanism can also be employed during data collection at I11 
for future KRAIC-D experiments, which will greatly reduce the significant background 
subtraction previously employed in the continuous collect strategy, whilst also increasing the 
hit rate. The slug triggering can be used in future to avoid collecting unnecessary data at I11 
with the KRAIC-D, such as background frames of the air slugs and the carrier fluid, thus 
removing time-consuming post-data collection analysis and allowing quick interpretation of 




Chapter 6 – Crystal Engineering for Materials Discovery: Co-
crystals in the Profen family 
6.1 Introduction and Aims of Research 
The Biopharmaceutics Classification System (BCS) is a scientific framework to categorise 
drug substances based upon their aqueous solubility and intestinal permeability. According to 
the BCS, drug substances can be categorised in terms of permeability and solubility: high 
permeability / high solubility (BCS I), high permeability / low solubility (BCS II), low 
permeability / high solubility (BCS III) and low permeability / low solubility (BCS IV).14, 26  
The use of crystal engineering for materials discovery, to improve physicochemical properties 
of a drug through co-crystallisation of the API with a benign co-former, can provide a means 
of improving drug solubility as well as stability.160 
Many APIs can be susceptible to polymorphic transformations, sensitive to moisture and 
exhibit the potential for solvent loss, whilst under the influence of raised temperature 
conditions.52, 161, 162 This causes problems in hot climates where shelf life (also known as 
expiration dating period) of pharmaceuticals is reduced when an instability to heat is evident; 
this can result in the need for APIs requiring refrigerated storage, which is not always 
convenient for patients. The stability testing to ascertain an appropriate shelf-life should be 
suitably chosen to cover storage, shipment, and subsequent use of the pharmaceutical product.  
Similarly, APIs can be susceptible to polymorphic transformations, as well as solvate 
formation, whilst under the influence of relatively mild humidity conditions. This instability to 
humidity can cause problems particularly when drug products are stored in humid countries 
before being administered, but also in early stages of the pharmaceutical supply chain, in drug 
production and transportation. The use of co-crystal formation can improve drug resistance to 
humidity changes, compared to the API alone, eliminating these undesirable phase 
transformations from occurring.161, 162  
In addition to the discovery of new API-containing multi-component materials, with the target 
of optimising physical properties, the work presented in this chapter encompasses property 
determination and transfer of the process between different crystallisation methods for the 
production of these materials, offering an increased scale of production in preparation for 
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potential continuous flow crystallisation. These methods include evaporative, cooling, 
mechanochemical, slurrying and flow crystallisation (the last of these for one complex, IBU-
ISO, only). These aspects are important in the context of the crystallisation basis of the overall 
project, whereby using these standard crystallisation techniques in batch allows for the 
discovery of novel materials. Some of these materials have the potential to be investigated in 
the novel KRAIC-D and KRAIC-S platforms coupled with the corresponding advanced data 
processing procedures presented in Chapter 4 and Chapter 5 respectively, driving capabilities 
towards novel materials crystallised in novel crystallisation platforms. 
In order for the co-crystallisation of pharmaceutical co-crystals to be compatible with the safety 
and environmental requirements adopted in the pharmaceutical industry, where crystallisations 
are carried out in batch at scale, or via continuous production methods, careful selection of 
solvent is required. A solvent mixture of 60:40 water:isopropanol H2O:IPA (v/v) is compliant 
with GRAS (Generally Regarded as Safe) Food and Drug Administration (FDA) classification, 
for deployment in industrial pharmaceutical processes and thus is a suitable solvent choice for 
batch scale-up and continuous crystallisation development. Co-crystallisation using a solvent 
mixture of 60:40 H2O:IPA (60:40 HI) was investigated for a range of candidate co-crystal 
systems via evaporative, mechanochemical, slurrying and cooling methods, initially focused 
on batch scale-up towards continuous crystallisations. The use of 60:40 HI is an appropriate 
solvent choice as co-crystallisation can be achieved in pure IPA; although the pure APIs 
examined exhibit poor aqueous solubility, an aqueous solvent mixture offers the ability to 
achieve co-crystallisation whilst maintaining pharmaceutical compliance.  
2-arylpropionic acid derivatives, also known as the profen family, are a sub-class of non-
steroidal anti-inflammatory drugs (NSAIDs), comprising flurbiprofen, ibuprofen, ketoprofen, 
naproxen, tiaprofenic acid and oxaprozin. This work focuses on four of the profens: 
flurbiprofen (FLU), ibuprofen (IBU), ketoprofen (KETO) and oxaprozin (OXA) (Figure 6.1) 
all classified as BCS Class II, with poor solubility and high permeability, which impacts 
dissolution of the drug product, as well as the rate and extent of absorption of the solid oral 
dosage form.26 Exploring co-crystal formation for these profens could help improve the 
inherent poor solubility of these targets, which have aqueous solubilities of 0.0105 mg/mL, 
0.120 mg/mL, 0.0325 mg/mL and 0.184 mg/mL at room temperature for FLU,163, 164 IBU,165 
OXA,166 KETO,167 respectively. Potential enhancements in physical properties of these target 
materials using a variety of API:co-former systems in various solvents at various temperature 
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regimes are explored. Investigations initially include evaporative crystallisations which are 
then translated into further crystallisation methods, including mechanochemical, slurrying and 
cooling, with a variety of API:co-former ratios in order to obtain significant coverage of the 
design space. 
 
Figure 6.1 – Chemical structures of the target materials from the profen family. 
A Cambridge Structural Database (CSD) search carried out of the four profen targets (Table 
6.1) found that IBU exhibits two polymorphic forms each adopting the P21/c space group, but 
featuring different lattice parameters. IBU form II (CSD refcode IBPRAC04) was accessed by 
Derollez et al. via annealing of the quenched IBU at 258 K and thus as this polymorph is not 
accessed under ambient conditions, this form is not expected nor considered in this study.168 
FLU features three polymorphic forms (FLU form I, II and III) and a hydrate form under 
ambient conditions whereas neither KETO nor OXA exhibit polymorphism. Whilst the profen 
targets of interest, with the exception of OXA, contain both enantiomeric forms, this work will 
primarily focus on the racemic form. Published examples of the profen family targets co-
crystals typically feature pyridine rings or nitrogen-based substituents on benzene rings (Table 
6.2 and Figure 6.2). There are no reported co-crystals of KETO currently in the CSD.33 
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Table 6.1 – CSD Refcodes for the four profen targets. 
Profen Target CSD Refcode  
rs-Ibuprofen (IBU) IBPRAC 
rs-Flurbiprofen (FLU) FLUBIP 
rs-Ketoprofen (KETO) KEMRUP 
Oxaprozin (OXA) OJURAO 
 
Table 6.2 – CSD Refcodes for the existing co-crystals of the four profen targets. 






HUPPEN - OJUQOB 
1,2-bis(4-pyridyl)ethane OWIGEH - - OJUQAN 
Trans-1,2-bis(4-pyridyl)ethylene - HUPPIR - - 
Nicotinamide SODDIZ QOBGAR - - 
D/L-Proline - VEVMOB/ 
VEVMUH 
- - 
2-aminopyrimidine TAWSOB - - - 
 
 
Figure 6.2 – Chemical structures of the co-former molecules involved in co-crystal formation with the four 
profen family targets. 
On the basis of this CSD search, co-former molecules with nitrogen functionalities were 
selected, due to their proven ability in co-crystal formation with the profen family. Additionally 
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some GRAS molecules were selected, on the premise these molecules contained either a 
nitrogen or an oxygen functionality, such as a carboxylic acid or hydroxyl group, which have 
the potential to facilitate hydrogen bond formation. As GRAS molecules are considered 
pharmaceutically acceptable, incorporation of GRAS molecules in crystal engineering studies 
offers the potential to discover a novel pharmaceutical co-crystals, with the opportunity to be 
marketed as a drug product.169 The chemical structures of the co-former molecules selected are 
shown in Figure 6.3. 
6.2 Materials and Methods 
IBU, FLU, OXA and KETO were purchased from TCI UK Ltd (Oxford, UK). All co-former 
molecules and laboratory grade solvents were purchased from Sigma Aldrich Chemie Gmbh 
(Steinheim, Germany). All reagents were used without further purification. The matrix of 
conditions for this profen family materials discovery screen, comprised four targets, fifteen co-
formers, three solvents and five temperature regimes (Table 6.3).  
Powder X-ray Diffraction (PXRD) and Differential Scanning Calorimetry (DSC) were initially 
used to screen all samples for the formation of a novel co-crystal(s). This led to the 
identification of three new co-crystals: IBU-ISO, OXA-ISO and OXA-IMID, which were 
structurally characterised using Single Crystal X-ray Diffraction (SCXRD) after single crystals 
of suitable quality were obtained through evaporative crystallisation methods. It should be 
noted that while IBU-ISO was discovered by the author in 2017, Walsh et al.170 published the 
crystallisation of IBU-ISO in 2018 by a different crystallisation methodology and determined 
the X-ray crystal structure (CSD Refcode KIPPAD). The Walsh et al. study compares spray 











Table 6.3 – Matrix of conditions to be investigated for the materials discovery of the profen family *Classified 
as GRAS by the Select Committee on GRAS substances (SCOGS). 
6.2.1 Evaporative Crystallisation for Co-crystal Screening 
 Small-scale evaporative crystallisations were prepared in 7 mL vials. The four profen family 
targets were combined in a 1:1 molar ratio with the co-former, using a consistent mass of 20 mg 
of the target. The API and co-former components were dissolved in minimal solvent 
(approximately 1-2 mL) at room temperature, with the use of sonication to aid dissolution of 
the materials. Once materials had fully dissolved, the lids were then punctured with four holes 
and left at the various temperature regimes detailed in Table 6.3, without the use of stirring, to 
allow for slow evaporation of the solvent (Figure 6.4).   
API Co-former Ratio Solvent Temp /°C 
IBU Urea* 1:1 Ethanol (EtOH) 4 
FLU Oxalic acid  1:2 Isopropanol (IPA) 18 
OXA Succinic acid   Acetone (ACE) 30 



























Figure 6.4 – Welled DrySyn forms fitted on hot-plates for crystallisation via evaporation of the solvent at 
elevated temperatures of 30, 40 and 50 ᵒC. 
6.2.2 Mechanochemical Crystallisation 
The co-crystals resulting from the evaporative screens were translated into both neat grinding 
(NG) and Liquid Assisted Grinding (LAG) methods using the same solvents as those in the 
evaporative screening, to investigate whether the use of mechanical energy could also favour 
the co-crystal formation achieved via evaporative crystallisation. The grinding was carried out 
in the same 1:1 molar ratio, by hand using a mortar and pestle, initially for 5 minutes and 
subsequently for 30 minutes. For the LAG, 3-4 drops of solvent were incorporated with the 
solid materials.  
6.2.3 Slurrying Crystallisation 
Solution Mediated Phase Transformations (SMPTs) can be investigated via slurrying 
crystallisation. This method of crystallisation is a suspension technique, whereby an excess of 
solid is added to solvent and stirred for a period of time without solid dissolution. This method 
can be used to investigate the effect of solution phases within a crystallisation process. The 
polymorph obtained from slurrying crystallisations can be tuned by varying experimental 
parameters such as slurrying time, stirring rate, temperature, solid loading and scale of 
operation.8 All co-crystals obtained through evaporative crystallisation were translated into 
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slurrying techniques, which in addition to allowing novel polymorph identification, or 
providing a way to establish the thermodynamic form from concomitant polymorphs with 
similar Gibbs Free energies, can be used to screen for novel multi-component materials.  
6.2.4 Cooling Crystallisation  
All co-crystals resulting from the evaporative screening were also produced via controlled 
batch cooling crystallisations initially at 1 mL scale with a range of concentrations, progressing 
towards batch cooling crystallisations up to the 200 mL scale. After dissolution, the solution 
was subjected to a linear cooling regime with magnetic bottom stirring using the Cambridge 
Reactor Design (CRD) Polar Bear Plus crystalliser (Figure 6.5). The cooling rates investigated 
were increased from 0.05 to 1 ℃ min-1 (Appendix 6.1) over subsequent cooling crystallisations, 
towards the cooling rates adopted in industry. Translation of the batch cooling crystallisations 
to continuous flow crystallisations in the KRAIC / KRAIC-D platforms was established and 
optimised for IBU-ISO.  
 
Figure 6.5 – Cambridge Reactor Design (CRD) Polar Bear Plus crystalliser for temperature controlled batch 
cooling crystallisations. 
6.2.4.1 Solubility Measurements 
To access the co-crystals via cooling, an understanding of the solubility behaviour of the 
various materials was required. Solubility studies were carried out on a physical mixture of the 
two starting components in a mixed solvent system of 60:40 (v/v) water:isopropanol (H2O:IPA, 
HI) for each of the three profen family co-crystals using turbidity measurements in the 
Technobis Crystal16 at small (1 mL) scale initially.  
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The solubility of the physical mixture of IBU and ISO showed interesting ‘oiling out’ 
behaviour, which led to further investigation in the Technobis Crystalline at 5 mL scale, with 
in-line Particle Visualisation Measurement (PVM). Laser-based turbidity measurements and 
images are collected in parallel, allowing for improved accuracy compared to turbidity 
measurements alone.  Both Crystal16 and Crystalline turbidity measurements were carried out 
at the University of Strathclyde, Glasgow.  
6.2.5 Stability Testing  
6.2.5.1 Thermal Stability 
Samples of the three co-crystals and their IBU and OXA starting API targets, prepared by LAG 
in 60:40 HI for 30 minutes, were stored under moderate heat of 45 ℃, within a temperature 
controlled oven. The samples were subjected to thermal ageing and monitored over the course 
of a month. Sampling occurred each week via PXRD using the STOE STADI powder X-ray 
diffractometer and DSC. 
6.2.5.2 Humidity Stability 
The co-crystals were prepared for humidity storage by both mechanochemical methods using 
LAG for 5 minutes and slurrying techniques for 24 hours at 10 mL scale. Products of both of 
the crystallisation methods were investigated under moderate (20 ℃ and 46 % relative 
humidity (RH)) humidity conditions using a salt solution171 over a 40 day period and analysed 
at various time intervals. In addition, the mechanochemical samples were also put under severe 
(45 ℃ and 80 % RH) humidity conditions using a controlled oven to ascertain the impact of 
this additional stress on the co-crystal.  
Moderate humidity testing used a sealed plastic container filled with approximately 400 g 
potassium carbonate mixed with approximately 10 mL of deionised water. A humidity sensor 
was suspended on a plastic shelf within the sealed container (Figure 6.6).  Severe humidity 
testing was carried out in a temperature and humidity controlled oven. The temperature and 
humidity conditions were allowed to equilibrate for 24 hours for both moderate and severe 
humidity conditions. The samples that were subjected to humidity ageing were monitored over 
the course of 4, 7, 14, 21, 28 and 40 days via PXRD. The initial experimental set-up and PXRD 
measurements were carried out by the author at the University of Strathclyde, Glasgow with 
Dr. Alan Martin, while data collected one week onwards was obtained in absence of the author.  
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A small quantity (10-50 mg) of sample was analysed using reflection Bragg-Brentano PXRD, 
collected on a Bruker D8 Discover diffractometer configured for θ/θ geometry, with Ni filtered 
Kα1,2 Cu radiation, λ = 1.540596 Å, line focused. Samples were mounted on a six position 
sample auto sampler. Samples were rotated at a rate of 15 rotations per minute throughout data 
collection to maximise particle sampling and minimise preferred orientation effects.   
 
Figure 6.6 – Inside of humidity ageing unit containing raised ledge for humidity sensor (left) and humidity 
sensor within sealed plastic container containing salt solution slurry (right). 
6.3 Analysis 
Diffraction Analysis  
6.3.1 Single Crystal X-ray Diffraction (SCXRD) 
Ibuprofen Isonicotinamide (IBU-ISO) 
SCXRD data for the IBU-ISO co-crystal was collected on an Agilent Technologies Supernova 
diffractometer, using Cu radiation (λ = 1.5406 Å) at 150 K. The sample temperature was 
controlled using an Oxford Diffraction Cryojet apparatus. 
Due to the disorder in the initial structure of IBU-ISO co-crystal obtained from the laboratory 
diffractometer, attempts were made to improve data quality through use of the Advanced Light 
Source (ALS) synchrotron, Berkeley, USA. Data was collected at 150 K with a 17 keV X-ray 
source with 1 % and 10 % transmission filters applied to only the first run, with a 1 s exposure 
applied for all runs. Similar to that obtained using the laboratory source diffractometer, the 
IBU-ISO structure obtained from the synchrotron data suffered from disorder. In light of this, 
the IBU-ISO structure obtained from the Supernova laboratory diffractometer is presented, 
with disorder restraints applied to improve the structural model. 
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Oxaprozin Isonicotinamide (OXA-ISO) 
SCXRD data for the OXA-ISO co-crystal was collected at the ALS synchrotron. Data were 
collected at 150 K with a 17 keV X-ray source with various transmission filters 0.1 % and 10 % 
for run 1, 10 % and 10 % for run 2 and 10 % and 25 % for runs 3, 4 and 5 applied to the 0.5 s 
exposure utilised for all runs. 
Oxaprozin Imidazole (OXA-IMID) 
SCXRD data were recorded on an Agilent Technologies Gemini A Ultra CCD diffractometer, 
using monochromatic Mo-Kα radiation (λ = 0.71073 Å). The diffractometer operated with use 
of an Atlas CCD area detector and an Oxford Instruments CryojetXL liquid nitrogen flow 
apparatus. The latter was used as a method of sample temperature control; data were collected 
in the range 150-340 K.  
Both the Supernova and the Gemini A Ultra CCD diffractometers were equipped with the 
Rigaku-Oxford diffraction software CrysAlis Pro, which was used to collect, index and prepare 
data for structural interpretation, whilst the Bruker software equivalent Apex3 was utilised for 
the ALS synchrotron data. These data were then analysed in SHELXT using dual-space 
methods and SHELXL with least squares refinement programmes, used to solve and refine the 
crystal structure respectively. Both programmes were executed as part of the GUI Olex2 
software package. Visualisation and analysis of the crystal structures produced was then 
conducted in Mercury. 
Thermal Analysis 
6.3.2 Thermogravimetric Analysis (TGA) coupled with Mass Spectrometry (MS) 
Thermogravimetric Analysis (TGA) measures the mass loss of a sample as a function of 
temperature and thus can be an effective way to ascertain the stoichiometry of solvates 
(API:solvent molecule or API:Co-former:solvent molecule stoichiometric ratios). This is 
particularly important where a solvent may be present in non-stoichiometric quantities or non-
uniformly within the lattice, and where this may depend on how tightly bound the solvent is 
within the crystal structure. In addition to quantifying the stoichiometry of solvates, TGA can 
be coupled with Mass Spectrometry (MS) in order to identify the gaseous phase evolving 




6.3.3 Hot-Stage Microscopy (HSM) 
A single crystal or a small quantity of the crystalline material produced from crystallisation 
was put onto a glass slide, which was then placed into a Mettler Toledo FP82 Hot-Stage set-up 
equipped with a Leica DM1000 microscope. The crystalline sample was subject to a specified 
heat program using the FP90 Processor, defining the initial and final temperature as well as the 
heating rate. The resultant activity, such as melting of the sample, was recorded using an 
Infinity 2 microscopy camera. 
Spectroscopy  
6.3.4 Infrared (IR) Spectroscopy 
Fourier Transform Infrared (FTIR) spectra were recorded at room temperature using a Perkin 
Elmer FTIR Spectrometer in the range 4000-500 cm-1 with an ATR (Attenuated Total 
Reflection) sampling accessory. The profen family co-crystals prepared by LAG in 60:40 HI 
for 30 minutes were compared to the spectra from their constituent starting materials prepared 
by the same method. The functional groups of focus were C=O and N-H due to their hydrogen 
bonding capabilities often observed during co-crystal formation.    
6.3.5 Particle Visualisation Measurements (PVM) Inline Images on Crystalline® 
The Crystalline® platform features in-line particle visualisation technology with “through the 
vial” analytical capabilities, such as PVM to observe crystal formation and dissolution in real 











Results and Discussion 
6.4 Ibuprofen Isonicotinamide (IBU-ISO) 
6.4.1 Evaporative Crystallisations of IBU-ISO 
The PXRD patterns for IBU_ISO (IBU 20 mg) in a 1:1 ratio dissolved in approximately 2 mL 
of EtOH, IPA and ACE solvent systems, evaporated at 30 °C, indicate that each of these co-
crystallisation attempts yielded the same potential co-crystal via evaporative methods, when 
compared to the PXRD patterns of the starting materials. The presence of new peaks, the most 
prominent at 2θ of 9°, not present in any of the starting material PXRD patterns (Figure 6.7), 
is evidence of co-crystal formation. Excess IBU is evident in each of the evaporative samples 
indicated by the representative IBU peak at 6° 2θ. 
 
Figure 6.7 – PXRD patterns of the IBU-ISO 1:1 molecular complex prepared via evaporative crystallisation in 
three different solvents each at 30 °C, compared to the PXRD patterns of the constituent starting materials 
including various polymorphic, racemic and S-enantiomeric forms (Refcodes: IBPRAC (IBU), JEKNOC (S-
IBU),  EHOWIH01-05 (ISO I-V respectively)). 
The same samples analysed via PXRD, were also analysed by DSC using a ramp rate of 
10 ℃ min-1. The DSC traces for IBU_ISO in a 1:1 ratio dissolved in these three solvent 


























systems, further indicate the formation of potential IBU-ISO co-crystal by evaporation. The 
DSC traces show an endothermic event around 121 °C for each of these attempted co-
crystallisations, which does not correspond to a thermal event of either of the starting materials, 
which exhibit melting endotherms at 77 °C and 158 °C for IBU and ISO respectively (Figure 
6.8). The DSC trace of IBU_ISO evaporated from ACE also features an additional endotherm 
around 70 ℃, which can be attributed to excess IBU in the sample.  
The DSC trace of ISO features a minor endothermic event around 120 ℃, which required 
further investigation. A DSC trace of ISO at a significantly slower ramp rate of 1 ℃ min1 
(Appendix 6.2) allows further elucidation of this thermal event. The DSC data confirms this to 
be a very subtle endothermic event at 117 ℃, compared to the sharp and intense endotherm 
attributed to the melting event of ISO at 158 ℃; the melting endotherm of the co-crystal is at 
a higher temperature of 121 ℃ and is also sharp and intense.  The melting point of the IBU-
ISO co-crystal is intermediate between the two starting materials and thus has an increased 
thermal stability relative to the API IBU. 
 
Figure 6.8 – DSC heat profile for the molecular complex IBU-ISO 1:1 prepared via evaporative crystallisation 
methods in ACE, EtOH and IPA solvent systems at 30 °C. 
 




















Structural determination of IBU-ISO 
Masses of 20 mg of IBU and 11.8 mg of ISO (1:1 molar ratio) were dissolved in 2 mL of ACE 
and the solvent allowed to evaporate at 30 ℃ producing single crystals of suitable quality for 
analysis (Appendix 6.3). A suitable single crystal was subjected to SCXRD analysis; the crystal 
data for IBU-ISO is summarised in Table 6.4.  
Table 6.4 – Crystal data and structural refinement parameters for IBU-ISO. 
Empirical formula C19H24N2O3 
(C13H18O2· C6H6N2O) 
Formula weight 328.40 
Temperature /K 292.05(10) 
Crystal system Triclinic 
Space group P1̅ 
a /Å 5.7031(3) 
b /Å 11.5570(4) 
c /Å 27.7335(18) 
α /° 95.483(4) 
β /° 93.695(5) 
γ /° 102.004(4) 
Volume /Å3 1773.10(16) 
Z 4 
ρcalc /g cm-3 1.230 
μ /mm-1 0.084 
F(000) 704.0 
Crystal dimensions /m 200 × 40 × 10 
Radiation /Å MoKα (λ = 0.71073) 
2θ range for data collection /° 6.594 to 50.7 
Index ranges -6 ≤ h ≤ 6, -13 ≤ k ≤ 13, -33 ≤ l ≤ 33 
Reflections collected 30522 
Independent reflections 6467 [Rint = 0.0697, Rsigma = 0.0597] 
Data/restraints/parameters 6467/196/518 
Goodness-of-fit on F2 1.156 
Final R indexes [I>=2σ (I)] R1 = 0.1182, wR2 = 0.2260 
Final R indexes [all data] R1 = 0.1612, wR2 = 0.2482 
Largest diff. peak/hole /e Å-3 0.67/-0.35 
The IBU-ISO 1:1 co-crystal crystallises in the triclinic space group P1̅, with two molecules of 
IBU and two molecules of ISO in the asymmetric unit. On co-crystal formation, a hydrogen 
bonding interaction is produced between the oxygen on the carbonyl group of the carboxylic 
acid of IBU and the amide nitrogen of ISO, depicted by the blue dotted line in Figure 6.9. The 
crystal structure of IBU-ISO contains the common acid-pyridine hydrogen bonded 
heterosynthon and intermolecular O-H∙∙∙N hydrogen bond. The IBU and ISO molecules are 
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held together by a strong to moderate strength intermolecular hydrogen bond with a bond 
length of 2.608(5) Å and bond angle of 166.2° for O3-H3∙∙∙N4, with the corresponding 
hydrogen-to-acceptor (H3∙∙∙N4) bond length of 1.804 Å (Figure 6.9). 
 
Figure 6.9 – The asymmetric unit of the novel co-crystal structure IBU-ISO. 
Beyond the asymmetric unit, dimers of ISO containing hydrogen bonding between the amide 
nitrogen and the oxygen on the carbonyl group can be observed, whereby ISO dimers are 
formed through a [R22(8)] homosynthon (Figure 6.10). Also in the layers of molecules, a 
hydrogen bonding interaction is observed between the nitrogen on the pyridine ring in ISO 
with the oxygen on the alcohol group in the carboxylic acid functionality found in IBU. 
Intermolecular hydrogen bonds are also present between the layers, which is the same bonding 
interaction described for the asymmetric unit. The phenyl rings of the IBU and ISO units do 
not sit within the same molecular plane, with the angle relating the mean planes of the phenyl 
rings for the API and co-former molecule equating to 83.72°. The intermolecular hydrogen 
bond O3-H3∙∙∙N4 also sits in another plane to the planes incorporating the sets of phenyl rings, 
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whereby the angle from this intermolecular hydrogen bond to the mean plane of the IBU and 
ISO rings equates to 87.28° and 24.80° respectively.  
 
Figure 6.10 – The packing of the novel co-crystal structure IBU-ISO. 
6.4.1.1 IR Spectroscopy of IBU-ISO 
The IR spectrum of IBU-ISO shows an increase in the N-H stretching frequency of ISO on co-
crystal formation, corresponding with the intermolecular hydrogen bond formation of O3-
H3∙∙∙N4. The C=O stretching frequency of IBU-ISO dimers, corresponding with C26-O4 
within IBU and the carbonyl functional groups within the ISO dimers, is intermediate between 
the two starting components (Table 6.5 and Figure 6.11).  
Table 6.5 – Comparison of IR stretching frequencies of key functional groups in IBU-ISO compared to the 
constituent IBU and ISO starting materials. 
Vibration Frequency (cm⁻¹) IBU ISO IBU-ISO 
N-H stretch - 3362 3434 
(H3∙∙∙N4) 








Figure 6.11 – FTIR spectra of IBU-ISO compared to the constituent IBU and ISO starting materials. 
Comparing the predicted PXRD pattern of the IBU-ISO co-crystal with IBU-ISO crystallised 
from evaporative techniques and predicted patterns of the pure polymorphs of the starting 
components confirmed that a new co-crystalline material has been identified from evaporative 
crystallisation (Figure 6.12). Subsequent to this work, the PXRD pattern corresponding with 
the IBU-ISO co-crystal was found to match with the KIPPAD170 co-crystal reported by spray 




















Figure 6.12 – PXRD patterns comparing IBU-ISO predicted pattern simulated in Mercury and IBU_ISO 1:1 
evaporated from EtOH, with the PXRD patterns of the polymorphs of the pure starting materials as well as the 
KIPPAD170 co-crystal obtained from Mercury (Refcodes: IBPRAC (IBU), EHOWIH01-05 (ISO I-V) 
respectively). The intense IBU-ISO peak at 2° 2θ has been truncated for clarity. 
6.4.2 Mechanochemical Crystallisations of IBU-ISO 
Once co-crystal formation for the IBU-ISO co-crystal had been achieved through evaporation 
and confirmed through SCXRD, PXRD and DSC analytical techniques; this system was 
translated into grinding approaches.  
PXRD confirms the presence of IBU-ISO with an excess of starting material for all experiments 
presented in Figure 6.13. An increase in grinding time could lead to complete conversion to 
the co-crystal, or a change in stoichiometric ratio of the starting components could mitigate the 
excess starting material observed. The peaks are notably broader in the grinding samples than 
evaporative samples; this peak broadening can be attributed as inherent to the method of 
grinding, which reduces the particle size of the crystallites. 


























Figure 6.13 – PXRD patterns of the IBU-ISO 1:1 molecular complex prepared via mechanochemical 
crystallisation both NG and LAG in 3 different solvents, compared to the PXRD pattern of the IBU-ISO 
predicted pattern simulated in Mercury and IBU (Ref code: IBPRAC) and IBU_ISO 1:1 evaporated from EtOH 
powder patterns. 
The DSC traces for IBU-ISO 1:1 co-crystals formed via LAG and NG approaches show similar 
events to those from the evaporative crystallisations. The DSC traces for these 
mechanochemical crystallisations, also feature an additional endothermic peak compared with 
the evaporative crystallisations, at approximately 71 °C, attributed to the presence of excess 
IBU starting material (Figure 6.14). This indicates that mechanochemical crystallisation for 
five minutes of IBU and ISO 1:1 does not achieve the co-crystal in 100 % yield, evident from 
both PXRD and DSC analysis; future attempts could look at IBU and ISO 1:2 ratio and an 
extended grinding time for the mechanochemical crystallisations.  
























Figure 6.14 – DSC heat profile for the molecular complex IBU-ISO 1:1 prepared via mechanochemical 
crystallisations using both NG and LAG in ACE, EtOH and IPA solvent systems compared to the DSC trace of 
the IBU-ISO 1:1 crystallised from evaporation of EtOH, and those of the starting materials IBU and ISO. 
6.4.3 Slurrying Crystallisations of IBU-ISO 
Investigations into whether the IBU-ISO co-crystal could be accessed using small-scale slurry 
techniques were conducted using the same three solvents (ACE, EtOH, IPA), as those 
investigated in evaporative and mechanochemical techniques used to access the co-crystal 
previously. The slurries were prepared using a 1:1 molar ratio of IBU (400 mg) and ISO in 
2 mL of solvent, left stirring at 250 rpm on a hot-plate with DrySyn attachment set to 30 ℃ for 
one week. After this stirring period, the resultant product was isolated from the solvent using 
vacuum filtration and left to dry for 24 hours before being analysed via PXRD and DSC.  
The PXRD analysis carried out after slurrying a physical mixture of IBU_ISO 1:1 in various 
solvents for one week showed similar results to the evaporative and mechanochemical 
crystallisations, largely the IBU-ISO co-crystal, but with some additional peaks, which can be 
attributed to excess IBU starting material (Figure 6.15). 






















The DSC analysis on the same samples, showed some contrasting results across solvent 
systems. IBU_ISO slurry mediated in ACE and IPA solvent systems yielded a mixture of IBU 
and IBU-ISO co-crystal in both cases, whereas when EtOH was used the co-crystal was 
produced in purity (Figure 6.16). Melting of this co-crystal corresponds to the endotherm in 
the DSC data at 120 ℃; additional peaks within the DSC traces from IBU and ISO slurry-
mediated in ACE and IPA correspond to excess IBU.  
 
 
Figure 6.15 – PXRD patterns of the IBU-ISO 1:1 molecular complex prepared via slurrying crystallisations for 
1 week in three different solvents systems (truncated in intensity), compared with the PXRD pattern of the IBU-
ISO predicted pattern simulated in Mercury and IBU (Refcode: IBPRAC) powder pattern. 























Figure 6.16 – DSC heat profile for the molecular complex IBU-ISO 1:1 prepared via slurrying crystallisation 
for 1 week in ACE, EtOH, IPA solvent systems. 
6.4.4 IBU-ISO crystallisations in 60:40 water:isopropanol (HI) 
PXRD analysis of attempted co-crystal formation of IBU-ISO in 60:40 HI yielded a mixture 
of IBU and IBU-ISO via LAG for 5 minutes and via evaporative crystallisation at 30 ℃, 
whilst slurrying for 24 hours at 20 ℃ produced pure IBU (Figure 6.17). This slurry result 
indicates that IBU is less soluble than the co-crystal and more thermodynamically stable. The 
PXRD analysis across the crystallisation methods is in agreement with the DSC analysis, 
which clearly show two endotherms at 78 ℃ and 120 ℃ confirming the presence of IBU and 
IBU-ISO respectively in both the evaporative and mechanochemical experiments. In contrast, 
slurrying IBU and ISO in 60:40 HI yielded a single DSC endotherm matching the melt of 
IBU (Figure 6.18). 





















Figure 6.17 – PXRD patterns of the IBU-ISO 1:1 molecular complex prepared in 60:40 HI via various 
crystallisation methods: evaporative, LAG, slurrying at 20 ℃ at 10 mL scale for a slurry time of 24 hours, 
compared to the PXRD patterns of pure IBU and the IBU-ISO predicted pattern simulated in Mercury. 
 
Figure 6.18 – DSC heat profiles of the IBU-ISO 1:1 molecular complex prepared in 60:40 HI via various 
crystallisation methods: evaporative, LAG, slurrying at 20 ℃ at 10 mL scale for a slurry time of 24 hours, 
compared to the DSC traces of pure IBU and pure ISO starting materials. 







































6.4.4.1 Relative Thermal Stability Studies of IBU-ISO 
The thermal stability of the IBU-ISO co-crystal monitored over a month is shown in Appendix 
6.4; the PXRD patterns and DSC traces sampled each week are the same, highlighting the 
stability of the IBU-ISO co-crystal on thermal ageing. The same analysis was carried out on 
the API IBU for comparison, which similarly shows resistance to 45 °C temperature conditions 
over a month (Appendix 6.5), confirmed by both PXRD and DSC analysis.  
6.4.4.2 Humidity Stability studies of IBU-ISO 
The IBU-ISO humidity stability results reported in Figures 6.19-6.21 show that the PXRD 
patterns exhibit changes over time, including the appearance of additional peaks between 13-
18° 2θ, as well as peak broadening. The shift in PXRD patterns from seven days can be 
attributed to differing heights of the powder samples. This resistance to solid form changes of 
either solvate formation or dissociation into the constituent starting components, under either 
moderate or severe humidity conditions, shows the stability of IBU-ISO co-crystal prepared by 
both mechanochemical and slurrying crystallisations. A couple of additional peaks from excess 
IBU starting material are evident, as reported previously in the 5 minute mechanochemical 
crystallisations of IBU-ISO, so the samples did not consist of the co-crystal in purity at t=0.  
 
Figure 6.19 – IBU-ISO 1:1 prepared in 60:40 HI via LAG for 5 minutes – Humidity studies at 46 % RH 
monitored over 40 days. The intensity of the 3° 2θ peak for both the t = 28 and t = 40 days diffraction patterns 
has been truncated for ease of display and comparison. 

























Figure 6.20 – IBU-ISO 1:1 prepared in 60:40 HI via LAG for 5 minutes – Humidity studies at 80 % RH 
monitored over 40 days. The intensity of the 3° 2θ peak for both the t = 28 and t = 40 days diffraction patterns 
has been truncated for ease of display and comparison. 
 
Figure 6.21 – IBU-ISO 1:1 prepared in 60:40 HI via for 5 minutes slurrying – Humidity studies at 46 % RH 
monitored over 40 days. The intensity of the 3° 2θ peak for both the t = 28 and t = 40 days diffraction patterns 
has been truncated for ease of display and comparison. 














































6.4.4.3 Solubility measurements of IBU ISO in 60:40 HI 
Solubility measurements were carried out in preparation for translating the co-crystallisation 
of IBU and ISO into cooling crystallisation initially in batch and then into flow crystallisation 
in the KRAIC-D. Once the cooling crystallisation of the co-crystal has been designed from the 
physical mixture of starting components and the corresponding co-crystal accessed, analysis of 
the solubility behaviour of a pre-made co-crystal can be investigated, allowing for comparison 
between solubility of the physical mixture and the multi-component material. 
6.4.4.3.1 Solubility by Turbidity 
Solubility analysis to obtain a combined solubility of a physical mixture of IBU and ISO was 
carried out by turbidity measurements at two different scales using the Crystal16® and 
Crystalline® reactors at the University of Strathclyde. The platforms allowed the elucidation of 
solubility behaviour at 1 mL and 5 mL scale for the Crystal16® and Crystalline® respectively, 
with largely similar concentration / temperature dependence (Figure 6.22 and 6.24). Most 
interestingly, the data shows that the cloud points are observed at a lower corresponding 
concentration than the clear points, which is unusual behaviour and required further 
investigation.  
 














































Observations of the vials within the Crystal16® after dissolving at 70 ℃ showed the 
phenomenon of ‘oiling out’. This signifies that the solutions have reached supersaturation, but 
require an external stimulus to crystallise, which could explain the observation of cloud points 
at a lower temperature than the corresponding clear points.  
The phenomenon of oiling out is evident in the literature; for example, Deneau et al. published 
an in-line study of oiling out and crystallisation of a pharmaceutical compound (which cannot 
be identified for commercial reasons) from a 50:50 v/v water-ethanol mixture.172 The aim of 
the study was to improve knowledge of the process of oiling out, allowing for greater control 
to be imparted on the crystallisation process. In situ measurements using a FBRM (Focussed 
Beam Reflectance Measurement) probe and in-line PVM images, highlighted a number of 
events during the heat-cool cycles: dissolution, oiling out, coalescence of oil droplets, release 
of pharmaceutical compound from the droplets, nucleation and crystal growth. The solubility 
curve and the liquid-liquid phase separation boundary were also determined by FBRM, 
revealing that the two curves were largely separated at low temperature, whilst the MSZW 
decreased with an increase in temperature, until the curves merged into a single curve at high 
temperature.172 This study highlights the importance of coupling turbidity measurements with 
in-line visual observations to monitor the phenomenon of oiling out, allowing for 
differentiation between crystallisation and oiling out in the turbidity cool cycles to be made.  
Given these considerations, the choice of solubility limit from the turbidity data in the presence 
of the ‘oiling out’173 affecting the nucleation of the IBU_ISO in 60:40 HI was not clear. As the 
curves show overlap, it was chosen to focus on the cloud points on the solubility curve, 
acknowledging that the metastable zone (MSZ) is unknown. 
To gain a greater understanding of the solubility behaviour of the IBU_ISO 1:1 physical 
mixture in 60:40 HI, in-line PVM images were collected during the three heat-cool cycles in 
the Technobis Crystalline® analysis, with images collected every minute throughout the 
temperature programme. The double spike in solubility (indicated by the orange stars in Figure 
6.23) features only once in the repeat heat-cool cycles, indicating that this is a short-lived event. 
This double spike could be attributed to inhomogeneity of the oil droplets in the solution, 
whereby a reduction in oil droplets aligning with the beam path is evident from the increase in 
transmission at 750 minutes (45 000 seconds) into the turbidity analysis. Similar to findings 
from Deneua et al., the solubility of IBU_ISO 1:1 physical mixture showed a great variance 
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between the clear and cloud points at lower temperature, whereas at high temperature the 
MSZW is no longer distinguishable as the two curves merge (Figure 6.24). 
 
Figure 6.23 – Repeated heat-cool cycles to obtain clear (red circle) and cloud points (green circle) for IBU_ISO 
1:1 physical mixture in 60:40 HI in Crystal16 and Crystalline® platforms. The heat-cool cycles presented 
coincide with a sample containing 0.4 g IBU and 0.474 g ISO in 5 mL 60:40 HI in the Crystalline®. The PVM 
images obtained alongside the Crystalline® turbidity measurements convey different stages of the crystallisation 




Figure 6.24 – Solubility curve of IBU and ISO 1:1 physical mixture in 60:40 HI at 5 mL scale in Crystalline®. 
6.4.4.3.2 Solubility by Visual Observation  
Due to the unusual solubility behaviour observed in both the Crystal16® and Crystalline® 
platforms, an alternative, visual observation, approach to solubility analysis was investigated.  
Incremental amounts of solid (either a physical mixture of starting components or a pre-
prepared batch of the IBU-ISO co-crystal) were added to a saturated solution (20 mL volume) 
undergoing very slow temperature ramping. The temperature of dissolution is noted after each 
addition of solid.  
The challenge with measuring the solubility of a multi-component system is the uncertainty in 
the material being measured. If the system dissociates into the constituent starting materials in 
solution, it is likely that the solubility of the least soluble component is being measured, 
although it is also possible that an initial physical mixture could phase transform in solution 
into the co-crystal, in which case solubility behaviour of the co-crystal can be obtained. It is 
therefore important to investigate the physical mixture and compare this to the starting 














































A physical mixture of IBU_ISO in 60:40 HI was investigated in both 1:1 and 1:2 stoichiometric 
ratios of IBU:ISO and compared with the pure IBU API (Figure 6.25) and ISO (Figure 6.26) 
starting components. Once the IBU-ISO co-crystal can be accessed in purity via cooling, it was 
then possible to ascertain whether this IBU co-crystal formation has improved the solubility 
compared to pure IBU. In each case, three repeats were investigated for reliability, in order to 
provide statistical relevance. The solubility of IBU was consistent across the repeat 
experiments, whereas the solubility of ISO showed great variance, particularly at low 
concentration / temperature and thus the data for ISO could not be fitted to an exponential 
curve. The solubility by visual observation of a physical mixture of IBU_ISO 1:1 in 60:40 HI 
is consistent between repeats at low temperature, but as the temperature is increased the 
variance between repeats increases (Figure 6.27). The greater variance in repeat observation 
measurements at higher temperature could be attributed to inconsistency in heating.   
The heating programme was stopped when a cloud emulsion was produced (Figure 6.28). 
Importantly, an emulsion is observed for the parent compounds IBU and ISO, as well as for 
the physical mixture of IBU_ISO.   
 
Figure 6.25 – Solubility of IBU in 60:40 HI via visual observation, three repeats Obs 1, 2, 3 with exponential 































Figure 6.26 – Solubility of ISO in 60:40 HI via visual observation, three repeats Obs 1, 2, 3. 
 
Figure 6.27 – Solubility of IBU_ISO 1:1 physical mixture in 60:40 HI via visual observation, three repeats Obs 


























































Figure 6.28 – Cloudy emulsion resulting from solubility of IBU_ISO 1:1 physical mixture in 60:40 HI. 
 
Figure 6.29 – PXRD patterns of the resultant crystalline material produced from the solubility by visual 
observation of the physical mixture (phys mix) of IBU and ISO in 60:40 HI, compared to the PXRD patterns of 
pure IBU and the IBU-ISO predicted pattern simulated in Mercury. 
The resulting crystalline material produced once the heating regime was complete and the 
sample allowed to return to room temperature, produced a mixture of IBU and IBU-ISO co-
crystal (Figure 6.29). This is in agreement with the solubility data presented in Figure 6.25 and 
6.27, which is similar for IBU and the IBU_ISO 1:1 physical mixture respectively, so it can be 




















postulated that the IBU_ISO 1:1 physical mixture is largely measuring the solubility behaviour 
of IBU, or the solubilities could be very similar. The solubility measurements via visual 
observation did not yield the co-crystal in purity, therefore controlled cooling crystallisation 
experiments were carried out at 1:1 and 1:2 stoichiometric ratios of IBU:ISO to access the co-
crystal in purity. Once the pure IBU-ISO co-crystal was accessed, this allowed for solubility 
analysis via visual observation of the pure co-crystal to be carried out and compared to the 
solubility behaviour of pure IBU in the 60:40 HI solvent mixture.  
As the solubility behaviour of ISO in 60:40 HI is largely different to IBU and IBU_ISO 1:1 
measured in the same solvent system, the solubility behaviour of IBU_ISO 1:2 physical 
mixture was investigated (Figure 6.30). The average solubility behaviour of IBU_ISO 1:2 is 
similar to the average solubility of IBU_ISO 1:1, particularly at high temperature, whereby the 
solubility curves will intersect above 40 ℃. According to the equation for the exponential 
curves describing the solubility behaviour of IBU_ISO 1:1 and IBU_ISO 1:2, the concentration 
at 20 ℃, equates to 0.0125 g/mL and 0.00691 g/mL for 1:1 and 1:2 respectively. As seen in 
Figure 6.27, the uncertainty in the data points presented in Figure 6.30 increases with increasing 
temperature; this could be attributed to poor heat transfer at higher temperatures.  
 
Figure 6.30 – Solubility of IBU_ISO 1:2 physical mixture in 60:40 HI via visual observation, three repeats Obs 


































6.4.4.4 Cooling Crystallisations of IBU-ISO 
6.4.4.4.1 Batch via Polar Bear Plus from Cambridge Reactor Design (CRD) 
The IBU-ISO co-crystal was translated into a cooling crystallisation regime as that 
crystallisation method is more easily controlled at larger scale, thus is widely adopted in the 
pharmaceutical industry. The quantities of IBU and ISO were initially based upon the room 
temperature solubility of the physical mixture of IBU_ISO 1:1 in 60:40 HI at 1 mL scale in the 
Crystal16®, which provides a suitable start point for a cooling crystallisation experiment. A 
concentration range was selected to ascertain the concentration dependence of IBU-ISO co-
crystal formation (Table 6.6). The IBU_ISO 1:1 in 1 mL 60:40 HI samples were heated to 
70 ℃, followed by a 1 hour dwell time, to ensure complete dissolution before cooling to 5 ℃ 
at a cooling rate of 0.05 ℃ min-1.  
Table 6.6 – Quantities of each component and overall concentration of IBU_ISO 1:1 in 1 mL of 60:40 HI used 
in the initial cooling crystallisation trials at 1 mL in the CRD Polar Bear Plus crystalliser. 
Vial  Moles of IBU 
/x10-4 moles 
Moles of ISO 
/ x10-4 moles 
Concentration 
g/mL 
1 3.88 3.88 0.1274  
2 4.12 4.12 0.1353 
3 4.24 4.24 0.1393 
4 4.36 4.36 0.1462 
5 3.39 3.39 0.1114 
6 3.64 3.64 0.1194 
7 3.76 3.76 0.1234 
8 4.00 4.00 0.1313 
A mixture of IBU and the IBU-ISO co-crystal is produced across the full concentration range, 
with slight shifts in the 2θ (°) positions (Figure 6.31). This is confirmed by DSC (Figure 6.32), 




Figure 6.31 – PXRD of products from cooling crystallisations of IBU_ISO 1:1 in 60:40 HI at 1 mL scale over a 
concentration range performed in the CRD Polar Bear Plus crystalliser. 
 
Figure 6.32 – DSC trace of cooling crystallisation of IBU_ISO 1:1 in 60:40 HI at 1 mL scale (vial 5) versus 
starting material DSC traces of IBU, ISO and the co-crystal IBU-ISO accessed via LAG in 60:40 HI for 30 
minutes. 











































In subsequent cooling crystallisations, a 1:2 stoichiometric ratio of the IBU_ISO starting 
materials was used in an attempt to remove the excess IBU. In addition to altering the 
stoichiometric ratio of the starting components, to crystallise the IBU-ISO in purity, a faster 
cooling rate of 1 ℃ min-1, comparable to those typically adopted in industry, was investigated. 
The PXRD patterns of the cooling crystallisations of IBU_ISO 1:2 in 60:40 HI at both 
0.05 ℃ min-1 and 1 ℃ min-1 cooling rates are compared to the initial cooling crystallisation of 
a 1:1 stoichiometric ratio at the slower cooling rate in Figure 6.33.  
 
Figure 6.33 – PXRD of products of cooling crystallisations of IBU_ISO 1:1 and 1:2 in 60:40 HI at 1 mL scale 
cooled at 0.05 ℃ min-1 (slow) and 1 ℃ min-1 (fast) cooling rates performed in the CRD Polar Bear Plus 
crystalliser, with the intense peak at 17° 2θ truncated for clarity. 






















Figure 6.34  – DSC traces of cooling crystallisations of IBU_ISO 1:1 and 1:2 in 60:40 HI cooled at 
0.05 ℃ min-1 (slow) and 1 ℃ min-1 (fast) cooling rates performed in the CRD Polar Bear Plus crystalliser at 1 
mL scale versus starting material DSC traces of IBU and ISO. 
The DSC traces of the IBU_ISO 1:2 in 60:40 HI cooled at both 0.05 ℃ min-1 and 1 ℃ min-1 
features a single endothermic peak at 120 ℃ (Figure 6.34). Importantly, the reduction of the 
IBU in the IBU_ISO stoichiometric ratio resulted in the removal of the excess IBU peak, which 
featured in the previous IBU_ISO 1:1 in 60:40 HI DSC trace. 
Production of the IBU-ISO co-crystal has also been successfully scaled up via cooling 
crystallisations to 200 mL scale at 1 ℃ min-1, using both magnetic bottom (Figure 6.35) and 
overhead (Figure 6.36 and 6.37) stirring. There are no discernible differences in crystalline 
outcome from the different stirring methods, regardless of the difference in mixing 
homogeneity and shear.  





















Figure 6.35 – PXRD of products from cooling crystallisations of IBU_ISO 1:2 in 60:40 HI scale-up with 
magnetic bottom stirring. 
 
Figure 6.36 – PXRD of products from cooling crystallisations of IBU_ISO 1:2 in 60:40 HI scale-up with 
overhead stirring. 










































Figure 6.37 – DSC traces of cooling crystallisations of IBU_ISO 1:2 in 60:40 HI scale-up with overhead 
stirring. 
The solubility of a physical mixture of IBU_ISO in 60:40 HI was investigated in both 1:1 and 
1:2 stoichiometric ratios previously, and this can be compared with the solubility of the IBU-
ISO co-crystal as this has been produced up to 200 mL scale via batch cooling (Figure 6.38).  
Comparison of the IBU-ISO co-crystal solubility behaviour in 60:40 HI with IBU and 
IBU_ISO 1:2 physical mixture in the same solvent system shows that the IBU-ISO co-crystal 
is more soluble than both IBU in 60:40 HI and the IBU_ISO 1:2 physical mixture in 60:40 HI 
(Figure 6.38). Interestingly, the solubility behaviour of IBU in 60:40 HI and IBU_ISO 1:2 
physical mixture in 60:40 HI show very similar exponential concentration / temperature 
dependence, so it can be postulated that the solubility of IBU is measured in the IBU_ISO 1:2 
physical mixture. The solubility of IBU was only analysed to an upper limit temperature of 
approximately 40 ℃ for each of the repeats, as the IBU produced a cloudy emulsion and further 
analysis would not be accurate. This solubility study has shown that co-crystal formation has 
improved the solubility of IBU; for example by a factor of 5 at 20 ℃.  






















Figure 6.38 – Comparison of Solubility of IBU-ISO co-crystal with IBU in 60:40 HI and IBU_ISO 1:2 physical 
mixture via visual observation, three repeats Obs 1, 2, 3. The data for the solubility behaviour of the co-crystal 
IBU-ISO does not follow an exponential trend and therefore exponential fitting was not carried out.  
6.4.4.5 Slurry stability testing of IBU-ISO co-crystal 
Slurrying a physical mixture of IBU_ISO in 60:40 HI at 10 mL scale for 24 hours was 
previously shown to produce IBU. The stability of a slurry of the pre-made IBU-ISO co-crystal 
over a period of 48 hours, which is beyond the lifetime of the rate of release of a drug product 
in the gut, was investigated as a comparison to the behaviour of the physical mixture. In order 
to ascertain whether the co-crystal would remain intact as the multi-component material, PXRD 
and DSC analysis of aliquots sampled at various time points was carried out. Two temperatures 
were investigated, room temperature (RT) and 37.5 ℃ (HT – high temperature) to simulate 
temperature conditions in the gut. The co-crystal sample used in the slurry stability testing was 
prepared using IBU_ ISO 1:2 in 60:40 HI achieving co-crystal formation via cooling at 200 mL 
scale with the use of overhead stirring. The IBU-ISO co-crystal material produced from the 
cooling experiment was dried and confirmed to yield the co-crystal in purity via PXRD analysis 


































Offline PXRD measurements of the pre-prepared IBU-ISO co-crystal slurried in 60:40 HI 
sampled over 2, 4, 6, 24 and 48 hours showed no discernible differences over time and yielded 
a mixture of IBU and IBU-ISO co-crystal at both RT and HT (Figure 6.39 and 6.41). ISO is 
significantly more soluble than IBU at room temperature, which causes an excess of IBU to 
crystallise when slurrying in solution, also evident from DSC analysis (Figure 6.40 and 6.42).  
 
Figure 6.39 – PXRD patterns of IBU-ISO pre-prepared co-crystal used in 60:40 HI mediated slurry at room 
temperature (RT), sampled at t = 2, 4, 6, 8, 24 and 48 hours after slurry preparation. The intensity of the 2.5° 2θ 
peak has been truncated for ease of display and comparison. 

























Figure 6.40 – DSC traces of IBU-ISO pre-prepared co-crystal used in 60:40 HI mediated slurry at room 
temperature (RT), sampled at t = 2, 4, 6, 8, 24 and 48 hours after slurry preparation compared to IBU and ISO 
starting material DSC traces. 
 
Figure 6.41 – PXRD patterns of IBU-ISO pre-prepared co-crystal used in 60:40 HI mediated slurry at 37.5 ℃ 
(HT), sampled at t = 2, 4, 6, 8, 24 and 48 hours after slurry preparation. 














































Figure 6.42 – DSC traces of IBU-ISO pre-prepared co-crystal used in 60:40 HI mediated slurry at 37.5 ℃ (HT), 
sampled at t = 2, 4, 6, 8, 24 and 48 hours after slurry preparation compared to IBU and ISO starting material 
DSC traces. 
The endothermic event coinciding with the melting of IBU at 78 ℃ appears to become more 
prominent over time, while simultaneously the area of the co-crystal melting endotherm 
becomes less dominant. No endotherm corresponding with the melting event of ISO is evident 
even over time, confirming IBU is more stable and less soluble than ISO in 60:40 HI. Similarly, 
the switch in relative prominence of the IBU and co-crystal endotherms with time confirms 
that IBU is more stable and less soluble than the co-crystal in 60:40 HI.  
6.4.4.6 Continuous Cooling Co-crystallisation in the KRAIC and KRAIC-D platforms: 
IBU-ISO in 60:40 HI (IBU-ISOK and IBU-ISOKD) 
Formation of the IBU-ISO co-crystal has been achieved via batch cooling up to 200 mL scale; 
this highlights the potential of translating the production of this co-crystal via cooling into 
continuous crystallisation platforms, such as the KRAIC / KRAIC-D.  
The solubility behaviour of IBU-ISO was previously investigated in the Crystal16® at 1 mL 
and via observation at 20 mL batch scales (Section 6.4.4.3). The MSZ of IBU_ISO in 60:40 HI 
in the Crystal16® was not well known due to the unusual ‘oiling out’ behaviour and subsequent 























relative concentrations of clear and cloud points at a given temperature. Nonetheless, the MSZ 
in the KRAIC / KRAIC-D platforms will not only be different to the 1 mL batch scale, but the 
MSZ cannot be ascertained in these platforms as the cooling is not controlled. The MSZW is 
dependent on the kinetics of the system and thus the use of segmentation will increase the MSZ, 
due to the removal of the solid-liquid phase boundary, the corresponding mixing strategy is an 
intrinsic recirculation within slugs.174 It is expected that the concentration requirements in the 
KRAIC / KRAIC-D will be notably higher due to the use of segmentation and the gentle mixing 
conditions inherent to the bolus flow within each solution slug in these milliscale crystallisers. 
However, as the MSZW is unknown, initial experiments adopted a cooling regime close to the 
solubility curve. 
To develop the flow crystallisation process of IBU_ISO 1:2 in 60:40 HI for in-beam operation 
in the KRAIC-D, developmental work optimised offline was carried out in the KRAIC. The 
experimental set-ups for the cooling co-crystallisation of IBU_ISO 1:2 in 60:40 HI for the 
KRAIC and KRAIC-D platforms are illustrated in Chapter 5 in Figure 5.20 and Figures 6.43-
6.44 respectively. Depending on how rapidly nucleating the IBU-ISO system is, coupled with 
the concentration and temperature conditions, further temperature controlled tubing such as a 
section of sub-ambient jacketed crystalliser tubing (represented by the nucleation promoter in 
Figure 6.44) may be required to promote nucleation as the crystallisation process is optimised.  
The flow parameters and experimental conditions for the IBU-ISOK and IBU-ISOKD 





Figure 6.43 – Schematic of KRAIC-D IBU-ISO cooling co-crystallisation experimental set-up employed for 
IBU-ISOKD experiments1-3 at I11. 
 
 
Figure 6.44 – Schematic of KRAIC-D IBU-ISO cooling co-crystallisation experimental set-up employed for 
IBU-ISOKD4 at I11. 
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Table 6.7 – Flow parameters for the continuous co-crystallisation of IBU-ISO in the KRAIC / KRAIC-D 
platforms, identified by IBU-ISOK and IBU-ISOKD respectively. 




Carrier fluid Air Neutral 
solvent (NS) 
Solution 
Flow rate /mL/min 2.1 4.18 12.5 1.6 7.88 
 
Table 6.8 – Experimental parameters for offline KRAIC and online KRAIC-D experiments, identified by IBU-
ISOK and IBU-ISOKD respectively. *Temperature was reduced to 40 ℃, 10 minutes into the crystallisation 
process. **Water bath set to 35 ℃ initially, increased to 40 ℃ at 15 minutes. 
Experiment Concentration 
of IBU g/L 
Concentration 





IBU-ISOK1 40 47.4 50* No 
IBU-ISOK2 80 94.8 40** No 
IBU-ISOKD1 60 71.1 40 No 
IBU-ISOKD2 70 83 40 No 
IBU-ISOKD3 80 94.8 40 No 
IBU-ISOKD4 60 71.1 40 Yes  
 
IBU-ISOK1 
The initial ratio of IBU_ISO 1:2 in 60:40 HI (40 g/L IBU, 47.4 g/L ISO) was selected (IBU-
ISOK1). All temperature controls including feeds, the circulator used for the tubing jackets and 
the segmentation water bath, were set to 50 ℃; this was reduced to 40 ℃, as the feed solution 
had good solubility at room temperature. The experimental residence time (RT) was measured 
at 27 minutes. At 1 hour 36 minutes into the continuous run, no crystallisation had been 
observed; ice was thus introduced inside coil 1 at 1 hour 58 minutes, as a crude way to provide 
insight as to whether additional temperature control in the form of a cold tube could promote 
nucleation at this concentration. At 2 hours into the crystallisation run an emulsion was 
observed in the solution slugs in coil 1; this is consistent with the oiling out observed in the 
Crystalline® images in the solubility study of IBU_ISO 1:1 (Section 6.4.4.3.1). This emulsion 
re-dissolved in coil 2. Crystallisation was not observed under these conditions so an increase 
in concentration of the crystallising feed was required. 
IBU-ISOK2 
The concentration of IBU_ISO 1:2 in 60:40 HI was doubled to 80 g/L IBU and 94.8 g/L ISO 
in 60:40 HI to promote crystallisation. The circulator bath and feed solution were controlled at 
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40 ℃, whilst the water bath was set to 35 ℃ and an ice bag was again placed inside coil 1. The 
previous flow parameters were maintained, whilst employing the same pumps, however a large 
decrease of 12 minutes in experimental residence time to 15.0 minutes was observed. The 
theoretical residence time for these flow rates is 15.1 minutes, suggesting that the residence 
time for IBU-ISOK1 is inaccurate.  
Slugs in the emulsion phase were observed emerging from the 35 ℃ water bath, indicating that 
the ice bag in coil 1 may not be required at this increased concentration. Crystallisation was 
observed at 9 minutes into the crystallisation run at coil 1, rung 5. A number of crystals were 
observed in several slugs, with the extent of crystal growth in each slug sufficient to cause a 
blockage in coil 1. This suggested a reduction in feed concentration in addition to removal of 
the ice bag from the inside of coil 1 was required. The ice bag was removed from the inside of 
coil 1 and the temperature of the water bath was increased to 40 ℃ after a full residence time 
(15 minutes into the experiment time), after which slugs in the emulsion phase were no longer 
observed emerging from the water bath.  
Samples under these conditions were collected to establish whether the IBU-ISO co-crystal 
was accessed in flow and the level of purity of the crystalline product. These samples were not 
collected for a full RT and due to blockages the flow rate was not always consistent over the 
collection time; a yield could therefore not be determined. Samples were taken at different 
times within the experiment for two collection periods: 15-30 minutes and 35-44 minutes for 
samples 1 and 2 respectively. The corresponding PXRD patterns IBU-ISOK2_sample 1 and 
IBU-ISOK2_sample 2 (Figure 6.45) show the IBU-ISO co-crystal is produced over both 
collection times, with sample 1 also containing some IBU starting material.  
The corresponding DSC traces feature a single endothermic peak at 120 ℃ showing that the 
co-crystal had been accessed in flow consistently across two separate collection times (Figure 
6.46). However, sample 1 is not pure with respect to the co-crystal, with a representative IBU 
peak at 78 ℃. This difference in purity between the two samples could result from blockages; 
the KRAIC experienced a greater degree of encrustation for sample 1 compared to sample 2. 
The decrease in the extent of blockages between the two collection times can be attributed to 




Figure 6.45 – PXRD patterns from experiment IBU-ISOK2, sample 1 and 2 were collected at 15 minutes and 
35 minutes into the experiment respectively. The PXRD patterns for IBU-ISOK2_sample 1 and IBU-
ISOK2_sample 2 have been truncated for clarity. 
 
Figure 6.46 – DSC traces of IBU_ISO 1:2 in 60:40 HI in the KRAIC platform sampled at two different time 
points corresponding with experiment times of 15-30 minutes and 35-44 minutes compared to the DSC traces of 
the IBU and ISO starting materials. 





































The IBU-ISOKD1-2 experiments showed that the crystallisation process requires further 
optimisation in terms of concentration and temperature conditions to crystallise the IBU-ISO 
co-crystal in flow without blockages. 
IBU-ISOKD1-4 
Following the offline experiments, the cooling crystallisation of IBU-ISO in 60:40 HI was 
investigated in the KRAIC-D at I11 through in situ XRD characterisation (IBU-ISOKD). 
However, the initial suggested parameters from offline experiments in the KRAIC (reduced 
concentration, altered temperature control) did not yield crystallisation at I11 (IBU-ISOKD1 
and IBU-ISOKD2). The conditions were altered accordingly towards those adopted in the 
KRAIC experiments IBU-ISOK1 and IBU-ISOK2 at Bath (Tables 6.7 and 6.8), but 
crystallisation was still not observed (IBU-ISOKD3). For experiment IBU-ISOKD4, the 
introduction of a nucleation promoter to encourage nucleation at 15 ℃ also did not produce 
crystallisation. Decreasing the temperature of the nucleation promoter to 10 ℃ caused 
crystallisation to occur uncontrollably, rapidly creating a blockage. This suggests that the MSZ 
in the KRAIC / KRAIC-D segmented flow platforms must be extremely narrow to move from 
no crystallisation to uncontrollable crystallisation with small changes in experimental 
conditions.  
Another important conclusion from this work was that the blockages resulted from the oil phase 
preferentially combining with the Galden® (carrier fluid) in the segmented flow. This results 
in an emulsion comprising the carrier fluid and crystallising solution, whereby the crystallising 
solution has reached the ‘oiling out’ phase and thus on the premise of miscibility will 
preferentially combine and mix with the carrier fluid rather than the solvent in the crystallising 
solution slugs. This resulted in encrustation, which did not sit within a solution slug, but instead 
within the tubing interfacing with the walls of the inside of the FEP, whilst the segmented flow 
was simultaneously attempting to pass the blockage. This encrustation on the tubing contrasts 
with the plug shaped blocks usually observed when encrustation occurs in the KRAIC / 
KRAIC-D platforms. This highlights that the segmented flow utilised in the KRAIC / KRAIC-
D is not suitable for every crystallisation process.  
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6.5 Oxaprozin Isonicotinamide (OXA-ISO) 
6.5.1 Evaporative Crystallisations of OXA-ISO 
The PXRD patterns for OXA (20 mg) and ISO (8.3 mg) in a 1:1 ratio dissolved in 
approximately 2 mL of EtOH, IPA and ACE, solvent systems, evaporated at 30 °C, confirm 
that EtOH and IPA solvent systems yield OXA starting material, whilst ACE yields a potential 
co-crystal via evaporative methods, when compared to the PXRD patterns of the starting 
materials including various polymorphic forms. The evidence of co-crystal formation is 
especially prominent from peaks at 8° and 13° 2θ, a peak not present in any of the starting 
material PXRD patterns (Figure 6.47). The PXRD patterns of pure OXA and potential OXA-
ISO co-crystal are very similar and therefore DSC and structurally definitive SCXRD are 
particularly beneficial analytical techniques for the OXA-ISO system. The variance in 
crystalline outcome across the various solvent systems indicates the influence of solvent on co-
crystal formation and highlights the importance of solvent screening in material discovery.   
 
Figure 6.47 – PXRD patterns of attempted co-crystallisations of OXA-ISO prepared via evaporative 
crystallisations in three different solvents each at 30 °C, compared to the PXRD patterns of the constituent 
starting materials including various polymorphic forms (Refcodes: OJURAO (OXA),  EHOWIH01-05 (ISO I-V 
respectively)). 

























The same samples analysed via PXRD, were also analysed by DSC using a ramp rate of 
10 ℃ min-1. The DSC traces for OXA-ISO co-crystallisation attempts in a 1:1 ratio dissolved 
in these three solvent systems, reconfirmed the possible formation of OXA-ISO, through the 
presence of an endothermic event around 124 °C for each of these attempted co-crystallisations. 
This endothermic event does not correspond to a melting event of either of the starting 
materials, which exhibit endotherms at 163 °C and 158 °C for OXA and ISO respectively 
(Figure 6.48). The co-crystal is confirmed in purity across all solvent systems from DSC 
analysis, with no OXA endotherm in any of the traces.  This is contradictory to the indications 
from PXRD analysis, where access to co-crystal formation is only indicated from ACE.  
 
Figure 6.48 – DSC heat profiles for the molecular complex OXA-ISO 1:1 prepared via evaporative 
crystallisations at 30 °C in ACE, EtOH and IPA solvent systems. 
Structural determination of OXA-ISO 
A mass of 20 mg of OXA and 8.3 mg of ISO in a 1:1 ratio were dissolved in 2 mL of ACE and 
the solvent allowed to evaporate for one week at 30 ℃ via holes punctured in the lid of the 
vial, producing single crystals of suitable quality for diffraction analysis. A suitable single 
crystal was subjected to SCXRD analysis at the Advanced Light Source (ALS) synchrotron on 




















beamline 12.2.1, to determine the full 3D crystal structure of the novel co-crystal; the crystal 
data for OXA-ISO are summarised in Table 6.9.  
Table 6.9 – Crystal data and structural refinement parameters for OXA-ISO. 
Empirical formula C24H21N3O4 
Formula weight 415.12 
Temperature /K 273.15 
Crystal system Monoclinic 
Space group P21/c 
a /Å 19.3865(9) 
b /Å 16.3714(8) 
c /Å 39.7044(19) 
α /° 90 
β /° 103.510(2) 
γ /° 90 
Volume /Å3 12252.9(10) 
Z 24 
ρcalc /g cm-3 1.3501 
μ /mm-1 0.098 
F(000) 5226.9 
Crystal dimensions /μm3 160 × 40 × 20  
Radiation /Å ALS Synchrotron (λ = 0.7288) 
2θ range for data collection /° 2.22 to 52.94 
Index ranges -23 ≤ h ≤ 23, -19 ≤ k ≤ 20, -48 ≤ l ≤ 48 
Reflections collected 214902 
Independent reflections 23371 [Rint = 0.1564, Rsigma = 0.0927] 
Data/restraints/parameters 23371/0/1731 
Goodness-of-fit on F2 1.033 
Final R indexes [I>=2σ (I)] R1 = 0.0767, wR2 = 0.2013 
Final R indexes [all data] R1 = 0.1019, wR2 = 0.2364 
Largest diff. peak/hole / e Å-3 1.04/-0.48 
 
The OXA-ISO 1:1 co-crystal crystallises in the monoclinic space group P21/c, with six 
molecules of OXA and six molecules of ISO in the asymmetric unit; the high Z’ value (6) is 
discussed below. On co-crystal formation, a hydrogen bonding interaction is produced between 
the oxygen on the alcohol group of the carboxylic acid of OXA and the pyridine nitrogen of 
ISO forming a carboxylic acid:amide 𝑅2
2(7) heterosynthon, corresponding with the 
intramolecular hydrogen bond O11-H∙∙∙N8 in Figure 6.49. Figure 6.49 displays half of the 
asymmetric unit containing two linked tetramers of molecules, allowing visualisation of the 
interaction between tetramers, whereby each tetramer comprises four molecules: two OXA and 
two ISO molecules. The other half of the asymmetric unit is similar to the half presented in 
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Figure 6.49 but with some changes in torsion angle of the phenyl rings. The OXA and ISO 
molecules are held together by a strong to moderate strength intermolecular hydrogen bond 
with a bond length of 2.628(3) Å and bond angle slightly offset from linearity, of 176(2)° for 
O11-H∙∙∙N8, with the corresponding hydrogen-to-hydrogen donor length (H∙∙∙N8) bond length 
of 1.59(3) Å (Figure 6.49). 
Other hydrogen bonds are present in this complex asymmetric unit, including dimers of ISO 
(amide dimer 𝑅2
2(8) homosynthon) between the amide nitrogen and the oxygen on the carbonyl 
group (O12-H∙∙∙N10 and N9-H∙∙O13). This interaction happens twice for each of the 
functionalities on the adjacent molecules and is observed within the chains of molecules. 
Intermolecular hydrogen bonds are also present between the chains formed from the carbonyl 
oxygen on the carboxylic acid functionality of OXA with the amide nitrogen of ISO.  
 
Figure 6.49 – Half of the asymmetric unit of the novel co-crystal structure of OXA-ISO. 
Beyond the asymmetric unit, the extended structure is connected through π-π stacking. The 
packing diagram (Figure 6.50) features many molecules, each with slightly shifted orientations 
of the phenyl rings in a wave like arrangement. This twisting of the phenyl groups explains the 





Figure 6.50 – The packing diagram of the novel co-crystal structure OXA-ISO, viewed down the 
crystallographic b-axis. 
6.5.1.1 IR Spectroscopy of OXA-ISO 
The IR spectrum of OXA-ISO compared to the constituent starting components of OXA and 
ISO shows a decrease in the N-H stretching frequency of ISO on co-crystal formation. One of 
the C=O stretching frequencies of OXA-ISO is intermediate with respect to the two starting 
components (Table 6.10 and Figure 6.51), while the other is very similar to the C=O stretching 
frequency of OXA.   
Table 6.10 – Comparison of IR stretching frequencies of key functional groups in OXA-ISO compared to the 
constituent OXA and ISO starting materials. 
Vibration Frequency (cm⁻¹) OXA ISO OXA-ISO 
N-H stretch - 3362 3337 
(O11-H∙∙∙N8) 






Figure 6.51 – FTIR spectra of OXA-ISO compared to the constituent OXA and ISO starting materials. 
Comparing the predicted PXRD pattern of the OXA-ISO co-crystal (using Mercury Version 
4.2.0), with the pure starting components obtained from the CSD and simulated in Mercury, a 
new co-crystalline material has been identified (Figure 6.52). Differentiating between co-
crystal formation of OXA-ISO and re-crystallising the OXA API is challenging in this case as 
there are few discernible differences between the PXRD patterns of the two materials. An 
additional challenge in fingerprinting the PXRD patterns against the starting material and co-
crystal is that the temperature of collection of the co-crystal is 150 K, whilst the various 
crystallisations will be analysed by PXRD at room temperature. Therefore, the slight shift in 
peaks, for instance the pair of diffraction peaks at 10° 2θ for OXA and OXA-ISO, could be 
shifted because of a different crystalline product or because of temperature effects. The OXA-
ISO single crystal selected for SCXRD is not fully representative of the bulk sample of 


















Figure 6.52 – PXRD patterns comparing OXA-ISO predicted pattern simulated in Mercury and OXA_ISO 1:1 
evaporated from ACE, with the PXRD patterns of the pure starting materials obtained from Mercury (Refcodes: 
OJURAO (OXA), EHOWIH01-05 (ISO I-V respectively)). 
6.5.2 Mechanochemical Crystallisations of OXA-ISO 
Once co-crystal formation for the OXA-ISO co-crystal had been achieved through evaporation 
and confirmed through SCXRD, PXRD and DSC analytical techniques, this system was 
translated into grinding approaches. The OXA_ISO 1:1 sample prepared via NG and LAG 
across each of the solvents yields the same diffraction patterns, which can be identified as 
mainly OXA starting material, but with some additional representative OXA-ISO peaks 
aligning at 26° and 27° 2θ (Figure 6.53).  Similar to the DSC traces from the evaporative 
crystallisations of OXA-ISO, the DSC traces for these mechanochemical crystallisations also 
feature a single endotherm at 120 °C, confirming co-crystal formation from thermal analysis 
(Figure 6.54).  

























Figure 6.53 – PXRD patterns of the OXA-ISO 1:1 molecular complex prepared via mechanochemical 
crystallisation both NG and LAG in three different solvents, compared to the PXRD pattern of OXA_ISO 1:1 
crystallised from evaporation of ACE, as well as OXA (Refcode OJURAO) and OXA-ISO predicted patterns 
simulated in Mercury. 
 
Figure 6.54 – DSC heat profile for the molecular complex of OXA-ISO 1:1 prepared via 
mechanochemical crystallisation using both NG and LAG in ACE, EtOH and IPA solvent systems, 
compared to the DSC trace of OXA_ISO 1:1 crystallised from evaporation of ACE, as well as the DSC 
traces of OXA and ISO starting materials. 











































Importantly, the discrepancy between PXRD and DSC analysis in addition to the data obtained 
from OXA-ISO crystallised via evaporative methods is also evident from these 
mechanochemical crystallisations. It can be postulated that a large proportion of the bulk 
sample is the OXA-ISO co-crystal, however the sample is not solely comprised of crystalline 
material, so co-crystal formation is not as prominent in the PXRD analysis as in the DSC 
analysis, where this thermal analysis has the ability to analyse amorphous material.  
This indicates that mechanochemical crystallisation for 5 minutes of OXA and ISO 1:1 does 
not achieve the co-crystal in 100 % yield, evident from PXRD but not DSC analysis. An 
increase in grinding time could lead to complete conversion to the co-crystal, or a change in 
stoichiometric ratio of the starting components could mitigate the excess starting material 
observed. 
6.5.3 Slurrying Crystallisations of OXA-ISO 
Investigations into whether the OXA-ISO co-crystal could be accessed using small-scale slurry 
techniques were conducted using the same three solvents (ACE, EtOH, IPA) as those 
investigated in evaporative and mechanochemical techniques used to access the co-crystal 
previously. The slurries were prepared using a 1:1 molar ratio of OXA (400 mg) and ISO in 
2 mL of solvent, left stirring at 250 rpm on a hot-plate with DrySyn attachment set to 30 ℃ for 
one week. After this stirring period, the resultant product was isolated from the solvent using 
vacuum filtration and left to dry for 24 hours before being analysed via PXRD and DSC.  
The PXRD analysis shows OXA starting material is produced via slurrying methods (Figure 
6.55; but note that this conclusion is affected by the similarity of the OXA and OXA-ISO 
predicted PXRD patterns). In contrast, the DSC analysis on the same samples, showed 
consistency in endotherms across each of the solvent systems with a single melting event at 
123 ℃, which does not coincide with the melting event of OXA, which is expected at 160 ℃ 




Figure 6.55 – PXRD patterns of the OXA-ISO 1:1 molecular complex prepared via slurrying crystallisations for 
1 week in three different solvents systems compared to the PXRD pattern of the OXA-ISO predicted pattern 




Figure 6.56 – DSC heat profile for the molecular complex OXA-ISO 1:1 prepared via slurrying crystallisation 
for 1 week in three different solvent systems. 







































6.5.4 OXA-ISO crystallisations in 60:40 water:isopropanol (HI) 
The crystallisation of the OXA-ISO co-crystal was evaluated in 60:40 HI across the range of 
crystallisation methods already investigated. The PXRD data confirms OXA-ISO co-crystal 
formation via evaporative methods, although the co-crystal has not been accessed in purity, 
indicated by the presence of additional diffraction peaks. Mechanochemical methods produced 
OXA-ISO largely in purity while OXA_ISO slurry mediated in 60:40 HI produces OXA 
starting material (Figure 6.57). These observations were confirmed by DSC data (Figure 6.58). 
 
Figure 6.57 – PXRD patterns of the OXA-ISO 1:1 prepared in 60:40 HI via various crystallisation methods: 
evaporative, LAG, slurrying at 20 ℃ at 10 mL scale for a slurry time of 24 hours, compared to the PXRD 
pattern of the OXA-ISO predicted pattern simulated in Mercury and OXA (Refcode: OJURAO) starting 
material. 
 






















Figure 6.58 – DSC heat profiles of the OXA-ISO 1:1 molecular complex prepared in 60:40 HI via various 
crystallisation methods: evaporative at 30 ℃, LAG, slurrying at 20 ℃ at 10 mL scale for a slurry time of 24 
hours, compared to the DSC traces of pure OXA and pure ISO starting materials. 
6.5.4.1 Relative Thermal Stability Studies and Humidity Studies of OXA-ISO 
It is evident that the samples prepared by mechanochemical crystallisations compared to the 
solution-based preparations show marked differences in crystalline outcome, producing the 
OXA-ISO co-crystal and recrystallisation of the OXA starting material respectively. This 
highlights a distinct difference between solid and solution phase co-crystal preparation.  
Both thermal stability and humidity stability studies of the OXA-ISO co-crystal, carried out as 
outlined for ISO-IBU above, showed small but not significant changes in the diffraction peaks 
presented in the PXRD analysis. Similarly, thermal analysis using DSC did not show any 
significant changes to the phase adopted when investigating thermal ageing monitored over 
time.  
6.5.4.2 Solubility measurements of OXA ISO in 60:40 HI 
Solubility analysis to obtain a combined solubility of a physical mixture of OXA and ISO in a 
1:1 molar ratio was carried out by turbidity measurements at 1 mL scale using the Crystal16® 
platform at the University of Strathclyde (Figure 6.59). This solubility curve of OXA_ISO 1:1 




















in 60:40 HI will be used in the design of the cooling regime used to access the OXA-ISO co-
crystal by cooling at scale.  
 
Figure 6.59 – Solubility curve of OXA and ISO 1:1 physical mixture in 60:40 HI at 1 mL scale in Crystal16®. 
6.5.4.3 Cooling Crystallisations of OXA-ISO 
6.5.4.3.1 Batch via Polar Bear Plus from Cambridge Reactor Design (CRD) 
The OXA-ISO co-crystal was translated into cooling crystallisation, with the quantities of OXA 
and ISO initially based upon the solubility at room temperature of the physical mixture of 
OXA_ISO in 60:40 HI at 1 mL scale in the Crystal16®. A concentration range was selected to 
ascertain how concentration choice influences OXA-ISO co-crystal formation. The OXA_ISO 
1:1 in 1 mL 60:40 HI samples were heated to 70 ℃, followed by a 1 hour dwell time, to ensure 
complete dissolution before cooling to 5 ℃ at a cooling rate of 0.05 ℃ min-1. Attempts to 
crystallise OXA-ISO co-crystal by cooling in 60:40 HI produced OXA starting material, 
confirmed by both PXRD and DSC. 
6.5.4.3.2 Solubility by Visual Observation of OXA in ACE 
Investigations into accessing the OXA-ISO co-crystal via a solvent swap from 60:40 HI led to 










































Figure 6.60 – Solubility of OXA in ACE via visual observation, three repeats Obs 1, 2, 3 with an exponential 
trend curve to fit the median data. 
The concentration of OXA in OXA_ISO 1:1 physical mixture was based upon the solubility of 
OXA at 40 ℃. However, initial attempts did not crystallise enough material for both PXRD 
and DSC analysis, so the concentration range was increased from approximately 0.06 g/mL to 
0.08 g/mL of OXA in a 1:1 molar ratio with ISO in ACE. A cooling regime was adopted 
whereby the samples were heated to 45 ℃, followed by a 1 hour dwell time, to ensure complete 
dissolution before cooling to 5 ℃ at a cooling rate of 0.05 ℃ min-1, followed by a further 1 
hour dwell time. 
The PXRD data (Figure 6.61) again show a potential mixture of OXA and OXA-ISO co-crystal 
across the concentration range examined, while as before the DSC data shows the OXA-ISO 
co-crystal is formed in purity, with no OXA melting event present (Figure 6.62). The initial 
melting endotherm is consistent with the DSC traces presented for the OXA-ISO co-crystal 
prepared by evaporative, mechanochemical and slurrying crystallisations in Sections 6.5.1-
































Figure 6.61 – Cooling crystallisations of OXA_ISO 1:1 in ACE at 1 mL scale over a concentration range for 
samples 1, 2 and 3 performed in the CRD Polar Bear Plus crystalliser. 
 
Figure 6.62 – DSC heat profiles of OXA_ISO 1:1 in ACE at 1 mL scale over a concentration range for samples 
1, 2 and 3 performed in the CRD Polar Bear Plus crystalliser versus starting material DSC traces of OXA and 
ISO. 







































The OXA-ISO co-crystal has successfully been accessed by slow (0.05 ℃ min-1) 1 mL batch 
cooling across a concentration range and thus has the potential to be scaled-up. Cooling 
crystallisations at increased scales were undertaken at an increased rate of 1 ℃ min-1 using a 
concentration of OXA of 0.08 g/mL in the physical mixture of OXA_ISO 1:1 in ACE. The 
PXRD and DSC data both confirm the formation of the OXA-ISO co-crystal up to 100 mL 
scale as shown in Figure 6.63 and 6.64 respectively. The PXRD data presented in Figure 6.63 
show co-crystal formation of OXA-ISO most clearly of all the crystallisation methods 
presented in the study of OXA-ISO.  
 
Figure 6.63 – Cooling crystallisation of OXA_ISO 1:1 in ACE scale-up with overhead stirring, with exception 
of 1 mL scale, which utilised magnetic bottom stirring. 
 























Figure 6.64 – DSC profiles of OXA_ISO 1:1 in ACE scale-up with overhead stirring, with exception of 1 mL 
scale, which utilised magnetic bottom stirring compared to the starting material DSC traces of OXA and ISO. 
 
6.6 Oxaprozin Imidazole (OXA-IMID) 
Preliminary work for the discovery of the OXA-IMID system was performed by A. Alam 
(MChem 2018) under the direction of the author, including the VT-SCXRD measurements, 
which were supported by Dr. Lauren Hatcher. 
6.6.1 Evaporative Crystallisations of OXA-IMID 
The PXRD patterns for OXA (20 mg) and IMID in a 1:1 molar ratio dissolved in approximately 
1 mL of EtOH, IPA and ACE solvent systems, evaporated at 30 °C, confirm that each of these 
attempted co-crystallisations yielded a new potential co-crystal via evaporative methods, when 
compared to the PXRD patterns of the starting materials. The evidence of co-crystal formation 
is especially prominent from peaks around 15° 2θ, where these peaks are not present in any of 
the starting material PXRD patterns (Figure 6.65). Excess OXA is evident in the sample 
evaporated from IPA, from the representative OXA peak at 10° 2θ. 






















Figure 6.65 – PXRD patterns of the OXA-IMID 1:1 molecular complex prepared via evaporative crystallisation 
in three different solvents each at 30 °C, compared to the PXRD patterns of the constituent starting materials 
(Refcodes: OJURAO (OXA) and IMAZOL01 (IMID)). 
The same samples analysed via PXRD, were also analysed by DSC using a ramp rate of 
10 ℃ min-1, the results of which show an endotherm similar to the melting event of IMID for 
each of the evaporative samples (Figure 6.66); the DSC traces do, however, show multiple 
endothermic events around 90 °C for each of these attempted co-crystallisations. Due to the 
excess OXA in the IPA evaporated sample and the melting events in the DSC traces similar to 
the melting event of IMID, the stoichiometric ratio of the OXA and IMID starting materials 
requires further investigation and optimisation.  
 






















Figure 6.66 – DSC heat profiles for the molecular complex OXA-IMID 1:1 prepared via evaporative 
crystallisations at 30 °C in ACE, EtOH and IPA solvent systems. 
Structural determination of OXA-IMID 
Initial attempts to produce single crystals of suitable quality for single crystal structural analysis 
via evaporative methods at 30 ℃ were unsuccessful. Instead, the use of an anti-solvent was 
used to promote crystallisation. The use of EtOH with butanol acting as the anti-solvent 
promoted crystallisation from solution.  
20 mg of OXA and 4.6 mg of IMID in a 1:1 ratio were dissolved in 2 mL of an ethanol:butanol 
50:50 solvent mixture and the solvent allowed to evaporate at 4 ℃, produced single crystals of 
suitable quality for analysis (Figure 6.67). Due to the markedly different crystal morphologies 
resulting from the anti-solvent evaporative crystallisations prepared under the same 
experimental conditions, the samples from three repeats were subjected to a Single Crystal X-
ray Diffraction (SCXRD) pre-screening experiment and were confirmed to all have the same 
novel unit cell parameters.  A suitable single crystal was subjected to SCXRD analysis to 
determine the full 3D crystal structure of the novel co-crystal; the crystal data for OXA-IMID 
are summarised in Table 6.11. 





















Figure 6.67 – Single crystals with varying crystal morphologies formed from repeat samples of OXA_IMID 1:1 
in an ethanol:butanol 50:50 (v/v) solvent mixture: yellow blocks (left) clear plates (middle) and yellow lathes 
(right). 
Table 6.11 – Crystal data and structure refinement parameters for OXA-IMID. 
Empirical formula C21H19N3O3 
(C18H15NO3· C3H4N2·H2O) 
Formula weight 361.39 
Temperature /K 150.00(10) 
Crystal system Monoclinic 
Space group P21/n 
a /Å 15.7924(10) 
b /Å 6.7945(4) 
c /Å 18.6655(12) 
α /° 90 
β /° 110.461(8) 
γ /° 90 
Volume /Å3 1876.5(2) 
Z 4 
ρcalc /g cm-3 1.279 
μ/mm-1 0.087 
F(000) 760.0 
Crystal dimensions /μm3 200 × 40 × 20 
Radiation MoKα (λ = 0.71073) 
2θ range for data collection /° 6.434 to 52.744 
Index ranges -19 ≤ h ≤ 15, -6 ≤ k ≤ 8, -18 ≤ l ≤ 23 
Reflections collected 7604 
Independent reflections 3832 [Rint = 0.0232, Rsigma = 0.0377] 
Data/restraints/parameters 3832/0/260 
Goodness-of-fit on F2 1.044 
Final R indexes [I>=2σ (I)] R1 = 0.0469, wR2 = 0.1144 
Final R indexes [all data] R1 = 0.0621, wR2 = 0.1261 
Largest diff. peak/hole / e Å-3 0.61/-0.51 
 
The OXA-IMID 1:1 solvate crystallises in the monoclinic space group P21/n, with one 
molecule of OXA, one molecule of IMID and one molecule of water (solvent) in the 
asymmetric unit (Figure 6.68). In the asymmetric unit, OXA and IMID are bonded through a 
288 
 
hydrogen bonding intermolecular interaction between the N-H from IMID with the carbonyl 
oxygen on the carboxylic acid moiety of OXA, with an N2-H…O1 bond length of 2.577(2) Å. 
The other N-H bond in IMID (N3-H) produces an intermolecular hydrogen bond with the 
oxygen atom on the water molecule, with an N3-H…O4 bond length of 2.692(2) Å. The water 
acts as a linking molecule between adjacent OXA-IMID units. These two intermolecular N-
H…O bonding interactions from the IMID molecule positioned in the middle of the other two 
molecules in the asymmetric unit are highlighted by blue dotted lines in Figure 6.68. Beyond 
the asymmetric unit, the packing diagram (Figure 6.69) as observed down the crystallographic 
b-axis is dominated by hydrogen bonding interactions forming a chain-like network of 
molecules, with no obvious π–π stacking observed.   
 




Figure 6.69 – The crystal packing of the OXA-IMID solvate molecular complex as viewed down the 
crystallographic b-axis. 
The structure of IMID contains a single N-H group, allowing IMID to exist in two equivalent 
tautomeric forms, with the hydrogen bound to either of the imidazole nitrogen atoms. The 
asymmetric unit of OXA-IMID solvate contains hydrogen atoms on both of the pyrrole 
nitrogen atoms, indicating that hydrogen transfer has occurred from the oxygen, O1, of the OH 
group of the carboxylic acid of OXA to N2 on IMID upon co-crystal formation. This results in 
carboxylate anion formation on OXA and as a result of this ionic transfer, the OXA-IMID 
solvate system is strictly a salt.   
However, inspection of the N2-H and O1-H distances in this hydrogen bonding interaction 
suggest that the hydrogen is shared between both functionalities, rather than exhibiting formal 
bonding to N2. This is supported by an N2-H bond length of 1.04(2) Å, which is longer than 
expected for an N-H bond and lies above the upper parameter for a strong, mostly covalent 
hydrogen bond (see Table 1.1). The hydrogen bonding interaction between OXA and IMID, 
represented by N2-H∙∙∙O1 has a bond distance of 2.575(1) Å. 
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Proton migration involves the gradual shift in position of a hydrogen atom across a hydrogen 
bond. Proton migration is a tuneable affect, which can be induced by external influences such 
as through the application of temperature.175, 176 The use of Variable Temperature (VT) Single 
Crystal X-ray Diffraction (SCXRD) analysis can elucidate whether the hydrogen transferred 
from the alcohol functionality on the carboxylic acid of OXA to IMID, can transition back 
towards the carboxylate. This potential to restore the neutrality of the component materials 
through the application of temperature would subsequently result in the system classified as a 
co-crystalline solvate rather than a solvated salt and may show potential as a material with 
electronic properties.  
6.6.1.1 Variable Temperature (VT) Single Crystal X-ray Diffraction (SCXRD) analysis 
of OXA-IMID  
Analysis of the N2-H, O1-H and N2-O1 distances were conducted as a function of temperature 
by VT-SCXRD collected at 20 K intervals, with the temperature of collection ranging from 
160-340 K. By reviewing these distances (Table 6.12), the positioning of the hydrogen atom 
and subsequently the nature of its interaction with both the N-heterocyclic and carboxylate 
functionality on IMID and OXA respectively was investigated.  
Table 6.12 – Variation in N2-H, O1-H and O1-N2 bond distances in the OXA-IMID molecular complex 
through the application of temperature. 
Temperature /K N2-H distance /Å O1-H distance /Å O1-N2 distance /Å 
340 1.21(3) 1.36(3) 2.565(3) 
320 1.13(2) 1.44(2) 2.570(3) 
300 1.14(2) 1.43(2) 2.564(2) 
280 1.12(2) 1.45(2) 2.565(2) 
260 1.11(2) 1.46(2) 2.568(2) 
240 1.11(2) 1.46(2) 2.570(2) 
220 1.07(2) 1.51(2) 2.571(2) 
200 1.09(2) 1.48(2) 2.570(2) 
180 1.10(1) 1.47(1) 2.571(2) 
160 1.06(2) 1.51(2) 2.573(1) 




With increasing temperature, there is an increase in the N2-H bond distance (Figure 6.70) and 
corresponding decrease in the O1-H bond distance (Figure 6.71). As these bond distances 
converge with an increase in temperature, this provides evidence of the hydrogen atom 
migrating significantly towards the carboxylate oxygen on OXA, positioning itself more 
centrally between the two molecules of OXA and IMID.  
 
Figure 6.70 – Variation in N2-H bond distance with temperature for OXA-IMID molecular complex. 
 





















Variation in N2-H bond distance with temperature for Oxaprozin Imidazole 































Variation in O1-H intermolecular bond distance with temperature for Oxaprozin 
Imidazole molecular complex with water
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This increased sharing of the hydrogen atom between the OXA and IMID molecules with 
temperature is further supported by the overall distance between the heterocyclic nitrogen and 
the carboxylate oxygen, which is seen to decrease marginally with increasing temperature 
(Figure 6.72). This contrasts to the expected trend of an increase in bond distance with 
temperature, resulting from unit cell expansion, which would result in molecular separation of 
the OXA and IMID components increasing.  
 
Figure 6.72 – Variation in O1-N2 intermolecular bond distance with temperature for OXA-IMID molecular 
complex. 
The most significant shift in hydrogen position between N2 and O1 was observed from 320-
340 K. The final temperature for data collection was 340 K, as data collection attempts at 360 K 
were unsuccessful as the single crystal became dull and a loss of extinction under the polariser 
on the microscope was observed. This structural change observed at 360 K can be attributed to 
loss of water from the solvate structure, indicating that the presence of water is integral to the 
crystal structure. Hot-stage Microscopy (HSM) was used to observe the solvent evolution from 


































Variation in O1-N2 intermolecular bond distance with temperature for Oxaprozin 




Figure 6.73 – HSM images of OXA-IMID solvate at different temperatures, with solvent emerging at 86 ℃. 
Further investigation into desolvation of the OXA-IMID and molecular complex including 
relative stoichiometries of the components was carried out using TGA.  
6.6.1.2 Thermogravimetric Analysis (TGA) of OXA-IMID solvate 
The TGA trace for the OXA-IMID solvate sample produced from evaporative crystallisation 
of OXA_IMID 1:1 from EtOH at 30 ℃ shows a distinct mass loss of 4 % around 100 ℃, 
consistent with water being driven out of the crystal structure (Figure 6.74), which is in 
agreement with previous VT-SCXRD and HSM studies.  
 
























6.6.1.3 IR Spectroscopy of OXA-IMID 
Multi-component solvate formation is further confirmed by IR spectroscopy, in which the 
carbonyl stretching frequency was shifted to a significantly lower wavelength compared to free 
OXA from 1719 cm-1 to 1648 cm-1 (Appendix 6.6 and Table 6.13) due to its increased single 
bond behaviour, which can be rationalised using resonance structures (Figure 6.75).  
Table 6.13 – Comparison of IR stretching frequencies of key functional groups in OXA-IMID compared to the 
OXA target. 
Vibration Frequency (cm⁻¹) OXA OXA-IMID 
N-H stretch - 3438 (N2-H∙∙∙O1) 
C=O stretch 1719 1648 (C1=O1) 
 
Figure 6.75 – Resonance structures arising from the hydrogen bond donation from the hydrogen on the OXA 
carboxylic acid group (donor) to the IMID (acceptor). 
The predicted powder pattern from the solved single crystal structure of the OXA-IMID novel 
solvate is clearly shown by PXRD to match that observed experimentally, and to be distinct 




Figure 6.76 – PXRD patterns comparing OXA-IMID predicted pattern simulated in Mercury, with OXA-IMID 
crystallised from evaporation of ACE, as well as the PXRD patterns of the pure starting materials obtained from 
Mercury (Refcodes: OJURAO (OXA) and IMAZOL01 (IMID)). 
6.6.2 Mechanochemical Crystallisations of OXA-IMID 
Once co-crystal formation for the OXA-IMID co-crystal had been achieved through 
evaporation and confirmed through SCXRD, PXRD, DSC and TGA analytical techniques; this 
system was translated into grinding approaches. The OXA_IMID 1:1 sample prepared via NG 
and LAG across each of the solvents yields the same diffraction patterns, which can be 
identified as the OXA-IMID solvate (Appendix 6.7). The DSC traces also confirm co-crystal 
formation via mechanochemical crystallisations (Appendix 6.7), where samples exhibit the 
same thermal behaviour as OXA-IMID solvate samples prepared by evaporation. However, the 
NG method has not facilitated access to the OXA-IMID solvate in purity as is observed for the 
LAG approaches, evident from PXRD and DSC analysis. 
6.6.3 Slurrying Crystallisations of OXA-IMID 
Investigations into whether the OXA-IMID co-crystal could be accessed using small-scale 
slurry techniques were conducted using the same three solvents (ACE, EtOH, IPA) as those 
investigated in evaporative and mechanochemical techniques used to access the co-crystal 
previously. The slurries were prepared using a 1:1 molar ratio of OXA (400 mg) and IMID in 




















2 mL of solvent, left stirring at 250 rpm on a hot-plate with DrySyn attachment set to 30 ℃ for 
one week. After this stirring period, the resultant product was isolated from the solvent using 
vacuum filtration and left to dry for 24 hours before being analysed via PXRD and DSC.  
The PXRD analysis carried out after slurrying a physical mixture of OXA and IMID in various 
solvents for 1 week showed that in addition to evaporative and mechanochemical preparations, 
slurrying can also be used to access the OXA-IMID solvate in purity (Figure 6.77). The DSC 
analysis on the same samples (Figure 6.78), showed endotherms consistent with OXA-IMID 
formation across solvent systems. The DSC traces of the slurrying crystallisations feature the 
same additional endotherm as was observed in the NG, at 58 ℃, which cannot be attributed to 
OXA, IMID or the solvents utilised in the slurrying. This feature was not able to be investigated 
further in this work.  
 
Figure 6.77 – PXRD patterns of the OXA-IMID molecular complex prepared via slurrying crystallisations for 1 
week in three different solvents systems compared to the predicted PXRD pattern of the OXA-IMID solvate 
simulated in Mercury. 





















Figure 6.78 – DSC heat profiles for the molecular complex OXA-IMID prepared via slurrying crystallisation 
for 1 week in ACE, EtOH, IPA solvents. 
6.6.4 OXA-IMID crystallisations in 60:40 H2O:IPA (HI) 
The crystallisation of the OXA-IMID co-crystal was evaluated in 60:40 HI across the range of 
crystallisation methods already investigated, to elucidate the potential for this system to be 
crystallised via cooling at scale. The PXRD patterns of OXA_IMID 1:1 prepared in 60:40 HI 
via slurrying and evaporative methods yield OXA-IMID in purity, whilst LAG in this solvent 
mixture yields OXA (Appendix 6.8). DSC traces for products from the various methods were 
inconsistent and not able to be interpreted in terms of the PXRD findings (Appendix 6.8). 
6.6.4.1 Relative Thermal Stability Studies of OXA-IMID 
The thermal stability of the OXA-IMID co-crystal prepared by LAG in 60:40 HI using a mortar 
and pestle for 30 minutes monitored over a month is presented in Figure 6.79, showing that the 
OXA-IMID co-crystal is resistant to thermal ageing at 45 ℃ for up to two weeks, by which 
time additional peaks emerge. Interestingly by day 21 the sample has reverted back to the pure 
co-crystal once more, however by four weeks of oven ageing the co-crystal has dissociated into 
OXA starting material with an unassigned peak at 3° 2θ also emerging. These findings show 
discrepancy with the thermal DSC analysis, where DSC traces at t=0 and day 21 both contain 




















the same endothermic events, notably a melting event at 55 ℃, whilst day 7, 14 and 28 look 
largely similar. Interestingly there is no OXA melting event evident in the one month DSC 
trace (Figure 6.80), which contrasts with the diffraction data that yields OXA starting material.  
In light of these contradictory indications, it can be postulated that the thermal ageing of OXA-
IMID is affected by the tendency of OXA-IMID to ‘oil out’ during sample preparation via 
grinding.  
 
Figure 6.79 – OXA-IMID prepared in 60:40 HI via LAG for 30 minutes – Thermal studies at 45 ℃ monitored 
over 28 days. 
























Figure 6.80 – DSC heat profiles for OXA-IMID prepared in 60:40 HI via LAG for 30 minutes – Thermal 
studies at 45 ℃ monitored over 28 days. All samples were heated to 200 ℃, with no thermal events evident 
above 160 ℃ for any of the samples. 
6.6.4.2 Relative Humidity Stability studies of OXA-IMID 
OXA-IMID prepared by LAG subjected to both 46 % and 80 % RH conditions, show resistance 
to humidity ageing under both moderate and severe humidity conditions, as observed from no 
discernible differences in the PXRD patterns over the various time points (Appendix 6.9), with 
only some peak broadening observed over time.  
6.6.4.3 Cooling Crystallisations of OXA-IMID 
6.6.4.3.1 Batch via Polar Bear Plus from Cambridge Reactor Design (CRD) 
Attempts to ascertain the solubility behaviour of OXA_IMID 1:1 physical mixture in 60:40 HI 
were unsuccessful due to the substantial aqueous solubility of the solvate structure; the 
concentration requirements were extremely high at >0.8 g/mL OXA in OXA_IMID 1:1 in 
60:40 HI. Initial batch cooling crystallisations aimed at accessing the OXA-IMID multi-
component material used the solubility behaviour of OXA in ACE (Figure 6.60 in section 
6.5.4.3.2) as a start point in designing the cooling crystallisations. 






















A concentration range 0.08 g/mL (sample 1), 0.085 g/mL (sample 2) and 0.09 g/mL (sample 
3) of OXA in OXA_IMID 1:1 in ACE was selected to ascertain how overall concentration 
might influence OXA-IMID co-crystal formation. The OXA_IMID 1:1 in 1 mL ACE samples 
were heated to 45 ℃, followed by a 1 hour dwell time, to ensure complete dissolution before 
cooling to 5 ℃ at a cooling rate of 0.05 ℃ min-1, followed by a further 1 hour dwell time. The 
OXA-IMID co-crystal was produced across each of the concentrations, confirmed by both 
PXRD and DSC (Appendix 6.10). Further attempts to scale-up the cooling crystallisation 
process of OXA-IMID were not pursued as the concentration requirements were substantial.  
6.7 Discussion and Conclusions of Crystal Engineering for Materials 
Discovery in the Profen Family 
This Chapter has investigated the use of crystal engineering for materials discovery of the 
profen family, exploring whether co-crystal formation could be an alternative approach to the 
improvement of physicochemical properties of the profen targets, most notably with respect to 
the BCS class II solubility classification.  
This work reports the discovery of three co-crystals accessed by a range of crystallisation 
methods: ibuprofen-isonicotinamide (IBU-ISO), oxaprozin-isonicotinamide (OXA-ISO) and 
oxaprozin-imidazole (OXA-IMID) solvate. IBU-ISO was reported simultaneously by Walsh et 
al. as a model system to investigate spray drying versus hot-melt extrusion.170 Each of the 
profen co-crystals have been fully structurally characterised and the transferability of 
crystallisation methods and possible physical property enhancement on these systems 
investigated. Solid-state stability testing was investigated through thermal stability tests to 
ascertain the co-crystal shelf-life compared to the pure API, as well as humidity stability tests 
to establish whether the co-crystals demonstrate resistance to moderate and severe humidity 
conditions.  
IBU-ISO 
The IBU-ISO co-crystal can be accessed by evaporative, mechanochemical, slurrying in a 
range of solvents, as well as via cooling crystallisation in 60:40 HI up to 200 mL scale. 
Investigations into the translation of this system into continuous cooling co-crystallisation were 
less successful as a result of the ‘oiling out’ behaviour established during the extensive 
solubility testing by a range of methods including turbidity and visual observation. The use of 
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in-line particle visualisation in the Crystalline® platform capturing dissolution, crystallisation 
and ‘oiling out’ events during repeated heat cool cycles in the turbidity measurements, proved 
invaluable in gaining an improved understanding of the unusual behaviour of this co-crystal 
system. The IBU-ISO co-crystal exhibits an improved solubility in 60:40 HI compared to the 
IBU target. The IBU-ISO co-crystal also features an improved thermal stability compared to 
IBU, from DSC analysis which quantified the melting events to be 123 ℃ and 78 ℃ 
respectively. The IBU-ISO co-crystal showed robustness to thermal ageing. Slurry stability 
testing of pre-prepared co-crystal of IBU-ISO found that IBU-ISO undergoes partial 
dissociation to IBU from 2 hours of slurrying at both room and body temperature, which is an 
acceptable result on the premise of drug delivery in the gut.   
OXA-ISO 
The OXA-ISO co-crystal features very large unit cell dimensions for a small-molecule organic, 
due to the slight positional disorder of the phenyl rings in the structure. The OXA-ISO co-
crystal can be accessed by evaporative, mechanochemical and slurrying in a range of solvents 
and while cooling crystallisation of OXA_ISO 1:1 in 60:40 HI yielded OXA, a solvent swap 
from 60:40 HI  to ACE led to the production of the co-crystal, which was scaled to 100 mL. 
Similar to IBU-ISO, an increase in grinding time could lead to complete conversion to the 
OXA-ISO co-crystal via mechanochemical methods, or a change in stoichiometric ratio of the 
starting components could mitigate the excess starting material observed. The OXA-ISO co-
crystal exhibits a reduced thermal stability compared to OXA, as confirmed by DSC melting 
events of 124 ℃ and 163 ℃ respectively. The OXA-ISO co-crystal showed robustness to 
thermal ageing, but showed sensitivity towards humidity ageing. 
The analysis of OXA-ISO co-crystallisation via the range of crystallisation methods was 
particularly challenging, partly because of the similarity in the PXRD patterns of the OXA-
ISO co-crystal and OXA target. The PXRD data for the OXA-ISO co-crystal accessed via 
cooling crystallisation in ACE at scale with the use of overhead stirring yielded the most 
successful pattern matching to the OXA-ISO predicted pattern of all the crystallisation methods 
investigated.  
To elucidate the diffraction behaviour of the OXA-ISO system, the use of Rietveld structural 
refinement would facilitate the refinement of the lattice parameters, as well as providing a 
correlation between the particle size and the peak parameters. This structural refinement 
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analysis would be particularly beneficial applied to the thermal ageing diffraction data, which 
showed some interesting behaviour over time. In addition, as both the structure of OXA and 
the OXA-ISO co-crystal are known, for samples where a mixture of OXA and OXA-ISO are 
present, multiple phase refinement could be carried out, whereby the relative quantities of the 
various components present in the bulk sample can be quantified, which is useful for co-crystal 
purity optimisation.  
OXA-IMID 
OXA-IMID solvate is a hydrate as confirmed by TGA analysis, in which water is driven out of 
the structure around 100 ℃, which is confirmed and visualised by HSM. The use of VT-
SCXRD helped to understand the hydrogen bonding within the structure and the temperature 
induced proton migration behaviour of the OXA-IMID salt. The proton migration with 
temperature found in this complex establishes a salt-co-crystal continuum that offers an 
opportunity for property tuning;  the OXA-IMID co-crystal is a dynamic solid-state material, 
which may exhibit temperature induced switchable properties.177 IR spectroscopy also helped 
confirm this finding by comparing the N-H stretching frequencies between the OXA-IMID and 
the OXA starting component. The thermal behaviour of OXA-IMID is similar to IMID, but 
shows reduced thermal stability compared to the OXA API target, as confirmed by DSC. The 
OXA-IMID DSC trace is complex and can vary with crystallisation method employed for 
preparation of this novel material, which is particularly interesting when the PXRD data 
indicate the multi-component material consistently in purity. OXA-IMID is also not resistant 
to thermal ageing, but exhibits resistivity to humidity ageing.  
Due to the low boiling point of ACE, translation of both OXA-ISO and OXA-IMID into 
continuous cooling co-crystallisation in the KRAIC / KRAIC-D platforms was not pursued, 
nor were cooling crystallisations above 100 mL scale. As OXA-IMID has demonstrated 
hydrogen transfer capabilities with temperature, this salt-like behaviour explains why the 
concentration requirements of OXA-IMID were much greater than OXA-ISO due to the greater 
solubility in aqueous environments. Cooling crystallisations of OXA-IMID were thus not 
investigated above 1 mL scale in batch.  
Interestingly, the profen family co-crystals with the ISO co-former (IBU-ISO and OXA-ISO), 
exhibit identical thermal stability, as confirmed by their DSC endotherm melting events 
between 120-124 ℃. This physical property similarity between the profen family targets co-
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crystallised with ISO reflects very similar intermolecular interactions, which directly impacts 
the melting points of these materials.  The IBU-ISO and OXA-ISO co-crystals crystallise in 
the P1̅ and P21/c space groups respectively. The strong to moderate intermolecular O-H∙∙∙N 
hydrogen bonding interaction has a similar corresponding hydrogen bond length of 2.608(5) Å 
and 2.628(3) Å for IBU-ISO and OXA-ISO respectively. The bond angle for this O-H∙∙∙N 
hydrogen bond is also similar at 166.2° and 176(2)° for IBU-ISO and OXA-ISO respectively. 
The hydrogen-to-hydrogen donor length (H∙∙∙N) varies slightly at 1.804 Å and 1.591(3) Å for 
IBU-ISO and OXA-ISO respectively. 
Structural Comparisons 
Comparing the hydrogen bonding behaviour of the IBU-ISO co-crystal, with the previously 
reported SODDIZ178 structure, in which the IBU target is co-crystallised with the structural 
isomer of ISO, Nicotinamide (NICO), showed some structural differences, as well as 
similarities. IBU-NICO (SODDIZ) crystallises in the non-centrosymmetric space group Pca21, 
whilst IBU-ISO is crystallised in the centrosymmetric space group P1̅. The single crystal 
structure of IBU-NICO features a long cell axis of 56.5 Å, which is an uncommon feature for 
small organic molecules; the OXA-ISO system studied in the present work also possesses a 
large unit cell, in that case due to slight variations of phenyl group geometries in neighbouring 
molecules.  
The packing observed in both the IBU-ISO and IBU-NICO crystal structures are dominated by 
the attachment of IBU to the ISO / NICO co-former molecule through a simple O-H∙∙∙N 
hydrogen bond, rather than through a carboxylic acid-pyridine synthon, as well as a 
dimerisation interaction of the co-former molecule. Similar to the ISO dimers formed through 
a [R22(8)] homosynthon in IBU-ISO, dimers of NICO molecules formed through a [R
2
2(8)] 
homosynthon are present in the IBU-NICO crystal structure. The strong to moderate 
intermolecular O-H∙∙∙N hydrogen bonding interaction has a similar corresponding hydrogen 
bond length of 2.608(5) Å and 2.658(11) Å for IBU-ISO and IBU-NICO respectively. The 
bond angle for this O-H∙∙∙N hydrogen bond is also similar at 166.2° and 165.2° for IBU-ISO 
and IBU-NICO respectively. The hydrogen-to-hydrogen donor length (H∙∙∙N) is also similar at 
1.804 Å and 1.835 Å for IBU-ISO and IBU-NICO respectively.178  
Similar to the improved solubility of IBU-ISO relative to the pure IBU target, the use of NICO 
in the IBU-NICO co-crystal also improves the solubility of IBU. In addition, both IBU-ISO 
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and IBU-NICO exhibit improved thermal stability compared to pure IBU, where the melting 
of IBU occurs at 78 ℃, whilst for IBU-ISO and IBU-NICO the melting events of these co-
crystals occurs at 120 ℃ and 89.5 ℃ respectively.178 The notable difference in melting point 
of the IBU-ISO and IBU-NICO structures implies that hydrogen bonding is more extensive in 
the IBU-ISO structure, than the IBU-NICO structure.  
Comparing the OXA-ISO with the previously reported OXA co-crystals OJUQOB166 and 
OJUQAN166, in which the OXA target is co-crystallised with 4,4-bipyridine (BP) and 1,2-bis(4-
pyridyl)ethane (BPE) respectively, showed structural differences. OXA-BP 1:0.5 (OJUQOB) 
crystallises in the monoclinic C2/c space group with one molecule of OXA and half a molecule 
of BP present in the asymmetric unit. OXA-BPE 1:0.5 (OJUQAN) crystallises in the triclinic 
P1̅ space group with one molecule of OXA and half a molecule of BPE present in the 
asymmetric unit.166  The OXA-ISO 1:1 co-crystal reported in the present work crystallises in 
the monoclinic space group P21/c, with six molecules of OXA and six molecules of ISO in the 
asymmetric unit corresponding with a high Z’ value of 6.  
Similar to OXA-ISO, the OXA-BP and OXA-BPE co-crystals exhibit reduced thermal 
stability, with 124 ℃, 148.5 ℃ and 134.5 ℃ melting temperatures respectively, in comparison 
to the melting event of the OXA target at 160 ℃.  
Comparing the OXA-IMID salt with the previously reported molecular salts of OXA with 
piperazine (PIP), 2-amino-3-picoline (2A3P) and salbutamol (SAL), showed some distinct 
differences in structural, solubility and thermal behaviour. OXA-PIP 1:1 crystallises in the 
triclinic P1̅ space group with one molecule of OXA– and half a molecule of PIP–H+ in the 
asymmetric unit. Proton transfer from the carboxyl of the OXA to the N of the PIP was shown. 
OXA-SAL 1:1 crystallises in the triclinic P1̅ space group with one molecule of OXA– and one 
molecule of SAL–H+ present in the asymmetric unit. The presence of multiple hydrogen bond 
donors and acceptors sites on SAL–H+ results in a four component supramolecular unit 
recurring throughout the crystal structure.166  The OXA-IMID 1:1 solvate reported in the 
present work crystallises in the monoclinic space group P21/n, with one molecule of OXA, one 
molecule of IMID and one molecule of water (solvent) in the asymmetric unit. 
In both the OXA-PIP and OXA-SAL salts, all the potential hydrogen bonding sites are involved 
in strong ionic and neutral hydrogen bonds, with no free hydrogen donor or acceptor site with 
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which water may interact. This contrasts with OXA-IMID, in which water forms an 
intermolecular hydrogen bond with one of the nitrogen atoms in the ring of the IMID molecule.  
The thermal behaviour of OXA-IMID was shown to be complex, whilst the melting events of 
the OXA-PIP, OXA-2A3P and OXA-SAL molecular salts exhibited much simpler thermal 
behaviour, comprising a single melting event at 204.8 ℃, 111.7 ℃ and 172.7 ℃ respectively.  
Interestingly, Aitipamula et al.166 reported the salts of OXA-PIP and OXA-SAL to exhibit 
reduced solubility compared to the OXA target, whereas, although not quantified, the OXA-
IMID salt is shown in the present work to exhibit significantly increased solubility in 60:40 HI 
compared to OXA in the same solvent system. Importantly, the equilibrium solubility 
measurements of OXA-PIP and OXA-SAL were quantified in a phosphate buffer, whilst OXA-
IMID was not considered in the same buffer solution; therefore, only relative comparisons in 
the same solvent systems can be made. For the OXA-PIP and OXA-SAL molecular salts, no 
correlation was found between the melting point of the salt and the solubility of the salt. Instead, 
the lower solubility of the salts was attributed to the more extensive hydrogen-bond 
arrangement and efficient packing of the molecular fragments in the crystal lattice compared 






Chapter 7 – In situ X-ray Diffraction (XRD) analysis for capturing 
Solution Mediated Phase Transformations (SMPTs) during 
slurrying crystallisations in capillaries at High Resolution Powder 
Diffraction Beamline, I11 – Ibuprofen-isonicotinamide (IBU-ISO) 
The research presented in Chapter 7 was supported by Pollyanna Payne and Dr. Lauren Hatcher 
during beamtime experiments at Beamline I11 at the Diamond Light Source.  
7.1 Introduction and Aims 
The overriding goal of the development of solid-state forms of pharmaceutical materials is to 
establish which solid form has the optimal characteristics for the intended use,21 which usually 
is the most thermodynamically stable polymorph.13 This is because the thermodynamic 
polymorph is the only form that does not tend to undergo spontaneous polymorphic 
transformation. On the other hand, a significant disadvantage of using the thermodynamic 
polymorph for a pharmaceutical application is that the most stable polymorph is the least 
soluble due to its high crystal packing density and hence potential issues with low 
bioavailability are possible. Control over polymorphism is paramount in overcoming problems 
associated with polymorphism in industrial-scale production.  
Systems that exhibit polymorphism in solution will undergo solution mediated phase 
transformations (SMPTs), dictated by Ostwald’s Law of Stages: first, the metastable phase will 
undergo dissolution; second, nucleation of the stable phase; third, growth of the stable phase 
will occur. This implies that a low-energy route to interconversion between polymorphic forms 
exists.53  This transformation from the metastable to stable polymorph is possible in solution as 
molecules possess a number of degrees of freedom in this phase. Therefore, molecules in 
solution have the opportunity to re-orientate and re-align themselves so that as the molecules 
crystallise the free energy of the system is minimised.  
These SMPTs can be investigated via solution-mediated crystallisation techniques, also known 
as slurrying. This method of crystallisation is a suspension technique allowing for the 
investigation of thermodynamically related polymorphs, solvates and multi-component 
crystalline systems. The SMPT is thermodynamically driven by the solubility difference 
between polymorphs or co-crystals.  
307 
 
Slurrying can produce preferred polymorphic outcomes, as well as different polymorphic 
outcomes, dependent on varying slurrying time, mixing and temperature conditions, amount of 
solid loading, as well as scale of operation8; in addition, the polymorphic transformation time 
can very much depend upon the nucleation behaviour of the stable polymorph.179  
These SMPTs can be monitored in situ via slurrying in capillaries on synchrotron beamlines, 
where many more crystallising phases, including transient phases, can be captured in the fast 
data collection times available during synchrotron studies.  
Chapter 6 reported a novel pharmaceutical co-crystal of ibuprofen and isonicotinamide (IBU-
ISO) accessed via a range of crystallisation methods including slurrying crystallisation. The 
IBU-ISO co-crystal exhibits an improved solubility in 60:40 water:isopropanol (HI) compared 
to the IBU target. Slurry stability testing of the pre-prepared co-crystal of IBU-ISO found that 
IBU-ISO undergoes partial dissociation to IBU from 2 hours of slurrying at both room and 
body temperature, which is an acceptable result on the premise of IBU drug delivery in the gut. 
Through consideration of the relative solubility curves of IBU and IBU-ISO in 60:40 HI, a 
SMPT from the more soluble IBU-ISO co-crystal to the IBU starting material would be 
expected as the SMPT is thermodynamically driven by the solubility difference between the 
single and multi-component systems. This indicates that IBU-ISO slurry mediated in 60:40 HI 
shows potential for undergoing SMPTs, which can be monitored via in situ characterisation at 
the high-resolution powder diffraction beamline I11.  
The IBU-ISO co-crystal exhibits an improved thermal stability compared to IBU, demonstrated 
from extensive DSC analysis presented in Chapter 6, which quantified the melting events to be 
123 ℃ and 78 ℃ respectively. The IBU-ISO co-crystal also showed robustness to thermal 
ageing via monitoring periodically over 1 month. The IBU-ISO co-crystal also indicates 
potential in undergoing SMPTs and solid state phase transformations, thus variable temperature 
powder X-ray diffraction (VT-PXRD) analysis is appropriate for this co-crystal material.  
7.2 Slurry preparation and capillary loading 
7.2.1 Preparation of Slurrying Crystallisations 
The slurries were prepared using a 1:1 and 1:2 molar ratio of IBU (1 g and 0.5 g respectively) 
and ISO in 5 mL of a 60:40 water:isopropanol (HI) solvent stock, left stirring at 300 rpm at 
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room temperature for 5 minutes to allow equilibration of the slurry. After this stirring period, 
the resultant product was transferred into the 1 mm borosilicate capillary using a glass pipette. 
7.2.2 Capillary Loading 
The samples were prepared by cutting a sealed end of a 1 mm borosilicate capillary to allow 
the slurry solution to be fed into the open-ended capillary using a glass pipette; the capillary 
was then sealed at both ends using wax, fed into a brass holder, sealed with superglue and 
secured into a brass holder stand, ready to be mounted onto the diffractometer for data 
collection (Figure 7.1). The capillary was mounted onto the capillary spinner on the 
diffractometer as swiftly as possible before data collection in order to capture the crystallisation 
process as early as possible in the experiment. The use of the capillary spinner positioned on 
the diffractometer provided gentle mixing of the slurry suspension, whilst the intensity of 
mixing provided by stirring inherent in batch slurrying experiments is notably more intense. 
Routine batch slurrying experiments are subsequently filtered and analysed offline by PXRD, 
without capturing insight into the crystallisation pathway of the slurrying crystallisation 
process.  
Weight percent (wt %) solid loading of a slurry within a capillary cannot be ascertained as the 
loading process is not guaranteed to maintain the same solid loading as the stock vial, due to 
separation of solid upon capillary preparation (slurries were stirred on a stirrer plate before 
capillaries were prepared).  Glass pipettes were used instead of the initially trialled syringe and 
needle to improve slurry homogeneity transferred into the borosilicate capillary.  
 
Figure 7.1 – Capillary containing slurry sample set-up. 
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7.3 Data Capture and Analysis Procedure 
7.3.1 Data Capture 
In situ XRD characterisation was performed at Diamond beamline I11, using an X-ray beam 
of 15 keV energy and 0.8265 Å wavelength with a position sensitive detector (PSD) based on 
Mythen, appropriate for this time-resolved work. The size of the X-ray beam used was 0.5 mm 
x 2.5 mm, to ensure compatibility with the 1 mm ID borosilicate capillaries. For Variable 
Temperature Powder X-ray Diffraction (VT-PXRD) measurements, a Cryostream Plus was 
employed to provide controlled heating to the sample in the range 293-408 K. 
7.3.2 Data Analysis Procedure 
Background diffraction was an important consideration as the sample, in addition to containing 
crystalline material, also comprised of a solvent mixture of water and isopropanol. As a result 
of the inherent background associated with solvents used within crystallisation experiments; 
the use of solvent background subtraction allows for patterns to be obtained containing only 
the scattering resulting from the crystalline material.  
Various strategies for removing the background experimentally, as well as via a mathematical 
approach were attempted. The experimental approach involved subtracting acquired patterns 
of an air filled 1 mm borosilicate capillary and a borosilicate capillary containing pure 60:40 
HI, from the diffraction obtained during the slurrying experiments. However, due to the slurry 
mediator comprising a solvent mixture containing water and isopropanol, this did not achieve 
suitable subtraction of the background, possibly due to inhomogeneity of the solvent mixture 
within the borosilicate capillary.  
Instead of achieving background subtraction experimentally, a mathematical approach to 
background subtraction was therefore carried out using the in-house Data Analysis WorkbeNch 
(DAWN) created at the Diamond Light Source.91 The raw data was loaded into the processing 
window and the background rolling ball baseline subtraction was set to a ball radius of 50 
pixels and applied to each of the files. A local background value is determined for every pixel 
by averaging over a very large ball around the pixel. This value is subtracted from the original 
image, removing large spatial variations of the background intensities. The radius is selected 
on the premise that it is at least the magnitude of the largest object that is not considered to be 
resulting from the background. The background-subtracted files were subsequently loaded into 
the Data Visualisation window and the data combined into an image using the concatenate tool, 
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which allows alterations to be made to the number of pixels, as well as the interval and range 
of scans presented.   
The resulting diffraction patterns were then compared with PXRD patterns of the anticipated 
crystalline materials simulated in Mercury from available structural information of IBU and 
the IBU-ISO co-crystal (Chapter 6), and also to experimental reference patterns measured from 
pure IBU and pure ISO, each slurry mediated in 60:40 HI loaded into a 1 mm borosilicate 
capillary.  
7.4 Solution Mediated Phase Transformation (SMPT) monitoring of IBU-
ISO  
7.4.1 Offline XRD analysis of slurrying crystallisation of IBU_ISO in 60:40 HI 
Ex situ PXRD measurements of IBU_ISO 1:1 slurry mediated in 60:40 HI over 24 hours at 
20 ℃ and 30 ℃ yielded IBU in polymorphic purity, whilst slurrying at 40 ℃ produced a 
mixture of IBU and the IBU-ISO co-crystal evident from the representative IBU-ISO peaks, 
particularly prominent at 10° 2θ (Figure 7.2). This indicates that the IBU-ISO co-crystal is 
favoured at higher slurrying temperatures and highlights the potential of in situ VT-PXRD 
analysis to study the slurrying crystallisation of IBU_ISO in 60:40 HI.  
To elucidate the solution-based phases of IBU_ISO physical mixture in solution, in situ 
measurements can capture early solution-based phases, which are missed in offline 
measurements. In situ measurements of a slurry suspension also allows for the relative stability 




Figure 7.2 – Offline PXRD patterns of a physical mixture of IBU_ISO 1:1 slurry mediated for 24 hours in 
60:40 HI at 20 ℃, 30 ℃ and 40 ℃ compared to IBU (Refcode: IBPRAC) and IBU-ISO predicted PXRD 
pattern simulated in Mercury. 
7.4.2 In situ XRD monitoring of early stage crystallisation: IBU_ISO in 60:40 HI 
In situ XRD monitoring of a physical mixture of IBU_ISO 1:1 in 60:40 HI was carried out 
continuously for 10 minutes to determine early stage phase changes in the crystallisation 
process. Data visualisation in DAWN was set to present PXRD patterns accumulated over each 
30 second period over the 10 minute data collection time (Figure 7.3). 
A diffraction peak at 6.5° 2θ corresponding to IBU disappears between 5 minutes 30 seconds 
and 6 minutes into the in situ XRD monitoring. Similarly, a diffraction peak present at 9.5° 2θ, 
representative of IBU-ISO emerges between 4 minutes 30 seconds and 5 minutes into the 
analysis of the slurrying crystallisation process. This in situ XRD analysis highlights that the 
IBU-ISO co-crystal is not formed in purity; the characteristic IBU diffraction peak at 3° 2θ is 
present throughout the 10 minute collection time.  






















Figure 7.3 – In situ PXRD characterisation of a physical mixture of IBU_ISO 1:1 in 60:40 HI loaded into a 
borosilicate slurry and monitored at room temperature over a 10 minute data collection time (t = 10:00) at I11, 
compared to the IBU in 60:40 HI experimental reference collected at I11 and the IBU-ISO predicted powder 
pattern simulated in Mercury. 
7.4.3 In situ VT-XRD monitoring of early stage crystallisation: IBU_ISO in 60:40 HI 
In situ VT-XRD monitoring of a physical mixture of IBU_ISO 1:1 in 60:40 HI was carried out 
at a heating / cooling rate of 0.8 ℃ min-1 with a PXRD pattern collected at every 5 ℃ change 
in temperature (Figure 7.4). The VT-PXRD measurements show three defined areas, where a 
mixture of IBU and the IBU-ISO co-crystal are evident on heating. Interestingly, between 
323 K and 328 K a phase transformation occurs to yield the pure IBU-ISO co-crystal. The 
disappearance of IBU evident form the PXRD pattern at 328 K does not correspond to the 
melting of pure IBU at 351 K. After the sample is heated to 328 K, the PXRD data indicate the 
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sample is now amorphous, as seen through the loss of the consistent baseline of the diffraction 
patterns and the absence of sharp diffraction peaks. This amorphous state could be attributed 
to dissolution of the crystalline sample and subsequent scattering from the 60:40 HI solvent 
mixture, as well as possible ‘oiling out’ seen previously in Chapter 6 for the IBU-ISO system. 
Upon cooling, the pure IBU-ISO co-crystal re-crystallises at 313 K and no further phase 
changes are evident over the temperature range 313-293 K.   
Visual observations using a camera alongside the in situ XRD measurements would be a useful 
approach to provide insight to the state of the slurry within the capillary at the temperature at 
which the diffraction data is showing an amorphous state is present. It is difficult to make 
comparisons between this in situ XRD data and the temperature of ‘oiling out’ monitored via 
in situ turbidity measurements coupled with in situ image acquisition measurements using 
particle visualisation measurements (PVM) in the Crystalline®, as presented in Chapter 6. In 
addition, the metastable zone width (MSZW) of a 5 mL vial in the Crystalline® will be largely 
different to that in a 1 mm borosilicate capillary, which also experience largely different mixing 
conditions.180-183  
Ni et al. showed that the improved mixing and heat transfer conditions accessible in the 
continuous oscillatory baffled crystalliser (COBC) resulted in a narrow MSZW compared to 
traditional stirred tank crystallisers employed for the unseeded cooling crystallisation of L-
glutamic acid.181, 182 On this basis, the more efficient mixing achievable in the 5 mL vials in 
the Crystalline® with agitation provided by magnetic bottom stirring in comparison to the less 
homogeneous mixing accessible for the slurries of high solid content loaded in the 1 mm 
capillaries, would suggest that the MSZW for the 5 mL vials will be smaller than in the 1 mm 
borosilicate capillaries. Importantly, for the VT-XRD measurements of the slurrying 
crystallisation process, the slurry did not dissolve before cooling, whilst for the VT studies in 
the Crystalline®, it was ensured that complete dissolution was achieved before the cooling cycle 
had begun; thus, the method of crystallisation is also a significant differentiating factor during 





Figure 7.4 – In situ VT-PXRD measurements collected in capillary mode at I11 of a physical mixture of 
IBU_ISO 1:1 slurry mediated in 60:40 HI. The 313 K and 318 K patterns overlap in this plot as DAWN uses a 
set stacking for the diffraction patterns and the 318 K amorphous pattern with a higher background overlaps that 
at 313 K. 
7.4.4 In situ VT-XRD monitoring of IBU-ISO  
In situ VT-XRD monitoring of a pre-prepared co-crystal of IBU-ISO was analysed neat using 
a heating rate of 0.8 ℃ min-1 with a PXRD pattern collected at every 5 ℃ change in temperature 
(Figure 7.5). Diffraction peaks corresponding with IBU (at 3° and 9° 2θ) are seen to disappear 
after 338 K; this temperature could coincide with the melting event of IBU expected at 351 K, 
which would show a depression in melting temperature as the sample is impure with the 
majority of the crystalline sample containing the IBU-ISO co-crystal. Furthermore, this 
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disappearance of certain diffraction peaks after 338 K coincides with the dissolution observed 
by 333 K for the in situ VT-XRD monitoring of a physical mixture of IBU_ISO 1:1 in 60:40 
HI shown above in Section 7.4.3. The approximate 5 K discrepancy in the disappearance of 
diffraction peaks could be attributed to the 60:40 HI solvent environment experienced by the 
IBU_ISO 1:1 physical mixture, whilst the pre-prepared IBU-ISO co-crystal was monitored dry 
without the presence of solvent in the capillary. This difference could lead to changes in the 
moisture content in the atmosphere within the capillary, which is facilitating this SMPT. 
The IBU-ISO co-crystal is present throughout the PXRD monitoring between temperatures of 
293 K to 388 K, and is observed to melt at 393 K (120 ℃). The melting event from VT-PXRD 
analysis is consistent with the melting event of 123 ℃ observed in the DSC data presented in 
Chapter 6. 
 
Figure 7.5 – VT-PXRD measurements collected in capillary mode at I11 of the pre-made IBU-ISO co-crystal 




7.5 Conclusions of IBU-ISO in situ XRD characterisation 
Chapter 7 investigated the use of in situ XRD as a monitoring approach to analyse SMPTs 
occurring during slurrying crystallisation of the pharmaceutical co-crystal IBU-ISO in 60:40 
HI. The findings are in agreement with those presented in Chapter 6. The IBU-ISO co-crystal 
is shown to exhibit thermal stability to 388 K, before melting at 393 K  (consistent with the 
melting temperature of IBU-ISO at 120 ℃ reported in Chapter 6) evident from the VT-PXRD 
measurements of a neat sample loaded into a borosilicate capillary. IBU-ISO is shown to re-
crystallise on cooling in a solution of 60:40 HI, evident from VT-PXRD measurements at a 
temperature of 40 ℃. The in situ XRD measurements captured over a 10 minute collection 
period showed the formation of the IBU-ISO co-crystal in 60:40 HI via slurry crystallisation.  
7.6 Overall discussion and conclusions  
Chapter 7 presented diffraction data from in situ XRD analysis of slurries loaded into 
borosilicate capillaries. The pharmaceutical co-crystal of IBU-ISO was used during method 
development, in which the data demonstrates that scattering from crystalline material 
suspended in a solvent can be achieved, as well as phase changes monitored via in situ XRD 
measurements at beamline I11 at Diamond Light Source. This work provides an improved 
insight into the various transient solution phases found in solution-based crystallisations, which 
can be overlooked during traditional solid-state analysis and highlights the potential of this 
technique for capturing transient phases and polymorphic transformations observed in the 





Chapter 8 – Conclusions and Future Work 
8.1 Conclusions 
The work presented in this research project has demonstrated the potential of in situ 
synchrotron X-ray diffraction techniques to reveal information on the crystallisation pathway 
adopted by the crystallisation process. The development of capabilities for in situ diffraction 
of flow processes at Diamond Light Source, through use of segmented flow crystallisers known 
as the KRAIC-D (Kinetically Regulated Automated Input Crystalliser – for Diffraction) and 
KRAIC-S (Kinetically Regulated Automated Input Crystalliser – Single Crystal) have been 
presented. The design of these continuous platforms were developed and optimised for 
implementation on the Diamond beamlines I11 (High Resolution Powder Diffraction) and I19 
(Small Molecule Single Crystal Diffraction). 
As a result of the steady-state operation of the KRAIC-D and KRAIC-S platforms, an analytical 
set point will be at the same stage of the crystallisation process irrespective of the experiment 
time, which allows events that evolve with the crystallisation time, such as polymorphic 
transformations and crystal growth to be investigated. 
Polymorphic transitions and stability during cooling crystallisation processes in an industrially 
relevant crystalliser, known as the KRAIC-D, were uncovered through in situ synchrotron 
powder X-ray diffraction (PXRD) analysis. Using the KRAIC-D installed at I11, the 
crystallisation pathways of the highly polymorphic pharmaceutical compounds  carbamazepine 
(CBZ) in EtOH and urea-barbituric acid (UBA) in MeOH were monitored with respect to 
polymorphic form and crystal growth during unassisted crystallisation and also in response to 
various seeding regimes. Using both unseeded and seeded (pre- and post-nucleation) cooling 
crystallisation methodologies, the evolving crystal structures of CBZ in EtOH and UBA in 
MeOH were uncovered as a function of residence time by probing different set positions 
comprising Kapton® windows along the length of this milliscale tubular flow crystalliser, 
KRAIC-D.  
The CBZ in EtOH experiments confirmed the established CBZ form II to CBZ form III 
nucleation and growth pathway, whilst also demonstrating the sensitivity of this pathway to 
seeding. The nucleation of CBZ form II could be bypassed completely or existent CBZ form 
II crystallites could undergo rapid transformation to CBZ form III depending on the location 
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of the CBZ form III seeding, corresponding with pre-nucleation and post-nucleation seeding 
respectively. Through analysis of a single 100 ms diffraction frame from the KRAIC-D, 
sufficient data is available for polymorph identification from flowing droplets. Furthermore, 
through this segmented flow cooling crystallisation technique, an unusual CBZ form III needle 
morphology can be accessed and when combined with CBZ form III blocks in a single solution 
slug, can lead to morphology separation via segmentation as a result of the interaction of the 
different habit with the flow path in the solution slug.  
Monitoring UBA in MeOH in the KRAIC-D at I11, helped to determine solution state versus 
solid state stability of this pharmaceutical co-crystal. During solution-based cooling 
crystallisation and slurrying, UBA form III readily transforms to UBA form I in both unassisted 
and UBA form III seeded experiments. In contrast, dry crystals of UBA form I undergo solid 
state transformation to UBA form III under ambient laboratory storage for 12 months. These 
findings highlight the need for accurate knowledge of the media-dependent stability (in this 
case in MeOH versus air) of a pharmaceutical as integral to the design and process optimisation 
of the development of an effective pharmaceutical product.  
The use of in situ synchrotron single crystal analysis using the KRAIC-S installed at I19 has 
demonstrated both the implementation and optimisation of a unique method for collecting 
single crystal data of small organic molecule single crystals crystallised and monitored in situ. 
The development of a slug triggering mechanism facilitated the trigger of the motorised stage, 
which artificially suspended a single crystal in the X-ray beam for sufficient time to achieve 
indexation from a single diffraction frame. An optimised slug triggering design, whereby the 
optical trigger was positioned adjacent to the X-ray beam, whilst residing on the motorised 
stage greatly improved the crystal hit rate and reduced the time delay between data acquisitions.  
Paracetamol (PCM) in 60:40 water:isopropanol (HI) was a suitable model system to yield 
single crystals in solution slugs in the KRAIC-S, whereby this highly reproducible 
crystallisation environment was suitable for these serial-crystallography type experiments. 
Monitoring the unseeded cooling crystallisation process at two set points (6.7 m and 8.7 m), 
allowed the extent of lattice rotation with crystal growth to be established. The use of relative 
integrated intensities across hkl reflection sets at the two set points, compared to single crystals 
of known size was explored as an approach for crystal size prediction. Seeding the cooling 
crystallisation process of PCM in 60:40 HI with the metastable PCM form II highlighted the 
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need for seed delivery optimisation and compatibility of certain crystal habits for this in situ 
single crystal diffraction technique, as a result of the interaction of the single crystal with the 
flow path in the solution slug.  
Two data processing methodologies were employed to process the in situ single crystal 
diffraction data, whereby CrysAlisPro required manual handling, whilst DIALS has been 
employed for full automation. The significant advantage of employing DIALS is the fully 
automated data processing, which includes spot finding, indexation, refinement, integration 
and merging can be carried out in a few minutes. The significance of this means that data 
checks can be automatically triggered after a 4 second data collection and thus data capture and 
processing can be carried out for each single crystal in under 5 minutes, allowing experimental 
conditions to be altered during the beamtime if the data suggests this is necessary. On the 
premise that the merged datasets at 8.7 m and 6.7 m achieved a completeness of 2 % and 7 % 
respectively, it would be expected that structural solution could be achieved from 20-50 of 
these datasets to sample the entire sphere, although due to symmetry of the lattice, this number 
of datasets could be reduced, whilst still achieving structural solution.   
The use of crystal engineering for materials discovery of the profen family, exploring whether 
co-crystal formation could be an alternative approach to the improvement of physicochemical 
properties of the profen targets, most notably with respect to the BCS class II solubility 
classification, was investigated. The discovery of three co-crystals accessed by a range of 
crystallisation methods: ibuprofen-isonicotinamide (IBU-ISO), oxaprozin-isonicotinamide 
(OXA-ISO) and oxaprozin-imidazole (OXA-IMID) solvate was reported. Each of the profen 
co-crystals have been fully structurally characterised and the transferability of crystallisation 
methods and possible physical property enhancement on these systems investigated. Solid-state 
stability testing was investigated through thermal stability tests to ascertain the co-crystal shelf-
life compared to the pure API, as well as humidity stability tests to establish whether the co-
crystals demonstrate resistance to moderate and severe humidity conditions.  
The IBU-ISO co-crystal exhibits an improved solubility in 60:40 HI compared to the IBU 
target. The IBU-ISO co-crystal also features an improved thermal stability compared to IBU, 
from DSC analysis, which quantified the melting events to be 123 ℃ and 78 ℃ respectively. 
The IBU-ISO showed robustness to both thermal and humidity ageing. The IBU-ISO co-crystal 
can be accessed by evaporative, mechanochemical, slurrying in a range of solvents, as well as 
320 
 
via cooling crystallisation in 60:40 HI up to 200 mL. Investigations into the translation of this 
system into continuous cooling co-crystallisation were less successful as a result of the ‘oiling 
out’ behaviour, highlighting that the segmented flow employed in the KRAIC-D is not 
appropriate for every crystal system.  
The OXA-ISO co-crystal features very large unit cell dimensions for a small-molecule organic, 
due to the slight positional disorder of the phenyl rings in the structure. The OXA-ISO co-
crystal exhibits a reduced thermal stability compared to OXA, as confirmed by DSC melting 
event of 124 ℃ and 163 ℃ respectively. The OXA-ISO showed robustness to thermal ageing, 
but showed sensitivity towards humidity ageing. The diffraction analysis for the OXA-ISO co-
crystal system was particularly challenging attributed to the similarity in diffraction patterns 
for the OXA-ISO co-crystal and OXA target.  
The OXA-IMID solvate is a hydrate as confirmed by TGA analysis, in which water is driven 
out of the structure around 100 ℃, which is confirmed and visualised by HSM. The use of VT-
SCXRD helped to understand the hydrogen bonding within the structure and the temperature 
induced proton migration behaviour of the OXA-IMID salt. The proton migration with 
temperature found in this complex establishes a salt-co-crystal continuum that offers an 
opportunity for property tuning. 
The use of in situ synchrotron powder X-ray diffraction techniques have also been applied to 
batch slurrying crystallisations through a novel sample preparation technique, whereby pre-
prepared slurries were loaded into borosilicate capillaries and monitored at various time points 
at I11 have been explored. The model system employed for method development focused on 
the novel co-crystal system ibuprofen isonicotinamide (IBU-ISO) accessed by co-
crystallisation attempts to improve physicochemical properties. This in situ synchrotron 
powder X-ray diffraction technique has facilitated the collection of diffraction data obtained 
from crystalline material within the slurry contained in the capillary. The data capture approach 
highlighted that changes in crystalline phase can be observed for the various IBU-ISO 
experiments, over various time frames and temperature conditions. 
8.2 Future Work 
The work presented on PCM in 60:40 HI in the KRAIC-S in Chapter 5 demonstrates the 
potential of the novel technique in terms of data collection and the associated information 
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obtained from the data processing, and promises applications for other systems in the future. 
The serial-crystallography approach to data capture will be particularly valuable for the 
analysis of X-ray and photosensitive samples. The slug triggering mechanism presented in 
Chapter 5 for single crystal analysis can also be employed in future KRAIC-D experiments to 
optimise the data collection at I11. This avoids the collection of background frames of the air 
slugs and the carrier fluid, thus removing time-consuming post-data collection analysis and 
allowing quick interpretation of the data quality allowing alterations to the experimental set-up 
to be made promptly. 
To supplement the in situ synchrotron powder X-ray diffraction analysis of slurrying 
crystallisations in capillaries, a novel and bespoke milliscale tubular segmented flow 
crystalliser known as the KRAIC-T (Kinetically Regulated Automated Input Crystalliser – 
Temperature Cycling) has been designed and built to investigate slurrying in flow (Figure 8.1). 
The key difference in the design of the KRAIC-T compared to the KRAIC-D is the cylinders 
are made of aluminium, which allows the temperature of the two coils to be set at different 
temperatures to facilitate temperature cycling. During temperature cycling experiments, the 
two holding pillars will be set to disparate temperatures to reflect the different energetic minima 
of, for example, enantiotropic systems. The outlet from each pillar traverses directly through 
the X-ray transparent Kapton® windows to capture the alternating phases without risk of 
transformation prior to detection. Non-invasive time-resolved PXRD studies of slurrying 
concomitant systems and temperature cycled enantiotropic systems will facilitate the 
identification and understanding of the crystallisation pathways of crystallising systems that 
have a very close energy relationship between polymorphs. 
The capabilities established for the study of crystallisation processes in situ at Diamond Light 
Source can become a valuable tool for a wider user base, following their successful 
establishment, and demonstration of their capabilities in this work. The KRAIC-D concept is 
also now being transferred to a laboratory diffractometer set-up by the collaborative team, as 
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Chapter 10 – Appendix 
Chapter 4 Appendix (A4) 




Figure A4.1 – 870 nm peak absorbance versus time (5 ms increments) for 1 mL/min seed flow rate, with 1.6, 
1.8 or 2.0  mL/min solution flow rate, with a PP T-piece (used for optimal seeding configuration). N.B. orange 
vertical bars show location of detected local minima (left) and the corresponding slug analysis chart for each 
flow rate combination featuring solution troughs (blue) and slug distances (orange) (right). 
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Figure A4.2 – 870 nm peak absorbance versus time (5 ms increments) for 1 mL/min seed flow rate, with 2.5 or 
3.0 mL/min solution flow rate, or 2.0 mL/min seed flow rate and 2.5 mL/min solution flow rate, with a PP T-
piece (used for optimal seeding configuration). N.B. orange vertical bars show location of detected local minima 
(left) and the corresponding slug analysis chart for each flow rate combination featuring solution troughs (blue) 
and slug distances (orange) (right). 
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4.2 Seeding Inlet Development – UV-vis Data for Glass T-piece Configuration 
 
Figure A4.3 – 870 nm peak absorbance versus time (5 ms increments) for 1 mL/min seed flow rate, with 1.0, 
1.2 or 1.4 mL/min solution flow rate, with a glass T-piece (used for optimal seeding configuration). N.B. orange 
vertical bars show location of detected local minima (left) and the corresponding slug analysis chart for each 




Figure A4.4 – 870 nm peak absorbance versus time (5 ms increments) for 1 mL/min seed flow rate, with 1.6, 
1.8 or 2.0  mL/min solution flow rate, with a glass T-piece (used for optimal seeding configuration). N.B. 
orange vertical bars show location of detected local minima (left) and the corresponding slug analysis chart for 
each flow rate combination featuring solution troughs (blue) and slug distances (orange) (right). 
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Figure A4.5 – 870 nm peak absorbance versus time (5 ms increments) for 1 mL/min seed flow rate, with 2.5 or 
3.0 mL/min solution flow rate, or 2.0 mL/min seed flow rate and 2.5 mL/min solution flow rate, with a glass T-
piece (used for optimal seeding configuration). N.B. orange vertical bars show location of detected local minima 
(left) and the corresponding slug analysis chart for each flow rate combination featuring solution troughs (blue) 
and slug distances (orange) (right). 
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Table A4.1 – Images of segmentation corresponding with a range of flow rate combinations for the solution 
feed and seed addition using a glass T-piece. 
Segmentation Image 
Number 
Flow rate of solution feed 
mL/min 
Flow rate of seed 
mL/min 








9 2.0 2.0 
 
Figure A4.6 – Images of segmentation corresponding with a range of flow rate combinations for the solution 
feed and seed addition using a glass T-piece. 
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4.3 Seeding Inlet Development – UV-vis Data for PP Y-piece Configuration 
 
Figure A4.7 – 870 nm peak absorbance versus time (5 ms increments) for 1 mL/min seed flow rate, with 1.0, 
1.2 or 1.4 mL/min solution flow rate, with a PP Y-piece (used for optimal seeding configuration). N.B. orange 
vertical bars show location of detected local minima (left) and the corresponding slug analysis chart for each 




Figure A4.8 – 870 nm peak absorbance versus time (5 ms increments) for 1 mL/min seed flow rate, with 1.6, 
1.8 or 2.0 mL/min solution flow rate, with a PP Y-piece (used for optimal seeding configuration). N.B. orange 
vertical bars show location of detected local minima (left) and the corresponding slug analysis chart for each 
flow rate combination featuring solution troughs (blue) and slug distances (orange) (right). 
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Figure A4.9 – 870 nm peak absorbance versus time (5 ms increments) for 1 mL/min seed flow rate, with 2.5 or 
3.0 mL/min solution flow rate, or 2.0 mL/min seed flow rate and 2.5 mL/min solution flow rate, with a PP Y-
piece (used for optimal seeding configuration). N.B. orange vertical bars show location of detected local minima 
(left) and the corresponding slug analysis chart for each flow rate combination featuring solution troughs (blue) 
and slug distances (orange) (right). 
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Table A4.2 – Images of segmentation corresponding with a range of flow rate combinations for the solution 
feed and seed addition using a PP Y-piece. 
Segmentation Image 
Number 
Flow rate of solution feed 
mL/min 
Flow rate of seed 
mL/min 









Figure A4.10 – Images of segmentation corresponding with a range of flow rate combinations for the solution 




4.4 Absorbance data for each seed inlet geometry and flow rate ratio 
Table A4.3 –Absorbance data for PP Y-piece. 
PP Y-piece  
seed slurry 
(mL/min) 
1 1 1 1 1 1 1 1 2 
solution (mL/min) 1 1.2 1.4 1.6 1.8 2 2.5 3 2 





































std dev 0.060 0.030 0.080 0.054 0.070 0.074 0.074 0.081 0.106 
max dist (s) 2.204 1.656 2.653 1.650 1.745 1.501 1.502 1.341 1.247 
min dist 0.742 0.600 0.641 0.497 0.450 0.396 0.399 0.397 0.344 
av dist 1.253 1.166 1.284 0.992 0.892 0.891 0.830 0.717 0.722 
std dev 0.278 0.215 0.430 0.282 0.229 0.238 0.246 0.209 0.191 
 





1 1 1 1 1 1 1 1 2 























































std dev 0.015 0.013 0.012 0.013 0.013 0.104 0.108 0.091 0.095 
max dist (s) 2.097 2.154 2.150 2.007 1.793 1.607 1.446 1.348 1.247 
min dist 0.650 0.903 1.000 0.900 0.849 0.393 0.340 0.345 0.358 
av dist 1.455 1.487 1.420 1.339 1.220 0.911 0.797 0.732 0.795 
std dev 0.248 0.249 0.205 0.229 0.199 0.242 0.236 0.206 0.189 
 





1 1 1 1 1 1 1 1 2 
solution (mL/min) 1 1.2 1.4 1.6 1.8 2 2.5 3 2 
























































std dev 0.089 0.094 0.084 0.067 0.050 0.061 0.033 0.026 0.060 
max dist (s) 3.702 2.698 3.348 3.092 5.303 3.057 2.694 1.992 1.999 
min dist 0.655 0.596 0.608 0.600 0.705 0.649 0.645 0.755 0.602 
av dist 1.749 1.663 1.602 1.654 1.699 1.540 1.413 1.214 1.137 
std dev 0.611 0.555 0.554 0.550 0.667 0.440 0.375 0.239 0.321 
 
4.5 CBZ Seed Generation and Stability Testing 
 
 
Figure A4.11 – PXRD pattern of CBZ starting material compared to the pure polymorphs both anhydrous and 
























Figure A4.16 – PXRD patterns of varying concentrations of CBZ in EtOH at 500 rpm for 30 minutes slurrying 




Figure A4.17 – PXRD patterns of varying concentrations of CBZ in EtOH at 300 rpm for 30 minutes slurrying 





Figure A4.18 – PXRD patterns of varying concentrations of CBZ in EtOH at 300 rpm for 20 minutes slurrying 




Figure A4.19 – PXRD patterns of varying concentrations of CBZ in EtOH at 300 rpm for 10 minutes slurrying 
time at 20 ℃. 
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4.6 Integrated intensity values for growth plots for all crystallisation runs 
Table A4.6 – Integrated intensity values for growth plots for all crystallisation runs. 
Hit rate  Scan Number Background threshold 
(intensity) 
Polymorphic form 
NRP = Not right position 
Unseeded 66.6 g/kg CBZ in EtOH (CBZKDB1) 
 Diffraction poor 
NRP = 8 W1 (8)   
NRP = 4 W2 (8)   
3/5 W3 (5)   
 
Unseeded 71.9 g/kg CBZ in EtOH (CBZKDB2) 





in 5 sampling 
(2/5) 
W1 (30017) 25 (0.0617) CBZ form II 
W1 (30025) 25 (0.0439) CBZ form II or III 







W2 (30007) 25 (0.8219) CBZ form I or II 
W2 (30008) 20 (3.3936) CBZ form I, II, V 
W2 (30009) 20 (5.8870) CBZ form II 
W2 (30040) 25 (0.0283) CBZ form I, II 





W3 (30052) 25 (11.1291) CBZ form III (some 
additional) W3 (30053) 25 (13.0532) 
W3 (30054) 25 (17.1724) 
W3 (30055) 25 (3.5890) 
W3 (30060) 25 (5.6932) 
 




W1 (29757) 25 (97.8690) CBZ form III 
W1 (29758) 25 (3.4011) 
W1 (29760) 25 (76.1559) 
W1 (29765) 25 (257.3721) 




W2 (29795) 25 (120.1241) CBZ form III 
W2 (29799) 25 (418.6823) 
W2 (29800) 25 (246.9676) 
W2 (29803) 25 (77.0891)  
W2 0  
 






W3 (29769) 25(7.0249) 
W3 (29780) 25(48.3571) 
W3 (29794) 25(220.3667) 
W3 (29796) 0 
 
Seeded Post-nucleation CBZ form III (CBZKDB4) 
 W1 No data   
 
9 
1 SC (Shutter 
Closed) 
W2 (29967) 25 (0.2439) CBZ form III 
W2 (29968) 25 (1.6443) 
W2 (29970) 25 (0.1650) 
W2 (29955) 0 
W2 (29971) 0 




W3 (29920) 25 (86.4557) CBZ form III 
W3 (29921) 25 (238.8568) 
W3 (29930) 25 (122.9822) 
W3 (29931) 25 (310.2949) 
W3 (29953) 25 (169.5978) 
 
Unseeded UBA in MeOH (UBAKDB1) 
7 
2/7 
W1 (30425) 25 (0.6106) UBA form III 








W2 (30453) 25 (3.5770) UBA form III 
W2 (30454) 25 (4.3701) 
W2 (30470) 25 (3.1886) 
W2 (30477) 25 (9.6535) 





W3 (30485) 25 (48.2470) UBA form I, III 
W3 (30490) 25 (29.1441) 
W3 (30500) 0 
W3 (30501) 0 
W3 (30502) 173.0879 
 
UBA Pre-nucleation seeded form III (UBAKDB2) 
5 
5/5 
W1 (30264) 25 (3.7726) UBA form III 
W1 (30265) 25 (10.6449) 
W1 (30280) 25 (2.4514) 
W1 (30281) 25 (5.0458) 
W1 (30290) 25 (25640) 
  
5 W2 (30292) 25 (43.5318) UBA form III, some I 
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5/5 W2 (30300) 25 (33.6745) 
W2 (30301) 25 (72.5553) 
W2 (30318) 25 (29.4925) 
W2 (30291) 25 (62.5991) 
    
5 
5/5 
W3 (30319) 25 (59.0006) UBA form III, some I 
W3 (30320) 25 (49.7182) 
W3 (30330) 25 (64.8975) 
W3 (30345) 25 (164.4119) 
W3 (30346) 25 (220.3533) 
 









W2 (30237) 25 (0.1667) UBA form III 







W3 (30196) 20 (34.5925) UBA form I and III 
W3 (30197) 25 (33.0175) 
W3 (30210) 25 (2.6199) 
W3 (30211) 25 (4.5048) 
W3 (30223) 25 (90.4002) 
    
UBA Pre-nucleation seeded form I (UBAKDB4) 
5/5 W1 (30347) 20 (13.5733) UBA form I 
W1 (30348) 20 (8.8730) 
W1 (30356) 20 (6.7179) 
W1 (30357) 20 (15.4396) 
W1 (30358) 20 (13.2893) 
5/5 W2 (30380) 20 (182.0228) UBA form I 
W2 (30381) 20 (156.4067) 
W2 (30391) 20 (207.3885) 
W2 (30392) 20 (304.2517) 




4.7 UBA form III pre-nucleation seeded experiment UBAKDB2 showing combined data 
from 10 scans  
 
Figure A4.20 – UBA form III pre-nucleation seeded experiment UBAKDB2 showing combined data from 10 
scans across W1, W2 and W3 compared to the PXRD patterns of the pure polymorphs UBA form I and UBA 




























Chapter 5 Appendix (A5) 
5.1 Automated Data Processing Trials via Xia2 
Table A5.1 – Cytidine: the full 124° dataset was collected on a PILATUS 300K diffractometer and processed 
across a range of wedge sizes using Xia2. Attempts to index a 5° wedge of data via manual input of unit cell 
parameters failed.  
Parameter Wedge of data 
90° 20° 10° 
Unit cell finding Yes Yes Manual 
a /Å 5.1195(7) 5.1126(12) 5.1158(14) 
b /Å 13.9918(13) 14.001(19) 13.99(2) 
c /Å 14.8013(12) 14.785(3) 14.769(5) 
α /° 90.0 90.0 90.0 
β /° 90.0 90.0 90.0 
γ /° 90.0 90.0 90.0 
Number of spots 544 103 51 
Number of images 449 100 49 
 
Table A5.2 – PCM: the full 180° dataset was collected on a PILATUS 2M diffractometer and processed across 
a range of wedge sizes using Xia2. 
Parameter Wedge of data 
180° 90° 20° 
Unit cell finding Yes Yes Yes 
a /Å 7.10362(9) 7.10361(10) 7.10362(9) 
b /Å 9.38220(15) 9.3779(3) 9.38220(15) 
c /Å 11.7093(2) 11.7078(3) 11.7093(2) 
α /° 90.0 90.0 90.0 
β /° 97.4296(13) 97.4317(15) 97.4296(13) 
γ /° 90.0 90.0 90.0 
Parameter Wedge of data 
10° 5° 2° 1° 
Unit cell finding Manual Manual Manual Manual 
a /Å 7.0989(5) 7.0976(8) 7.0904(15) 7.12 
b /Å 9.3851(7) 9.3874(11) 9.398(3) 9.37 
c /Å 11.7074(9) 11.7111(14) 11.714(4) 11.71 
α /° 90.0 90,0 90.0 90.00 
β /° 97.434(6) 97.463(9) 97.486(17) 97.45 




5.2 Slug Triggering Testing  
5.2.1 Identifying constituent media in segmented flow on oscilloscope read-out 
Figure A5.1 – Image of segmented flow (left) versus oscilloscope read-out (right), flow rates of air and solution 
are 4.18 mL/min and 1.6 mL/min respectively. 
Figure A5.2 – Image of segmented flow (left) versus oscilloscope read-out (right), flow rates of air and solution 
are 12.5 mL/min and 6.4 mL/min respectively. 
5.2.2 In vitro Data Processing Optimisation 
For the top, middle and bottom measured segmentation patterns (Figure A5.3); the distance 
between adjacent slugs is 3.2 cm for each of the images, coupled with an adjacent peak 
separation of 1.5 seconds, equating to a slug translation speed of 21 mm/s. This translation rate 
is both too fast for the speed capabilities of the motorised stage and will not allow sufficient 
data to be collected for indexing of a single solution slug.  
To decrease the speed of the solution slugs, subsequent experiments were carried out as 
follows: 
The flow rates were decreased to air pump 4.18 mL/min, carrier fluid pump 2.1 mL/min and 
solution pump 1.6 mL/min. The distance between adjacent solution slugs increased to 4.2 cm, 
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but the time between adjacent solution slugs also increased to 2 seconds. Therefore, the speed 
of the solution slugs remains too fast at 21 mm/s; in addition, the size of the air slugs under 
these conditions was too large.  
The flow rates were decreased to air pump 2.1 mL/min, carrier fluid pump 2.1 mL/min and 
solution pump 1.6 mL/min. The distance between adjacent solution slugs decreased to 2.6 cm; 
with the time between adjacent solution slugs remaining at 2 seconds, the speed of the solution 
slugs is reduced to 13 mm/s, within the capabilities of both the speed of the motorised stage 
and the data collection. 
                                           
Figure A5.3 – Images of segmented flow for flow rates of air pump (4.18 mL/min), carrier fluid pump (2.1 
mL/min) and solution pump, water (3.2 mL/min). 
5.3 DIALS Commands 
5.3.1 DIALS Data Processing Trials 
dials.import /path/to/data/image_01_00001.cbf 
Command A5.1 – DIALS import. 
dials.find_spots imported.expt min_spot_size=1 d_max=15 sigma_strong=8 
Command A5.2 – DIALS spot finding. 
dials.index imported.expt strong.refl            
Command A5.3 – DIALS index. 
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5.3.2 Xia2 Data Processing Trials 
xia2 small_molecule=true image=/path/to/data/image_01_00001.cbf 
Command A5.4 – General Xia2 command. 
5.3.3 DIALS Data Analysis Procedure 
dials.import /path/to//image_01_00001.cbf reference_geometry=/path/to/instrument_model.expt 
distance=124.61 
Command A5.5 – DIALS single image import. 
dials.find_spots imported.expt spotfinder.filter.min_spot_size=1 spotfinder.filter.d_max=15 sigma_strong=5 
resolution_range=5.28,4.72 rectangle=0,612,824,858 circle=620,851,27  
Command A5.6 – DIALS spot finding. 
dials.index imported.expt strong.refl unit_cell=7.08,9.2,11.54,90,97.9,90 space_group=P21/n 
scan_varying=false refinement.parameterisation.beam.fix=all 
refinement.parameterisation.auto_reduction.action=fix 
Command A5.7 – DIALS indexing. 
dials.refine indexed.refl indexed.expt refinement.parameterisation.beam.fix=all 
refinement.parameterisation.auto_reduction.action=fix refinement.parameterisation.scan_varying=false 
refinement.parameterisation.detector.fix=all refinement.parameterisation.crystal.unit_cell.force_static=true 
Command A5.8 – DIALS refine. 
dials.import /path/to/raw/data/folder/ reference_geometry=/path/to/instrument_model.expt distance=124.61 
Command A5.9 – DIALS import all images. 
dials.find_spots imported.expt spotfinder.filter.min_spot_size=1 spotfinder.filter.d_max=15 sigma_strong=5 
resolution_range=6.232,5.1 rectangle=0,612,824,858 circle=620,851,27 
Command A5.10 – DIALS peak hunting after removal of resolution band from FEP and beamstop background. 
dials.index imported.expt strong.refl unit_cell=7.08,9.2,11.54,90,97.9,90 space_group=P2/m 
outlier.algorithm=null beam.fix=all detector.fix=all index_assignment.method=local local.epsilon=0.15 
Command A5.11 – DIALS local index assignment. 
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5.4 Lattice Rotations from Commissioning Time 
 
Figure A5.4 – R1 lattice rotation with respect to the instrument over time. 
 













































Figure A5.6 – R3 lattice rotation with respect to the instrument over time. 
 
5.5 Diode read-out for PCMKSB1 
 


























5.6 Unseeded PCM in 60:40 HI at 8.7 m (Beamtime) 
5.6.1 Unit cell parameters over time for each of the five datasets at 8.7 m  
 
Figure A5.8 – b-axis lattice parameter over time for each of the five datasets compared to the magnitude of the 
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Figure A5.9 – c-axis lattice parameter over time for each of the five datasets compared to the magnitude of the 
c-axis for PCM form I obtained from the CSD (PCMKSB3).
 
Figure A5.10 – Beta angle lattice parameter over time for each of the five datasets compared to the magnitude 
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Figure A5.11 – Unit cell volume over time for each of the five datasets compared to the magnitude of the unit 
cell volume for PCM form I obtained from the CSD (PCMKSB3). 
5.6.2 Lattice rotations over time for each of the five datasets at 8.7 m  
 























































Figure A5.13 – R2 lattice rotation with respect to the instrument over time. 
 

















































5.7 Unseeded PCM in 60:40 HI at 6.7 m (Beamtime) 
5.7.1 Unit cell parameters over time for each of the five datasets at 6.7 m  
Figure A5.15 – b-axis lattice parameter over time for each of the five datasets compared to the magnitude of the 
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Figure A5.16 – c-axis lattice parameter over time for each of the five datasets compared to the magnitude of the 
c-axis for PCM form I obtained from the CSD (PCMKSB6).
 
Figure A5.17 – Beta angle lattice parameter over time for each of the five datasets compared to the magnitude 
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Figure A5.18 – Unit cell volume lattice parameter over time for each of the five datasets compared to the 
magnitude of the unit cell volume for PCM form I obtained from the CSD (PCMKSB6). 
5.7.2 Lattice rotations over time for each of the five datasets at 6.7 m 
 



















































Figure A5.20 – R2 lattice rotation with respect to the instrument over time. 
 










































5.8 Details of Electronic Supplementary Information (ESI) – Videos of single crystals 
tracked in solution slugs 
Wayment, L., in press. Dataset for "Continuous flow for materials synthesis, assembly and 
crystallisation at Diamond: discovery and delivery of high value materials". Bath: University 
of Bath Research Data Archive. 
The videos associated with Chapter 5 include single crystals produced from the range of 
experiments investigated. Each video tracks a different single crystal in a solution slug; where 
through use of the slug triggering mechanism, whereby an optical trigger prompts translation 
of the motorised stage to artificially suspend the single crystal in the X-ray beam during data 
collection. These videos complement the diffraction data and can provide explanation for data 
collections, which do not achieve cell indexation as the single crystal is shown to move in and 
out of the X-ray beam in these videos. 
N.B videos are rotated by 180° and thus is observed as residing in the top of solution slug, 
when in fact the single crystals position themselves in the rear end of a solution slug at the 
bottom. 
Unseeded PCM Form I 
6.7 m 
 20190728_1517_0003_Unseeded PCM_6_7m_Set 1 Video 
 20190728_1521_0003_Unseeded PCM_6_7m_Set 2 Video 
 20190728_1521_0009_Unseeded PCM_6_7m_Set 3 Video 
 20190728_1559_0003_Unseeded PCM_6_7m_Set 4 Video 
 20190728_1614_0001_Unseeded PCM_6_7m_Set 5 Video 
8.7 m 
 Set 1 - No video to accompany diffraction data 
 Set 2 - No video to accompany diffraction data  
 20190726_1839_0014_Unseeded PCM_8_7m_Set 3 Video 
 20190726_1928_0010_Unseeded PCM_8_7m_Set 4_Video 
 20190726_2023_0043_Unseeded PCM_8_7m_Set 5_Video 





Seeded PCM Form II 
 20190727_2340_0004_Seeded PCM form II_Set 1_Get Form I_Video 
 20190727_2355_0010_Seeded PCM form II_Set 2_Get Form II_Video 
 20190728_0038_0007_Seeded PCM form II_Set 3_Get Form II_Video 
 20190728_0038_0008_Seeded PCM form II_Set 4_Get Form II_Video 
 20190727_1347_0050_Seeded PCM form II_Video with no accompanying diffraction 
data 
Chapter 6 Appendix (A6): 
6.1 Linear cooling profiles for cooling crystallisations 
 



























6.2 Thermal Behaviour of ISO Co-former 
 
Figure A6.2 – DSC trace of ISO via a slower 1 ℃ min-1 heating ramp to 200℃. 
 
6.3 Microscope Images of IBU-ISO 
 




6.4 Thermal stability studies of IBU-ISO monitored over one month 
 
Figure A6.4 – IBU-ISO 1:1 prepared in 60:40 HI via LAG for 30 minutes – Thermal studies at 45 ℃ monitored 
over 28 days. 























Figure A6.5 – DSC heat profiles for IBU-ISO 1:1 prepared in 60:40 HI via LAG for 30 minutes – Thermal 
studies at 45 ℃ monitored over 28 days. 
6.5 Thermal stability studies of IBU monitored over one month 
 
Figure A6.6 – IBU subjected to 60:40 HI LAG for 30 minutes – Thermal studies at 45 ℃ monitored over 28 days. 











































Figure A6.7 – DSC heat profiles for IBU prepared in 60:40 HI via LAG for 30 minutes – Thermal studies at 45 
℃ monitored over 28 days. 
6.6 IR Spectroscopy for the OXA-IMID multi-component material 
 
Figure A6.8 – FTIR spectra of OXA-IMID compared to the OXA target. 


































6.7 Mechanochemical Crystallisations of OXA-IMID 
Figure A6.9 – PXRD patterns of the OXA-IMID molecular complex prepared via mechanochemical 
crystallisation both NG and LAG in 3 different solvents, compared to the PXRD pattern of OXA_IMID 1:1 
crystallised from evaporation of ACE, as well as the OXA-IMID predicted pattern simulated in Mercury. 
Figure A6.10 – DSC heat profile for the molecular complex of OXA-IMID prepared via mechanochemical 
crystallisation using both NG and LAG in ACE, EtOH and IPA solvent systems compared to the DSC trace of 










































OXA_IMID 1:1 crystallised from evaporation of ACE at 30 ℃, as well as the DSC traces of OXA and IMID 
starting materials. 
6.8 OXA-IMID crystallisations in 60:40 H2O:IPA (HI) 
 
Figure A6.11 – PXRD patterns of the OXA-IMID  prepared in 60:40 HI via various crystallisation methods: 
evaporative, LAG, slurrying at 20 ℃ at 10 mL scale for a slurry time of 24 hours, compared to the PXRD 
pattern of the OXA-IMID predicted pattern simulated in in Mercury and OXA (Refcode: OJURAO) starting 
material. 
 






















Figure A6.12 – DSC profiles of the OXA-IMID 1:1 molecular complex prepared in 60:40 HI via various 
crystallisation methods: evaporative, LAG, slurrying at 20 ℃ at 10 mL scale for a slurry time of 24 hours, 
compared to the DSC trace of pure OXA and pure ISO starting materials. 
6.9 Relative Humidity Stability studies of OXA-IMID 
Figure A6.13 – OXA-IMID 1:1 prepared in 60:40 HI via LAG for 5 minutes – Humidity studies at 46 % RH 
monitored over 40 days. 











































Figure A6.14 – OXA-IMID 1:1 prepared in 60:40 HI via LAG for 5 minutes – Humidity studies at 80 % RH 
monitored over 40 days. 
6.10 Cooling Crystallisations of OXA-IMID 
Figure A6.15 – Cooling crystallisations of OXA_IMID 1:1 in ACE at 1 mL scale over a concentration range for 
samples 1, 2 and 3 performed in the CRD Polar Bear Plus crystalliser. 












































Figure A6.16 – DSC of OXA_IMID 1:1 in ACE at 1 mL scale over a concentration range for samples 1, 2 and 
3 performed in the CRD Polar Bear Plus crystalliser versus starting material traces of OXA and IMID. 
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